Seaweeds as a source of non-digestible complex polysaccharide components for the development of novel prebiotic ingredients for the functional food industry by Cherry, Paul
Seaweeds as a source of non-digestible 
complex polysaccharide components for the  
development of novel prebiotic ingredients for  
the functional food industry 
 
A thesis presented for the degree of 
Doctor of Philosophy  
in  
The Nutrition Innovation Centre for Food and Health (NICHE) 
School of Biomedical Sciences 
Faculty of Life & Health Sciences 
Ulster University 
 
Paul Cherry, BSc (Hons) Physiological Sciences  
July 2020 
I confirm that the word count of this thesis is less than 100,000 words
  i 
 
Contents 
Declaration   ................................................................................................................... viii 
Acknowledgements .............................................................................................................. x 
Abstract   ................................................................................................................... xiii 
List of Figures   .................................................................................................................... xv 
List of Tables   ................................................................................................................. xxix 
Note on access to contents ............................................................................................ xxxvi 
Statement of Collaboration........................................................................................... xxxvii 
1 General Introduction ..................................................................................... 2 
 Introduction ......................................................................................................... 2 
 The Human Gut Microbiota ................................................................................. 3 
 Dietary Fibre and Colonic Health ........................................................................ 4 
 Prebiotics ............................................................................................................. 6 
 Aims and objectives ............................................................................................. 8 
 References ........................................................................................................... 9 
2 Literature Review - Risks and Benefits of Consuming Edible Seaweeds ..... 17 
 Abstract ............................................................................................................. 17 
 Introduction ....................................................................................................... 17 
 Nutritional Composition .................................................................................... 20 
 Protein ................................................................................................................ 21 
 Dietary Fibre ....................................................................................................... 24 
 Fat  ...................................................................................................................... 30 
 Polyphenols ........................................................................................................ 33 
 Fucoxanthin ........................................................................................................ 36 
 Micronutrients ................................................................................................... 38 
 Vitamins ............................................................................................................. 39 
  ii 
 
 Salt ...................................................................................................................... 41 
 Iodine ................................................................................................................. 42 
 Heavy Metals ...................................................................................................... 46 
 Arsenic ................................................................................................................ 47 
 Whole seaweeds: Impact of habitual intake on health .................................... 52 
 Conclusion ......................................................................................................... 54 
 References ......................................................................................................... 56 
 Tables ................................................................................................................. 95 
3 Literature Review - Prebiotics from Seaweeds: An Ocean of 
Opportunity? .............................................................................................147 
 Abstract ...........................................................................................................147 
 Introduction .....................................................................................................148 
 Complex Polysaccharides ................................................................................150 
 Brown Seaweed Polysaccharides .....................................................................153 
 Red Seaweed Polysaccharides .........................................................................160 
 Green Seaweed Polysaccharides .....................................................................164 
 Future Prospective – Obtaining Oligosaccharides ...........................................165 
 Polyphenols .....................................................................................................166 
 Other Seaweed Phytochemicals ......................................................................170 
 Carotenoids ......................................................................................................170 
 Polyunsaturated Fatty Acids (PUFAs) ...............................................................172 
 Fermented foods .............................................................................................172 
 Seaweeds and Animal Health ..........................................................................174 
 Conclusions ......................................................................................................176 
 References .......................................................................................................177 
 Tables ...............................................................................................................209 
  iii 
 
4 Effects of the edible Irish brown seaweeds, Fucus vesiculosus and 
Laminaria digitata, on the composition and metabolic activity of the 
human gut microbiota using an in vitro model of the distal colon. ..........225 
 Abstract ...........................................................................................................225 
 Introduction .....................................................................................................226 
 Materials and Methods ...................................................................................228 
 Chemicals and reagents ...................................................................................228 
 Seaweed harvest ..............................................................................................228 
 Polysaccharide-rich extract production ...........................................................229 
 FVE and LDE characterisation ..........................................................................229 
 Mineral and trace element content of FVWS, LDWS, FVE and LDE .................230 
 In vitro digestion ..............................................................................................230 
 In vitro batch culture fermentation .................................................................231 
 DNA extraction .................................................................................................231 
 qPCR .................................................................................................................231 
 16S rRNA amplicon sequencing .......................................................................232 
 Bioinformatics ..................................................................................................233 
 Short chain fatty acid and branched chain fatty acid analysis .........................234 
 Statistical analysis ............................................................................................235 
 Results .............................................................................................................236 
 FVE and LDE characterisation ..........................................................................236 
 Mineral and trace element analysis .................................................................237 
 Batch culture fermentation ..............................................................................238 
 Discussion ........................................................................................................247 
 Conclusion .......................................................................................................255 
 References .......................................................................................................256 
 Figures .............................................................................................................271 
  iv 
 
 Tables ...............................................................................................................297 
5 Effects of the edible Irish red seaweed, Palmaria palmata, on the 
composition and metabolic activity of the human gut microbiota 
using an in vitro model of the distal colon ................................................311 
 Abstract ...........................................................................................................311 
 Introduction .....................................................................................................312 
 Materials and Methods ...................................................................................314 
 Chemicals and reagents ...................................................................................314 
 Seaweed harvest ..............................................................................................314 
 Polysaccharide-rich extract (PPE) production ..................................................315 
 PPE characterisation ........................................................................................315 
 Mineral and trace element content of PPWS and PPE ....................................316 
 In vitro digestion ..............................................................................................316 
 In vitro batch culture fermentation .................................................................316 
 Culture-dependent analysis .............................................................................317 
 DNA extraction .................................................................................................318 
 qPCR .................................................................................................................318 
 16S rRNA amplicon sequencing .......................................................................319 
 Bioinformatics ..................................................................................................320 
 Short chain fatty acid and branched chain fatty acid analysis .........................320 
 Statistical analysis ............................................................................................321 
 Results .............................................................................................................322 
 PPE characterisation ........................................................................................322 
 Mineral and trace element analysis .................................................................323 
 Batch culture fermentation ..............................................................................323 
 Discussion ........................................................................................................329 
 Conclusion .......................................................................................................336 
  v 
 
 References .......................................................................................................337 
 Figures .............................................................................................................351 
 Tables ...............................................................................................................367 
6 Effects of seaweed polysaccharides on the composition and 
metabolic activity of the human gut microbiota using an in vitro 
model of the distal colon ...........................................................................374 
 Abstract ...........................................................................................................374 
 Introduction .....................................................................................................375 
 Materials and Methods ...................................................................................376 
 Chemicals and Reagents ..................................................................................376 
 Seaweed Polysaccharides ................................................................................377 
 Polysaccharide Molecular Weight ...................................................................377 
 Polysaccharide in vitro Digestion .....................................................................377 
 Batch culture fermentation - preparation of human faecal inoculum and 
basal media ................................................................................................378 
 Batch culture fermentation ..............................................................................378 
 DNA extraction .................................................................................................379 
 qPCR .................................................................................................................379 
 16S rRNA amplification and MiSeq sequencing ...............................................380 
 Bioinformatics ..................................................................................................381 
 Short chain fatty acid and branched chain fatty acid analysis .........................381 
 Statistical Analysis ............................................................................................382 
 Results .............................................................................................................383 
 Seaweed polysaccharide molecular weight .....................................................383 
 qPCR .................................................................................................................384 
 16S rRNA Amplicon Sequencing: Effect of seaweed polysaccharides on 
the bacterial diversity of the faecal microbiota .........................................384 
  vi 
 
 16S rRNA Amplicon Sequencing: Effect of seaweed polysaccharides on 
the microbial abundance of the faecal microbiota ...................................385 
 Effect of seaweed polysaccharides on short chain fatty acid production .......388 
 Effect of seaweed polysaccharides on branched chain fatty acid 
production ..................................................................................................389 
 Discussion ........................................................................................................390 
 Conclusion .......................................................................................................398 
 References .......................................................................................................400 
 Figures .............................................................................................................413 
 Tables ...............................................................................................................430 
8 General Discussion ....................................................................................438 
 Conclusion .......................................................................................................446 
 References .......................................................................................................448 
9 Appendix  1 – Experimental Materials and Methods ................................455 
 Chemicals and reagents...................................................................................455 
 Seaweed fermentation substrates ..................................................................455 
 Seaweed harvest ..............................................................................................455 
 Polysaccharide-rich extract production ...........................................................455 
 Individual seaweed polysaccharides ................................................................456 
 Seaweed extract characterisation ...................................................................457 
 Mineral and trace metal content of whole seaweeds and seaweed extracts ...........459 
 In vitro digestion ..............................................................................................459 
 Batch culture fermentation experiments ........................................................461 
 Preparation of human faecal inoculums ..........................................................461 
 Preparation of basal media ..............................................................................461 
 in vitro batch culture fermentation: individual seaweed polysaccharides......462 
  vii 
 
 in vitro batch culture fermentation: whole seaweeds and seaweed 
extracts .......................................................................................................463 
 Culture-dependent analysis ............................................................................463 
 DNA extraction ................................................................................................464 
 Quantitative PCR .............................................................................................464 
 16S rRNA amplification and MiSeq sequencing ..............................................466 
 Bioinformatics and statistical analysis ............................................................469 
 Short chain fatty acid and branched chain fatty acid analysis ........................470 
 References .......................................................................................................473 
10 Appendix  2 – CPD Activities ......................................................................476 
 Conferences .....................................................................................................476 
 Voluntary .........................................................................................................476 
 
 
  
  viii 
 
Declaration 
I hereby declare that with effect from the date on which the thesis is deposited in 
the Research Office of the University of Ulster, I permit  
1. The librarian of the University to allow the thesis to be copied in whole or in 
part without reference to me on the understanding that such authority applies 
to the provision of single copies made for study purposes or for inclusion within 
the stock of another library. 
2. The thesis to be made available through the Ulster Institutional Repository 
and/or EThOS under the terms of the Ulster e Theses Deposit Agreement which 
I have signed. 
This thesis is the sole work of the author and has not been submitted for any 
previous application for a higher degree. 
 
Paul Cherry 
 
 
 
 
 
  ix 
 
 
          C            D       G            Em        
“You got to__ take good care of business, my 
friend 
C          D            G 
Take good care of yourself 
          C            D       G            Em 
You got to__take good care of business, my 
friend 
C                D             G 
Otherwise you'll end up on the shelf” 
 
 
Lindisfarne - Taking Care Of Business 
Written by Alan Hull 
Roll On. Ruby (1973) 
  
  x 
 
Acknowledgements 
Acknowledgements must go to the funders of my postgraduate studentship, the 
Department for Employment and Learning Northern Ireland, and to the 
Department of Agriculture Food and the Marine, for funding the PREMARA project 
(13F511). Thanks to the institutions I worked at during the PhD - the Nutrition 
Innovation Centre for Food and Health (NICHE), Ulster University; Teagasc Food 
Research Centre, Moorepark; APC Microbiome Ireland, University College Cork; IT 
Sligo; Teagasc Food Research Centre Ashtown; and The National University of 
Ireland Galway. 
I would like to express gratitude to my supervisors, Dr Philip Allsopp and Dr Emeir 
McSorley for their support, guidance, hard work, patience, and for sharing their 
expertise during this PhD. I am incredibly grateful for their stewardship throughout 
the peaks and troughs of this ordeal. I am also thankful for their encouragement to 
pursue several professional development opportunities, in the UK, Republic of 
Ireland, and internationally. 
I wish to thank Professor Catherine Stanton, of Teagasc Food Research Centre 
Moorepark and APC Microbiome Ireland, and Professor Paul Ross, also of APC 
Microbiome Ireland, for their supervision during my time as a visiting PhD 
researcher at Teagasc Moorepark. Thanks also to the lab members of APC2 
Teagasc Moorepark, past and present, and to other staff at Teagasc Moorepark. 
Special thanks go to Dr Conall Strain, who has been an empathetic mentor and a 
friend from day one. 
  xi 
 
Thanks also to Dr Supriya Yadav and Dr Michelle O’Donnell for their guidance 
during the in vitro fermentation experiments at Teagasc Moorepark; to Dr Silvia 
Arboleya (Teagasc Moorepark) for her guidance during the qPCR analysis; to Dr 
Paul Cotter, Dr Fiona Crispie, and Ms Laura Finnegan (Teagasc Moorepark)  for 
their sequencing expertise; to Dr Fiona Fouhy (Teagasc Moorepark) for her 
bioinformatics expertise; to Dr Thomas Smyth (IT Sligo) for his expertise in 
analytical chemistry; to Dr Mary Slevin (NICHE) for giving me the opportunity to 
contribute to the human studies at NICHE; and to Dr Zoë Popper (NUI Galway), my 
supervisor during a research visit to NUI Galway. 
I especially thank the many friends I made in Cork, including Ronan Strain, Kizkitza 
Busca, Mattia Boiani, Heni Wijiyanti, Andrea Bertuzzi, Vincenzo Pennone, Andrea 
Badelino, Annalisa Segat, Serena Boscaini, Mariarosaria Marotta, Ilaria Carafa, 
Alessia Diana, Sara Lisai, and Patrick Higgins. Without you it would have been a 
much tougher journey.  
Having worked in each Irish province during this PhD (Ulster, Munster, Leinster, 
and Connaught), I have been extremely lucky to explore this beautiful island; to 
climb rugged mountains and undulating hills; to saunter along wonderful beaches; 
and to take a splash in the wild Atlantic Ocean. Thanks also to friends from home, 
Paul Jefferson, Carl Johnson, Ryan Laws, Mark Roberts, Raymond Brown, Sam 
Burnstone, and Geoff Pettitt, for visiting and experiencing what Ireland has to 
offer.  
Finally, I would like to thank my family, and the friends who are as close as family. 
Mam, Dad, Tim, Joe, and Nanna, thanks for the constant support in person and 
over the phone. Dolly, if it weren’t for a conference I attended during this PhD, we 
  xii 
 
would have never met. I will always be grateful for your support and patience 
during this time – we’re both relieved it’s done! Margaret, thank you for instilling a 
curiosity to learn since childhood. Hilary, Martin, and Kate, thank you for being my 
family in Ireland and making your place feel like a home from home.  
  
  xiii 
 
Abstract 
This thesis used in vitro batch culture fermentation models to investigate the 
fermentability and prebiotic potential of the brown seaweeds Fucus vesiculosus 
and Laminaria digitata, and the red seaweed Palmaria palmata. Fermentation 
substrates included each whole seaweed (a food matrix) and a polysaccharide-rich 
extract from each seaweed (a mixture of dietary fibre components). Purified 
seaweed polysaccharides (alginate, fucoidan and laminarin from brown seaweeds; 
ulvan from green seaweeds; and xylan from red seaweeds) were also evaluated as 
fermentation substrates to understand the effect of individual seaweed dietary 
fibre components on gut microbiota composition and metabolic activity. Cellulose 
and Synergy 1 were used as negative and positive controls, respectively. Analysis 
was conducted on bacterial composition (qPCR, and 16S rRNA amplicon 
sequencing) and bacterial metabolic activity (GC-MS to quantify short chain fatty 
acid (SCFA) concentration). 
Fermentation in the presence of the whole seaweed powders of Fucus vesiculosus 
and Laminaria digitata resulted in significantly higher concentrations of SCFA when 
compared cellulose (total SCFA: cellulose = 7214.85 µM; FVWS = 15501.80 µM; 
LDWS = 23465.80 µM; p < 0.05). The whole brown seaweed powders and 
polysaccharide extracts stimulated glycan degrading bacterial families such as 
Bacteroidaceae, Ruminococcaceae and Lachnospiraceae when compared to 
cellulose. After 24 hrs fermentation, purified alginate polysaccharides yielded 
significantly higher concentrations of propionic acid (cellulose = 280.64 µM; 
Alginate-Fv = 725.26 µM; Alginate-Lj = 613.40 µM; p < 0.05) and butyric acid 
(cellulose = 549.43 µM; Alginate-Fv = 944.45 µM; Alginate-Lj = 864.27 µM; p < 
  xiv 
 
0.05), respectively. While fermentation in the presence of laminarin also yielded 
significantly higher concentrations of propionic acid after 24 hrs (cellulose = 280.64 
µM; Laminarin-Ld = 933.57 µM; p < 0.05). Alginate and laminarin substrates also 
stimulated populations of Bacteroides and Lachnospiraceae, respectively, when 
compared to cellulose. 
Fermentation in the presence of the Palmaria palmata whole seaweed powder and 
purified xylan resulted in significantly higher concentrations of SCFA when 
compared to cellulose (total SCFA: cellulose = 1162.1 µM; Xylan-Pp = 4781.92 µM; 
p < 0.05), whereas the polysaccharide extract did not. Fermentation in the 
presence of the Palmaria palmata whole seaweed powder, polysaccharide-rich 
extract, and purified xylan elicited a bifidogenic effect.  
Future in vivo investigations regarding the effect of seaweed polysaccharides on 
the gut microbiota and host health should investigate the effects of purified 
alginate, laminarin and xylan, and their respective oligosaccharides. Cost-effective 
methods to obtain these potential food ingredients are needed.  
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E McSorley, and P Magee. 
Chapter 3: Literature review 
The conception, design, and interpretation were carried out by C Stanton, P 
Allsopp, E McSorley, R P Ross, C Strain, S Yadav and I. The literature search, 
literature appraisal and the write-up were conducted by me, with assistance from S 
Yadav. The critical review of the chapter was carried out by me. Feedback was 
provided by P Allsopp, E McSorley, C Strain, C Stanton and R P Ross. 
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Chapter 4: Effects of the edible brown seaweeds, Fucus vesiculosus and Laminaria 
digitata, on the composition and metabolic activity of the human gut microbiota 
using an in vitro model of the distal colon 
Z Popper, C O’ Callaghan, and I harvested the seaweed and Z Popper confirmed the 
identification of the collected seaweed. The extraction method was carried out by 
S Yadav and I, based on previously established work by T Smyth and C Strain. The 
following was solely carried out by me: simulated human digestion of seaweeds 
and polysaccharide extracts, SCFA analysis by GC-MS, 16S rRNA amplicon 
sequencing library preparation, qPCR, collection of data, statistical analysis, 
interpretation of results and write-up. P Allsopp, C Strain, Catherine Stanton and I 
designed the experiment. The in vitro fermentations and bacterial gDNA 
extractions were carried out by S Yadav and I. 16S rRNA amplicon sequencing was 
carried out by F Crispie and the bioinformatics analysis by F Fouhy. SCFA analysis 
via GC-MS was carried out by me, under the supervision of T Smyth. All work 
relating to the faecal fermentation experiments was carried out at Teagasc Food 
Research Centre, Moorepark. The critical review of this chapter was conducted by 
me and feedback was provided by P Allsopp and E McSorley. 
Chapter 5: Effects of the edible red seaweed, Palmaria palmata, on the 
composition and metabolic activity of the human gut microbiota using an in vitro 
model of the distal colon 
Z Popper, C O’ Callaghan, and I harvested the seaweed and Z Popper confirmed the 
identification of the collected seaweed. The extraction method was carried out by 
S Yadav and I, based on previously established work by T Smyth and C Strain. The 
following was solely carried out by me: simulated human digestion of seaweeds 
and polysaccharide extracts, 16S rRNA amplicon sequencing library preparation, 
qPCR, collection of data, statistical analysis, interpretation of results and write-up. 
P Allsopp, C Strain, Catherine Stanton and I designed the experiment. The in vitro 
fermentations and bacterial gDNA extractions were carried out by S Yadav and I. 
16S rRNA amplicon sequencing was carried out by F Crispie and the bioinformatics 
analysis by F Fouhy. SCFA analysis via GC-MS was carried out by me, under the 
supervision of T Smyth. All work relating to the faecal fermentation experiments 
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was carried out at Teagasc Food Research Centre, Moorepark. The critical review of 
this chapter was conducted by me and feedback was provided by P Allsopp and E 
McSorley. 
Chapter 6: Effects of seaweed polysaccharides on the composition and metabolic 
activity of the human gut microbiota using an in vitro model of the distal colon 
Seaweed polysaccharides were sourced as follows: Fucoidan from Fucus 
vesiculosus (F5631) and Laminarin from Laminaria digitata (L9634) were purchased 
from Sigma Aldrich (St. Louis, USA). Alginate from Fucus vesiculosus (ALG101), 
Alginate from Laminaria japonica (ALG100), Fucoidan from Ascophyllum nodosum 
(FUC400), Ulvan from Ulva spp. (ULV100), and Xylan from Palmaria palmata 
(XYL100) were purchased from Elicityl (Crolles, France).  
The following was solely carried out by me: simulated human digestion of seaweed 
polysaccharides, 16S rRNA amplicon sequencing library preparation, qPCR, 
collection of data, statistical analysis, interpretation of results and write-up. P 
Allsopp, C Strain, and I designed the experiment. The in vitro fermentations and 
bacterial gDNA extractions were carried out by C Strain and I. 16S rRNA amplicon 
sequencing was carried out by F Crispie and the bioinformatics analysis by F Fouhy. 
SCFA analysis via GC-MS was carried out by me, under the supervision of T Smyth. 
All work relating to the faecal fermentation experiments was carried out at Teagasc 
Food Research Centre, Moorepark. The critical review of this chapter was 
conducted by me and feedback was provided by P Allsopp and E McSorley. 
Chapter 7: General discussion 
The analysis of results and write-up, and critical review was carried out by me. 
Feedback was provided by P Allsopp and E McSorley. 
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1 General Introduction 
 Introduction  
The shores surrounding the island of Ireland are habitat to multiple species of 
brown, green, and red edible seaweeds, which have been historically consumed by 
coastal communities (Monagail and Morrison, 2020). Seaweeds are also 
predominant in East Asian cuisine, where consumption of 5.3 g/day in Japan has 
been inversely correlated with chronic disease incidence (Matsumura, 2001). 
Whilst the nutritional properties of seaweed are well established as known sources 
of macronutrients (e.g. dietary fibre, protein, and lipids) and micronutrients (e.g. 
vitamins and minerals), there is also a suggestion that some components present in 
seaweed may modulate host physiology to benefit health, conducive to a 
functional food (Brown et al., 2014). In particular, it has been suggested that 
fermentation of seaweed polysaccharides by the human gut microbiota can 
modulate bacterial composition and metabolic output to improve host health, 
which is conducive to a prebiotic (Gibson et al., 2017; O’Sullivan et al., 2010). This 
has generated significant interest in the use of seaweeds as a source of functional 
fibre food ingredients with the capacity to convey health benefits through the 
modulation of the gut microbiota (de Jesus Raposo et al., 2016; Peñalver et al., 
2020). However, owing to the high iodine contents of seaweeds, there is a concern 
that seaweed consumption can exceed daily upper tolerable limits for iodine 
(Aquaron et al., 2002; Bouga and Combet, 2015). Thus, there is in increasing 
interest to extract individual fibre components for functional food ingredients, 
including complex polysaccharide such as alginate, fucoidan, and laminarin from 
brown seaweeds; ulvan from green seaweeds; and agar, carrageenan, porphyran, 
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and xylan from red seaweeds (Charoensiddhi et al., 2016; O’Sullivan et al., 2010; 
Postma et al., 2017; Yuan and Macquarrie, 2015).  
 The human gut microbiota 
The human gastrointestinal tract is colonised by an ecosystem of microorganisms 
that has co-evolved with humans, including approximately 1014 bacteria (Thursby 
and Juge, 2017). Approximately 160 prevalent bacterial species are reported, and 
dominant phyla include Firmicutes, Bacteriodetes, Actinobacteria, Proteobacteria, 
and Fusobacteria (Thursby and Juge, 2017). The composition of an individual’s gut 
microbiota is usually stable beyond the first 2-3 years of life, however, inter-
individual variation in gut microbiota composition, diversity, and metabolic activity 
exists, which is dependent on host genetics, and environmental and lifestyle 
factors such as diet and medication use (Conlon and Bird, 2015; Valdes et al., 
2018). Differences in gut microbiota composition, diversity and metabolic output 
have also been implicated in human health outcomes, for instance, observational 
evidence shows that individuals with obesity, type 2 diabetes, and inflammatory 
bowel disease have lower gut bacterial diversity than healthy individuals (Valdes et 
al., 2018). 
Methods to understand the bacterial composition and metabolic output of the 
human gut microbiota include the use of microbial culture, while culture-
independent techniques such as 16S rRNA amplicon sequencing and whole 
genome shotgun metagenomics have been used to characterise microbial 
abundance, diversity and potential metabolic function based on microbial genomic 
data (Jovel et al., 2016). A combination of microbial culture and next generation 
sequencing has also resulted in the advent of culturomics to generate specific 
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conditions to identify unknown bacteria of the human gut microbiota (Lagier et al., 
2018). Approaches to understand the metabolic output of the gut microbiota 
include the use of targeted and untargeted metabolomics (Daliri et al., 2017). This 
includes the identification and quantification of short chain fatty acids (SCFA), the 
end products of carbohydrate fermentation by the gut microbiota, using analytical 
techniques such as gas chromatography and mass spectrometry.  
 Dietary fibre and health 
Dietary fibres are carbohydrate polymers that are resistant to endogenous 
digestive enzymes and are widely acknowledged for digestive health benefits 
including reduced gastric emptying, increased satiety, and increased stool mass 
(Anderson et al., 2009; Capuano, 2017). Dietary fibre intake (25 – 29 g/day) is also 
associated with a reduced risk of developing non-communicable diseases such as 
cardiovascular disease, diabetes and obesity (Reynolds et al., 2019). The 
mechanisms of which relate to the regulation of glycaemic control and cholesterol 
metabolism (Capuano, 2017), and increasing evidence suggests that this is 
mediated, in part, by the gut microbiota, owing to the fermentation of dietary fibre 
components in the lower gastrointestinal tract (O’Grady et al., 2019; Valdes et al., 
2018). This has led to significant efforts to understand how dietary fibre influences 
gut bacterial composition, diversity, and metabolic output, to impact host 
physiology (Flint et al., 2012; Rowland et al., 2018). For instance, long-term 
reduction of dietary fibre intake has been associated with a loss of gut microbial 
diversity (Sonnenburg et al., 2016), which is associated with the onset of non-
communicable disease and negative health outcomes (Valdes et al., 2018). 
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Undigested carbohydrates provide a substrate for saccharolytic fermentation by 
colonic bacteria to produce acetate, propionate and butyrate short chain fatty acid 
(SCFA) metabolites, with an approximate abundance of 60%, 25% and 15%, 
respectively (Tazoe et al., 2008). Collectively (but not exclusively), luminal SCFA 
reduce colonic pH which increases hostility for pathogens. SCFA are absorbed by 
colonocytes via passive diffusion or active transport, where they are utilised by the 
cell or reach the portal blood via basolateral membrane transport proteins (den 
Besten et al., 2013; Velazquez et al., 1997). Acetate and propionate are then 
utilised for hepatic cholesterol synthesis and gluconeogenesis, respectively, whilst 
acetate is also associated with hormonal control of satiety (promotion of CKK, PYY 
and GLP-1 release) (Canani et al., 2011; Frost et al., 2014; Halford and Harrold, 
2012).  
Butyrate is the primary colonocyte energy source widely considered a regulator of 
intestinal homeostasis through multiple mechanisms. For example, butyrate 
facilitates increased colonic blood flow and cell motility, promotes electrolyte 
absorption, cell differentiation/turnover and influences mammalian cell gene 
expression through histonedeacetylase (HDAC) inhibition, which is associated with 
carcinogenesis prevention (Velazquez et al., 1997). HDAC inhibition cell signalling is 
one of two mechanisms identified for SCFAs – the other is GPR41/GPR43 G-protein 
coupled receptor activation, associated with metabolism and inflammation 
regulation (Tan et al., 2014).  
Furthermore, butyrate has a role in restoring gut barrier function via increased 
mucin synthesis, decreased gut permeability and immunoregulation (Leonel and 
Alvarez-Leite, 2012). The latter has highlighted an anti-inflammatory capacity via 
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Foxp3+ Treg cell proliferation and NF-κB transcription factor inhibition; such that 
pro-inflammatory signalling mechanisms may be impaired and pro-inflammatory 
cytokine production can become dampened (Arpaia et al., 2013). Owing to the 
associated health benefits of SCFA (particularly butyrate), there is significant 
interest in the provision of dietary fibre to enhance colonic SCFA levels, including 
the use of prebiotics (Gibson et al., 2017).  
 Prebiotics  
The concept of prebiotics was first proposed by Gibson and Roberfroid (Gibson and 
Roberfroid, 1995), and is currently defined as “a substrate that is selectively 
utilised by host microorganisms conferring a health benefit”. It is suggested that 
many of the purported health benefits of prebiotics are mediated by the local and 
systemic effects of SCFA fermentation metabolites. Some reported effects of 
prebiotics include the inhibition of pathogens, activation of the immune system, 
and the microbial synthesis of vitamins (Gibson et al., 2017). Other reported health 
benefits of prebiotics include the reduction of diarrhoea and gut inflammation, 
which may hold importance in conditions such as irritable bowel syndrome, 
inflammatory bowel disease and colon cancer. Prebiotics are also reported to 
improve satiety, which may have implications in the control of obesity and related 
diseases such as metabolic syndrome, type 2 diabetes and cardiovascular disease 
(Pandey et al., 2015).  
At present, the prebiotics inulin, fructo-oligosaccharides (FOS) and galacto-
oligosaccharides (GOS) are used as functional ingredients in food, beverages, 
dietary supplements and animal feed (Kellow et al., 2014). Only FOS and inulin 
have been recognised by the European Food Standards Agency (EFSA), for reducing 
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post-prandial glucose responses and maintaining normal defecation, respectively 
(Hutkins et al., 2015). Therefore, there is scope to use high-throughput in vitro 
methods to identify additional sources of potential prebiotics. This includes the use 
of seaweeds, given that seaweed polysaccharides have distinct chemical structures 
to terrestrial-derived polysaccharides. 
Firstly, in vitro simulated digestions can be used to determine whether a putative 
prebiotic is resistant to gastric acid, endogenous digestive enzymes, and 
gastrointestinal absorption (Brodkorb et al., 2019; Gibson et al., 2004; Minekus et 
al., 2014; Uriot et al., 2016). Secondly, static and dynamic in vitro gut fermentation 
models can be used to determine whether a candidate prebiotic is fermented by 
the intestinal microbiota, and whether the fermentation promotes the growth of 
health-associated bacteria (Gibson et al., 2004; Gibson and Fuller, 2000; Maccaferri 
et al., 2012; Marteau et al., 1997; Sivieri et al., 2014; Uriot et al., 2016; Wichienchot 
et al., 2006; Williams et al., 2015). This can be achieved by obtaining samples from 
the in vitro gut model at multiple time points to facilitate culture-dependent 
analysis (e.g. plating on selective media for Bifidobacterium spp. and Lactobacillus 
spp.)., culture-independent analysis (e.g. qPCR with Bifidobacterium spp. specific 
primers or next generation sequencing to obtain a profile of microbial diversity and 
relative abundance), and metabolomics analysis (e.g. GC-MS to quantify SCFA 
concentration). 
The investigation herein forms an evaluation of the prebiotic activity of seaweeds 
and seaweed polysaccharides, using in vitro batch culture fermentation as a model 
of the human distal colon. Test substrates included seaweed powders and 
polysaccharide-rich extracts of the edible Irish seaweeds, Fucus vesiculosus, 
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Laminaria digitata, and Palmaria palmata; and purified alginate, laminarin 
fucoidan, ulvan, and xylan seaweed polysaccharides. 
 
 Aims and objectives 
- Conduct a literature review on the nutritional composition, health benefits and 
potential risks associated with consumption of edible seaweeds. 
- Conduct a literature review to evaluate the current evidence that implicates 
bioactive components from seaweeds with prebiotic effects. 
- Evaluate the prebiotic potential of Irish brown seaweeds Fucus vesiculosus and 
Laminaria digitata and their extracted polysaccharide components using in 
vitro batch culture fermentation models of the distal colon.  
- Evaluate the prebiotic potential of Irish red seaweed Palmaria palmata and its 
extracted polysaccharide components using in vitro batch culture fermentation 
models of the distal colon.  
- Evaluate the prebiotic potential of purified seaweed polysaccharides using in 
vitro batch culture fermentation models of the distal colon. This includes the 
brown seaweed polysaccharides, fucoidan, alginate and laminarin; the green 
seaweed polysaccharide, ulvan; and the red seaweed polysaccharide, xylan. 
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2 Literature Review - Risks and Benefits of Consuming Edible 
Seaweeds 
 Abstract  
Recent interest in seaweeds as a source macronutrients, micronutrients, and 
bioactive components has highlighted prospective application within functional 
food and nutraceutical industries, with impetus towards the alleviation of risk 
factors associated with non-communicable diseases such as obesity, type two 
diabetes, and cardiovascular disease.  
This narrative review summarises the nutritional composition of edible seaweeds 
and evaluates the evidence regarding the health benefits of consuming whole 
seaweeds, extracted bioactives, and seaweed-based food products in humans, in 
balance with the determination of potential adverse effects such as excessive 
iodine and arsenic ingestion. If potential functional food and nutraceutical 
applications of seaweeds are to be realised, more evidence from human 
intervention studies is needed to evaluate the nutritional benefit of seaweeds and 
the efficacy of purported bioactive components, with mechanistic evidence 
imperative to substantiate health claims.   
 Introduction 
Edible seaweeds (macroalgae) have the potential to provide a rich and sustainable 
source of macronutrients and micronutrients to the human diet, particularly in 
regions where seaweed makes a significant contribution to regular meals, for 
example, in Japan, where approximately one fifth of meals contain seaweed (Lange 
et al., 2015; MacArtain et al., 2007; Rebours et al., 2014). Inclusion of seaweeds in 
western diets has traditionally been limited to artisanal practises and coastal 
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communities, but has gained wider consumer interest in recent years, courtesy of 
the health-food industry (Bouga and Combet, 2015). The recent surge of interest in 
seaweed is fuelled by attention towards the bioactive components from seaweed, 
which have potential applications in the lucrative functional food and nutraceutical 
industries, with impetus towards the alleviation of metabolic risk factors such as 
hyperglycaemia, hypercholesterolaemia, and hyperlipidemia, as well as anti-cancer 
activity and anti-microbial function (Collins et al., 2016). The candidate bioactive 
components of interest to industry include isolated polysaccharides (e.g. alginate, 
fucoidan), proteins (e.g. phycobillirubins), polyphenols (e.g. phlorotannins), 
carotenoids (e.g. fucoxanthin), and omega-3 long chain polyunsaturated fatty acids 
(e.g. eicosapentaenoic acid). The focus of scientific experiments and human studies 
to date has predominantly focused on brown seaweeds and derivatives, owing to 
their commercial abundance and perceived sustainability.  
Despite the nutritional attributes of red seaweeds such as Porphyra spp. (nori) or 
Palmaria palmata (dulse) with high protein content, there are relatively few 
investigations which have focused upon red seaweeds as a source of bioactives, 
albeit an abundance of in vitro studies and in vivo animal studies represent 
progress towards understanding their heath promoting activities. There are limited 
reports of green seaweeds contributing to the human diet or as a source of 
bioactives, despite the potential to exploit transient algal blooms (Postma et al., 
2017).  
Aquaculture is recognised as the most sustainable means of seaweed production 
and accounts for approximately 27.3 million tonnes (96%) of global seaweed 
production per annum, yet, the growing demand for seaweed based food 
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ingredients has called for more established guidelines and regulations to ensure 
sustainability (Mac Monagail et al., 2017). Future considerations for stakeholder 
management include best practises for cultivation, resource ownership, harvesting 
rights/licencing, certification/validation, over-exploitation, biomass regrowth, 
environmental impacts, and the development of a sustainable value chain within 
the agri-food sector (Rebours et al., 2014; Tiwari, 2015). 
An abundance of seaweed products currently available to purchase, including both 
whole seaweed and seaweed extracts, are marketed both directly and indirectly as 
value-added products for the promotion of health in the supplement market. The 
health claims associated with seaweed products are often based on insufficient (or 
completely absent) evidence from human intervention studies to substantiate such 
statements. Furthermore, there are considerable safety concerns in relation to 
potential adverse events associated with seaweed consumption, particularly in 
light of the variable and potentially dangerously high concentrations of iodine and 
heavy metals (including arsenic species) in certain seaweeds (Holdt and Kraan, 
2011; Suleria et al., 2015). There is currently limited legislation to enforce food or 
supplement companies to disclose mineral, heavy metal or iodine content of 
seaweed products or provide guidance on a safe portion size of certain whole 
seaweeds in order to prevent excessive intakes (Bouga and Combet, 2015). 
Ultimately, if the nutrients present in seaweeds shall contribute towards future 
global food security, either as a feed ingredient or directly as a food, the industry 
should develop a sustainable heavy metal/iodine monitoring programme or 
alternatively identify novel processing technologies to ensure that unsafe 
components such as arsenic are minimised to achieve safe levels and thus protect 
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the food chain (European Commission, 2009; FAO, 2016; Kraan, 2013; Rebours et 
al., 2014; Republic of the Philippines Ministry of Natural Resources, 1983).  
The health benefits of seaweed beyond the provision of essential nutrients has 
been supported by in vitro studies and some animal studies; however, many of 
these studies have inappropriate biomarkers to substantiate a claim and have not 
progressed to suitably designed human intervention trials to evaluate efficacy. The 
limited evidence that does exist makes some seaweed components attractive as 
functional food ingredients, however, more human evidence is needed to evaluate 
the nutritional benefit conferred and the efficacy of purported bioactives (with 
mechanistic evidence) in balance with determination of potential adverse effects. 
Through an evaluation of the nutritional composition of edible seaweeds, this 
review summarises the available evidence and outlines potential risks alongside 
the health benefits of consuming whole seaweeds, extracted bioactives, and 
seaweed-based food products in humans, and identifies future opportunities for 
functional food and nutraceutical applications.  
 Nutritional composition 
A number of edible seaweeds are recognised as novel foods in Europe, albeit the 
nutritional composition of brown, red and green seaweeds vary between species, 
season, and ecology of the harvesting location (European Commission, 2018). 
Therefore, there is a need to characterise the composition of seaweeds in relation 
to the influence of location and seasonality on seaweed content. There are 
continuing efforts to catalogue such information on the variability of nutritional 
composition which will facilitate the identification of optimal harvesting periods 
and/or locations for a given species which would be of interest to the functional 
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food industry for targeting optimal conditions for isolating target bioactives 
(Madden et al., 2012; Schiener et al., 2015; Soares et al., 2017). Table 2-1, Table 
2-2 , and Table 2-3 present the macronutrient content of multiple brown, red, and 
green seaweeds, respectively, and consider a 5g serving relative to reference 
nutrient intakes. Table 2-4 and Table 2-5 present the same nutritional information 
for a selection of dried seaweed products available to purchase throughout the UK 
and the Republic of Ireland, to provide context regarding the current market, and 
to compare with the compositional studies discussed.  
 Protein  
The protein content of seaweed has gained considerable attention given the 
emerging challenges to food security in relation to identifying alternative and 
sustainable protein sources (Harnedy and FitzGerald, 2011). As outlined in Table 
2-1, Table 2-2, and Table 2-3, the protein content ranges from 5.02% to 19.66% in 
brown seaweeds; from 0.67% to 45.00% in red seaweeds; and from 3.42% to 
29.80% in green seaweeds; where a 5g portion of dried seaweed corresponds to a 
maximum of 1.97%, 4.50%, and 2.98% of the recommended nutrient intake for 
protein, for brown, red, and green seaweeds, respectively. On a gram for gram 
basis, seaweeds have comparable protein and amino acid contents to beef, 
however, seaweeds are consumed in much smaller quantities (Greenwood et al., 
1951). It should also be noted that seaweed protein content is often derived from 
total nitrogen using a conversion factor of 6.25 (Kjeldahl method), which is likely an 
overestimate given the non-protein sources of nitrogen in seaweed. Hence, species 
specific conversion factors for seaweed, ranging from 3.57 – 5.72 have been 
proposed (Lourenço et al., 2002). The amino acid composition of proteins is critical 
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to determining its value to the human diet, particularly in achieving an adequate 
intake of essential amino acids. However, the digestibility of seaweed protein 
within the gastrointestinal tract will significantly impact its nutritional value, with 
protein-polysaccharide interactions significantly reducing digestion efficiency. 
An overview of the amino acid contents of several brown, red, and green seaweeds 
is presented in Table 2-6, Table 2-7, and Table 2-8. Seaweeds offer a source of 
lysine, an essential amino acid often limited in terrestrial plant protein sources 
such as corn, maize, soy, rice, and wheat (EFSA, 2012; Misurcova et al., 2014; 
Qasim, 1991). It is reported that an 8g portion of Palmaria palmata contains up to 
21.9% cysteine recommended daily intake, however, seasonal variation in the total 
protein content of Palmaria palmata is evident, reported as 21.9% in winter-spring 
compared to 11.9% in summer-autumn, with 26 – 50% comprising of essential 
amino acids (Galland-Irmouli et al., 1999; Misurcova et al., 2014). Thus, exploiting 
seaweeds as non-animal protein sources may be possible through harvesting plans, 
which optimise protein and amino acid contents. 
The digestibility of seaweed protein has been estimated using in-vitro methods, 
and is reported as: Fucus vesiculosus = 14.7%, Laminaria digitata = 16.9%, Undaria 
pinnatifida = 28.0%, Chondrus crispus = 45.0%, Porphyra tenera = 69.4%, Palmaria 
palmata = 56%, Porphyra columbina = 74.3% (Cian et al., 2014; Galland-Irmouli et 
al., 1999; Goñi et al., 2002). The digestibility of protein from Undaria pinnatifida 
and Porphyra tenera in rodents is reported as 86.1% and 86.2%, respectively; while 
the digestibility of Undaria pinnatifida protein in humans is reported as 70.0%, 
which is similar to the protein digestibility of land based plants (Cerna, 2011; 
Urbano and Goni, 2002; Yamada et al., 1991). Although in vivo digestibility data 
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suggest that seaweed protein is bioaccessible, protein-polysaccharide interactions 
within the seaweed matrix could prevent enzyme-substrate complex formation 
and hinder proteolysis of seaweed proteins. Indeed, xylanase and cellulase 
polysaccharide enzymatic treatments have improved Palmaria palmata protein 
bioaccessibility 1.7-fold and 3-fold, respectively, which may favour the use of 
protein extracts to maximise protein and amino acid intake from seaweeds, with 
food, feed, supplement, and nutraceutical applications (Beasley et al., 2013; Cerna, 
2011; Maehre et al., 2016). Methods for protein extraction from brown, red and 
green seaweeds are described comprehensively elsewhere, where the use of 
proteolytic and saccharolytic enzymes such as Celluclast® or Shearzyme® 
(Novozymes, Copenhagen, Denmark) are reported to improve protein extraction 
yield and endogenous digestion (Bleakley and Hayes, 2017; Harnedy and 
FitzGerald, 2015, 2013, 2013; Kadam et al., 2017). Hitherto, the bioactivities 
pertained to peptides extracted from red seaweeds such as Palmaria palmata and 
Porphyra spp., and brown seaweeds such as Undaria pinnatifida include 
antihypertensive, antioxidant, and antidiabetic effects (Admassu et al., 2018). This 
includes cardio-protective effects such as reduced blood pressure via angiotensin 
converting enzyme inhibition, anti-diabetic activity via dipeptidyl peptidase IV 
inhibition, and promotion of iron absorption; as well as potential application as 
food preservatives owing to anti-oxidant capacities (Cian et al., 2016; Fitzgerald et 
al., 2014; Harnedy et al., 2017, 2015; Jimenez-Escrig et al., 2011; Sato et al., 2002; 
Suetsuna et al., 2004). Therefore, seaweed protein extracts hold promise as a 
seaweed-based protein source, providing bioactivity is validated in humans. 
It is estimated that 56 million metric tonnes of algae will be required per annum as 
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an alternative protein source by 2054, which will represent 5.94% of global protein 
demand (Probst, 2015). Given the variability of protein content and bioavailability 
of protein from whole seaweeds, protein extracts may offer a substantial 
contribution to non-animal protein sources in the future.   
 Dietary fibre 
Many populations are failing to meet daily requirements for dietary fibre (EFSA, 
2010a; FDA, 2017; Scientific Advisory Committee on Nutrition, 2015). The potential 
functional properties of dietary fibre are associated with its viscous and water 
binding properties within the gastrointestinal tract, which has been suggested to 
promote satiety and weight loss; delay gastric emptying to improve glycaemic 
control; enhance stool bulking to reduce gut transit time and increased defecation 
frequency; and enhance bile acid excretion resulting in reduced blood LDL 
cholesterol (Clark and Slavin, 2013; EFSA, 2011a). Dietary fibre components are 
also suggested to improve health through their fermentation by the colonic 
microbiota, which can favourably alter gut microbial composition and enhance the 
production of health-associated volatile fatty acids such as acetate, propionate, 
and butyrate. The fibre induced alterations to microbiota composition and the 
associated metabolites produced are increasingly associated with the promotion of 
gastrointestinal, cardiometabolic, immune, bone, and mental health (Gibson et al., 
2017). 
Owing to the range of pertained beneficial health effects associated with dietary 
fibre consumption, there is increasing interest from the food industry to identify 
sustainable, alternative sources of dietary fibre (Clark and Slavin, 2013; EFSA, 
2011a). The high fibre content of seaweed makes it a promising candidate. 
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However, the contribution of consuming whole seaweed to the current 
recommended dietary fibre intake of 25g/day is limited, with a 5g serving of 
brown, red, and green seaweeds contributing up to 14.28%, 10.64%, and 12.10% of 
dietary fibre intake, respectively (Table 2-1, Table 2-2, and Table 2-3) (EFSA, 
2010a). This has led to increasing interest towards industrially applicable extraction 
and isolation of individual fibre components from seaweed. The range of fibre 
components in seaweed is diverse with brown seaweeds known to contain 
alginate, laminarin, and fucoidan polysaccharides; red seaweeds contain agar, 
carrageenan, porphyran, and xylan; whilst green seaweeds contain ulvan, xylan, 
and cellulose (Brownlee et al., 2005; Devillé et al., 2007; Lahaye and Robic, 2007; 
Lahaye and Rochas, 1991; Li et al., 2008; Usov, 2011).  
Whilst industry has used some seaweed derived fibres (alginate, carrageenan, and 
agar) for decades for their emulsifying, stabilising and thickening characteristics to 
improve the sensory properties of food, there is limited interest on their impact as 
functional dietary fibre ingredients. The existing widespread use of these seaweed 
derived fibre components in the food industry has ensured that they are deemed 
to be safe for human consumption according to EFSA and the FDA, thus the use of 
alginate isolated from brown seaweeds by the food industry makes it a leading 
candidate for application in the functional food market (EFSA, 2017a, 2016; FDA, 
2016a). The recent novel food classification of fucoidan by EFSA also makes it an 
emerging functional food ingredient candidate, whilst suggestions that low 
molecular weight carrageenan components (<50 kDa) may negatively impact 
health (pro-inflammatory), have tempered interest in its potential as a functional 
ingredient (Burges Watson, 2009; European Commission, 2017). Other seaweed 
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fibres such as xylan, laminarin, and ulvan, have not received official EFSA approval, 
thus more research is needed to ascertain whether these carbohydrates are safe 
for human consumption, and the designated safety of these seaweed derived fibre 
components will make them ready for the food market as a nutritional ingredient, 
providing associated health claims are substantiated.  
The majority of research in humans regarding the health benefits of seaweed 
derived dietary fibre components have focused on the potential anti-obesogenic 
effects, including improved satiation, delayed nutrient absorption, and delayed 
gastric emptying, but the effects of whole seaweeds containing alginate appear to 
be limited (Brownlee et al., 2005; Chater et al., 2015; El Khoury et al., 2015). 
Several human intervention placebo-controlled trials have shown alginate 
consumption to significantly impact appetite and food intake. An acute study by 
Peters et al. (Peters et al., 2011) showed that consumption of an alginate drink 
enhanced self-reported satiety and reduce feeling of hunger in a dose dependent 
manner compared to the placebo control. Another parallel study in overweight 
men showed consumption of a Ascophyllum nodosum enriched (4%) bread reduced 
energy intake by 109 and 506 kCal at 4 and 24-hours post consumption compared 
to an isocaloric placebo and similar results were reported when consumption of a 
preload alginate drink reduced energy intake of 44kcal following an ad libitum 
lunch (Georg Jensen et al., 2012; Hall et al., 2012). A crossover study has reported a 
reduced daily energy intake of 135 kcal when consuming alginate (1.5g/100ml) 
prior to meals, but no significant effect of a preload alginate drink on measures of 
energy intake, or concentration of satiety hormones in overweight/obese 
individuals is reported elsewhere (Odunsi et al., 2010; Paxman et al., 2008). The 
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role for alginate on appetite and food intake would appear to be convincing, albeit 
research is needed to the characterise the efficacy of alginates taking into 
consideration the relationship between structure and function (particularly 
molecular weight and the guluronate:mannuronate ratio) and the role of the 
gelling capacity of the alginate. Furthermore, research into the mechanism of 
action is required given the lack of effect of alginate on gastric emptying (Georg 
Jensen et al., 2012; Odunsi et al., 2010). The formulation of alginate food products 
that are organoleptically acceptable to the consumer is another consideration to 
industry. Longer term studies are required to provide information of these benefits 
on appetite control and weight management. 
There is also considerable interest in the role of alginate on glycaemic control, 
particularly its impact on postprandial glucose absorption. A review of the evidence 
by EFSA concluded that sodium alginate failed to reduce post-prandial glycaemic 
responses without a disproportionate increase in post-prandial insulinaemic 
responses and thus a health claim was rejected (Torsdottir et al., 1991; Wolf et al., 
2002). Other fibres such as beta glucan have received favourable EFSA opinions for 
its ability to reduce postprandial glucose absorption which has been attributed to a 
reduction in the rate of gastric emptying (EFSA, 2011b). The effect of alginate on 
glucose metabolism needs to be further investigated; particularly the impact it may 
have on postprandial insulinaemic response.  
The recent designation of fucoidan with FDA GRAS status and EU novel food status 
along with the accumulating in vitro and in vivo evidence of its potential anti-
obesogenic effects make it an attractive ingredient for the functional food industry 
(European Commission, 2017; FDA, 2016b; Kim et al., 2014; Lim et al., 2017). 
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Nevertheless, only one human study has investigated the anti-obesogenic effects 
of seaweed derived fucoidan. A randomised double blind parallel placebo 
controlled trial in an overweight/obese cohort showed that participants who 
consumed fucoidan (500mg/day) for three months had significantly reduced 
diastolic blood pressure and LDL cholesterol compared to the placebo control 
(Hernandez-Corona et al., 2014). No changes in weight, waist circumference, BMI, 
adiposity, systolic blood pressure, total cholesterol, HDL cholesterol, blood glucose, 
or blood triglyceride were observed, however, blood insulin and insulin resistance 
(HOMA-IR) were increased following the fucoidan intervention compared to 
baseline, but not compared with the placebo group. The authors suggested that 
fucoidan consumption downregulated PPARγ transcription factor expression to 
suppress adipocyte differentiation and insulin signalling.  
Conversely, evidence from animal models of obesity and diabetes suggest that low 
molecular weight fucoidan could ameliorate dyslipidemia and improve insulin 
sensitivity through the activation of insulin signalling pathways in adipocytes and 
hepatocytes (Jeong et al., 2013; Kim et al., 2014; Lin et al., 2017; J. Wang et al., 
2013; Yokota et al., 2016). 
Further evidence is required from human intervention trials to understand how 
dietary fucoidan may modulate host glucose and lipid metabolism to exert anti-
obesigenic and anti-diabetic effects. This may also require an understanding of 
how the molecular weight of fucoidan affects bioactivity. 
Fucoidan is also reported to have anti-coagulant properties, serving as a catalyst 
for anti-thrombin mediated and heparin cofactor II–mediated thrombin inhibition 
(Church et al., 1989; Dockal et al., 2011; Irhimeh et al., 2009). Oral administration 
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of Undaria pinnatifida extract (9g/day) with 75% fucoidan (MW ~713KDa) for 
twelve days increased activated partial thromboplastin time, decreased thrombin 
time, and increased antithrombin-III compared with placebo, albeit the authors 
concluded the improvements were small and that the impact of oral delivery may 
be limited (Irhimeh et al., 2009). Another study investigated oral administration of 
400mg/day fucoidan (extracted from Laminaria japonica, MW ~300kDa) for five 
weeks and reported a significant reduction in thrombus lysis time, albeit fucoidan 
was not detected in subjects’ blood using a fucoidan specific monoclonal antibody 
ELISA (Ren et al., 2013). This suggests that fucoidan may not be bioavailable in 
humans, although fucoidan has been demonstrated to be absorbed through the 
small intestine using in vitro and in vivo experiments (Nagamine et al., 2014). The 
anticoagulant properties of fucoidan are gaining attention by the pharmaceutical 
industry; however its anticoagulant function as a food ingredient and its potential 
impact on health will require much more human evidence to verify both safe and 
efficacious doses particularly with consideration to individuals on anticoagulant 
therapy.  
There is also a wealth of evidence to support an anti-cancer function of fucoidan, 
however, the majority of evidence is from in vitro studies and animal studies and is 
reviewed elsewhere (Atashrazm et al., 2015). A recent clinical trial in colon cancer 
patients investigated the impact of consuming a fucoidan (4g twice daily) 
supplement alongside their chemotherapy (Tsai et al., 2017). The study showed 
that the patients consuming fucoidan had a significantly better disease control rate 
compared to placebo control, however, did not show any change in overall 
response rate, progression-free survival, overall survival, adverse effects, and 
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quality of life. Whilst the effect of fucoidan on disease control rate is a notable 
benefit, its role in contributing to cancer treatment remains unknown. While the 
advertisement of cancer treatments is prohibited in the UK, the legislation 
regarding cancer prevention is less (Cancer Act 1939, 1939; The Consumer 
Protection from Unfair Trading Regulations 2008, 2008). Further, marketing 
fucoidan as a food ingredient with cancer prevention effects is extremely difficult 
to substantiate and may prove a very difficult regulatory environment to navigate. 
There is increasing interest in the potential prebiotic effect of seaweed derived 
fibre through its effect on the composition and metabolism of the colonic 
microbiota and how fibre fermentation may impact human health. A range of in 
vitro faecal batch culture studies have demonstrated the fermentability of 
seaweed fibre components with noted increased production of short chain fatty 
acids and modulation of gut microbial communities (Bai et al., 2017; Bajury et al., 
2017; Fu et al., 2018; Michel et al., 1996; Ramnani et al., 2012). Whilst animal 
studies have confirmed gut microbiota modulation and short chain fatty acid 
production, the health benefits are only attributed to weight management thus far 
(Devillé et al., 2007; Liu et al., 2015; Nguyen et al., 2016). There is a lack of human 
intervention trials which have investigated the fermentability of seaweed fibre 
components, and their potential to impact health outcomes associated with 
prebiotics (Gibson et al., 2017).  
 Fat 
The fat content of seaweed tends to be low relative to total dry weight, where the 
% fat content is highest in winter, lowest in summer, and fatty acid composition 
varies dependent on season (Gressler et al., 2011; Madden et al., 2012; Yamada et 
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al., 1991). An example of the latter includes Saccharina latissima grown in 
integrated multi-trophic aquaculture, where lipid concentration and 
polyunsaturated fatty acid (PUFA) content was highest in March and November, 
yet lowest in January (Marinho et al., 2015). In terms of nutritional contribution, it 
is reported that seaweed-derived lipids have good digestibility, for example, up to 
98% of Undaria pinnatifida fat contents (1.5% DW) are digestible in adults (Yamada 
et al., 1991). 
Table 2-1, Table 2-2, and Table 2-3 present the total fat content of several brown, 
red, and green seaweeds, respectively, while Table 2-9, Table 2-10, and Table 2-11 
present a breakdown of lipid contents. Total lipid contents range from 0.29% in 
Sargassum polycystum to 8.88% in Porphyra spp. (Matanjun et al., 2009; Paiva et 
al., 2014). Porphyra spp. have the lowest saturated fatty acid (SFA) content (17.4% 
of total fatty acids, FA), whereas SFAs constituted 74% of total FA in Plocamium 
Brasiliense (Gressler et al., 2011). Monounsaturated Fatty Acid (MUFA) content 
relative to total FA content ranged from 3.3% in Ochtodes secundiramea to 47.1% 
in Fucus vesiculosus (Maehre et al., 2014). PUFA content of total FA ranges from 
6.7% in Ulva lactuca to 69.1% in Undaria pinnatifida (Sanchez-Machado et al., 
2004; Yaich et al., 2011). This sample also had the highest PUFA/SFA ratio (3.39), 
while the three Palmaria species recorded demonstrate the lowest n-6/n-3 ratio, 
whereas Gracilaria gracilis had the highest (Francavilla et al., 2013).  
Dietary reference values are not set for PUFAs collectively, but an adequate intake 
of 4% energy intake is recommended for n-6 linoleic acid (EFSA, 2010b). Foods with 
a greater ratio of PUFAs, relative to SFAs, may be favourable, in order to maintain 
blood LDL-cholesterol within normal concentrations, although more human 
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intervention studies are needed to confirm efficacies of PUFAs upon dyslipidemia 
management and the attenuation of low-grade inflammation (EFSA, 2011a; Hunter 
and Hegele, 2017). 
Evidence for bioactive efficacies specific to seaweed lipids is limited, although male 
KK-Ay mice treated with 1% Undaria pinnatifida lipid were seen to have a 
significant reduction in body weight after four weeks when compared to the 
control group, whilst total white adipose tissue weight was reduced in mice who 
consumed both the Undaria pinnatifida lipid and n-3 polyunsaturated fatty acid 
rich scallop phospholipids (Okada et al., 2011). Other anti-inflammatory activities 
of seaweed lipids concern the inhibition of LPS-induced inflammation in human 
THP-1 macrophages by lipids derived from the red seaweeds Porphyra dioica, 
Palmaria palmata and Chondrus crispus, while lipids extracted from Gracilaria spp. 
inhibited LPS-induced nitric oxide production in murine RAW 264.7 macrophage 
cells and decreased cell viability in human T-47D breast cancer cells and 5637 
human bladder cancer cells (da Costa et al., 2017; Robertson et al., 2015). An anti-
cancer effect of a C18 fatty acid extracted from Ulva lactuca was also reported, via 
the activation of the Nrf2-ARE pathway to promote ROS scavenging (R. Wang et al., 
2013). 
Given that whole seaweed consumption is unlikely to make a significant 
contribution to dietary fat intake, owing to low lipid contents, macroalgae may 
offer a sustainable source of extractable PUFAs for further investigation regarding 
the anti-inflammatory effects to ameliorate obesity and associated co-morbidities. 
This may have prospective supplement or nutraceutical applications.  
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 Polyphenols  
Polyphenols are highly complex cell wall structural components, often bound to 
cell wall polysaccharides, and function to protect against oxidative damage 
(Heffernan et al., 2015). A diverse number of flavonoid and phlorotannin 
polyphenols are abundant in brown seaweeds, which vary in structure, molecular 
weight, and level of isomerisation (Hwang and Thi, 2014; Murugan et al., 2015).  
The purported bioactivities of seaweed polyphenols include potential anticancer 
activities, antioxidant activities, and digestive enzyme inhibition, where the latter 
may prevent lipid absorption and maintain glucose homeostasis (Farasat et al., 
2014; Machu et al., 2015; Murugan et al., 2015; Shanura et al., 2016; Wan-Loy and 
Siew-Moi, 2016; H. C. Yang et al., 2010).   
The bioavailability of polyphenolic compounds in food varies greatly, but it is 
understood to be low (Bohn, 2014). There is currently a lack of information 
regarding the bioavailability of seaweed derived polyphenolic compounds, 
however, a recent human intervention trial investigated the bioavailability of 
polyphenols extracted from Ascophyllum nodosum, provided initial indications of 
interpersonal variation in polyphenol uptake, with 0.011 – 7.757 µg/ml of 
polyphenols detected in the serum, whilst total urinary phlorotannin and 
metabolite concentration ranged from 0.15 – 33.52 µg/ml (Corona et al., 2016). 
The authors concluded, based on the rate of absorption (6-24 hours), that gut 
microbiota-mediated metabolism of the polyphenols could be a major contributor 
to the apparent interpersonal variation of polyphenol absorption. Consequently, 
more human studies are needed to investigate the bioavailability of polyphenolics 
when consuming whole seaweeds, as there is potential for seaweed-derived 
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fermentable fibres and polyphenols to exert synergistic effects on the gut 
microbiota and the host. There is also scope for more fundamental research to 
further characterise the role of the gut microbiota on phlorotannin metabolism, 
which could significantly impact associations with health benefits.  
There is considerable evidence from animal studies to support a role for seaweed 
polyphenols to impact glucose and lipid digestion and metabolism, suggested to 
have potential in preventing diabetes and obesity associated complications.  
Diabetic rats fed an ethanol extract (150 and 300mg/kg) or a water extract 
(300mg/kg) from Sargassum polycystum significantly reduced blood glucose, 
glycated haemoglobin, total cholesterol, blood triglycerides and plasma 
atherogenic index in diabetic rats (Motshakeri et al., 2014, 2013). Polyphenols from 
both Ecklonia stolonifera and Ascophyllum nodosum have been shown to 
favourably alter glucose and insulin metabolism in diabetic mouse models, whilst 
Ecklonia cava polyphenols significantly reduced serum and liver triglycerides and 
total cholesterol in a diabetic mouse model (Iwai, 2008; Kim and Kim, 2012; Zhang 
et al., 2007). Another study showed that inclusion of Gelidium amansii phenoic-rich 
extract reduced blood glucose and serum insulin in diet-induced obese mice, and 
protected against the adverse effects of diet-induced obesity in mice via decreased 
blood triglycerides and total cholesterol (Kang et al., 2016). Hitherto, the 
mechanism of action remains elusive, but current evidence supports a role for the 
inhibition of digestive enzymes including α-amylase, α-glucosidase, and lipase 
(Austin et al., 2018; Chater et al., 2016; Pantidos et al., 2014; Zhang et al., 2007).  
There is limited evidence for the efficacy of seaweed polyphenols to exert anti-
obesigenic effects or to maintain glucose homeostasis in healthy humans. For 
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example, consumption of 500 mg seaweed extract with ≥ 10% polyphenols did not 
improve postprandial glucose concentration after a 50g carbohydrate load (bread) 
compared to the placebo, but lowered plasma insulin incremental area under the 
curve in healthy adults (n = 23) (Paradis et al., 2011). Elsewhere, neither a 500 mg 
nor 2000 mg dose of Fucus vesiculosus polyphenol-rich extract reduced 
postprandial glucose or insulin responses beyond that of the cellulose placebo 
after a 50g carbohydrate load (white bread) in healthy adults (n = 38) (Murray et 
al., 2018b).  
In Korean adults with increased cholesterol, however, a significant reduction in 
total cholesterol, LDL cholesterol, and C-reactive protein was observed compared 
to baseline, following the treatment of 400mg/day Ecklonia cava polyphenol 
extract for 12 weeks (Lee et al., 2012). Potential mechanisms of action may be 
associated with the inhibition of adipogenesis, where dieckol is demonstrated to 
down-regulate AMPK signalling in 3T3-L1 preadipocytes (Ko et al., 2013).  
A recent meta-analysis concluded that polyphenol-rich marine extracts could 
reduce fasting blood glucose, total cholesterol, and LDL cholesterol in humans, but 
a paucity of human intervention studies has led to inconsistent findings for the 
effect of seaweed polyphenols upon other biomarkers associated with type two 
diabetes and cardiovascular disease risk, including postprandial blood glucose, 
fasting insulin, HDL cholesterol and triglycerides (Murray et al., 2018a).  
With Ecklonia cava phlorotannins deemed safe for food supplement use in the EU, 
further evidence in healthy and at-risk human populations is required to ascertain 
the bioactivities of seaweed polyphenols, while efforts to optimise polyphenol 
extraction procedures will be crucial to maximise their potential as food 
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ingredients (EFSA, 2017b; Gall et al., 2015; Li et al., 2017; Murray et al., 2018b; 
Yoon et al., 2017).  
 Fucoxanthin 
Carotenoids are a group of tetrapenoid compounds in seaweeds that contribute to 
photosynthesis and their antioxidant properties facilitate protection from UV 
damage. The main carotenoid present in seaweeds with potential application in 
the food industry is fucoxanthin, extracted from brown seaweeds (Christaki et al., 
2013; Mikami and Hosokawa, 2013). Evidence suggests that fucoxanthin may have 
potential as a food preservative to prevent lipid peroxidation in meat through its 
antioxidant activities (Sellimi et al., 2017).  
Previous research regarding fucoxanthin has focused on its potential as a 
functional food ingredient to reduce diabetes and obesity risk, albeit the evidence 
is predominantly derived from in vitro and animal studies. Fucoxanthin is thought 
to mediate its effects through the inhibition of α-amylase and α-glucosidase 
digestive enzymes, and impact lipid metabolism through the modulation of leptin 
and adiponectin, which results in a downregulation of lipogenesis and an 
upregulation lipolysis (Harris, 2014; Nagappan et al., 2017). A range of in vivo 
animal studies have shown fucoxanthin supplementation to reduce: body weight 
gain, lipid accumulation in the liver, blood glucose and plasma insulin, decreased 
insulin resistance and also improve plasma lipid profile (Maeda et al., 2008; 
Muradian et al., 2015). The impact of fucoxanthin on cholesterol metabolism in 
mice differs, where Beppu et al. (Beppu et al., 2012) reported increased serum HDL 
and non-HDL cholesterol and serum total cholesterol, whilst Jeon et al. (Jeon et al., 
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2010) reported decreased serum cholesterol and increased fecal cholesterol 
following fucoxanthin diets.  
The anti-obesogenic effects of fucoxanthin have been reported in a human 
intervention trial in which consumption of fucoxanthin over four weeks 
significantly decreased BMI, body weight, and visceral fat area in mildly obese 
adults (BMI 25 – 30 kg/m2), with no adverse events reported, however, “mixed 
tocopherol” and “kelp extract” components were included in each capsule (Hitoe, 
2017). There is evidence to support a role for a proprietary product containing 
brown seaweed fucoxanthin, omega-3 fatty acids and punicic acid to exert anti-
obesigenic effects (Abidov et al., 2010). Consuming the fucoxanthin product over 
16 weeks significantly reduced bodyweight by 5.5kg and 5kg in premenopausal 
woman with non-alcoholic fatty liver disease (NAFLD) and normal liver fat (NLF), 
respectively, in comparison to the placebo. Furthermore, statistically significant 
improvements in liver fat content, systolic and diastolic blood pressure, and CRP 
were recorded in both cohorts consuming the fucoxanthin product, but not for the 
placebo; whilst significantly reduced waist circumference and serum triglycerides 
occurred in the Xanthigen-NAFLD group only. Interpretation of the role of 
fucoxanthin in this study is confounded by the additional components (omega-3 
fatty acids, punicic acids derived from pomegranate seed oil) also present in the 
treatment, thus more effort is needed to verify such activity with fucoxanthin 
alone. 
There is a need to undertake more research in healthy human participants to 
determine the role of fucoxanthin in altering lipid metabolism and its potential to 
reduce the risk of obesity. There is also scope to investigate other carotenoids 
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present in red seaweeds, such as lutein, β-carotene, and zeaxanthin, and 
carotenoids present in green seaweeds, such as lutein, β-carotene, echinenone, 
violaxanthin, neoxanthin, for their potential anti-obesigenic, anti-diabetic, or anti-
oxidant bioactivities (Bjornland and Aguilarmartinez, 1976; Owen, 1954; 
Parjikolaei, 2016; Pirian et al., 2016; Takaichi, 2011).  
As with polyphenols, cost-effective and scalable extraction protocols must be 
developed to produce sufficient quantities of fucoxanthin for clinical trials which 
assess bioactive efficacy and mechanism of action, and for prospective application 
as food ingredients or supplements.  
 Micronutrients 
Several studies indicate that seaweed consumption contributes to dietary mineral 
intake, and a higher intake of foods containing seaweed has been associated with 
sufficient calcium intake to prevent osteoporosis in Korean postmenopausal 
women (Desideri et al., 2016; Lim et al., 2015; MacArtain et al., 2007; Ruperez, 
2002). In contrast, one report indicates no meaningful contribution to dietary 
intake of Na, K, Mg, P, Ca, Fe, Mn, Zn, Se or Cu, when considering a portion size of 
5g/day DW of 17 brown seaweed and 17 red seaweed food products sourced from 
China, Japan, and South Korea (Dawczynski et al., 2007). This suggests great 
differences in mineral content between sources, and the data presented in Table 
2-12, Table 2-13, and Table 2-14 reiterate this.  
Seaweed could be important as a source of iron, where Sargassum spp. is reported 
to contain 156.9 mg iron per 100g DW, and the addition of this seaweed to both 
wheat and maize based bread increased the proportion of absorbed iron (Garcia-
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Casal et al., 2009). Elsewhere, Sargassum spp, improved iron absorption of a rice 
meal, where the iron content ranged from 81 – 290 mg/100g dry weight over 12 
months (highest iron content in July and the lowest in January) (Garcia-Casal et al., 
2007). 
Seaweeds are also considered a rich source of magnesium, but the bioaccessibility 
of magnesium varies between seaweeds, where Ulva pertusa, Laminaria japonica 
and Gloiopeltis furcate contained 10.47 mg/kg (41.8% bioaccessible), 6.55mg/kg 
(60.8% bioaccessible), and 8.18mg/kg (72.5% bioaccessible) magnesium, 
respectively, under simulated gastrointestinal conditions (Nakamura et al., 2012). A 
subsequent mouse study found that magnesium from Laminaria japonica was 
absorbed most efficiently, which indicates that magnesium intake from seaweed 
will vary between sources.  
 Vitamins 
Multivitamin supplements are commonly used in the general population to achieve 
recommended daily intakes, whereas seaweeds may represent an abundant source 
of both fat and water-soluble vitamins, as outlined in Table 2-15, Table 2-16, and 
Table 2-17. For example, the vitamin A content (retinol equivalents of carotenoid 
content, determined by HPLC) of a 5g dried portion varies from 14.5μg (2% RNI) in 
Ulva rigida to 70.5μg in Fucus spiralis (10% RNI) (Paiva et al., 2014; Taboada et al., 
2010). The vitamin C content varies from 0.41mg (1% RNI) in Ascophyllum nodosum 
to 9.24mg (23% RNI) in Undaria pinnatifida (MacArtain et al., 2007). Reported 
folate (vitamin B9) content varies from 7.5μg (3.75% RNI) in Ulva spp. to 5400μg in 
Ulva rigida (2700% RNI) (MacArtain et al., 2007; Taboada et al., 2010). Both 
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seasonal and geographical variation may explain such variation within the same 
genus. 
Only one study to date has analysed the vitamin D3 content of seaweeds, which 
reported 0.83mg/100g DW in Fucus spiralis and 1.05mg/100g dry weight in 
Porphyra spp.(Paiva et al., 2014). This equates to 41.5μg (415% RNI) and 63.5μg 
(635% RNI) per 5g dried portion in Fucus spiralis and Porphyra spp., respectively 
(European Parliament, 2011). Further characterisation studies are therefore 
required to corroborate such findings which suggest seaweed is a valuable dietary 
source of vitamin D. 
Seaweed is one of the few non-animal sources of vitamin B12, where 
Enteromorpha spp. and Porphyra spp. are reported to contain 63.58μg and 32.26μg 
per 100g DW, respectively (Watanabe et al., 1999). Elsewhere, Porphyra spp. 
contained 6.69μg (446% RNI), while other reports of vitamin B12 content of 
seaweeds do not specify whether it is present in the active form that can be 
absorbed and utilised in humans (MacArtain et al., 2007; Miyamoto et al., 2009). 
Seaweeds containing active vitamin B12 may favour individuals following a vegan 
diet, who are at risk of vitamin B12 deficiency, where the authors of a cohort study 
in children following a vegan diet for 4 - 10 years attributed healthy vitamin B12 
status to Nori consumption (Porphyra spp.) (Pawlak et al., 2014; Suzuki, 1995). 
Other seaweeds recorded in this study, such as hijiki, wakame, and kombu are 
understood to contain limited amounts of vitamin B12, or contain vitamin B12 
analogues that, because of structural differences, do not have vitamin B12 activity 
in humans (Watanabe et al., 2002). It is also reported that drying Porphyra spp. 
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inactivates vitamin B12, therefore processing methods may impact vitamin 
bioavailability (Yamada et al., 1999).  
In summary, seaweeds represent a source of both fat and water-soluble vitamins, 
where consumption may improve vitamin status. Owing to inter-species, seasonal 
and geographical variation in seaweed vitamin contents, however, characterisation 
of vitamin contents is required for prospective seaweed supplements, and there 
are a limited number of human studies, with few participants, that have 
investigated the bioavailability and activity of vitamins obtained from seaweeds. 
 Salt 
According to the National Diet and Nutrition Survey: Assessment of dietary sodium, 
adults aged 19 to 64 years consume, on average, 7.8 g, 8.0 g, and 8.6 g salt per day 
in Scotland, England, and Northern Ireland, respectively, which far exceed the 
recommended nutrient intakes (RNI) for salt (6g/day) and sodium (1.6g/day) 
(Bates, 2015). Of the dried seaweed products presented in Table 2-4 and Table 2-5, 
Laminaria digitata and Palmaria palmata may have a favourable Na/K ratio for 
application as salt replacing condiments (1.03 and 0.84, respectively) (Rodrigues et 
al., 2015). However, low portion sizes of seaweed may be required to prevent 
excessive salt intake, given that a 5g daily portion of Laminaria digitata can provide 
up to 0.35g salt and 0.26g sodium, whilst Palmaria palmata may provide up to 
0.27g salt and 0.15g sodium. These exceed salt and sodium levels in an equivalent 
amount of bacon (0.144g salt and 0.0575g sodium), which is regarded as a high salt 
food (Food Standards Agency, 2017). 
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 Iodine 
Iodine is a trace element required for the synthesis and function of 
triiodothyronine (T3) and thyroxine (T4) thyroid hormones. In Japan, where 
approximately 20 different types of seaweed are consumed, the majority being 
Wakame (Undaria spp.), Kombu (Laminaria spp.) and Nori (Porphyra spp.), iodine 
intake varies from 0.1 – 20mg/day (average intake = 1-3mg/day), which can exceed 
the upper tolerable limits of 600µg/day (EFSA) and 1100 µg/day (WHO) (EFSA, 
2014; WHO, 2011; Zava and Zava, 2011) 
The epidemiological evidence detailing the risks and benefits of iodine intake from 
seaweeds remains inconclusive. Seaweed consumption was associated with the 
increased risk of papillary carcinoma of the thyroid in postmenopausal Japanese 
women but not premenopausal women, whereas no association was established 
between seaweed consumption and total thyroid cancer risk or papillary carcinoma 
in premenopausal or postmenopausal women (Michikawa et al., 2012; Wang et al., 
2016). 
Iodine-induced hypothyroidism is reported in iodine-sufficient, kelp-consuming 
populations of Japan, and iodine-induced hyperthyroidism is also reported in 
individuals who consume kelp (Eliason, 1998; Konno et al., 1994; Mussig et al., 
2006). The use of seaweed supplements is not recommended for pregnant women, 
owing to the variability and excessive iodine content of seaweeds, with particular 
concern for kelp based products (Bath et al., 2017; Zimmermann and Delange, 
2004). Synergy between iodine supplementation and exposure to heavy metals in 
seaweed, such as mercury, may also impair thyroid function through the reduction 
of total T3 (Llop et al., 2015).  
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The iodine contents of the seaweeds presented in Table 2-18, Table 2-19, and 
Table 2-20 range from 0.06mg/100g (Ulva lactuca) to 624.5mg/100g (Laminaria 
digitata), but many characterisation studies do not quantify iodine. Desideri et al. 
(Desideri et al., 2016) found that 3.3g of Laminaria digitata would provide 4017% 
of the tolerable daily intake for iodine, and suggested that habitual intake of 
seaweed with an iodine content >45mg/kg DW could impair thyroid function. 
Given that Laminaria spp. is widely abundant and currently used as a food 
ingredient, characterisation of iodine is warranted in Laminaria products owing to 
such high iodine content. In contrast, a 5g portion of Porphyra tenera is reported to 
provide only 80µg iodine (Teas et al., 2004). 
Static in vitro digestion studies have reported seaweed iodine bioavailability in: 
Laminaria spp. (17 - 28%); Sargassum fusiforme (12%); Palmaria palmata (10%); 
Undaria pinnatifida (2 - 12%); Himanthalia elongata (4%); Porphyra spp. (5%); Ulva 
rigida (2%); Cooked Himanthalia elongate and Sacchoriza polyschides (<LOD) 
(Dominguez-Gonzalez et al., 2017; Nitschke and Stengel, 2015). Boiling has been 
shown to reduce the iodine content of Alaria esculenta (670 → 165 µg/g), Palmaria 
palmata (97 → 66 µg/g) and Ulva intestinalis (92 → 79 µg/g), which may be 
beneficial cooking instructions for industry to provide to the consumer (Nitschke 
and Stengel, 2016).   
In humans, urinary iodine excretion following Ascophyllum nodosum ingestion was 
reported as only 33% (potassium iodide control = 59%), where reduced iodine 
bioavailability was attributed to reduced release from the seaweed food matrix 
(i.e. bound to proteins, polysaccharides, polyphenols and pigments) (Hou et al., 
2000). In a Caco-2 and HT29-MTX co-culture, iodine uptake following an in vitro 
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digestion was only 4 – 6% (Hijiki), 2 – 4% (Kombu), 4 – 7% (Wakame), which also 
suggests limited liberation of iodine species, limited solubility, or limited 
absorption (Dominguez-Gonzalez et al., 2017; Nathans et al., 1960; Nicola et al., 
2012, 2009).  
Urinary excretion of iodine from Gracilaria verrucosa and Laminaria hyperborea 
were reported as 101% and 90%, respectively in an iodine sufficient population, yet 
85% and 61.5% in an iodine deficient population (Aquaron et al., 2002). Reduced 
urinary iodine excretion in the deficient cohort was attributed to increased iodine 
storage in the thyroid, thus, seaweed consumption may improve iodine status in 
those at risk of iodine deficiency, as demonstrated in a vegan population 
(Krajcovicova-Kudlackova et al., 2003; Lightowler and Davies, 1998; Remer et al., 
1999).  
Iodine absorption from Laminaria japonica is estimated as 57-71%, however, and 
serum TSH was significantly increased above the normal limits in 4/6 participants 
who consumed 15g/day of Laminaria japonica for 7-10 days, in 4/14 consuming 
30g/day for 7-10 days, and 1/3 consuming 15g/day for 55-87 days, which 
corroborates previous evidence that kelp supplementation increased serum TSH 
over 4 weeks (Clark et al., 2003; Miyai et al., 2008). Urinary iodide excretion 
increased 30-fold and 44-fold from baseline (15g and 30g subgroups, respectively), 
but returned 7– 40 days after seaweed consumption ceased. Furthermore, iodine 
intake was improved without compromising thyroid function when 500mg of 
Ascophyllum nodosum containing 356µg iodine was given to healthy females for 14 
days (Combet et al., 2014). Urinary iodine concentrations significantly increased, 
reflecting sufficient intake and subsequent renal excretion. Plasma concentrations 
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of T3, T4 free T3, or free T4 were unchanged between pre- and post-intervention, 
whilst serum TSH significantly increased, albeit within the normal range.  
It is suggested that future human intervention studies should quantify iodine 
content of a seaweed food ingredient/supplement during product development, 
and urinary iodine concentration could be measured as a biomarker for iodine 
intake and bioavailability at time points throughout interventions (Katagiri et al., 
2016; Nitschke and Stengel, 2015). 
Efforts to disclose iodine contents on product labelling and the provision of cooking 
instructions represent strategies to prevent excessive iodine intake from seaweed 
food products. It is reported that only 22 of 224 seaweed-containing food products 
on sale in the UK disclosed iodine concentrations on their food labelling, while a 
total of 40 presented an estimate (Bouga and Combet, 2015). Some 26 products 
had the potential to exceed 600µg/day upper limits when serving suggestions were 
applied, but for the remaining 162, this was unknown. Guidance relating to an 
individuals’ iodine status and how seaweed consumption may benefit the 
individual could also ensure consumer safety.  
Variations in iodine concentration between seaweed species, season, and harvest 
location presents a challenge to the food industry, while there is limited and 
conflicting information as to how individual seaweeds may impact iodine status 
and thyroid health. Diligence regarding the long-term effects of seaweed 
consumption upon iodine status is needed, especially in non-consumers who wish 
to include seaweed into their diet.  
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 Heavy Metals 
A concern regarding seaweed consumption is exposure to heavy metals such as 
arsenic, aluminium, cadmium, lead, rubidium, silicon, strontium, and tin (Desideri 
et al., 2016). The contamination of seaweeds with heavy metals depends on 
habitat ecology, which has led to inconsistency in research findings. Seaweeds 
growing in contaminated sites, often a result of industry or poor sewage systems, 
accumulate heavy metals from the surrounding water and rocks, but seaweeds 
from contaminated sites have demonstrated little risk to human health due to 
heavy metal content (Phaneuf et al., 1999). Yet, perennial seaweeds suffer 
increased exposure to contaminants, and regular consumption may risk heavy 
metal toxicity in humans (Burger et al., 2012; Caliceti et al., 2002). The presence of 
arsenic, mercury, lead, and cadmium in 426 Korean dried seaweed products 
contained up to 0.2–6.7% of provisional tolerable weekly intakes when 8.5g 
seaweed was consumed per day (Hwang et al., 2010; Phaneuf et al., 1999). A 
concluding remark from this study called for continuous monitoring of heavy 
metals in seaweed-based food products, owing to differences in metal biosorption 
between species (Giusti, 2001; Jarvis and Bielmyer-Fraser, 2015; Murphy et al., 
2007). This is evident in Laminaria spp. whereby, 3.3–12.5 g/day of Laminaria 
digitata is reported to contain 24 – 90µg cadmium, which corresponds to 40 – 
150% of tolerable daily intake, while Laminaria japonica is reported to contain 0.45 
– 0.80 mg/kg, which exceeds maximum limits for seaweed product legislation in 
France (0.5 mg/kg DW) and Australia/New Zealand (0.2 mg/kg DW), but not China 
(1.0 mg/kg) (Desideri et al., 2016; Zhao et al., 2012). Table 2-18, Table 2-19 and 
Table 2-20 provide further details of the heavy metal content of several brown, red 
and green seaweeds, respectively, albeit there is limited information regarding the 
47 
 
toxicokinetics of heavy metals ingested from seaweeds to understand potential 
health risks. 
In a cross-sectional study of heavy metal concentrations in 3404 healthy Korean 
adults, urinary arsenic concentrations were significantly increased in both the 
second and third tertile for seaweed consumption (Park and Lee, 2013). Arsenic 
species were not determined in this study, whilst blood mercury was significantly 
higher in the highest consumers of seaweed versus the lowest consumer. 
Preliminary research shows that increased water temperatures can increase 
mercury absorption by fish, and the same biosorption of mercury may happen in 
seaweed (Pack et al., 2014). Considering global warming, trends in seaweed heavy 
metal content should also be monitored, in addition to the presence of rare earth 
elements, recently identified in northwest Mediterranean seaweeds (Squadrone et 
al., 2017). Ultimately, the extraction of bioactive or nutritional components from 
seaweeds may mitigate excessive heavy metal ingestion, which can be mutagenic 
and carcinogenic to humans, whilst the placental transfer of heavy metals from the 
mother to the foetus can cause neurological, developmental, and endocrine 
disorders in infants (Caserta et al., 2013; Koedrith et al., 2013; Taylor et al., 2014).  
 Arsenic 
A major consideration for the exploitation of seaweeds as health foods or 
functional food ingredients is the need to speciate and quantify the levels of 
arsenic present in seaweed products. Arsenic species may be categorised as toxic 
(inorganic arsenic, iAs - class I carcinogen), non-toxic (arsenobetaine), and 
potentially toxic (fat-soluble arsenic, arsenosugars, and other organoarsenicals) 
(Feldmann and Krupp, 2011). The health risks pertained to inorganic hydrogen 
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arsenate species concern DNA damage, which predispose carcinogenesis, and 
consumption of iAs has been shown to increase the incidence of lung, bladder, 
skin, and kidney cancer and has also been linked with skin lesions, cardiovascular 
disease, neurological effects, and diabetes (Arslan et al., 2017; Khan et al., 2017; 
Taylor et al., 2017).  
Most arsenic species in seaweeds are arsenosugars, typically ligated to glycerol, 
sulphonate or phosphonate. Arsenosugars resist degradation in the stomach, and 
upon entering the lower gastrointestinal tract, they are metabolised to at least 12 
different metabolites, including dimethylarsinate (DMA), methylarsinate (MA), and 
dimethylarsinoylethanol (DMAE), but the toxicology of these metabolites is 
unknown (Andrewes et al., 2004; Feldmann and Krupp, 2011; Francesconi et al., 
2002; Van Hulle et al., 2004).  
Speciation and concentration of arsenic in brown seaweeds (Ascophyllum 
nodosum, Laminaria digitata, Fucus vesiculosus, Fucus spiralis, Alaria esculenta, 
and Saccharina latissima); red seaweeds (Porphyra umbilicalus, Chondrus crispus, 
Gracliaria vermiculophylla, and Palmaria palmata); and green seaweeds (Ulva 
prolifera and Ulva lactuca) revealed that total arsenic ranged from 4.1 – 111 µg/g, 
with the majority of arsenic present as arsenosugars (iAs was <1.0 µg/g). (Caserta 
et al., 2013; Ronan et al., 2017). The exception was Laminaria digitata, which 
contained 2.8-20 µg/g iAs (USA) and 2.2 – 87 µg/g iAs (Ireland), which represents a 
large proportion of the total arsenic contents of Laminaria digitata, reported to 
range from 36 – 131 µg/g DW (Desideri et al., 2016; Ronan et al., 2017; Taylor and 
Jackson, 2016). In contrast, Laminaria japonica sourced from China contained 0.16 
– 0.58 mg/kg iAs, which is below maximum limits set by China (1.0 mg/kg DW), 
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France (3 mg/kg DW), and Australia/New Zealand (1 mg/kg DW) (Food Standards 
Australia New Zealand, 2013; French Food Safety Agency, 2009; Zhao et al., 2012). 
Such variation in iAs contents may warrant regular testing for inorganic arsenic 
within Laminaria spp. food products. 
Another recent study reported that iAs content (µg/g) was negligible in 23 seaweed 
food products except for: Hijiki (19.83); Agar (0.06); Nori (0.03), where total arsenic 
(µg/g) was: Hijiki (83.7) > Kombu (51.2) > Kelp Seasoning (43.5) > Arame (41.6) > 
Wakame (34.7) > Dried Red Seaweed (35.2) > Nori (19.4) > Dulse (12.1) > Agar 
(0.23) > Kelp Noodles (0.08) (Taylor et al., 2017). The amount of iAs within 112 
edible seaweed products sold in Spain was also within safe limits, with the 
exception of Hijiki, where iAs ranged from 41.6 to117 µg/g (Almela et al., 2006).  
Inclusion of 3% Hijiki powder has caused arsenic poisoning in rats, and there are 
current recommendations against the consumption of Hijiki in Asia, Australia, 
Europe and the USA, owing to its public health risk (Food Safety Authority of 
Ireland, 2015; Food Standards Agency, 2004; Food Standards Australia New 
Zealand, 2016; Government of Hong Kong Centre for Food Safety, 2011; Superior 
Health Council of Belgium, 2015; Yokoi and Konomi, 2012). Seaweeds such as 
Arame, Wakame, Kombu, and Nori, however, are suggested as safe products to eat 
because they contain <0.3 µg/g iAs, which is encouraging for food ingredient 
applications (Rose et al., 2007).  
The amount of potentially bioaccessible arsenite (As III), arsenate (As V), 
methylarsonate (MMA), and dimethylarsinate (DMA) following the in vitro 
digestion of Laminaria japonica, Undaria pinnatifida, Hizikia fusiformis, Porphyra 
yezoensis, and Enteromorpha prolifera was low enough to indicate no hazard of 
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inorganic arsenic to human health (Zhao et al., 2014). However, the cooking 
process has been shown to increase iAs species within Porphyra spp. and Hijika 
fusiforme, after baking and boiling, respectively, whilst soaking, cooking, boiling, 
and washing/soaking seaweeds reduced total arsenic by 58.8%, 91.5%, 50%, and 
60% respectively (Hajeb et al., 2014; Laparra et al., 2003).  
Studies investigating the bioavailability of arsenic from Porphyra spp. have been 
carried out, where Wei et al. (Wei et al., 2003) reported that total urinary As 
peaked (average = 92.5 ng/ml), after 20 – 30 hours, resulting in a 20 fold increase 
in DMA, before returning to normal levels after 80 hours. Another study showed 
that arsenic metabolites, DMA and 2-dimethylarsinoyl ethanol (DMAE), were 
detected in urine of 5 volunteers whom consumed 20 – 25g of Laminaria spp. (total 
As = 43.2 µg/g), where peak arsenic/creatinine ratio was 228, 158, 141, 72, and 70 
ng/ml and levels normalised after 80 hours (Van Hulle et al., 2004).  
Consumption of 10g/day Nori, Kombu or Wakame for 3 days, followed by a 3-day 
washout between seaweeds, demonstrated increased arsenosugars, DMA, thio-
DMAA, and thio-DMAE in 24h urine samples following seaweed consumption, 
which varied between seaweeds and individuals (Taylor et al., 2017). Toxic thio-
DMA was only present at trace levels, and the authors identified thio-DMAE and 
thio-DMAA as unique arsenosugar metabolites and suggested their use as a urinary 
biomarker for dietary intake of arsenic from seaweeds. 
The arsenosugars present in seaweed are demonstrated to resist cooking and in 
vitro digestion processes, and have been suggested, in part, to be absorbed into 
the hepatic portal system intact (Almela et al., 2005). Human studies have shown 
considerable differences in the rate of excretion of arsenosugars ranging from 4-
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95% (Taylor et al., 2017). The high variability associated with arsenosugar 
metabolism may be attributable to interpersonal differences in endogenous 
digestion, gut microbiota composition and activity, passage across the intestinal 
barrier, or transformation in the liver (Taylor et al., 2017). Thus, there is a need to 
characterise the metabolic fate of arsenosugars in order to clarify the safety 
associated with arsenosugar rich seafoods (Mania et al., 2015).  
Whilst there are efforts by regulatory bodies to provide guidance in relation to 
arsenic intake, for example, the UK Food Standards Agency has advice to avoid 
against consuming Sargassum fusiforme (Hijiki), owing to significant food safety 
concerns over high levels of iAs, there is a need for clearer regulation and guidance 
in the permissible arsenic content of foods (Food Standards Agency, 2004). Regular 
environmental assessment and analysis of the arsenic species present in seaweed-
containing food products may be required to ascertain exposure and potential 
toxicity of heavy metals to alleviate health risks (Food Standards Australia New 
Zealand, 2013; Hwang et al., 2010). Indirect exposure to arsenic could also be a 
factor if seaweed is included in farming practises (Adamse et al., 2017; Castlehouse 
et al., 2003). Despite this, the majority of edible seaweeds have been reported to 
contain heavy metals in safe amounts. As with iodine, it is suggested that food 
regulation should ensure the disclosure of heavy metal contents on food labelling, 
with legal limits for seaweed iAs (Brandon et al., 2014). Cooking methods and food 
processing procedures may help to reduce the amount of heavy metal present in 
edible seaweeds, but the greatest challenge to the regulatory bodies in developing 
safe limits is the inter-individual differences in biotransformation, metabolism, and 
excretion. Whilst the greatest challenge to industry is the high within-species 
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variability of arsenic in the seaweed, and the potential costs of regularly 
monitoring product(s).  
 Whole seaweeds: Impact of habitual intake on health 
Whilst this review highlights the lack of human intervention trials investigating the 
potential risks and benefits of consuming seaweed components, some 
observational evidence does exist. Epidemiological evidence indicates that 
seaweed-containing diets are inversely associated with all-cause mortality and 
cardiovascular disease mortality in Japanese adults; yet, Korean men with 
metabolic syndrome are reported to consume significantly more seaweed than 
those without metabolic syndrome, although no mechanistic insight was 
disseminated (Nanri et al., 2017; Shin et al., 2009).   
Consumption of Porphyra spp. was inversely associated with breast cancer risk in 
premenopausal women, but not postmenopausal women, and no association was 
found between Undaria pinnatifida consumption and breast cancer risk (Key et al., 
2010; Teas et al., 2011; Y. J. Yang et al., 2010). A study by Michikawa et al. 
(Michikawa et al., 2012) identified a positive association between seaweed 
consumption and the risk of thyroid cancer (especially papillary carcinoma) in 
postmenopausal women, whilst Wang et al. (Wang et al., 2016) did not find an 
association between seaweed intake and thyroid cancer incidence in 
premenopausal or in postmenopausal women. A case-controlled study by 
Hoshiyama et al. (Hoshiyama et al., 1993; Hoshiyama and Sasaba, 1992) implicated 
an inverse relationship of seaweed with stomach and colon cancer, nevertheless 
interpretation warrants caution in light of the low sample power of the studies. 
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An inverse association is also reported between Undaria pinnatifida, Sargassum 
fusiforme, and Porphyra spp. intake and allergic rhinitis prevalence in pregnant 
Japanese women (n = 1002) (Miyake et al., 2006). The study did not measure 
iodine intake or iodine status, which could have contributed to the knowledge of 
iodine intake from seaweeds during pregnancy, where current recommendations 
in Australia and New Zealand limit brown seaweed intake to one portion per week 
in pregnant women (Food Standards Australia New Zealand, 2011). There are also 
concerns regarding the potential for seaweed to contribute to food borne 
infections as noted by reports of Norovirus contamination of Enteromorpha spp., 
and the presence of polycavernoside A toxin in Gracilaria edulis (Haddock and Cruz, 
1991; Park et al., 2015; Yotsu-Yamashita et al., 2004).  
Current Asian populations are reported to consume less seaweed than previous 
generations, shifting towards a high energy and low fibre westernised diet, which 
promotes the development of metabolic syndrome, and has increased the number 
of iodine deficient individuals in Japan (Katagiri et al., 2015; Zhou et al., 2003). One 
recent intervention study in a European population concluded that Palmaria 
palmata consumption could improve iodine status in adults, where serum thyroid 
stimulating hormone (TSH) was significantly increased (within the normal clinical 
range) following 5g/day Palmaria palmata for 28 days (Allsopp et al., 2016). The 
authors of this study highlighted the need to characterise seaweed composition 
when undertaking human interventions to help ascertain which components of 
seaweed impact on health, immune function and disease risk. Whilst the evidence 
from observational studies discussed above may provide indications of potential 
benefits, the outcomes must be treated with considerable caution and attempts 
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made to verify these observations using randomised controlled trials with suitable 
biomarkers, as well as supportive in vitro and in vivo animal studies to elucidate the 
mechanisms of action. 
 Conclusion  
Edible seaweeds are a rich and sustainable source of macronutrients (particularly 
dietary fibre) and micronutrients, but if seaweeds shall contribute towards future 
global food security, legislative measures to ensure monitoring and labelling of 
food products are needed to safeguard against excessive intakes of salt, iodine and 
heavy metals. 
Whilst the heavy metal concentration in edible seaweeds is generally below toxic 
levels, bioaccumulation of arsenic is a risk, and more studies concerning heavy 
metal toxicokinetics are needed. A trade-off between iodine and/or heavy metal 
ingestion and the amount of whole seaweed needed to obtain meaningful 
amounts of PUFAs, protein, or dietary fibre may limit portion size. Therefore, the 
extraction of individual components from the complex seaweed matrix is a 
legitimate strategy to create value-added products, where the efficacy of novel 
bioactive components extracted from seaweeds are increasingly studied as agents 
to combat non-communicable diseases. 
Looking ahead, more human intervention studies are needed to establish how 
chronic consumption of whole seaweeds and their extracted bioactive components 
impact human health, with defined health-related end points. Mechanisms of 
action must also be elucidated to substantiate any future claims associated with 
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seaweed consumption and human health benefits, to suffice application within 
food and nutraceutical industries. 
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Table 2-2. Macronutrient content of red seaweeds 
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Table 2-2 continued. Macronutrient content of red seaweeds 
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Table 2-3. Macronutrient content of green seaweeds 
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Table 2-3 continued. Macronutrient content of green seaweeds 
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Table 2-4. Nutritional information for a selection of seaweed products sold throughout the UK and the Republic of Ireland. 
%RNI Per 5g Portion 
Seaweed Product Energy (Kcal) Fat  Saturated Fat  Carbohydrate  Sugar Protein  Salt  Dietary Fibre 
Brown Seaweed         
Alaria esculenta 0.21 0.10 0.18 0.03 0.01 1.30 3.75 6.52 
Alaria esculenta ** 0.86 0.09 - 0.88 - 2.00 - - 
Ascophyllum nodosum1 - - - 0.43 - 0.24 - 3.33 
Fucus vesiculosus 0.21 0.05 0.08 0.15 0.07 1.00 0.11 4.67 
Himanthalia elongata 0.24 0.05 0.08 0.15 0.08 1.00 4.75 5.25 
Himanthalia elongata 0.24 0.05 0.08 0.15 0.08 1.00 4.75 5.25 
Laminaria digitata 0.24 0.14 0.23 0.04 0.01 1.40 3.67 5.35 
Laminaria digitata 0.31 0.14 0.23 0.06 0.00 1.42 3.83 4.92 
Laminaria digitata ** 0.75 0.07 - 0.92 - 1.40 - - 
Laminaria spp. 0.69 0.03 0.03 0.86 0.01 1.18 5.83 3.68 
Saccharina latissima 0.24 0.05 0.08 0.15 0.10 1.00 3.75 5.27 
Saccharina latissima ** 0.51 0.04 - 1.17 - 1.10 - - 
Red Seaweed                 
Chondrus crispus 0.16 0.09 0.03 0.04 0.01 1.00 1.08 8.05 
Chondrus crispus 0.33 0.10 - 0.03 0.00 1.12 0.33 7.95 
Chondrus crispus ** 0.86 0.21 - 1.27 - 1.80 - - 
Palmaria palmata 0.80 0.18 0.25 0.15 0.71 1.48 4.48 7.95 
Palmaria palmata 0.24 0.11 0.08 0.03 0.01 2.00 3.00 6.23 
Palmaria palmata 0.59 0.11 0.10 0.44 0.06 1.38 4.08 6.15 
Palmaria palmata ** 0.71 0.21 - 0.96 - 2.10 - - 
Porphyra spp. 0.27 0.09 0.15 0.04 0.03 1.50 0.58 - 
Porphyra spp. ** 0.99 0.18 - 1.46 - 3.70 - - 
*Calculated from Dietary Reference Values for Energy (Scientific Advisory Committee on Nutrition, 2015).  ** Maximum values taken from a range. 
1 Reported as %RNI for a 2g serving suggestion. 2 Reported as %RNI for a 1g serving suggestion (ingredient) and recommended dose (2x 500mg capsules per day - supplement). 
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Table 2-4 continued. Nutritional information for a selection of seaweed products sold throughout the UK and the Republic of Ireland. 
%RNI Per 5g Portion 
Seaweed Product Energy (Kcal) Fat  Saturated Fat  Carbohydrate  Sugar Protein  Salt  Dietary Fibre 
Mixtures                 
Ascophyllum nodosum, 
Pelvetia canaliculata, 
and Fucus spiralis2 
- - - 0.21 - 0.10 - 1.67 
 
Ulva spiralis, Palmaria 
palmata, Saccharina 
latissima, Porphyra 
umbilicalis, and Alaria 
esculenta  
0.80 0.12 0.25 0.22 0.14 1.31 2.69 5.52 
Palmaria palmata, 
Undaria pinnatifida, 
Laminaria saccharina, 
Porphyra spp., and Ulva 
lactuca  
0.35 0.13 0.23 0.28 0.03 1.60 1.75 5.98 
Brown, Red and Green 0.50 0.02 0.03 1.04 0.02 1.22 5.67 5.73 
*Calculated from Dietary Reference Values for Energy (Scientific Advisory Committee on Nutrition, 2015). ** Maximum values taken from a range. 
1 Reported as %RNI for a 2g serving suggestion. 2 Reported as %RNI for a 1g serving suggestion (ingredient) and recommended dose (2x 500mg capsules per day - supplement). 
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Table 2-5. Nutritional information for a selection of seaweed products sold throughout the UK and the Republic of Ireland. 
%RNI Per 5g Portion 
Seaweed Product Na  K  
Na/K 
Ratio 
Ca Mg Mn Zn Fe I Cu 
Vitamin 
B1  
Vitamin 
B2  
Vitamin 
B3  
Vitamin 
B6  
Vitamin 
B12  
Vitamin C  Vitamin E  
Brown Seaweed                  
Alaria esculenta ** 14.38 11 1.36 8 15 2.33 1.79 7.24 589 2.83 2.75 0.38 0.15 22.14 16667 6.25 - 
Ascophyllum nodosum1 4.31 1.04 4.14 3.86 5.50 1.67 0.93 2.74 1017 93.33 0.06 0.01 0.69 - 62.67 0.25 0.68 
Fucus vesiculosus - - - - - - - - - - - - - - - - - 
Himanthalia elongata - - - 5 14 - 1.32 - - - - - - - 17 - - 
Himanthalia elongata - - - 5 14 - 1.32 - - - - - - - 7 - - 
Laminaria digitata - - - 5 11 - 1.58 - 5 - - - - - 10 - - 
Laminaria digitata - - - - - - - - - - - - - - - - - 
Laminaria digitata ** 16.25 16 1.03 9 13 2.67 1.51 4.02 17857 2.08 2.50 8.46 1.00 30.82 200000 0.23 1.11 
Laminaria spp. - 6 - 7 16 0.68 1.74 2.09 12150 4.50 - - - - - - - 
Saccharina latissima - - - 6 12 - 1.58 - - - - - - - trace - - 
Saccharina latissima ** 10.63 7 1.49 7 12 2.67 1.58 5.75 17857 1.25 - - - - - 0.23 - 
Red Seaweed                                   
Chondrus crispus - - - 27 12 - 3.68 12.13 6 - - - - 2.14 7 - - 
Chondrus crispus - - - - - - - - - - - - - - - - - 
Chondrus crispus ** 8.13 4 1.90 1 14 4.67 3.76 12.07 1071 2.33 - - - - 133333 0.38 - 
Palmaria palmata - - - - - - - - - - - - - - - - - 
Palmaria palmata - - - - 3 - - 4.83 3 - - - - 0.54 20 - - 
Palmaria palmata - 13 -  5 19.83 0.68 8.02 468 1.71 - - - - - - - 
Palmaria palmata ** 9.38 11 0.84 6 8 25.83 1.51 20.11 1964 4.50 3.50 0.96 0.56 3.21 3000000 3.50 - 
Porphyra spp. - - - - - - - - - - - - - - - - - 
Porphyra spp. ** 10.00 4 2.26 6 8 13.83 2.16 20.11 1964 3.29 3.00 11.15 2.88 40.00 6666667 13.88 412.50 
*Calculated from Dietary Reference Values for Energy (Scientific Advisory Committee on Nutrition, 2015).  ** Maximum values taken from a range. 
1 Reported as %RNI for a 2g serving suggestion. 2 Reported as %RNI for a 1g serving suggestion (ingredient) and recommended dose (2x 500mg capsules per day - supplement). 
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Table 2-5 continued. Nutritional information for a selection of seaweed products sold throughout the UK and the Republic of Ireland. 
%RNI Per 5g Portion 
Seaweed Product Na  K  
Na/K 
Ratio 
Ca Mg Mn Zn Fe I Cu 
Vitamin 
B1  
Vitamin 
B2  
Vitamin 
B3  
Vitamin 
B6  
Vitamin 
B12  
Vitamin 
C  
Vitamin 
E  
Mixtures                                   
Ascophyllum 
nodosum, Pelvetia 
canaliculata, and 
Fucus spiralis2  
2.18 0.55 3.94 1.76 2.68 1.50 0.75 1.60 279 
62.5
0 
0.06 0.01 0.61 - 0.09 0.17 1.55 
Palmaria palmata, 
Undaria pinnatifida, 
Laminaria 
saccharina, 
Porphyra spp., and 
Ulva lactuca 
- - - 8.54 5.65 - 1.32 - 1.46 - - - - 1.79 3 - 2.25 
Brown, Red and 
Green 
- 8.81 - 
43.6
1 
12.7
5 
8.33 2.27 9.33 1464 1.67 - - - - - - - 
*Calculated from Dietary Reference Values for Energy (Scientific Advisory Committee on Nutrition, 2015).   ** Maximum values taken from a range. 
1 Reported as %RNI for a 2g serving suggestion. 2 Reported as %RNI for a 1g serving suggestion (ingredient) and recommended dose (2x 500mg capsules per day - supplement). 
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Table 2-6. Amino acid content of brown seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Alaria esculenta 1 2.00 4.60 7.70 6.10 1.30 5.30 6.40 - 6.80 13.4 5.40 - 6.40 4.60 4.00 13.6 16.0 5.80 
Munda and 
Gubenšek 
(1976) 
Alaria esculenta 1  1.60 3.80 7.50 5.30 2.40 4.80 5.10 - 5.50 18.9 4.80 - 5.70 5.10 2.90 8.40 20.1 5.20 
Maehre et al. 
(2014) 
Ascophyllum 
nodosum  
1.06 3.12 5.65 4.17 1.96 3.67 4.02 - 4.12 5.20 3.41 - 4.27 3.06 1.92 8.41 13.1 3.77 Munda (1977) 
Chnoospora minima 2.20 4.20 8.10 5.30 2.20 5.10 5.40 - 5.90 8.10 4.20 - 6.20 4.50 2.10 12.2 14.8 6.20 
Lourenço et al. 
(2002) 
Chorda filum 1 0.80 1.70 3.10 2.20 1.60 2.00 2.50 - 2.00 3.60 2.30 - 3.00 2.20 1.40 5.20 5.30 2.40 
Munda and 
Gubenšek 
(1976) 
Chordaria 
flagelliformis 1 
1.90 4.50 7.10 5.10 2.70 4.80 5.00 - 6.00 8.80 5.20 - 6.20 4.80 2.90 9.30 11.2 4.40 
Munda and 
Gubenšek 
(1976) 
Colpomenia sinuosa 1.58 1.09 3.34 0.74 2.95 0.97 1.05 - 2.46 3.32 - - 2.09 3.32 2.29 3.85 6.06 1.92 
Tabarsa et al. 
(2012) 
Desmarestia 
aculeata 1 
0.80 1.80 2.90 1.80 1.80 1.80 2.50 - 2.30 2.90 1.90 - 2.60 1.60 1.40 4.90 4.90 2.40 
Munda and 
Gubenšek 
(1976) 
Dictyosiphon 
foeniculaceus 1 
1.70 3.70 5.80 4.70 2.20 3.80 3.80 - 4.60 5.90 4.70 - 4.90 3.80 2.40 9.00 9.10 3.60 
Munda and 
Gubenšek 
(1976) 
Dictyota dichotoma 1.67 2.45 4.80 3.34 0.41 2.75 2.25 - 3.29 3.16 - - 3.36 2.76 1.86 5.81 8.47 2.60 
Tabarsa et al. 
(2012) 
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 
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Table 2-6 continued. Amino acid content of brown seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Dictyota menstrualis 2.20 4.70 8.70 5.40 1.30 5.40 5.30 - 5.70 6.90 5.40 - 6.10 4.80 2.30 13.8 12.7 6.10 
Lourenço et al. 
(2002) 
Durvillaea 
antarctica (leaves) 
0.75 0.35 0.60 0.51 0.91 0.37 0.26 - 0.46 0.45 0.33 
<0.0
1 
0.22 
<0.0
1 
0.18 0.75 1.05 0.43 
Ortiz et al. 
(2006) 
Durvillaea 
antarctica (stem) 
1.18 0.16 0.27 0.19 0.42 0.19 0.28 - 0.19 0.83 0.15 0.10 0.29 
<0.0
1 
0.08 2.02 0.97 0.26 
Ortiz et al. 
(2006) 
Ectocarpus 
siliculosus 1 
1.40 4.10 6.80 3.90 2.50 4.50 4.90 - 5.00 7.70 4.40 - 5.60 3.90 3.10 9.80 10.7 4.70 
Munda and 
Gubenšek 
(1976) 
Fucus ceranoides  1.24 2.77 4.80 3.54 0.74 2.99 3.82 - 3.54 6.08 3.94 - 3.63 2.76 2.01 9.88 31.5 3.58 Munda (1977)  
Fucus vesiculosus  1.37 3.21 6.05 4.08 1.81 3.89 3.65 - 4.26 5.81 4.38 - 4.50 3.47 1.85 8.55 14.7 3.65 Munda (1977) 
Fucus vesiculosus 1 1.10 2.70 5.00 4.30 1.50 3.30 3.40 - 3.70 5.00 3.20 - 3.80 3.10 1.50 8.30 17.9 3.50 
Maehre et al. 
(2014) 
Fucus vesiculosus 1 0.50 0.70 1.20 0.90 - 0.80 1.20 - 0.70 1.20 0.70 - 1.40 0.50 0.50 2.70 2.40 1.20 
Munda and 
Gubenšek 
(1976) 
Himanthalia elongata 
1 
1.00 2.10 3.80 2.90 1.30 2.80 2.60 - 3.10 3.40 2.60 0.31 2.70 1.80 2.70 5.20 6.80 2.90 
Cofrades et al. 
(2010) 
Hizikia fusiforme 2 2.60 4.00 6.70 3.10 1.60 4.60 4.10 0.40 4.90 4.30 4.50 0.90 4.80 3.80 2.80 9.10 18.7 3.70 
Dawczynski et 
al. (2007) 
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 
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Table 2-6 continued. Amino acid content of brown seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Laminaria digitata 1 1.20 2.70 5.20 3.70 1.80 3.40 3.80 - 3.60 5.20 3.40 - 4.10 3.90 1.80 6.20 8.50 3.60 Munda (1977) 
Laminaria digitata 1 1.20 3.10 4.60 3.20 1.30 3.10 3.30 - 4.10 3.60 2.80 - 3.80 2.80 2.40 7.60 7.40 2.70 
Munda and 
Gubenšek 
(1976) 
Laminaria 
hyperborea 1 
1.20 2.20 4.50 3.40 1.60 3.10 3.50 - 3.50 6.20 3.00 - 3.80 3.50 1.60 5.90 8.60 3.50 
Maehre et al. 
(2014) 
Laminaria sp. 2 2.20 2.70 4.90 3.90 0.90 3.20 3.50 0.50 3.80 5.70 3.30 1.20 4.00 3.10 1.70 12.5 23.8 3.30 
Dawczynski et 
al. (2007) 
Padina gymnospora 2.50 4.70 8.80 5.70 1.00 5.60 5.40 - 5.70 7.20 5.30 - 6.30 4.60 2.50 13.1 13.4 5.40 
Lourenço et al. 
(2002)  
Padina pavonica 3.12 4.32 8.62 4.55 1.05 4.33 5.66 - 6.96 7.19 - - 7.37 5.44 4.39 12.7 17.1 5.23 
Tabarsa et al. 
(2012) 
Pelvetia canaliculata 
1 
0.50 0.90 1.70 1.30 1.00 1.80 1.80 - 2.20 2.20 1.00 - 2.30 1.50 0.70 4.10 10.7 2.00 
Munda and 
Gubenšek 
(1976) 
Pelvetica canaliculata 
1 
1.00 3.00 5.20 3.70 1.40 3.40 3.50 - 3.90 5.50 3.20 - 4.10 3.20 1.40 5.90 15.0 3.60 
Maehre et al. 
(2014) 
Sargassum 
naozhouense 
1.07 4.02 6.52 3.66 2.41 4.38 3.93 0.89 4.64 5.27 4.20 0.54 4.38 3.30 2.95 8.39 13.2 3.21 
Peng et al. 
(2013)  
Sargassum 
polycystum 
0.26 2.94 4.67 2.11 1.25 30.4 2.60 - 3.13 4.25 2.88 - 3.19 2.55 1.26 4.47 8.08 2.58 
Matanjun et al. 
(2009) 
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 
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Table 2-6 continued. Amino acid content of brown seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Sargassum vulgare 2.10 4.80 8.50 5.40 2.20 5.30 4.80 - 5.80 7.20 4.30 - 5.70 4.60 2.20 10.9 17.6 5.10 
Lourenço et al. 
(2002) 
Scytosiphon 
lomentaria 1 
1.60 4.20 7.20 4.70 2.40 4.30 5.40 - 4.80 7.10 4.90 - 6.80 4.40 3.10 10.0 11.9 5.00 
Munda and 
Gubenšek 
(1976)  
Undaria pinnatifia 2 2.50 4.10 7.40 5.60 1.70 4.70 4.40 0.70 5.20 4.70 5.20 0.90 5.10 3.60 2.90 8.70 14.5 4.00 
Dawczynski et 
al. (2007)  
Undaria pinnatifida 
(Blade) 1 
6.60 4.23 7.50 6.43 3.08 4.05 3.85 - 5.85 6.35 5.10 - 6.43 - 6.33 10.8 13.2 5.40 
Zhou et al. 
(2015) 
Undaria pinnatifida 
(Sporophyll) 1 
6.33 4.33 7.18 5.28 3.13 5.13 3.78 - 6.53 11.9 4.20 - 7.70 - 5.63 9.58 12.9 5.48 
Zhou et al. 
(2015) 
Undaria pinnatifida 1 6.80 3.50 5.30 2.40 3.50 5.50 6.00 - 7.30 8.60 6.50 0.82 6.40 4.80 10.0 12.2 13.5 6.20 
Cofrades et al. 
(2010) 
Undaria pinnatifida 1 1.71 5.08 8.61 4.00 0.14 4.85 2.92 - 5.85 9.76 8.82 0.33 6.58 4.43 2.10 7.56 12.1 4.18 
Taboada et al. 
(2013) 
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 
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Table 2-7. Amino acid content of red seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Acanthophora 
spicifera 
1.70 4.10 7.40 7.20 0.70 4.80 5.50 - 5.40 6.00 5.10 - 5.00 4.10 2.70 14.4 16.9 4.80 
Lourenço et 
al. (2002) 
Aglaothamnion 
uruguayense 
2.00 4.80 8.00 6.60 0.60 5.10 5.70 - 6.10 7.60 4.80 - 6.60 5.10 2.60 12.6 15.8 5.40 
Lourenço et 
al. (2002) 
Ahnfeltia plicata 3 1.00 3.50 5.40 6.60 1.40 3.70 4.40 - 5.80 5.50 15.4 3.20 6.50 6.00 4.60 10.5 9.40 5.10 
Parjikolaei et 
al. (2016)  
Callithamnion 
arbuscula 1 
3.70 13.9 21.6 14.1 9.40 14.0 16.3 - 17.1 20.6 13.2 1.60 17.3 13.7 11.1 32.1 38.1 15.6 
Munda and 
Gubenšek 
(1976) 
Chondrus crispus 3 2.10 3.90 6.60 6.30 1.80 5.20 4.80 - 5.40 6.70 9.00 3.40 6.70 5.80 2.40 11.2 11.7 5.70 
Parjikolaei et 
al. (2016) 
Corallina officinalis 1 0.50 1.40 2.10 1.90 0.90 1.50 1.50 - 2.00 2.10 1.70 0.40 2.40 1.20 1.10 4.70 3.70 1.80 
Munda and 
Gubenšek 
(1976) 
Cryptonemia 
seminervis 
2.20 4.60 7.90 8.10 1.00 6.10 5.70 - 6.20 6.50 8.10 - 5.40 6.40 2.70 10.1 13.0 4.60 
Lourenço et 
al. (2002) 
Cystoclonium 
purpureum 1 
3.40 10.5 15.2 12.3 5.80 9.90 10.6 - 13.1 13.5 12.9 5.10 12.7 8.90 7.80 21.8 23.4 11.3 
Munda and 
Gubenšek 
(1976) 
Delesseria sanguinea 
3 
1.50 3.90 6.00 5.50 1.70 4.10 4.90 - 5.00 6.30 6.60 2.40 6.10 12.7 2.90 10.6 14.4 5.20 
Parjikolaei et 
al. (2016)  
Dilsea carnosa 1 2.00 6.30 9.00 7.00 3.10 6.10 6.80 - 7.80 8.30 7.70 0.70 7.70 5.50 4.00 13.6 17.1 6.70 
Munda and 
Gubenšek 
(1976) 
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 3 Expressed as % total amino acid. 
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Table 2-7 continued. Amino acid content of red seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Dilsea carnosa 3 1.60 3.60 6.40 5.60 1.60 4.50 4.70 - 4.80 7.70 13.5 2.60 4.70 5.30 0.60 15.4 10.8 5.90 
Parjikolaei et 
al. (2016)  
Eucheuma cottonii 0.25 2.41 3.37 1.45 0.83 19.1 2.09 - 2.61 3.14 2.60 - 2.27 2.02 1.01 2.65 5.17 1.92 
Matanjun et 
al. (2009)  
Furcellaria 
lumbricalis 3 
1.40 3.80 6.10 4.90 1.40 5.90 4.70 - 5.70 5.70 16.2 3.70 6.10 6.50 0.70 9.30 10.7 5.60 
Parjikolaei et 
al. (2016)  
Gelidium microdon  - - - 5.32 4.17 4.42 - - - - 8.48 - - - - - - - 
Paiva et al. 
(2016) 
Gigartina stellata 1 2.50 4.60 7.20 9.10 2.50 5.00 5.60 - 5.60 7.00 9.00 1.20 9.80 4.60 6.50 13.2 12.6 6.30 
Munda and 
Gubenšek 
(1976) 
Gracilaria 
domingensis 
2.90 4.10 8.80 5.70 0.70 5.70 6.10 - 5.60 8.10 4.70 - 6.60 5.10 2.30 12.2 12.6 5.30 
Lourenço et 
al. (2002) 
Gracilaria edulis  3.30 1.10 0.37 1.91 1.69 1.31 2.98 - 1.71 2.64 3.27 - 0.73 - 0.56 4.64 13.1 0.84 
Sakthivel 
and Devi 
(2015) 
Gracilaria salicornia 1.43 3.03 7.66 7.71 7.75 3.27 3.29 - 4.14 7.55 7.58 - 7.56 3.98 7.59 5.39 7.59 3.46 
Tabarsa et 
al. (2012) 
Gracilaria tenuifrons 2.40 4.80 8.20 6.60 1.30 5.10 5.60 - 6.10 7.40 6.00 - 6.30 4.20 2.40 11.5 13.8 5.20 
Lourenço et 
al. (2002)  
Gracilaria 
vermiculophylla 3 
1.50 4.30 7.60 5.60 2.10 4.90 5.60 - 5.60 6.90 8.30 2.40 6.20 5.40 2.40 11.4 12.4 6.20 
Parjikolaei et 
al. (2016)  
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 3 Expressed as % total amino acid. 
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Table 2-7 continued. Amino acid content of red seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Hypnea charoides 0.66 4.85 7.23 6.49 1.68 5.60 5.13 - 6.14 5.23 6.36 2.81 5.06 4.79 2.60 8.86 9.84 4.49 
Wong and 
Cheung 
(2000) 
Hypnea japonica 0.69 4.48 9.79 6.66 1.85 3.72 4.59 - 5.63 5.74 6.68 2.91 5.42 4.54 2.79 9.84 11.0 4.75 
Wong and 
Cheung 
(2000)  
Hypnea musciformis  0.58 4.82 7.74 5.53 1.46 3.08 4.15 - 5.37 5.24 5.19 - 4.92 4.08 2.58 7.63 11.9 3.23 
Siddique 
(2013)  
Hypnea pannosa  0.64 4.21 8.48 4.56 1.62 3.29 6.27 - 5.58 4.79 6.83 - 4.77 4.42 2.62 8.65 10.7 4.39 
Siddique 
(2013) 
Laurencia flagellifera 1.50 4.60 7.70 10.2 0.50 4.70 5.40 - 6.00 6.80 4.30 - 5.60 4.20 3.70 13.0 15.3 5.10 
Lourenço et 
al. (2002) 
Ochtodes 
secundiramea 1 
0.16 0.36 0.77 0.60 0.18 0.47 0.46 0.27 0.41 0.76 0.59 0.10 0.54 0.47 0.30 1.13 1.08 0.49 
Tabarsa et 
al. (2012) 
Odonthalia dentata 3 1.60 4.40 6.40 6.90 1.70 5.10 5.20 - 5.60 5.90 6.10 3.00 5.70 13.6 1.30 11.4 10.4 5.70 
Parjikolaei et 
al. (2016)  
Palmaria palmata 1 1.80 6.50 11.3 8.90 3.10 7.10 7.10 - 9.60 12.2 6.00 0.50 9.60 9.70 4.70 13.1 21.3 8.40 
Maehre et 
al. (2014) 
Palmaria palmata 1 2.60 6.70 10.2 8.30 3.90 7.10 8.70 - 10.5 13.2 8.70 - 10.2 9.70 5.60 18.4 10.0 7.60 
Munda and 
Gubenšek 
(1976) 
Palmaria palmata 3 1.80 3.80 6.50 7.00 2.10 4.50 4.40 - 6.10 7.50 6.10 3.50 6.30 4.70 0.90 13.3 16.0 5.50 
Parjikolaei et 
al. (2016)  
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 3 Expressed as % total amino acid. 
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Table 2-7 continued. Amino acid content of red seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Phycodrys rubens 3 1.70 4.20 6.60 6.20 1.80 4.60 5.00 - 5.80 7.80 6.90 2.50 7.20 8.20 2.50 11.8 11.4 5.60 
Parjikolaei et 
al. (2016)  
Plocamium 
brasiliense 
2.10 5.40 8.10 7.90 0.40 6.80 5.60 - 6.70 7.90 6.70 - 6.80 5.20 2.30 12.4 11.2 6.00 
Lourenço et 
al. (2002) 
Plocamium 
Brasiliense 
0.21 0.53 1.01 0.70 0.25 0.68 0.64 0.27 0.59 1.22 0.76 0.17 0.81 0.59 0.46 1.58 1.54 0.74 
Tabarsa et 
al. (2012) 
Plumaria elegans 1 3.40 10.1 16.1 12.6 6.00 10.7 13.8 - 11.5 16.1 16.0 4.20 19.7 13.7 9.20 39.9 29.7 14.1 
Munda and 
Gubenšek 
(1976) 
Polysiphonia lanosa 1 1.70 7.00 11.0 12.1 5.70 17.6 9.90 - 7.50 9.10 10.4 2.30 10.4 6.80 8.70 20.2 19.6 10.2 
Munda and 
Gubenšek 
(1976) 
Porphyra 
acanthophora 
3.20 4.40 8.60 6.70 1.20 5.00 6.20 - 6.80 9.40 5.10 - 7.50 4.90 2.50 13.3 13.7 5.70 
Lourenço et 
al. (2002) 
Porphyra columbina  1.26 2.71 7.38 6.01 1.68 3.70 5.91 0.63 5.85 12.5 6.19 1.89 8.87 3.96 2.55 12.2 10.5 6.16 
Cian et al. 
(2014) 
Porphyra linearis 1 5.70 12.3 23.8 20.6 9.50 11.7 19.2 - 18.8 40.6 24.9 - 18.5 12.2 10.0 34.4 39.5 18.1 
Munda and 
Gubenšek 
(1976) 
Porphyra purpurea 1 2.20 3.44 5.32 2.99 1.37 7.82 5.01 - 4.80 8.05 9.00 0.46 7.54 3.80 2.94 6.66 8.30 4.63 
Taboada et 
al. (2013)  
Porphyra purpurea 1 4.00 10.0 17.9 13.4 5.70 9.60 13.7 - 19.7 30.3 16.0 - 14.9 12.3 10.0 24.9 29.7 12.6 
Munda and 
Gubenšek 
(1976) 
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 3 Expressed as % total amino acid. 
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Table 2-7 continued. Amino acid content of red seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Porphyra sp. 2 2.60 3.10 5.50 4.90 1.80 3.30 5.30 0.70 5.20 6.20 5.90 1.20 5.10 3.50 3.40 8.50 10.2 4.00 
Dawczynski 
et al. (2007) 
Porphyra sp. 2 2.40 3.30 5.90 5.20 1.70 3.50 5.20 0.70 4.50 4.20 5.90 1.30 4.10 3.60 3.20 8.20 9.30 4.90 
Dawczynski 
et al. (2007) 
Porphyra umbilicalis 1 5.70 13.3 28.0 20.5 4.50 16.8 21.1 - 24.5 39.5 24.0 3.20 23.9 16.9 17.1 37.8 44.1 23.6 
Cofrades et 
al. (2010) 
Pterocladiella 
capillacea 
4.40 3.30 6.10 9.30 1.10 5.10 5.00 - 4.70 5.60 5.10 - 5.30 4.90 3.80 10.7 15.6 5.30 
Lourenço et 
al. (2002)  
Pterocladiella 
capillacea  
- - - 5.34 4.21 5.24 - - - - 5.46 - - - - - - - 
Paiva et al. 
(2016) 
Vertebrata lanosa 1 2.00 7.20 9.90 12.6 1.80 8.20 7.80 - 7.60 7.60 7.00 2.10 8.90 10.8 5.40 12.3 16.3 7.70 
Maehre et 
al. (2014) 
1 Expressed as g/100g DW. 2 Expressed as g/16g Nitrogen. 3 Expressed as % total amino acid. 
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Table 2-8. Amino acid content of green seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Acrosiphonia sp. 1 1.60 6.90 9.60 8.00 5.10 7.40 8.10 - 10.6 13.2 8.90 - 12.6 7.80 5.60 19.3 17.6 8.30 
Munda and 
Gubenšek 
(1976) 
Caulerpa fastigiata 2.20 4.00 8.70 7.10 1.50 6.60 4.80 - 6.10 6.20 5.50 - 7.10 7.70 3.90 10.1 10.7 6.20 
Munda and 
Gubenšek 
(1976) 
Caulerpa lentillifera 1.44 5.06 7.79 1.22 1.58 20.0 5.84 - 6.18 6.88 5.71 - 5.14 4.29 3.33 8.33 13.5 5.49 
Matanjun et 
al. (2009)  
Caulerpa lentillifera 0.80 6.20 9.90 8.20 - 6.10 7.90 - 8.70 8.50 8.70 - 8.50 5.70 4.80 14.3 17.8 7.60 
Ratana-
arporn and 
Chirapart 
(2006)  
Caulerpa racemosa 2.90 4.10 8.30 6.50 1.00 5.40 5.70 - 5.70 6.50 5.10 - 6.80 4.60 2.60 9.90 14.6 5.40 
Lourenço et 
al. (2002) 
Cladophora rupestris 
1 
0.70 1.60 2.70 2.10 0.90 2.10 2.20 - 2.40 3.10 2.50 0.50 3.30 2.90 1.50 3.50 5.70 2.20 
Maehre et al. 
(2014) 
Cladophora rupestris 
1 
4.30 11.0 16.0 14.4 7.30 11.2 12.5 - 16.0 15.5 14.9 6.70 18.2 14.1 11.6 40.6 34.4 11.9 
Munda and 
Gubenšek 
(1976) 
Codium decorticatum 3.50 4.00 8.50 6.40 0.70 5.10 6.10 - 6.30 8.90 5.20 - 7.30 4.90 2.30 10.8 12.0 5.20 
Lourenço et 
al. (2002) 
Codium spongiosum 2.30 4.40 8.40 6.80 0.80 5.40 5.40 - 6.60 8.10 4.00 - 6.10 4.60 2.30 12.0 14.1 5.30 
Lourenço et 
al. (2002) 
Codium taylorii 2.70 4.40 8.20 7.50 2.00 6.10 4.50 - 6.90 6.70 3.80 - 5.40 7.90 2.80 10.6 11.3 5.80 
Lourenço et 
al. (2002) 
1 Expressed as g/100g DW. 
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Table 2-8 continued. Amino acid content of green seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Enteromorpha 
ahlneriana 1 
0.90 4.10 5.60 3.50 2.40 4.30 5.40 - 6.10 8.30 4.50 - 5.90 3.70 2.40 9.80 10.6 4.50 
Munda and 
Gubenšek 
(1976) 
Enteromorpha sp.  2.24 3.22 4.43 3.20 2.64 3.71 4.04 - 5.50 4.81 3.45 4.25 3.49 4.72 2.69 4.66 8.58 5.25 
Aguilera-
Morales et al. 
(2005) 
Ulva compressa  - - - 11.3 6.55 8.45 - - - - 14.1 - - - - - - - 
Paiva et al. 
(2016)  
Ulva fasciata 2.40 3.90 7.60 5.10 0.90 5.10 5.10 - 5.70 8.50 5.60 - 6.50 4.60 3.30 13.0 12.6 5.80 
Lourenço et 
al. (2002) 
Ulva intestinalis 1 2.10 5.90 9.50 6.40 2.30 7.40 8.00 - 8.40 14.7 7.40 1.40 8.50 6.60 3.80 14.6 18.2 7.80 
Maehre et al. 
(2014) 
Ulva lactuca 0.48 3.82 6.71 6.58 1.57 3.50 5.06 - 5.50 7.39 8.44 1.33 6.74 4.46 3.50 9.87 8.73 5.54 
Wong and 
Cheung 
(2000) 
Ulva lactuca 1.00 4.00 7.40 4.60 2.20 5.40 4.70 0.70 5.80 7.80 7.60 1.10 5.90 5.50 3.60 13.8 13.2 4.90 
Bikker et al. 
(2016) 
Ulva lactuca  1.39 4.76 8.25 6.50 2.38 2.70 6.31 - 9.15 9.16 6.19 1.94 6.65 4.12 5.99 12.9 12.9 6.94 
Yaich et al. 
(2011) 
Ulva lactuca 1 1.60 4.40 85.0 5.10 2.20 6.00 6.20 - 7.10 10.1 6.00 1.00 7.30 5.80 3.40 9.00 12.2 5.90 
Maehre et al. 
(2014) 
Ulva lactuca 1 3.70 13.9 21.6 14.1 9.40 14.4 16.3 - 17.1 20.6 17.2 1.60 17.3 13.7 11.1 32.1 38.1 15.6 
Munda and 
Gubenšek 
(1976) 
1 Expressed as g/100g DW. 
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Table 2-8 continued. Amino acid content of green seaweeds. 
 Essential Amino Acids (g/100g protein) Non-Essential Amino Acids (g/100g protein)  
Seaweed His Ile Leu Lys Met Phe Thr Trp Val Ala Arg Cys Gly Pro Tyr 
Asn 
+ 
Asp 
Gln 
+ 
Glu 
Ser Author 
Ulva lactuca  1.34 5.50 10.4 7.23 6.72 12.5 7.98 - 3.39 11.0 4.87 0.55 8.16 
< 
0.01 
4.35 14.9 15.1 8.33 
Ortiz et al. 
(2006) 
Ulva lactuca  1.52 2.17 4.51 2.54 0.59 2.84 3.11 - 3.92 4.33 3.79 - 3.97 3.79 2.34 4.97 7.07 2.87 
Tabarsa et al. 
(2012) 
Ulva reticulata 2.30 9.00 16.8 12.8 - 11.2 11.5 - 13.4 17.2 18.4 - 13.8 10.8 7.70 26.6 27.6 13.6 
Ratana-
arporn and 
Chirapart 
(2006)  
Ulva rigida 1.62 3.72 6.63 3.49 2.03 4.78 3.17 - 4.54 6.05 9.09 1.00 4.98 2.43 3.78 7.63 9.79 3.40 
Taboada et 
al. (2013)  
Ulva rigida  - - - 2.38 1.43 1.78 - - - - 2.99 - - - - - - - 
Paiva et al. 
(2016)  
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Table 2-9. Lipid content of brown seaweeds. 
Seaweed Country Harvested 
Total Lipid 
(g/kg DW) 
5g portion 
(%RNI) 
Saturates 
(% FA) 
MUFAs 
(% FA) 
PUFAs 
(% FA) 
PUFA/SF
A Ratio 
n-3 
PUFAs 
(% FA) 
n-6 
PUFAs 
(% FA) 
n-6/n-3 
Ratio 
Trans 
Fats (% 
FA) 
Author 
Alaria 
esculenta 
Norway June 15.0 0.11 37.4 25.4 33.2 0.89 20.4 12.8 0.63 - Maehre et al. (2014)  
Ascophyllum 
nodosum 
Norway 
September/
October 
12.6* 0.09 - - 30.0 - 8.0 22.0 2.75 - 
van Ginneken et al. 
(2011)  
Colpomenia 
sinuosa 
Iran - 15.0 0.11 51.9 32.9 15.3 0.29 7.7 7.6 0.99 - 
Rohani-Ghadikolaei et al. 
(2012)  
Durvillaea 
antarctica 
Chile November 8.0 0.06 25.8 38.1 34.4 1.33 10.8 22.0 2.04 0.3 Ortiz et al. (2006)  
Fucus 
vesiculosis 
Norway June 26.5 0.19 24.3 47.1 25.8 1.06 8.6 17.2 2.00 - Maehre et al. (2014)  
Fucus 
serratus 
France 
September/
October 
37.4* 0.27 - - 31.0 - 9.0 22.0 2.44 - 
van Ginneken et al. 
(2011)  
Fucus 
spiralis 
Portugal January 52.3 0.37 27.1 39.0 15.7 0.58 14.0 25.0 1.78 6.4 Paiva et al. (2014)  
Himanthalia 
elongata 
Spain - - - 39.0 17.9 43.0 1.10 34.7 8.1 0.23 - Cofrades et al. (2010)  
Himanthalia 
elongata 
Spain July 9.7 0.07 39.1 22.8 38.2 0.98 18.7 15.1 0.81 - 
Sanchez-Machado et al. 
(2004)  
Laminaria 
digitata 
Norway June 8.5 0.06 31.5 18.7 45.6 1.45 29.1 16.5 0.57 - Maehre et al. (2014)  
Laminaria 
hyperborea 
France 
September/
October 
18.1* 0.13 - - 53.0 - 39.0 14.0 0.36 - 
van Ginneken et al. 
(2011)  
Laminaria 
hyperborea 
Norway June 11.4 0.08 33.7 26.5 34.2 1.01 21.5 12.7 0.59 - Maehre et al. (2014)  
Laminaria 
ochroleuca 
Spain July 9.2 0.07 33.8 19.2 46.9 1.39 25.1 21.0 0.84 - 
Sanchez-Machado et al. 
(2004)  
Pelvetia 
canaliculata 
Norway June 37.4 0.27 21.2 42.2 34.0 1.60 9.3 24.6 2.65 - Maehre et al. (2014)  
* Total Fatty Acids (g/kg DW) 
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Table 2-9 continued. Lipid content of brown seaweeds. 
Seaweed Country Harvested 
Total Lipid 
(g/kg DW) 
5g portion 
(%RNI) 
Saturates 
(% FA) 
MUFAs 
(% FA) 
PUFAs 
(% FA) 
PUFA/SF
A Ratio 
n-3 
PUFAs 
(% FA) 
n-6 
PUFAs 
(% FA) 
n-6/n-3 
Ratio 
Trans 
Fats (% 
FA) 
Author 
Sargassum 
ilicifolium 
Iran - 20.0 0.14 55.2 27.5 17.4 0.32 8.2 9.2 1.12 - 
Rohani-Ghadikolaei et al. 
(2012)  
Sargassum 
naozhouense 
China July 10.6 0.08 33.6 10.4 18.8 0.56 1.6 13.2 8.25 4.0 Peng et al. (2013)  
Sargassum 
natans 
North 
Atlantic 
Ocean  
September/
October 
44.7* 0.32 - - 31.0 - 20.0 11.0 0.55 - 
van Ginneken et al. 
(2011)  
Sargassum 
polycystum 
Malaysia, 
Brunei, 
Indonesi
a 
- 2.9 0.02 51.3 28.4 20.3 0.40 9.6 9.4 0.98 - Matanjun et al. (2009)  
Undaria 
pinnatifida 
Ireland 
September/
October 
14.5* 0.10 - - 56.0 - 35.0 21.0 0.60 - 
van Ginneken et al. 
(2011)  
Undaria 
pinnatifida 
Spain - - - 39.0 14.7 46.3 1.19 36.5 9.8 0.27 - Cofrades et al. (2010)  
Undaria 
pinnatifida 
Spain April 10.5 0.08 20.4 10.5 69.1 3.39 44.7 22.1 0.49 - 
Sanchez-Machado et al. 
(2004)  
* Total Fatty Acids (g/kg DW) 
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Table 2-10. Lipid content of red seaweeds. 
Seaweed  Country Harvested 
Total Lipid 
(g/kg DW) 
5g portion 
(%RNI) 
Saturates 
(% FA) 
MUFAs 
(% FA) 
PUFAs 
(% FA) 
PUFA/SF
A Ratio 
n-3 
PUFAs 
(% FA) 
n-6 
PUFAs 
(% FA) 
n-6/n-3 
Ratio 
Trans 
Fats (% 
FA) 
Author 
Chondrus 
crispus 
France 
September/
October 
14.7* 0.10 - - 42.0 - 22.0 20.0 0.91 - 
van Ginneken et al. 
(2011)  
Eucheuma 
cottinii 
Malaysia, 
Brunei, 
Indonesia 
- 11.0 0.08 25.2 23.3 51.6 2.05 45.7 4.7 0.10 - Matanjun et al. (2009)  
Gracilaria 
corticata 
Iran - 18.0 0.13 58.7 22.0 19.1 0.33 7.8 11.2 1.44 - 
Rohani-Ghadikolaei et 
al. (2012)  
Gracilaria 
salicornia 
Iran April 20.0 0.14 48.9 16.4 17.3 0.35 8.0 10.1 1.26 - Tabarsa et al. (2012)  
Gracilaria 
gracilis 
Italy January 4.2* 0.03 34.9 12.5 51.8 1.48 2.4 49.8 20.75 - 
Francavilla et al. 
(2013)  
Gracilaria 
gracilis 
Italy October 3.1* 0.02 51.7 25.3 22.5 0.44 3.7 18.9 5.11 - 
Francavilla et al. 
(2013)  
Gracilaria 
gracilis 
Italy July 4.7* 0.03 37.3 20.0 42.7 1.14 4.3 38.1 8.86 - 
Francavilla et al. 
(2013)  
* Total Fatty Acids (g/kg DW) 
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Table 2-10 continued. Lipid content of red seaweeds. 
Seaweed  Country Harvested 
Total Lipid 
(g/kg DW) 
5g portion 
(%RNI) 
Saturates 
(% FA) 
MUFAs 
(% FA) 
PUFAs 
(% FA) 
PUFA/SF
A Ratio 
n-3 
PUFAs 
(% FA) 
n-6 
PUFAs 
(% FA) 
n-6/n-3 
Ratio 
Trans 
Fats (% 
FA) 
Author 
Gracilaria 
gracilis 
Italy April 6.7* 0.05 34.2 18.6 47.2 1.38 9.5 37.5 3.95 - 
Francavilla et al. 
(2013)  
Hypnea 
valentiae 
Iran - 28.0 0.20 67.4 23.6 9.2 0.14 2.5 6.7 2.68 - 
Rohani-Ghadikolaei et 
al. (2012)  
Ochtodes 
secundirame
a  
Brasil October 
35.4 
(12.1*) 
0.25 66.1 3.3 15.7 0.24 6.6 9.1 1.38 0.8 Gressler et al. (2011)  
Osmundea 
pinnatifida 
Portugal January 75.3 0.54 20.6 20.6 22.2 1.08 17.0 5.2 0.31 1.0 Paiva et al. (2014)  
Palmaria 
palmata 
Ireland 
September/
October 
18.2* 0.14 - - 66.0 - 63.0 3.0 0.05 - 
van Ginneken et al. 
(2011)  
Palmaria 
palmata 
Norway June 13.9 0.10 43.7 8.7 35.4 0.81 34.3 1.1 0.03 - Maehre et al. (2014)  
Palmaria spp. Spain September 18.0 0.13 60.5 10.7 28.9 0.48 25.5 2.1 0.08 - 
Sanchez-Machado et 
al. (2004)  
* Total Fatty Acids (g/kg DW) 
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Table 2-10 continued. Lipid content of red seaweeds. 
Seaweed  Country Harvested 
Total Lipid 
(g/kg DW) 
5g portion 
(%RNI) 
Saturates 
(% FA) 
MUFAs 
(% FA) 
PUFAs 
(% FA) 
PUFA/SF
A Ratio 
n-3 
PUFAs 
(% FA) 
n-6 
PUFAs 
(% FA) 
n-6/n-3 
Ratio 
Trans 
Fats (% 
FA) 
Author 
Plocamium 
brasiliense 
Brasil October 
37.4 
(9.3*) 
0.27 74.2 4.3 20.4 0.27 8.6 11.8 1.37 1.1 Gressler et al. (2011)  
Porphyra 
umbilicalis 
Spain - - - 35.7 9.5 56.4 1.58 50.7 5.6 0.11 - Cofrades et al. (2010)  
Porphyra 
spp. 
Spain August 10.3 0.07 65.0 18.9 16.1 0.25 7.2 8.0 1.11 - 
Sanchez-Machado et 
al. (2004)  
Porphyra 
spp. 
Portugal January 88.8 0.63 17.3 25.0 18.4 1.06 9.8 15.2 1.55 4.2 Paiva et al. (2014)  
Vertebrata 
lanosa 
Norway June 18.0 0.13 28.6 22.6 45.8 1.60 33.8 11.9 0.35 - Maehre et al. (2014)  
* Total Fatty Acids (g/kg DW) 
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Table 2-11. Lipid content of green seaweeds. 
Seaweed Country Harvested 
Total 
Lipid 
(g/kg 
DW) 
5g 
portion 
(%RNI) 
Saturate
s (% FA) 
MUFAs 
(% FA) 
PUFAs 
(% FA) 
PUFA/S
FA Ratio 
n-3 
PUFAs 
(% FA) 
n-6 
PUFAs 
(% FA) 
n-6/n-3 
Ratio 
Trans 
Fats (% 
FA) 
Author 
Caulerpa 
lentillifera 
Malaysia, 
Brunei, 
Indonesia 
- 11.1 0.08 46.4 36.8 16.8 0.36 7.6 8.0 1.05 - 
Matanjun et al. 
(2009)  
Caulerpa 
taxifolia 
Indonesia 
Septembe
r/October 
7.3* 0.05 - - 42.0 - 38.0 4.0 0.11 - 
van Ginneken et al. 
(2011)  
Cladophora 
rupestris 
Norway June 8.8 0.06 40.8 27.3 21.5 0.53 14.7 7.4 0.50 - 
Maehre et al. 
(2014)  
Enteromorpha 
spp. 
Mexico 
Winter 
1997 
22.4 0.16 - - 21.3 - 10.4 10.9 1.05 - 
Aguilera-Morales et 
al. (2005)  
Enteromorpha 
spp. 
Mexico 
Winter 
1998 
22.7 0.16 - - 18.4 - 10.2 8.3 0.81 - 
Aguilera-Morales et 
al. (2005)  
Ulva 
intestinalis 
Iran - 29.0 0.21 60.6 24.8 14.8 0.24 9.8 4.8 0.49 - 
Rohani-Ghadikolaei 
et al. (2012)  
Ulva 
intestinalis 
Norway June 22.0 0.16 25.0 22.4 37.1 1.48 31.3 5.8 0.19 - 
Maehre et al. 
(2014)  
Ulva lactuca Iran - 36.0 0.26 66.3 23.8 9.8 0.15 4.8 5.1 1.06 - 
Rohani-Ghadikolaei 
et al. (2012)  
* Total Fatty Acids (g/kg DW) 
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Table 2-11 continued. Lipid content of green seaweeds. 
Seaweed Country Harvested 
Total Lipid 
(g/kg DW) 
5g portion 
(%RNI) 
Saturates 
(% FA) 
MUFAs 
(% FA) 
PUFAs 
(% FA) 
PUFA/SF
A Ratio 
n-3 
PUFAs 
(% FA) 
n-6 
PUFAs 
(% FA) 
n-6/n-3 
Ratio 
Trans 
Fats (% 
FA) 
Author 
Ulva lactuca Chile November 3.0 0.02 33.8 36.7 18.2 0.54 6.6 8.7 1.32 0.4 Ortiz et al. (2006)  
Ulva lactuca Iran April 9.9 0.07 48.3 5.1 24.8 0.51 11.4 13.4 1.18 - Tabarsa et al. (2012)  
Ulva lactuca Tunisia July 78.7 0.56 69.0 24.3 6.7 0.10 - - - - Yaich et al. (2011)  
Ulva lactuca 
Netherland
s 
September/
October 
22.4* 0.16 - - 64.0 - 32.0 32.0 1.00 - 
van Ginneken et al. 
(2011)  
Ulva lactuca Norway June 13.3 0.10 26.9 16.3 42.6 1.58 32.1 10.5 0.33 - Maehre et al. (2014)  
* Total Fatty Acids (g/kg DW) 
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Table 2-12. Essential minerals present in brown seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Alaria 
esculenta 
Norway May 2010 - - - - 800 870 8.7 4.9 0.56 0.24 22 230 0.004 - Maehre et al. (2014)  
Alaria 
esculenta 
Scotland 
March - July 
2011 
- - - - - - 2.33 0.309 0.115 0.031 62.5 - - 0.011 Schiener et al. (2015)  
Ascophyllum 
nodosum 
Canada 
September - 
October 1995 
- - - - - 17.1 3.56 1.91 0.42 482 0.23 - - 0.016 Phaneuf et al. (1999)  
Colpomenia 
sinuosa 
Egypt April 2011 2451 919 2.67 - 377 114 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Colpomenia 
sinuosa 
Iran April 2008 424 3510 0.12 - 5227 - 1581 - 9.11 0.94 - - - - Tabarsa et al. (2012)  
Colpomenia 
sinuosa 
Iran - - - - - - 78.1  45.2 1.9 1.5 0.51 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Dictyota 
dichotoma 
Iran April 2008 634 3417 0.19 - 5257 - 1196 - 8.5 1.29 - - - - Tabarsa et al. (2012)  
Durvillaea 
antarctica 
New 
Zealand 
April 2004 5290 1560 3.39 4149 1410 - 1.37 0.99 0.37 0.509 29.1 773 0.004 0.044 Smith et al. (2010)  
Ecklonia 
radiata 
New 
Zealand 
August 2004 3080 5890 0.52 6337 1100 - 28.4 2.07 0.71 1.53 399 1301 0.007 0.261 Smith et al. (2010)  
Ecklonia spp. 
New 
Zealand 
- 3190 6590 0.48 7313 1160 - 4.25 2.66 0.57 0.181 371.9 - 0.02 0.01 Smith et al. (2010)  
Fucus 
distichus 
Canada 
September - 
October 1995 
- - - - - 38.3 3.65 7.46 0.29 212 0.291 - - 0.026 Phaneuf et al. (1999)  
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Table 2-12 continued. Essential minerals present in brown seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Fucus 
serratus 
UK - - - - - 7.34 - - - - - - - - - Marsham et al. (2007)  
Fucus spiralis Portugal January 2013 1429 975.9 1.46 - 118.1 163.2 - - - - - - - - Paiva et al. (2014)  
Fucus 
vesiculosis 
Spain - 5469 4322 1.27 - 938 994 4.20 3.71 5.50 - - - - - Ruperez (2002)  
Fucus 
vesiculosis 
Canada 
September - 
October 1995 
- - - - - 42.7 3.26 15.8 0.41 226 0.316 - - 0.044 Phaneuf et al. (1999)  
Fucus 
vesiculosis 
Norway May 2010 - - - - 1200 740 9.2 2.6 3.4 0.18 13 84 0.003 - Maehre et al. (2014)  
Himanthalia 
elongata 
Spain 
Purchased in 
2002 
3700 6739 0.55 - 909 826.6 1.81 3.77 4.09 - - 0.02 <.05 - Cofrades et al. (2010)  
Hormosira 
banksii 
New 
Zealand 
April 2004 5670 4290 1.32 7727 1530 - 23.4 1.27 12.04 1.09 104.1 413 0.015 0.155 Smith et al. (2010)  
Laminaria 
digitata 
Spain - 3818 11579 0.33 - 1005 659 3.29 1.77 - - - - - - Ruperez (2002)  
Laminaria 
digitata 
Norway May 2010 - - - - 1000 840 5.8 2.4 0.31 0.16 310 120 0.002 - Maehre et al. (2014)  
Laminaria 
digitata 
Scotland 
August 2010 
- October 
2011 
- - - - - - 23.3 3.09 1.15 0.313 624.5 - - 0.109 Schiener et al. (2015)  
Laminaria 
digitata 
UK - - - - - 18.2 - - - - - - - - - Marsham et al. (2007)  
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Table 2-12 continued. Essential minerals present in brown seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Laminaria 
hyperborea 
Norway May 2010 - - - - 800 640 12 2.2 0.65 0.17 350 160 0.003 - Maehre et al. (2014)  
Laminaria 
hyperborea 
Scotland 
August 2010 
- October 
2011 
- - - - - - 58.6 2.26 2.38 0.225 81.5 - - 0.289 Schiener et al. (2015)  
Laminaria 
longicruris  
Canada 
September - 
October 1995 
- - - - - 76.3 3.12 0.97 0.15 763 0.601 - - 0.04 Phaneuf et al. (1999)  
Macrocysti 
spp. 
New 
Zealand 
- 4120 11800 0.35 14064 3790 - 26.7 1.893 0.78 0.092 211.6 - 0.001 0.07 Smith et al. (2010)  
Padina 
pavonica 
Iran April 2008 927 2970 0.31 - 3188 - 250 - 10.33 1.21 - - - - Tabarsa et al. (2012)  
Pelvetia 
canaliculata 
Norway May 2010 - - - - 830 960 13 3.1 0.86 0.26 21 73 0.004 - Maehre et al. (2014)  
Saccharina 
latissima 
Scotland 
August 2010 
- October 
2011 
- - - - - - 68.3 2.33 2.3 0.267 278.2 - - 0.276 Schiener et al. (2015)  
Saccorhiza 
polyschides 
Portugal April 2012 
2296.
2* 
7654 0.30 - 911 797 7.9 6.5 0.8 0.3 - 232 - - Rodrigues et al. (2015)  
Sargassum 
ilicifolium 
Iran - - - - - - 81.7 58.9  2.2 1.6 0.28 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Sargassum 
linifolium 
Egypt April 2011 2201 1055 2.09 - 144 58 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
* Sodium content was not declared for these species. Values were calculated from the K content and the Na/K ratio provided.  
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Table 2-12 continued. Essential minerals present in brown seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Sargassum 
naozhouense
  
China July 2011 3250 4170 0.78 - 66.98 - 147 9.08 5.84 0.36 - 120 - - Peng et al. (2013)  
Sargassum 
muticum 
Portugal April 2012 
1726.
8* 
5756 0.30 - 918 1504 19 2.5 1.1 0.5 - 228 - - Rodrigues et al. (2015)  
Sargassum 
polycystum 
Borneo - 1362 8371 0.16  3792 487.8 68.2 2.15  0.03 0.766 - 1.14 - Matanjun et al. (2009)  
Undaria 
pinnatifida 
Spain - 7064 8699 0.81 - 931 1181 7.56 1.74 0.87 - - - - - Ruperez (2002)  
Undaria 
pinnatifida 
Spain - 5163 10700 0.48 - 925 833.3 13.3 6.08 0.85 - - 0.06 <0.05 - Cofrades et al. (2010)  
Undaria 
pinnatifida 
New 
Zealand 
April -
September 
2004 
3610 7120 0.51 8918 1280 - 13.3 2.29 1.01 0.676 17.1 479 0.007 0.074 Smith et al. (2010)  
Undaria 
pinnatifida 
New 
Zealand 
- 8720 12300 0.71 20447 860 - 16.8 1.07 0.79 0.079 10.07 - 0.001 0.029 Smith et al. (2010)  
* Sodium content was not declared for these species. Values were calculated from the K content and the Na/K ratio provided.  
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Table 2-13. Essential minerals present in red seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Ahnfeltia 
plicata 
Denmark 
September 
2011 
613 2001 0.31  1151 346 27.3 1.8 17.7 0.41  246 17 0.11 Parjikolaei et al. (2016)  
Ceramium 
spp.  
UK - - - - - 10.4 - - - - - - - - - Marsham et al. (2007)  
Chondrus 
crispus 
Spain - 4270 3184 1.34 - 420 732 3.97 7.14 1.32 - - - - - Ruperez (2002)  
Chondrus 
crispus 
Denmark 
September 
2011 
3059 3256 0.94 - 5398 930 48.8 7.4 65.3 0.51  289 61 0.11 Parjikolaei et al. (2016)  
Delesseria 
sanguinea 
Denmark 
September 
2011 
1261 1939 0.65 - 1730 370 71.3 4.9 86.2 1.2  128 34 0.11 Parjikolaei et al. (2016)  
Dilsea 
carnosa 
Denmark 
September 
2011 
3311 1304 2.54 - 267 424 10.8 11.2 0.5 0.49  157 - 0.03 Parjikolaei et al. (2016)  
Dumontia 
contorta   
UK - - - - - 3.87 - - - - - - - - - Marsham et al. (2007)  
Eucheuma 
cottonii 
Borneo - 1771 13155 0.13 - 329.6 271.3 2.61 4.3 - 0.03 0.942 - 0.59 - Matanjun et al. (2009)  
Furcellaria 
lumbricalis 
Denmark 
September 
2011 
1889 3478 0.54 - 1347 663 46.9 1.6 76.4 0.33 - 84 - 0.07 Parjikolaei et al. (2016)  
Gelidium 
microdon 
Azores, 
Portugal 
January 
2013 
433.0 1238 0.35 - 74.73  127.0 - - - - - - - - Paiva et al. (2014)  
Gracilaria 
vermiculophyl
la 
Denmark 
September 
2011 
1017 4912 0.21 - 401 314 35.2 2.4 50.2 0.15  109 - 0.05 Parjikolaei et al. (2016)  
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Table 2-13 continued. Essential minerals present in red seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Gracilaria 
edulis 
India - 409.0 90.97 4.50 - 
89.37
8 
0.013 0.005 0.001 - - - - - - Sakthivel and Devi (2015)  
Gracilaria 
compressa 
Egypt April 2011 2908 446 6.52 - 333 173 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Gracilaria 
verrucosa 
Egypt April 2011 2280 817 2.79 - 94 29 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Gracilaria 
gracilis 
Portugal April 2012 1953* 6510 0.30 - 344 175 9 2.5 2 0.4 - 226 - - Rodrigues et al. (2015)  
Gracilaria 
corticata 
Iran - - - - - - 18.3 85.0  3.2 3.3 0.33 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Gracilaria 
salicornia 
Iran April 2008 1036 11380 0.09 - 948 - 67.35 - 4.16 0.57 - - - - Tabarsa et al. (2012)  
Grateloupia 
turuturu 
Portugal April 2012 960.8 1628 0.59 - 265 695 5 6.9 2.5 0.3 - 281 - - Rodrigues et al. (2015)  
Hypnea 
musciformis 
Egypt April 2011 2422 822 2.95 - 379 115 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Hypnea 
valentiae 
Iran - - - - - - 38.7 80.3  3.1 3.7 0.39 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Jania rubens Egypt April 2011 1318 283 4.66 - 332 287 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Kappaphycus 
alvarezzi 
India - - - - - - - 33.8 - - - - - - - Fayaz et al. (2005)  
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Table 2-13 continued. Essential minerals present in red seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Kappaphycus 
alvarezzi 
India 
September 
2004 - April 
2006 
2230 4100 0.54 - 840 740 65.94 1.85 1.1 0.76 - 120 - 3.88 Kumar et al. (2015)  
Mastocarpus 
stellatus 
UK - - - - - 8.91 - - - - - - - - - Marsham et al. (2007)  
Odonthalia 
dentata 
Denmark 
September 
2011 
924 2659 0.35 - 1382 342 67.6 2.8 47.9 0.81 - 105 30 0.12 Parjikolaei et al. (2016)  
Osmundea 
pinnatifida 
Portugal 
January 
2013 
2669.
2 
1464.
2 
1.82 - 411.5 418.6 - - - - - - - - Paiva et al. (2014)  
Osmundea 
pinnatifida 
Portugal April 2012 928.8 2610 0.36 - 541 480 37 5.8 1.2 0.5 - 173 - - Rodrigues et al. (2015)  
Osmundea 
pinnatifida 
UK - - - - - 4.426 - - - - - - - - - Marsham et al. (2007)  
Palmaria 
palmata  
Norway June 2012 - - - - 360 530 10 2.9 1.1 0.49 26 270 0.014 - Maehre et al. (2014)  
Palmaria 
palmata  
Denmark 
September 
2011 
319 4111 0.08 - 933 160 30.7 2.1 57.8 0.47 - 272 - 0.07 Parjikolaei et al. (2016)  
Palmaria 
palmata  
USA - - - - - - - - - - - 7.2 - - - Teas et al. (2004)  
Palmaria 
palmata  
Canada 
September 
- October 
1995 
- - - - - 100.9 3.12 3.58 0.81 173 0.094 - - 0.084 Phaneuf et al. (1999)  
Phycodrys 
rubens 
Denmark 
September 
2011 
837 1363 0.61 - 4573 1265 80.1 6 139.2 0.93 - 204 62 0.2 Parjikolaei et al. (2016)  
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Table 2-13 continued. Essential minerals present in red seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Polysiphonia 
spp. 
UK - - - - - 5.37 - - - - - - - - - Marsham et al. (2007)  
Porphyra 
umbilicais 
Spain - 1173 1407 0.83 - 687 283.3 18.2 4.23 2.72 - - 0.025 <.05 - Cofrades et al. (2010)  
Porphyra 
tenera 
Japan - - - - - - - - - - - 1.6 - - - Teas et al. (2004)  
Porphyra 
tenera 
Spain - 3627 3500 1.04 - 390 565 10.3 2.21 2.72 - - - - - Ruperez (2002)  
Porphyra 
columbina  
Argentina 
August - 
October 
2010 
414.2 1444 0.29  443.7 491.5 22 1.46 - 0.51 - 379.9 - - Cian et al. (2014) 
Porphyra 
spp. 
Portugal 
January 
2007 
2382.
6 
2481.
1 
0.96 - 124.5 396.4 - - - - - - - - Paiva et al. (2014)  
Porphyra 
spp. 
Canada 
September 
- October 
1995 
- - - - - 72.4 3.03 3.32 1.03 317 0.19 - - 0.067 Phaneuf et al. (1999)  
Porphyra 
spp. 
New 
Zealand 
May - 
October 
2004 
170 2170 0.08 914 850 - 56.9 35.2 1.26 2.362 6.4 547 0.016 0.13 Smith et al. (2010)  
Porphyra 
spp. 
New 
Zealand 
- 4240 4370 0.97 8554 210 - 15.89 4.503 1.854 0.424 4.503 - 0.038 0.07 Smith et al. (2010)  
Porphyra 
spp. 
UK - - - - - 5.16 - - - - - - - - - Marsham et al. (2007)  
Pterocladia 
capillacea  
Egypt April 2011 1792 832 2.15 - 305 208 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
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Table 2-13 continued. Essential minerals present in red seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Pterocladia 
capillacea  
Egypt April 2011 1002 942 1.06 - 139 141 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Pterocladia 
capillacea  
Egypt April 2011 2500 50 50.00 - 385 117 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Pterocladia 
capillacea  
Egypt April 2011 3966 837 4.74 - 1049 424 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Pterocladiella 
apillacea 
Azores, 
Portugal 
January 
2013 
635.6 2369 0.27  174  162.7 - - - - - - - - Paiva et al. (2014)  
Vertebrata 
lanosa 
Norway June 2012 - - - - 640 600 48 8.1 2 0.8 130 110 0.053 - Maehre et al. (2014)  
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Table 2-14. Essential minerals present in green seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Caulerpa 
lentillifera 
Thailand March - 970 - - 780 630 9.3 2.6 7.9 2.2 1.42 1030 - - 
Ratana-arporn and 
Chirapart (2006)  
Caulerpa 
lentillifera 
Borneo - 8917 1142 7.80 - 1874 1028 21.37 3.51 - 0.11 0.48 - 1.07 - Matanjun et al. (2009)  
Caulerpa 
racemosa 
India - 22060 1256 17.56 11510 14920 2536 1363 2.51 35 1.47 5.53 571.3 0.11 2.12 Mandlik et al. (2014)  
Cladophora 
rupestris 
Norway May 2010 - - - - 2900 1200 1000 3 24 1.7 6.3 87 0.007 - Maehre et al. (2014)  
Cladophora 
rupestris 
UK - - - - - 9.51 - - - - - - - - - Marsham et al. (2007)  
Codium 
tomentosum 
Egypt April 2011 1179 429 2.75 - 550 83 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Codium 
tomentosum 
Portugal April 2012 2045 3729 0.55 - 513 1046 28.3 1.8 1.9 0.6 - 180 - - Rodrigues et al. (2015)  
Enteromorpha 
spp. 
Canada 
September 
- October 
1995 
- - - - - 703.7 3.82 15.6 2.27 22.7 0.072 - - 0.32 Phaneuf et al. (1999)  
Enteromorpha 
spp. 
Mexico 
Winter 
1997 
7700 1100 7.00 - 2100 430 - 0.005 - - - 2.7 - - 
Aguilera-Morales et al. 
(2005)  
Enteromorpha 
spp. 
Mexico 
Winter 
1998 
9200 1800 5.11  2490 710 - 0.002 - - - 3.5 - - 
Aguilera-Morales et al. 
(2005)  
Ulva 
compressa 
Azores, 
Portugal 
April 2013 1322 693.3  1.91  242.6 1594 - - - - - - - - Paiva et al. (2014)  
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Table 2-14 continued. Essential minerals present in green seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Ulva intestinalis Egypt April 2011 2212 865 2.56 - 277 281 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Ulva intestinalis Iran - - - - - - 61.7 25.4 2.1 1.3 0.43 - - - - 
Rohani-Ghadikolaei et 
al. (2012)  
Ulva intestinalis Norway May 2010 - - - - 550 1500 600 2.5 13 0.49 13 120 0.003 - Maehre et al. (2014)  
Ulva intestinalis 
Philippin
es 
January - 
April 2016 
- - - - 4.9 - - - - - - - - - Escobido et al. (2016)  
Ulva lactuca Canada 
September 
- October 
1995 
- - - - - 248.6 3.33 40.9 1.92 136 0.06 - - 0.164 Phaneuf et al. (1999)  
Ulva lactuca Egypt April 2011 2191 770 2.85 - 286 173 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Ulva lactuca Egypt April 2011 637 168 3.79 - 647 56 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Ulva lactuca Egypt April 2011 2169 723 3.00 - 189 114 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Ulva lactuca Egypt April 2011 146 121 1.21 - 234 28 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Ulva lactuca Egypt April 2011 837 764 1.10 - 190 144 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Ulva lactuca Egypt April 2011 604 145 4.17 - 279 28 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
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Table 2-14 continued. Essential minerals present in green seaweeds. 
Essential Minerals (mg/100g) 
Seaweed  Country Harvested Na K 
Na/K 
Ratio 
Cl Ca Mg Fe Zn Mn Cu I P  Se Cr Author 
Ulva lactuca Egypt April 2011 333 443 0.75 - 1673 254 - - - - - - - - 
El-Said and El-Sikaily 
(2013)  
Ulva lactuca Iran - - - - - - 79.1 46.4 1.6 1.5 0.34 - - - - 
Rohani-Ghadikolaei et 
al. (2012)  
Ulva lactuca Norway June 2012 - - - - 350 2600 21 0.8 1.1 0.6 2.1 50 0.005 - Maehre et al. (2014)  
Ulva lactuca Iran April 2008 1805 2414 0.75 - 2782 - 199.4 - 2.11 1.45 - - - - Tabarsa et al. (2012)  
Ulva lactuca UK - - - - - 1.99 - - - - - - - - - Marsham et al. (2007)  
Ulva lactuca Ireland May 2015 1070 1150 0.93 960 2030 2420 35.3 1.7 8.6 2.2 - 256 <0.01 - Bikker et al. (2016)  
Ulva lactuca Tunisia July 2007 552 630 0.88 - 2720 3891 41 6.8 1.3 0.8 - 93 - - Yaich et al. (2011)  
Ulva reticulata Thailand May - 1540 - - 140 140 174.8 3.3 48.1 0.6 1.124 180 - - 
Ratana-arporn and 
Chirapart (2006)  
Ulva rigida Spain - 1595 1561 1.02 - 524.5 2094 283 0.6 1.6 0.5 0.8 210 - - Taboada et al. (2010)  
Ulva rigida 
Azores, 
Portugal 
April 2013 576.0 817.4 0.70 - 324.9 1775 - - - - - - - - Paiva et al. (2014)  
Ulva 
stenophylla 
New 
Zealand 
April 2004 190 790 0.24 672 1290 - 122.7 6.1 19.23 1.099 2.7 273 0.017 0.173 Smith et al. (2010)  
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Table 2-15. Vitamin contents of brown seaweeds.  
Vitamin (mg/100g DW) 
Seaweed 
Vitamin 
A 
Vitami
n D2 
Vitami
n D3 
α-
Tocop
herol 
Δ-
Tocop
herol 
γ-
Tocop
herol 
Vitami
n K1 
Vitami
n K3 
Vitami
n C 
Vitami
n B1 
Vitami
n B2 
Vitami
n B3 
Vitami
n B6 
Biotin 
(µg/kg 
DW) 
Folate 
(g/kg 
DW) 
Vitami
n B12 
(µg/kg 
DW) 
Author 
Ascophyllum 
nodosum  
- - - - - - - - 81.8 27 7.3 0 0.125 - 0.456 16.4 
MacArtain et 
al. (2007)  
Fucus 
spiralis 
1.41 0.21 0.83 51.1 trace trace trace trace - - - - - - - - 
Paiva et al. 
(2014)  
 
Laminaria 
digitata 
- - - - - - - - 355.3 1.38 1.38 612 64.1 - 0 61.9 MacArtain et 
al. (2007)  
 
Sargassum 
polycystum 
- - - 11.3 - - - - 34.5 - - - - - - - 
Matanjun et 
al. (2009)  
 
Undaria 
pinnatifida 
- - - - - - - - 1847 50.4 117 900 32.4 - 0.066 43.1 MacArtain et 
al. (2007)  
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Table 2-16. Vitamin contents of red seaweeds. 
 Vitamin (mg/100g DW) 
 
Seaweed 
Vitami
n A 
β-
Carote
ne 
Vitami
n D2 
Vitami
n D3 
α-
Tocop
herol 
Δ-
Tocop
herol 
γ-
Tocop
herol 
Vitami
n K1  
Vitami
n K3 
Vitami
n C 
Vitami
n B1 
Vitami
n B2 
Vitami
n B3 
Vitami
n B6 
Folate 
(g/kg 
DW) 
Vitami
n B12 
(µg/kg 
DW) 
Author 
Eucheuma 
cottonii 
- - - - 5.85 - - - - 35.3 - - - - - - 
Matanjun 
et al. 
(2009)  
 
Kappaphyc
us alvarezzi 
- 5.26 - - - - - - - - - - - - - - 
Fayaz et 
al. (2005)  
 
Osmundea 
pinnatifida 
1.2 - trace - 4.86 trace 14.2 0.92 1.64 - - - - - - - 
Paiva et al. 
(2014)  
 
Palmaria 
palmata 
- - - - - - - - - 690 3 10 100 0.25 
0.0026
3 
230 
MacArtain 
et al 
(2007)S43 
 
Porphyra 
umbilicalis 
- - - - - - - - - 1610.6 9.63 34.3 95.1 14.9 0.125 96.1 
MacArtain 
et al. 
(2007)  
 
Porphyra 
spp. 
- - - - - - - - - - - - - - - 250 
Watanabe 
et al. 
(1999)  
 
Porphyra 
spp. 
- - - - - - - - - - - - - - - 1338 
Miyamoto 
et al. 
(2009)  
 
Porphyra 
spp. 
1.27 - 0.17 1.05 27.3 1.01 0.18 trace trace - - - - - - - 
Paiva et al. 
(2014)  
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Table 2-17. Vitamin contents of green seaweeds. 
Vitamin (mg/100g DW) 
Seaweed Vitamin A 
α-
Tocophero
l 
Vitamin C Vitamin B1 Vitamin B2 Vitamin B3 Vitamin B5 Vitamin B6 
Biotin 
(µg/kg 
DW) 
Folate 
(g/kg DW) 
Vitamin 
B12 (µg/kg 
DW) 
Author 
Enteromorpha 
spp. 
- - - - - - - - - - 692 
Watanabe et 
al. (1999)  
 
Caulerpa 
lentillifera 
- 8.41 34.7 - - - - - - - - 
 
Matanjun et 
al. (2009)  
 
Ulva rigida 
0.29 1.97 94.2 4.7 1.99 < 5 1.7 < 0.1 0.12 1.08 60 
 
Taboada et 
al. (2010)  
 
Ulva spp.  
- - 1250 7.5 3.75 1000 - 0 - 0.0015 787.5 
 
MacArtain et 
al. (2007)  
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Table 2-18. Heavy metal content of brown seaweeds. 
Heavy Metal (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Al Author 
Alaria esculenta Norway May 2010 4.8 - 0.34 - - - >0.0005 - - Maehre et al. (2014)  
Alaria esculenta Scotland 
March - July 
2011 
0.73125 - - - 0.002625 - - 0.01 1.5975 Schiener et al. (2015)  
Ascophyllum 
nodosum 
Canada 
September - 
October 1995 
- 0.046 0.069 0.086 - - - - - Phaneuf et al. (1999)  
Colpomenia 
sinuosa 
Iran - - - - 0.43 - - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Colpomenia 
sinuosa 
Iran April 2008 - - - 0.52 - - - 2.58 - Tabarsa et al. (2012)  
Dictyota dichotoma Iran April 2008 - - - 0.45 - - - 2.36 - Tabarsa et al. (2012)  
Durvillae aantartica Chile - 1.52 0.0318 0.246 - - - - - - Almela et al. (2006)  
Durvillaea 
antarctica 
New 
Zealand 
April 2004 2.713 - - - 0.014 - 0.004 - - Smith et al. (2010)  
Ecklonia radiata 
New 
Zealand 
August 2004 5.132 - - - 0.061 - 0.017 - - Smith et al. (2010)  
Ecklonia spp. 
New 
Zealand 
- 3.6 0.15 - - 0.02 - 0.017 - - Smith et al. (2010)  
Eisenia bicyclis Japan - 2.24 0.0167 0.0549 - 0.0169 - - - - Almela et al. (2006)  
Eisenia bicyclis Japan - 2.52 0.135 0.0383 - 0.0218 - - - - Almela et al. (2006)  
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Table 2-18 continued. Heavy metal content of brown seaweeds. 
Heavy Metal (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Al Author 
Eisenia bicyclis Japan - 2.63 0.0135 0.0559 - 0.0239 - - - - Almela et al. (2006)  
Eisenia bicyclis Japan - 0.41 0.0292 0.0571 - 0 - - - - Almela et al. (2006)  
Eisenia bicyclis Japan - 2.66 0.0206 0.0549 - 0 - - - - Almela et al. (2006)  
Fucus vesiculosus  Norway May 2010 4.1 - 0.12 - - - 0.0011 - - Maehre et al. (2014)  
Fucus spiralis Portugal January 2013 - - - - - 118.1 - - - Paiva et al. (2014)  
Fucus vesiculosis Canada 
September - 
October 1995 
- 0.14 0.15 0.12 - - - - - Phaneuf et al. (1999)  
Fucus distichus Canada 
September - 
October 1995 
- 0.167 0.12 0.119 - - - - - Phaneuf et al. (1999)  
Himanthalia 
elongata 
Spain - 2.36 0 0.0389 - 0.0198 - - - - Almela et al. (2006)  
Himanthalia 
elongata 
Spain - 3.12 0.0202 0.0222 - 0.0126 - - - - Almela et al. (2006)  
Himanthalia 
elongata 
Spain - 2.13 0 0.0395 - 0.0115 - - - - Almela et al. (2006)  
Himanthalia 
elongata 
Spain - 3.26 - <0.04  <0.04 - - - - Cofrades et al. (2010)  
Hizikia fusiforme Japan 
- 
11.1 7.54 0.0621 - 0.0885 - - - - Almela et al. (2006)  
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Table 2-18 continued. Heavy metal content of brown seaweeds. 
Heavy Metal (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Al Author 
Hizikia fusiforme Japan 
- 
8.92 4.16 0.107 - 0 - - - - Almela et al. (2006)  
Hizikia fusiforme Japan 
- 
11.4 9.12 0.116 - 0 - - - - Almela et al. (2006)  
Hizikia fusiforme Japan 
- 
13.1 8.11 0.051 - 0.0537 - - - - Almela et al. (2006)  
Hizikia fusiforme Japan 
- 
9.39 6.16 0.116 - 0.006 - - - - Almela et al. (2006)  
Hizikia fusiforme Japan 
- 
12.4 8.03 0.0811 - 0 - - - - Almela et al. (2006)  
Hizikia fusiforme Japan 
- 
14.9 11.7 0.0948 - 0.0063 - - - - Almela et al. (2006)  
Hizikia fusiforme Japan 
- 
6.83 4.37 0.153 - 0.206 - - - - Almela et al. (2006)  
Hizikia fusiforme Japan 
- 
10.6 6.94 0.152 - - - - - - Almela et al. (2006)  
Hormosira banksii 
New 
Zealand 
April 2004 3.169 - - - 0.061 - 0.005 - - Smith et al. (2010)  
Laminaria japonica Japan 
- 
11.6 0.144 0.0908 - 0 - - - - Almela et al. (2006)  
Laminaria japonica Japan 
- 
10.4 0.0238 0.0074 - 0 - - - - Almela et al. (2006)  
Laminaria digitata Japan 
- 
6.57 0.0251 0.0343 - 0.0106 - - - - Almela et al. (2006)  
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Table 2-18 continued. Heavy metal content of brown seaweeds. 
Heavy Metal (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Al Author 
Laminaria digitata  Norway May 2010 6.4 - 0.01 - - - 0.0006 - - Maehre et al. (2014)  
Laminaria 
hyperborea  
Norway May 2010 5.5 - 0.048 - - - 0.0007 - - Maehre et al. (2014)  
Laminaria 
hyperborea  
Scotland 
August 2010 - 
October 2011 
6.73 - - - 0.116 - - 0.149 70.29 Schiener et al. (2015)  
Laminaria digitata Scotland 
August 2010 - 
October 2011 
7.31 - - - 0.0263 - - 0.1 15.98 Schiener et al. (2015)  
Laminaria 
longicruris 
Canada 
September - 
October 1995 
- 0.153 0.024 0.147 - - - - - Phaneuf et al. (1999)  
Macrocysti spp. 
New 
Zealand 
- 9.7 0.08 - - 0.03 - 0.005 - - Smith et al. (2010)  
Padina pavonica Iran April 2008 - - - 0.42 - - - 2 - Tabarsa et al. (2012)  
Pelvetia 
canaliculata  
Norway May 2010 2.8 - 0.048 - - - 0.0047 - - Maehre et al. (2014)  
Saccharina 
latissima 
Scotland 
August 2010 - 
October 2011 
7.5 - - - 0.113 - - 0.133 102.13 Schiener et al. (2015)  
Sargassum 
naozhouense  
China July 2011 - - 0.17 - - - - - - Peng et al. (2013)  
Sargassum 
ilicifolium  
Iran - - - - 0.75 - - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Undaria pinnatifida Japan 
- 
4.14 0 0.155 - 0.0113 - - - - Almela et al. (2006)  
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Table 2-18 continued. Heavy metal content of brown seaweeds. 
Heavy Metal (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Al Author 
Undaria pinnatifida Japan 
- 
4.52 0 0.102 - 0 - - - - Almela et al. (2006)  
Undaria pinnatifida Spain 
- 
4.62 0.112 0.19 - 0.11 - - - - Almela et al. (2006)  
Undaria pinnatifida Spain 
- 
2.8 0.0268 0.0227 - 0.0941 - - - - Almela et al. (2006)  
Undaria pinnatifida Spain 
- 
3.23 0.0371 0.0.2. - 0.244 - - - - Almela et al. (2006)  
Undaria pinnatifida Korea 
- 
4.6 0.106 0.215 - 0.0648 - - - - Almela et al. (2006)  
Undaria pinnatifida Japan 
- 
4.15 0.061 0.122 - 0.0795 - - - - Almela et al. (2006)  
Undaria pinnatifida Spain - 3.87 - <0.04  0.105 - - - - Cofrades et al. (2010)  
Undaria pinnatifida 
New 
Zealand 
April - 
September 
2004 
3.562 - - - 0.023 - 0.003 - - Smith et al. (2010)  
Undaria pinnatifida 
New 
Zealand 
- 3.4 0.01 - - 0.03 - 0.005 - - Smith et al. (2010)  
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Table 2-19. Heavy metal content of red seaweeds. 
Heavy Metals (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Author 
Chondrus crispus Spain 
- 
1.27 0.0357 0.0722 - 0.0348 - - - Almela et al. (2006)  
Chondrus crispus Spain 
- 
1.61 0.0842 0.0418 - 0.072 - - - Almela et al. (2006)  
Gracilaria corticata Iran - - - - 0.81 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Gracilaria edulis India - - - - - 0.0002    
Sakthivel and Devi 
(2015)  
Gracilaria salicornia Iran April 2008 - - - 0.24 - - - 0.92 Tabarsa et al. (2012)  
Hypnea valentiae Iran - - - - 0.45 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Kappaphycus 
alvarezzi 
India 
September 
2004 - April 
2006 
- - 1.00 0.56 - - 0.05 - Kumar et al. (2015)  
Osmundeap 
innatifida 
Portugal January 2013 - - - - - 421.6 - - Paiva et al. (2014)  
Palmaria palmata Japan - 1.26 0.0595 0.0877 - 0.152 - - - Almela et al. (2006)  
Palmaria palmata Canada 
September - 
October 1995 
- 0.032 0.049 0.21 - - - - Phaneuf et al. (1999)  
Palmaria palmata Norway June 2012 1.00 - 0.048 - - - 0.0005 - Maehre et al. (2014)  
Porphyra spp. Portugal January 2007 - - - - - 97.3 - - Paiva et al. (2014)  
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Table 2-19 continued. Heavy metal content of red seaweeds. 
Heavy Metals (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Author 
Porphyra spp. Canada 
September - 
October 1995 
- 0.029 0.022 0.018 - - - - Phaneuf et al. (1999)  
Porphyra spp. 
New 
Zealand 
May - October 
2004 
1.287 - - - 0.098 - 0.003 - Smith et al. (2010)  
Porphyra spp. 
New 
Zealand 
- 2.52 0.12 - - 0.041 - 0.001 - Smith et al. (2010)  
Porphyra tenera Japan 
- 
2.41 0.028 0.0089 - 0.0123 - - - Almela et al. (2006)  
Porphyra tenera Japan 
- 
2.32 0.0167 0.0235 - 0.0126 - - - Almela et al. (2006)  
Porphyra tenera Japan 
- 
2.41 0.028 0.0089 - 0.0123 - - - Almela et al. (2006)  
Porphyra tenera Japan 
- 
2.32 0.01667 0.0235 - 0.0126 - - - Almela et al. (2006)  
Porphyra umbilicais Spain - 3.78 - <0.04 - <0.04 - - - Cofrades et al. (2010)  
Porphyra umbilicalis Spain - 3.45 0.0239 0.0126 - 0.0817 - - - Almela et al. (2006)  
Vertebrata lanosa Norway June 2012 0.93 - 0.38 - - - 0.001 - Maehre et al. (2014)  
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Table 2-20. Heavy metal content of green seaweeds. 
Heavy Metals (mg/100g) 
Seaweed  Country Harvested As iAs Cd Co Pb Cs Hg Ni Reference 
Ulva lactuca Canada 
September - 
October 1995 
- 0.022 0.15 0.44 - - - - Phaneuf et al. (1999)  
Enteromorpha spp. Canada 
September - 
October 1995 
- 0.028 0.24 1.05 - - - - Phaneuf et al. (1999)  
Ulva lactuca Iran - - - - 0.07 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Ulva intestinalis Iran - - - - 0.24 - - - - 
Rohani-Ghadikolaei et al. 
(2012)  
Ulva stenophylla 
New 
Zealand 
April 2004 0.188 - - - 0.183 - 0.01 - Smith et al. (2010)  
Cladophora 
rupestris 
Norway May 2010 0.94 - 0.0091 - - - 0.0006 - Maehre et al. (2014)  
Ulva intestinalis Norway May 2010 0.49 - 0.012 - - - 0.0014 - Maehre et al. (2014)  
Ulva lactuca Norway June 2012 0.79 - 0.0092 - - - 0.0005 - Maehre et al. (2014)  
Ulva lactuca Iran April 2008 - - - 0.15 - - - 0.76 Tabarsa et al. (2012)  
Caulerpa racemosa India - 0.29 - 0.13 <1.3 1.09 5.6 <1 1.15 Mandlik et al. (2014)  
Ulva lactuca Ireland May 2015 0.58 - 0.0257 0.0271 0.0956  <0.001 0.85 Bikker et al. (2016)  
Ulva lactuca Tunisia July 2007 - - 0.12 - 1.26 - - - Yaich et al. (2011)  
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3 Literature Review - Prebiotics from Seaweeds: An Ocean of 
Opportunity? 
 Abstract 
Seaweeds are an underexploited and potentially sustainable crop which offer a rich 
source of bioactive compounds, including novel complex polysaccharides, 
polyphenols, fatty acids, and carotenoids. The purported efficacies of these 
phytochemicals have led to potential functional food and nutraceutical 
applications which aim to protect against cardiometabolic and inflammatory risk 
factors associated with non-communicable diseases, such as obesity, type 2 
diabetes, metabolic syndrome, cardiovascular disease, inflammatory bowel 
disease, and some cancers. Concurrent understanding that perturbations of gut 
microbial composition and metabolic function manifest throughout health and 
disease has led to dietary strategies, such as prebiotics, which exploit the diet-host-
microbe paradigm to modulate the gut microbiota, such that host health is 
maintained or improved. The prebiotic definition was recently updated to “a 
substrate that is selectively utilised by host microorganisms conferring a health 
benefit”, which, given that previous discussion regarding seaweed prebiotics has 
focused upon saccharolytic fermentation, an opportunity is presented to explore 
how non-complex polysaccharide components from seaweeds may be metabolised 
by host microbial populations to benefit host health. Thus, this review provides an 
innovative approach to consider how the gut microbiota may utilise seaweed 
phytochemicals, such as polyphenols, polyunsaturated fatty acids, and carotenoids, 
and provides an updated discussion regarding the catabolism of seaweed-derived 
complex polysaccharides with potential prebiotic activity. Additional in vitro 
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screening studies and in vivo animal studies are needed to identify potential 
prebiotics from seaweeds, alongside untargeted metabolomics to decipher 
microbial-derived metabolites from seaweeds. Furthermore, controlled human 
intervention studies with health-related end points to elucidate prebiotic efficacy 
are required. 
 Introduction 
Seaweeds are an underexploited and sustainable crop which offer a rich source of 
bioactive compounds, including novel dietary fibres, polyphenols, fatty acids, and 
carotenoids (Brown et al., 2014; Cherry et al., 2019). Epidemiological evidence 
comparing Japanese and Western diets have correlated seaweed consumption (5.3 
g/day in Japan) with decreased incidence of chronic disease (de Jesus Raposo et al., 
2016), while the purported efficacies of seaweed phytochemicals have led to 
potential functional food and nutraceutical applications which aim to protect 
against cardiometabolic and inflammatory risk factors associated with non-
communicable diseases, such as obesity, type two diabetes, metabolic syndrome, 
cardiovascular disease, inflammatory bowel disease, and some cancers (Brown et 
al., 2014). 
Current understanding of mutualistic diet-host-microbe interactions has generated 
efforts to exploit diet to maintain health status, and to prevent or overcome non-
communicable diseases, where an imbalance of gut microbiota composition and 
metabolic function manifests during the onset and pathophysiology of 
gastrointestinal, neurological, and cardio-metabolic diseases, often congruent with 
intestinal inflammation and compromised gut barrier function (Schippa and Conte, 
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2014; Thursby and Juge, 2017). As such, it has become pertinent to explore dietary 
strategies which modulate gut microbial composition and function to improve host 
health. This includes the use of prebiotics as fermentable substrates to enable 
selective gut commensal metabolism.  
The prebiotic definition was recently updated to “a substrate that is selectively 
utilised by host microorganisms conferring a health benefit” (Gibson et al., 2017), 
which includes the inhibition of pathogens, immune system activation, and vitamin 
synthesis and provides opportunity to explore the prebiotic efficacy of non-
complex polysaccharide components such polyphenols, phytochemicals, and 
polyunsaturated fatty acids (PUFAs) (Gibson et al., 2017). It is also recognised that 
other microbial species have the potential to catabolise prebiotics, besides the 
classical examples of Bifidobacterium and Lactobacillus (Gibson et al., 2017), 
courtesy of culture-independent techniques, such as 16S rRNA next generation 
sequencing and whole genome shotgun metagenomic sequencing which have 
provided taxonomic classification to identify microbial abundance/diversity and 
inferred or identified metabolic function (Arnold et al., 2016). 
Given that previous discussion regarding the prebiotic potential of seaweed 
components has focused solely upon the saccharolytic fermentation of complex 
polysaccharides and the physiological effects of short chain fatty acid metabolites 
(SCFAs) (de Jesus Raposo et al., 2016; O’Sullivan et al., 2010; Zaporozhets et al., 
2014), scope exists to explore the prebiotic potential of other phytochemical 
components derived from seaweeds, namely polyphenols, carotenoids, and PUFAs, 
applicable to both human and animal health.  
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This review aims to provide an updated discussion regarding the fermentation and 
potential prebiotic effect of seaweed polysaccharides and oligosaccharides, based 
on recent evidence from in vitro fermentation studies and in vivo animal models, 
and to postulate how other seaweed phytochemicals, such as polyphenols, PUFAs, 
and carotenoids, may interact with the gut microbiota to manipulate microbial 
composition and/or function to elicit bioactivities pertained to a prebiotic. The 
latter provides new opportunities to complete prebiotic screening studies using in 
vitro techniques and pre-clinical animal models to understand how parent 
compound biotransformation into endogenously derived or gut microbiota-derived 
metabolites impact bioaccessibility and bioavailability to influence gut microbial 
community structure and function, conducive to a prebiotic effect. Evidence from 
clinical trials with health-related endpoints and mechanistic insight is imperative to 
substantiate health claims associated with a prebiotic effect. 
 Complex polysaccharides 
Seaweeds contain 2.97–71.4% complex polysaccharides (Cherry et al., 2019; de 
Jesus Raposo et al., 2016), which include alginate, fucoidan, and laminarin in brown 
seaweeds; xylan and sulphated galactans, such as agar, carrageenan, and 
porphyran in red seaweeds; whilst ulvan and xylan are found in green seaweeds. 
The monosaccharide composition of the major brown, red, and green seaweed 
glycans are presented in Table 3-1, Table 3-2, and Table 3-3, respectively. Whilst 
no human study to date has explored prebiotic sources from seaweeds, several in 
vitro studies (Bajury et al., 2017; Devillé et al., 2004; Kong et al., 2016; Ramnani et 
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al., 2012), and in vivo animal studies (Devillé et al., 2007; Liu et al., 2015), have 
explored the prebiotic potential seaweeds and their polysaccharide components. 
Seaweed polysaccharides are atypical in structure to terrestrial glycans, and are 
understood to resist gastric acidity, host digestive enzymes, and gastrointestinal 
absorption (O’Sullivan et al., 2010). Seaweed glycans may, therefore, serve as 
fermentation substrates for specific gut microbial populations or facilitate 
substrate cross-feeding of partially broken-down intermediates, such as 
oligosaccharides and metabolic cross-feeding of SCFAs to cause indirect 
proliferation of specific bacteria (Belenguer et al., 2006; Macfarlane and 
Macfarlane, 2012; Rios-Covian et al., 2017; Rose et al., 2009; Timm et al., 2010). 
The physiological effects of SCFAs, primarily acetate, propionate, and butyrate, 
include the reduction of luminal pH to inhibit pathogens, the provision of energy 
sources to colonocytes, and the activation of free fatty acid receptors; where 
acetate and propionate are ligands for anorexigenic pathways in appetite 
regulation and can inhibit the rate limiting step of hepatic cholesterol synthesis via 
3-hydroxy-3-methylglutaryl CoA reductase inhibition (Byrne et al., 2015; den 
Besten et al., 2013; Gunness and Gidley, 2010). 
To facilitate saccharolytic fermentation in the colon, the gut microbiota must 
express functional carbohydrate active enzymes (CAZymes) to catabolise seaweed 
glycans as carbon sources within the colonic digesta. The repertoire of CAZymes 
expressed by the human gut microbiota includes glycoside hydrolase and 
polysaccharide lyase families to facilitate degradation via hydrolysis and 
elimination reactions, respectively (El Kaoutari et al., 2014; Ndeh and Gilbert, 2018; 
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Tasse et al., 2010). Whole genome sequencing has previously identified gene 
clusters which encode the catabolic machinery responsible for the breakdown of 
prebiotics, which includes the CAZyme families responsible for the catabolism of 
inulin, lactulose, fructo-oligosaccharides, xylo-oligosaccharides, and galacto-
oligosaccharides by human gut commensal strains, including Bifidobacterium 
longum NCC2705, Bifidobacterium adolescentis ATCC 15703, Streptococcus 
thermophilus LMD9, Eubacterium rectale ATCC 33656, Bacteroides vulgatus ATCC 
8482, and Fecalibacterium prausnitzii KLE1255 (Cecchini et al., 2013). 
Based on open source data from the Carbohydrate-Active enZYmes Database 
(Cantarel et al., 2008), Table 3-1, Table 3-2, and Table 3-3 detail the CAZyme 
families which may exert specificity for seaweed glycans and highlights the gut 
bacterial populations which have demonstrable evidence for seaweed glycan 
utilisation. This is dominated by Bacteroides, which have extensive glycolytic 
versatility (Benítez-Páez et al., 2017; Ndeh and Gilbert, 2018). This may explain why 
in vitro batch culture fermentation data of seaweeds and seaweed glycans indicate 
the proliferation of Bacteroides; whilst the degradation of complex seaweed 
glycans by Bacteroides could also facilitate the cross-feeding of oligosaccharides, 
monosaccharides, and SCFAs for gut commensals deemed beneficial to health, 
including Bifidobacterium. 
In vitro fermentation studies are frequently used as screening tools to model 
colonic fermentation and determine substrate utilisation by an ex vivo faecal 
inoculum, with seaweed as a sole carbon source. An overview of recent in vitro 
fermentation studies which have evaluated the fermentation of whole seaweeds or 
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extracted complex polysaccharide components by the human gut microbiota is 
presented in Table 3-4 (brown seaweeds), Table 3-5 (red seaweeds), Table 3-6 
(green seaweeds). These tables include differences in study methodologies, for 
example, test substrate dosage; the use of an in vitro digestion before the 
fermentation experiment (declared within the methods section of the cited 
research paper); how the inoculum was prepared; duration of the faecal 
fermentation experiment; microbial enumeration method; and the analytical 
technique used to ascertain metabolite changes during the fermentation. The use 
of an in vitro digestion before in vitro fermentation is often used to determine 
whether a substrate is resistant to endogenous digestive enzymes and small 
intestinal absorption, and to provide the fraction of a dietary component which is 
bioaccessible in the colon (Brodkorb et al., 2019). The lack of an in vitro digestion 
before fermentation experiments may cause false positive results, given that low 
molecular weight components present in seaweed extracts, normally absorbed in 
the small intestine, are used as fermentation substrates for the ex vivo microbiota.  
Table 3-7 highlights data from in vivo rodent studies which have evaluated the 
potential prebiotic effect of seaweeds and seaweed glycans.  
 Brown seaweed polysaccharides 
Brown seaweeds are commonly used as food ingredients owing to their 
commercial abundance (Usman et al., 2017). The anti-obesogenic effects of brown 
seaweeds are reported in mice, where supplementation of 5% (w/w) Saccorhiza 
polyschides extract, containing 12% dietary fibre, reduced body weight gain and fat 
mass of mice with diet-induced obesity (Huebbe et al., 2017). The anti-obesogenic 
effect was attributed to the fermentation of alginate and fucoidan complex 
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polysaccharide components, owing to reduced microbial bile salt hydrolase 
activity; however, no gut microbial compositional data were provided. Elsewhere, 
the in vitro evidence (Table 3-4) indicates that whole brown seaweeds and their 
extracted complex polysaccharide components are fermented by the ex vivo faecal 
microbiota, with increased production of acetate, propionate, butyrate, and total 
SCFAs reported during fermentation experiments. A corresponding increase in 
populations, such as Bifidobacterium, Bacteroides, Lactobacillus, Roseburia, 
Parasutterella, Fusicatenibacter, Coprococcus, Fecalibacterium is also reported 
(Charoensiddhi et al., 2017b, 2016; Fu et al., 2018). 
3.3.1.1 Alginate 
Alginates are composed of 1,4-linked α-l-guluronic (G) and β-d-mannuronic acid 
(M) residues to form GM, GG and MM blocks, and represent 17−45% dry weight of 
brown seaweeds (Vera et al., 2011). The colloidal properties of alginates have wide 
application in food processing, biotechnology, medicine and pharmaceutical 
industries (García-Ríos et al., 2012), while degraded sodium alginate is an approved 
item of “foods with specified uses”, under the categories of “Foods that act on 
cholesterol plus gastrointestinal conditions” and “Foods that act on blood 
cholesterol levels” in Japan (Maeda-Yamamoto, 2017). The presence of water 
soluble alginate oligosaccharides in the faeces of pigs fed alginate is indicative of 
alginate lyase activity by the luminal or mucus adherent gut microbiota (Jonathan 
et al., 2013), although an adaptation period of > 39 days is reported for the 
degradation of G blocks by the porcine microbiota whilst M blocks are readily 
degraded (Jonathan et al., 2015). 
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The capacity for alginate to modulate the gut microbiota of Japanese individuals 
was highlighted over 20 years ago (Terada et al., 1995), where alginate 
supplementation (30 kDa, 10 g/day, n = 8) significantly increased faecal 
Bifidobacterium populations in healthy male volunteers after both one and two 
weeks, alongside significantly increased acetic and propionic acids after two weeks. 
Deleterious metabolites, including faecal sulphide, phenol, p-cresol, indole, 
ammonia and skatole were significantly reduced compared to the control (free 
living) diet. Notably, faecal Bifidobacterium counts and SCFA concentrations 
returned to baseline in the week after alginate diet cessation, which highlights the 
transient nature of the gut microbiota and the need for greater powered long-term 
human intervention studies. 
Subsequent in vitro fermentation studies have indicated that alginate is fermented 
by the human gut microbiota, for example, a 24 h in vitro fermentation of a 212 
kDa alginate increased total bacterial populations, although no statistical increase 
in individual Bifidobacterium, Bacteroides/Prevotella, Lactobacillus/Enterococcus, 
Eubacterium rectale/Clostridium coccoides, or Clostridium histolyticum populations 
were observed (Ramnani et al., 2012). Acetic acid, propionic acid and total SCFAs 
were significantly increased after 24 h fermentation with the 212 kDa alginate, 
while alginate of 97 kDa increased total SCFA and acetate production after 10 h of 
fermentation. Alginates of 38 kDa, and 97 kDa did not change microbial 
abundance, although the authors could not correlate molecular weight with 
fermentation patterns. 
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Alginate oligosaccharides (AOS) (~3.5 kDa) can be obtained via acidic or enzymatic 
hydrolysis of alginate polysaccharides (Vera et al., 2011), and enzymatically derived 
AOS has promoted the growth of Bifidobacterium bifidum ATCC 29521, 
Bifidobacterium longum SMU 27001 and lactobacilli, in vitro (Wang et al., 2006). 
Supplementation of 2.5% AOS for two weeks significantly increased faecal 
Bifidobacterium. in rats compared to control and 5% FOS supplemented diets (13-
fold and 4.7-fold increase, respectively), while faecal Lactobacillus were 5-fold 
greater in rats who consumed AOS compared to FOS. Enterobacteriaceae and 
Enterococcus populations were significantly decreased following AOS 
supplementation. Elsewhere, the hydrolysis of alginate, mannuronic acid 
oligosaccharides (MO) and guluronic oligosaccharides (GO) during a 48 h batch 
culture fermentation with the faecal microbiota of Chinese individuals 
demonstrated increased production of acetate, propionate, butyrate, and total 
SCFAs compared to the substrate-free control, where GO generated the greatest 
increase (Li et al., 2016). Subsequent strain isolation from the stools of individuals 
who demonstrated alginate degradation during fermentation identified 
Bacteroides xylanisovlens G25, Bacteroides thetaiotomicron A12, Bacteroides 
ovatus A9, and Bacteroides ovatus G19 as strains capable of hydrolysing alginate 
and AOS, where Bacteroides ovatus G19 expressed α-1,4-guluronanlyase and β-1,4-
mannuronanlyase CAZymes (Li et al., 2017).  
A Bacteroides xylanisolvens strain with 99% similarity to Bacteroides xylanisolvens 
XB1A was recently isolated from the stool of a Chinese individual and the alginate 
lyase gene expressed was 100% homologous to the alginate lyase of Bacteroides 
ovatus strain ATCC 8483 (Bai et al., 2017). The preceding in vitro fermentation 
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study demonstrated increased production of acetate, propionate, butyrate, and 
total SCFAs compared to the soluble starch control vessel following a 72 h 
fermentation of alginate.  
Alginate lyase depolymerises alginate polysaccharides to lower molecular weight 
oligosaccharides via β-elimination, and is most commonly expressed by marine 
bacteria, including Flammeovirga, Vibrio, Pseudoalteromonas, Glaciecola 
chathamensis S18K6, and Zobellia galactanivorans (Chen et al., 2016; Dong et al., 
2017; Han et al., 2016; Xu et al., 2017; Zhu et al., 2018), while the terrestrial 
bacteria Paenibacillus sp. Strain MY03 was recently reported to possess genes 
encoding alginate lyase and agarase enzymes (Liu et al., 2017). The acquisition of 
genes encoding alginate lyase enzymes by human gut Bacteroides is a suggested 
consequence of horizontal gene transfer from the marine environment (Mathieu et 
al., 2016; Thomas et al., 2012), where seaweed consumption may have provided a 
vector to exert a selective pressure to induce diet-driven adaptations of the gut 
microbiota (Bhattacharya et al., 2015; Cantarel et al., 2012; Hehemann et al., 2014; 
Martin et al., 2015; Mathieu et al., 2018; Singh and Reddy, 2016). Recent work by 
Matthieu et al. (Mathieu et al., 2018) suggests that an alginate degradation system 
within the genome of human gut Bacteroides was a result of ancient acquisition, 
where the polysaccharide utilisation loci encodes PL6 and PL17 alginate lyase 
enzymes and hypothetical proteins responsible for alginate recognition, 
internalisation, and catabolism, including bacterial ABC transporter proteins to 
facilitate alginate uptake across the bacterial membrane (Maruyama et al., 2015). 
Nevertheless, in vivo rodent studies have demonstrated that seaweed glycans are 
fermented even though animals have never been exposed to dietary seaweeds 
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before the intervention, which suggests that the gut microbiome contains genes 
for CAZymes which can degrade seaweed glycans when expressed. 
3.3.1.2 Laminarin 
Laminarin is a water-soluble storage polysaccharide consisting of 1,3- or 1,6-β-
glucose with an average molecular weight of 5 kDa (Kadam et al., 2015) and 
accounts for 10–35% of the dry weight of brown seaweeds (Vera et al., 2011). One 
in vitro batch culture fermentation of laminarin demonstrated increased 
Bifidobacterium and Bacteroides after 24 h (Seong et al., 2019), while another 
demonstrated increased propionate and butyrate production after 24 h (Devillé et 
al., 2007). A subsequent in vivo rat study (143 mg laminarin per kg body weight per 
day for 14 days) indicated that laminarin was not selectively fermented by 
Lactobacillus and Bifidobacterium, but could modify jejunal, ileal, caecal and 
colonic mucus composition, secretion, and metabolism to protect against bacterial 
translocation. The authors suggest that increased luminal acidity and/or catabolism 
of laminarin by mucolytic commensals could elicit such effects, which corroborates 
the evidence that a complex polysaccharide-rich diet maintains mucus layer 
integrity to promote gut barrier function (Brownlee et al., 2003; Desai et al., 2016). 
Future studies regarding intestinal mucus modulation by laminarin may wish to 
characterise gut microbiota compositional and functional changes following 
laminarin ingestion, to detect the abundance and metabolic activity of glycan 
degraders, such as Bacteroides (Salyers et al., 1977; Salyers et al., 1977) or 
mucolytic species associated with health, such as Akkermansia muciniphila or 
Ruminococcus (Dao et al., 2016; Tailford et al., 2015). Elsewhere, laminarin 
increased L-cell GLP-1 secretion to attenuate diet-induced obesity in mice, and 
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improved glucose homeostasis and insulin sensitivity (Yang et al., 2017). The 
authors suggested that the observed cytosolic Ca2+ cascade caused GLP-1 secretion, 
which is in agreement with GPR41/43 receptor activation by SCFAs produced by 
gut microbial fermentation (Everard and Cani, 2014; Tolhurst et al., 2012), 
however, data obtained to assess laminarin-induced changes to gut microbiota 
composition and metabolic output is needed to ascribe a prebiotic effect in this 
study.  
The abundance of glycoside hydrolase and β-glucosidase enzymes expressed by the 
human gut microbiota may have the capacity to catabolise laminarin (Dabek et al., 
2008; Gloux et al., 2011; Michalska et al., 2013; Tasse et al., 2010), for example, a 
Bacteroides cellulosyliticus WH2 human gut isolate was able to grow on laminarin-
supplemented minimal media in vitro, (incidentally it did not grow on alginate, 
carrageenan, or porphyran) (McNulty et al., 2013); however, the molecular 
mechanisms by which human gut Bacteroides breakdown laminarin are likely 
distinct from those responsible for the degradation of mix linked β 1,3- 1,4- 
glucans, such as those found in cereals (e.g., by BoGH16MLG) (Tamura et al., 2017). 
3.3.1.3 Fucoidan 
Fucoidans are water soluble polysaccharides composed of sulphated 1,2- or 1,3- or 
1,4-α-l-fucose which exist as structural polysaccharides in brown seaweeds and 
occupy 5–20% of algal dry weight (Li et al., 2008; Vera et al., 2011). The structural 
heterogeneity of fucoidan encompasses varying degrees of branching, sulphate 
content, polydispersity, and irregular monomer patterns, which can include fucose, 
160 
 
 
uronic acid, galactose, xylose, arabinose, mannose, and glucose residues (García-
Ríos et al., 2012; Jiao et al., 2011; Zaporozhets et al., 2014).  
A recent in vitro fermentation study of fucoidan (< 30 kDa) extracted from 
Laminaria japonica demonstrated a greater increase in Bifidobacterium  and 
Lactobacillus  following 24 h and 48 h fermentation relative to > 30 kDa fucoidan 
(Kong et al., 2016), while fucoidan from Ascophyllum nodosum (1330 kDa) and 
Laminaria japonica (310 kDa) were shown to increase Lactobacillus and 
Ruminococcaceae, respectively, in the caecal microbiota of mice gavaged with 100 
mg/kg/day (Shang et al., 2016). Fucoidan also reduced serum LPS-binding protein 
levels in this study—indicative of a reduced antigen load and reduced 
inflammatory response. In contrast, fucoidan with a fucose-rich and highly 
sulphated fucoidan extracted from Cladosiphon okamuranus was not fermented by 
the rat gut microbiota (Choa An et al., 2013).  
While the purported bioactivities of fucoidan include anti-obesogenic, anti-
diabetic, anti-microbial, and anti-cancer properties (Collins et al., 2016), there is 
limited evidence to implicate a role for the gut microbiota with such bioactivities, 
and studies are needed to evaluate the structure-dependent fermentation of 
fucoidan to ascribe a prebiotic effect. For the latter, this is surprising given the 
myriad of α-fucosidase enzymes present in the human gut bacterial glycobiome. 
 Red seaweed polysaccharides 
3.3.2.1 Galactans (Carrageenan, Agar, and Porphyran) 
Red seaweeds, such as Gelidium spp. and Gracilaria spp., are used in the 
commercial production of agar and carrageenan food additives, including 
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thickening, stabilizing and encapsulation agents (Usman et al., 2017). A summary of 
evidence from recent in vitro fermentation experiments using red seaweed-derived 
substrates are presented in Table 3-5. 
Carrageenans are composed of sulphated 1,4-β-d-galactose, 1,3-α-d-galactose, and 
3,6-anhydro-d-galactose (Weiner, 2014), and constitutes 30−75% dry weight of red 
seaweeds (Vera et al., 2011). In rats fed 2.5% Chondrus crispus, of which 
carrageenan is a major polysaccharide component, faecal Bifidobacterium breve, 
and acetate, propionate, and butyrate SCFAs were significantly increased alongside 
a significant decrease in the pathogens Clostridium septicum and Streptococcus 
pneumonia, as compared to the basal diet (Liu et al., 2015). Furthermore, a 1:1 
mixture of polysaccharide extracts from Kappaphycus alvarezii (containing 
carrageenan) and Sargassum polycystum (brown seaweed) has lowered serum 
lipids in rats (Dousip et al., 2014). In a study by Li et al. (Li et al., 2017), β-
carrageenase activity in a Bacteroides uniforms 38F6 isolate complex of Bacteroides 
xylanisolvens and Escherichia coli hydrolysed κ-carrageenan oligosaccharides into 
4-O-sulfate-d-galactose, κ-carratriose, κ-carrapentaose, and κ-carraheptaose, 
which could facilitate cross-feeding to promote the growth of Bifidobacterium 
populations.  
Agar is composed of sulphated 1,3-β-d-galactose and 1,4- 3,6-anhydro-α-l-
galactose (Lahaye and Rochas, 1991) and can be fractionated into agarose and 
agaropectin (O’Sullivan et al., 2010). Low molecular weight agar of 64.64 kDa has 
demonstrated a bifidogenic effect alongside increased acetate and propionate 
SCFA concentrations after 24 h in vitro fermentation with human stool inoculum 
162 
 
 
(Ramnani et al., 2012), while mice fed with 2.5% (w/v) neoagarose oligosaccharides 
for 7 days demonstrated increased caecal and faecal Lactobacillus and 
Bifidobacterium (Hu et al., 2006). The utilisation of agaro-oligosaccharides was 
noted in vitro by Bacteroides uniforms L8, isolated from Chinese individuals, which 
secreted a β-agarase CAZyme to breakdown agarooligosaccharides into agarotriose 
and subsequently facilitated the growth of Bifidobacterium infantis and 
Bifidobacterium adolescentis via the cross feeding of agarotriose (Li et al., 2014).  
Porphyran is made up of sulphated 1,3-β-d-galactose, 1,4-α-l-galactose-6-sulfate 
and 3,6-anhydro-α-l-galactose (Hehemann et al., 2010; Muraoka et al., 2008; Zhang 
et al., 2004). An in vitro faecal fermentation study indicated that porphyran did not 
significantly increase SCFAs, but stimulated Lactobacillus and Bacteroides 
populations (Seong et al., 2019). While pure cultures of Bifidobacterium breve, 
Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium adolescentis, 
but not Bifidobacterium bifidum, were able to ferment dried Porphyra yezoensis 
(Nori), containing a low protein content (25%), whereas Nori with a high protein 
content (41%) was not fermented (Muraoka et al., 2008). It is likely that 
carbohydrate content was highest in the low protein Nori, thus seasonal- and 
species-variation and in seaweed macronutrient content should be considered a 
determinant factor for the fermentability of whole seaweeds (Kravchenko et al., 
2018; Medcalf et al., 1975; Rioux et al., 2009; Skriptsova, 2016). 
Evidence for the horizontal transfer of genes for porphyranase and agarase 
CAZymes from the marine bacteria, Zobellia galactanivorans, to Bacteroides 
plebeius of Japanese individuals is indicative of diet-driven adaptations of the 
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human gut microbiome (Hehemann et al., 2012, 2010); however, the North 
American counterparts in this study did not consume seaweeds and the gut 
microbiota of these individuals did not express such CAZymes. This may mean that 
the fermentation of seaweed polysaccharides, such as porphyran and agar, 
requires exposure to, and acquisition of, specific CAZymes usually present in the 
marine environment (Hehemann et al., 2014). Red seaweed galactans are 
emerging prebiotic candidates given the commercial availability of red seaweed 
hydrocolloids and the potential gut modulatory effects of oligosaccharides 
obtained from red seaweeds. Nevertheless, further in vivo evidence is needed, 
given the purported pro-inflammatory effects of low molecular weight carrageenan 
(Bhattacharyya et al., 2010; Shang et al., 2017; Younes et al., 2018).  
3.3.2.2 Xylan 
Xylan, composed of 1,3-1,4-β-D-xylose, is a major constituent of red seaweeds, 
such as Palmaria palmata (Usov, 2011). A previous in vitro faecal fermentation 
study of xylan derived from P. palmata, reported that xylose was fermented after 
six hours alongside a 58:28:14 ratio of acetate, propionate, and butyrate SCFAs 
(total SCFAs were 107 mM/L) (Lahaye et al., 1993). This study did not ascertain 
bacterial compositional data, and thus a knowledge gap is presented given that 
xylans and xylooligosaccharides (XOS) extracted from terrestrial plants, such as 
wheat husks and maize, are mooted as potential prebiotics owing to evidence of 
bifidogenesis, improved plasma lipid profile, and positive modulation of immune 
function markers in healthy adults (Childs et al., 2014; Lecerf et al., 2012). Given 
that human gut Bacteroides express a repertoire of xylanase and xylosidase 
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CAZymes (Mirande et al., 2010), investigations regarding the capacity of the human 
gut microbiota to catabolise red seaweed xylans and XOS are suggested. 
 Green seaweed polysaccharides 
3.3.3.1 Ulvan 
Ulvans are water-soluble cell wall polysaccharides that account for 8–29% dry 
weight of green seaweeds, and are composed of sulphated 1,3-α-L-rhamnose, 1,4-
β-D-glucuronic acid, and 1,4-β-D-xyloglucan (Lahaye and Robic, 2007). Previous 
reports indicate that Ulva lactuca and ulvan polysaccharides are poorly fermented 
by the human gut microbiota (Andrieux et al., 1998; Jiao et al., 2011; O’Sullivan et 
al., 2010), while an in vitro fermentation study of Enteromorpha spp. with a human 
faecal inoculum reported no difference in Enterococcus, Lactobacillus, and 
Bifidobacterium populations compared to the control; only an increase in 
Enterobacter after 24 h and 48 h of fermentation (Table 3-6) (Kong et al., 2016). In 
contrast, a recent in vitro faecal fermentation study indicated that Ulvan 
stimulated the growth of Bifidobacterium and Lactobacillus populations and 
promoted the production of lactate and acetate (Seong et al., 2019). Further, a 
murine study showed that Enteromorpha (EP) and Enteromorpha polysaccharides 
(PEP) ameliorated inflammation associated with Loperamide-induced constipation 
in mice (Ren et al., 2017), where alpha diversity, Firmicutes, and Actinobacteria 
were increased in the faecal microbiota of seaweed-supplemented mice compared 
to the constipated control. Bacteroidetes and Proteobacteria were decreased, 
while Bacteroidales family S24-7 and Prevotellaceae were increased in EP and PEP, 
respectively. Current evidence for the fermentation of green seaweeds and their 
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polysaccharides is limited and fermentation may require specific α-L-rhamnosidase 
activity by gut commensals (Munoz-Munoz et al., 2017). More experimental 
evidence is needed to understand the impact of ulvans and ulvan-oligosaccharides 
in the human and animal diet.  
 Future prospective – Obtaining oligosaccharides 
Enzyme technologies are reported to increase the extraction yield and reduce the 
molecular weight of bioactive components obtained from seaweeds, with 
examples of enhanced prebiotic activity when commercially available cellulases or 
seaweed-specific enzymes were used to hydrolyse polysaccharides (Charoensiddhi 
et al., 2017a; Rodrigues et al., 2016). Despite limited commercial availability of 
seaweed-specific enzymes, an avenue for functional oligosaccharide production is 
presented if efforts to develop commercially viable saccharolytic enzymes from 
microorganisms (primarily marine). Examples of such glycoside hydrolases include 
fucoidanase from Sphingomonas paucimobilis PF-1 (Kim et al., 2015); ulvan lyase 
from Alteromonas spp. (Coste et al., 2015) and the family Flavobacteriaceae 
(Thomas et al., 2012); β-agarase from Cellulophaga omnivescoria W5C (Ramos et 
al., 2018) and Cellvibrio PR1 (Xie et al., 2017); alginate lyase from Flammeovirga 
(Cheng et al., 2017), and Paenibacillus (Liu et al., 2017); and laminarinase from 
Clostridiium thermocellum (Kislitsyn et al., 2015). Factors which influence the 
stability and efficacy of such hydrolytic enzymes may include metal ion interaction, 
or thermostability at the high temperatures needed to prevent gelling of 
polysaccharides. Recent insight into the production of agarose oligosaccharides 
and neoagarose oligosaccharides from agar exemplify this (Xu et al., 2018).  
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 Polyphenols 
Seaweeds are rich in polyphenols, such as catechins, flavonols, and phlorotannins. 
Red and green seaweeds are a source of bromophenols, phenolic acids, and 
flavonoids (Gómez-Guzmán et al., 2018), while phlorotannins are the most 
abundant polyphenol in brown seaweeds. Most research to date concerns the 
bioactivity of phlorotannins, a class of polyphenol unique to brown algae 
comprised of phloroglucinol monomers and categorised as eckols, fucols, fuhalols, 
ishofuhalols, phloroethols, or fucophloroethols (Gómez-Guzmán et al., 2018). The 
purported bioactivities of seaweed polyphenols are associated with the mitigation 
of risk factors pertained to type 2 diabetes and cardiovascular disease, including 
hyperglycemia, hyperlipidemia, inflammation and oxidative stress (Lee et al., 2012; 
Lopes et al., 2017; Murray et al., 2018; Murugan et al., 2015; Shanura et al., 2016), 
and also anti-microbial activity (Eom et al., 2012). Owing to heterogeneity in both 
molecular weight and the level of isomerisation, characterisation of polyphenols is 
difficult (Heffernan et al., 2015; Melanson and MacKinnon, 2015; Montero et al., 
2016), and a paucity of information exists regarding the endogenous digestion and 
microbial catabolism of seaweed polyphenols, with a scarce mechanistic 
understanding of how they may exert health benefits via the gut microbiota.  
Most polyphenols of plant origin must undergo intestinal biotransformation by 
endogenous enzymes and the gut microbiota prior to absorption across 
enterocytes. These enzymatic transformations include the elimination of glycosidic 
bonds, for example, flavonoids are converted to glycones (sugars) and aglycones 
(non-sugars–polyphenols) by endogenous β-glucosidases in the small intestine 
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(Lewandowska et al., 2013). The transport of aglycones to the liver via the portal 
vein results in phase II biotransformation (coupling reactions, chiefly hepatic 
conjugation to O-glucuronides and O-sulfates) to facilitate urinary and biliary 
elimination. Phase II metabolites are absorbed into the systemic circulation, or 
excreted in bile and re-enter the duodenum (hepatic recycling), where subsequent 
glucuronidase, glycosidase, or sulphatase-mediated deconjugation by the colonic 
microbiota may favour aglycone reabsorption (Opara and Chohan, 2014). 
Approximately 90–95% of dietary polyphenols reach the colon intact (Clifford, 
2005), where biotransformation and metabolism by the gut microbiota occurs via 
hydrolysis, reduction, decarboxylation, demethylation, dehydroxylation, 
isomerisation, and fission (Selma et al., 2009), to produce low-molecular weight 
compounds with less chemical heterogeneity than the polyphenol parent 
compound (Lewandowska et al., 2013). It is suggested that a complex network of 
gut microbial species is necessary for full biotransformation of polyphenols, 
whereas simple reactions, such as deglycosylation, can be achieved by individual 
gut strains. Furthermore, the bioactivities associated with dietary polyphenol 
intake may be dependent on the catabolic capacity and composition of the gut 
microbiota, owing to the biological activity of metabolites rather than the parent 
polyphenol compound present in food (Espín et al., 2017; Williamson and Clifford, 
2017), while a synergistic effect between prebiotic polyphenols and probiotic 
bacteria may occur (Gibson et al., 2017). 
The identification of bacteria which possess the metabolic capabilities to utilise 
polyphenols was previously identified in Eubacterium oxidoreducens, which could 
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catabolise gallate, pyrogallol, phloroglucinol and quercetin (Krumholz and Bryant, 
1986). Quercetin biotransformation by Eubacterium ramulus has also been 
identified (Schneider and Blaut, 2000), and multiple human gut microbes which 
possess phenolic enzymes capable of breaking down glycosides, glucuronides, 
sulphates, esters, and lactones was summarised by Selma et al. (Selma et al., 
2009). Such microorganisms included E. coli with β-glucuronidase activity; 
Eubacterium, Bacteroides, and Clostridium with β-glucosidase activity; 
Lactobacillus, Eubacterium, Clostridium, Butyrbacterium, Streptococcus, and 
Methylotrophicum with demethylase activity; and E. coli, Bifidobacterium, 
Lactobacillus, Bacteroides, Streptococcus, Ruminococcus, and Enterococcus with 
esterase activity. There is also evidence for α-l-Rhamnosidase mediated hydrolysis 
of rutinose, present on glycosylated polyphenols (rhamnoglycosides), to produce 
aglycones, by species, such as Bacteroides thetaiotaomicron (Munoz-Munoz et al., 
2017), Bifidobacterium dentium (Bang et al., 2015), Bifidobacterium catenulatum 
(Amaretti et al., 2015), Bifidobacterium pseudocatenulatum (Amaretti et al., 2015), 
and Lactobacillus plantarum (Delgado et al., 2017). 
Current knowledge regarding the fate of seaweed polyphenols in the human 
gastrointestinal tract is scarce; however, it is understood that the limited 
absorption of Ascophyllum nodosum polyphenols from small intestinal enterocytes 
to the portal vein may facilitate the conjugation of polyphenols to methylated, 
glucuronidated, or sulphated forms rather than hydrolysis to aglycones (Corona et 
al., 2017, 2016). Subsequently, unabsorbed conjugated polyphenols are available 
for biotransformation by the colonic microbiota, then potentially absorbed across 
the colonocytes. Indeed, Corona et al. (Corona et al., 2017), observed a reduction 
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of total polyphenol contents of an Ascophyllum nodosum polyphenol extract, high 
molecular weight fraction (> 10 kDa), and low molecular weight fraction (1–10 kDa) 
following in vitro digestion and batch culture fermentation; although anti-
genotoxic activity against H2O2 induced DNA damage of HT-29 cells was increased 
(to a greater extent by the high molecular weight fraction). This study did not 
assess the microbiota composition, however, elsewhere, an in vitro fermentation 
of an Ecklonia radiata phlorotannin extract significantly increased Bacteroidetes, 
Clostridium coccoides, E. coli, and Fecalibacterium prausnitzii, but decreased 
Bifidobacterium and Lactobacillus populations after 24 h fermentation 
(Charoensiddhi et al., 2017c). More in vitro digestion studies would be useful to 
understand the stability of seaweed polyphenols as extracts or within the seaweed 
matrix (Oliveira and Pintado, 2015; Sadeghi Ekbatan et al., 2016). These studies 
may be complemented by studies which use ileostomy patient cohorts to 
determine structural changes to seaweed polyphenols following upper GI digestion 
in vivo to indicate polyphenol bioaccessibility in the colon (Brown et al., 2014).  
A recent review highlighted the potential for dietary polyphenols to modulate the 
gut microbiota by increasing Bifidobacterium, Lactobacillus, Bacteroides, 
Enterococcus, Akkermansia muciniphila, and Fecalibacterium prausnitzii 
populations (Duenas et al., 2015). This review did not include any studies which 
assessed modulation of the gut microbiota by seaweed polyphenols and, 
therefore, a research opportunity is presented. Inter-individual variation of gut 
microbiota composition and function is the key determinant for gut microbiota-
mediated biotransformation of phenolic compounds to bioactive metabolites 
(Duda-Chodak et al., 2015; Tomás-Barberán et al., 2016). Therefore, identification 
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of bacterial species or strains with the ability to catabolise seaweed polyphenols 
and their respective catabolic machinery is needed to understand if seaweed 
polyphenols could be prebiotic (Núñez-Sánchez et al., 2015; Ozdal et al., 2016). 
Moreover, considering that gut microbiota-derived secondary metabolites reach a 
peak plasma concentration much later than the original aglycone or hepatic 
conjugates, controlled nutrikinetic studies could elude how dietary polyphenols 
from seaweeds interact with host-microbiota metabolism (Laura et al., 2014; van 
Duynhoven et al., 2011). Identification of faecal, urinary, serum, or tissue 
biomarkers via untargeted and targeted metabolomics approaches, and the use of 
stable isotope studies, may also indicate variation in synthesis, bioavailability, 
metabolism, and excretion of polyphenols and associated metabolites. While 
integration of dose response studies alongside metagenomics and metabolomics 
analyses, akin to those conducted for berry and wine polyphenols, could elude how 
much seaweed polyphenol is required to have an impact, if any, on gut microbial 
composition, metabolic function, and host health (Duenas et al., 2015; Feliciano et 
al., 2017). 
 Other seaweed phytochemicals 
 Carotenoids 
Carotenoids are lipid soluble compounds which function within the photosynthetic 
machinery of seaweeds to produce pigments. Fucoxanthin is the predominant 
carotenoid in brown seaweeds (Rajauria et al., 2017), while lutein, β-carotene, 
astaxanthin, echinenone, violaxanthin, neoxanthin, and zeaxanthin are found in 
red and green seaweeds. Carotenoids are used as food colouring additives, while 
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the application of fucoxanthin as functional food ingredients is suggested, owing to 
putative anti-oxidant, anti-inflammatory, anti-cancer, anti-obesity, and anti-
diabetic bioactivities (Christaki et al., 2013; Kulczyński et al., 2017; Lopes-Costa et 
al., 2017; Maeda et al., 2008; Mikami and Hosokawa, 2013; Woo et al., 2010). 
While some carotenoids are absorbed by enterocytes and converted into vitamin A 
and retinoid derivatives by endogenous beta‐carotene oxygenase 1 (BCO1) and 
beta‐carotene dioxygenase 2 (BCO2) enzymes (Bohn et al., 2015; Widjaja-Adhi et 
al., 2015), the bioavailability of carotenoids in the blood is reported as 10−40% 
(Rein et al., 2013), which has led to suggestions that carotenoids could be 
fermented by the gut microbiota (Bohn, 2018; Bohn et al., 2015). The only 
evidence to date has demonstrated that male C57BL/6J mice supplemented with 
0.04% (w/w) astaxanthin during an eight-week pilot study had increased 
abundance of caecal Bifidobacterium (Lyu et al., 2018), whereas Proteobacteria 
and Bacteroides were significantly increased in the caecum of BCO2 knockout mice; 
however, analysis of health biomarkers was not reported. Given the differences in 
microbiota composition between wild type and BCO2 knockout mice in this study, 
there is scope to investigate how carotenoids and their endogenous derivatives 
interact with the gut microbiota. Looking ahead, the use of in vitro models of 
gastrointestinal digestion and colonic fermentation would be useful to assess 
whether there is a direct substrate to microbiota effect or a host–microbe effect 
(Kamiloglu and Capanoglu, 2018). 
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 Polyunsaturated fatty acids (PUFAs) 
The lipid content of seaweed ranges from 1–5% dry weight, which includes n-3 
PUFAs, such as eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA) 
(Robertson et al., 2015; van Ginneken et al., 2011). The n-3 PUFA are associated 
with the anti-inflammatory activity to reduce cardiovascular disease risk and may 
also exert beneficial effects on brain function and behaviour, as mediated by the 
microbiota-gut-brain axis (Costantini et al., 2017). Dietary EPA and DHA intake are 
reported to improve microbial diversity, reduce the Firmicutes/Bacteroidetes ratio, 
reduce LPS-producing bacteria, and increase populations of Bifidobacterium, 
Lachnospiraceae, and lipopolysaccharide (LPS)-suppressing bacteria in both 
humans and animal models (Costantini et al., 2017; Menni et al., 2017; Robertson 
et al., 2018). Although the evidence to date has focused on fish-derived n-3 PUFA, 
great scope exists to evaluate the prebiotic effect of n-3 PUFA obtained from 
seaweeds. 
 Fermented foods 
Fermented foods are understood to have improved nutritional and functional 
properties owing to bioactive or bioavailable components (Marco et al., 2017). 
Seaweeds (mainly kelp) are a common vegetable ingredient in the fermented food, 
Kimchi. The microbial content of kimchi provides a source of probiotics, nutrients, 
and bioactive metabolites, which are reported to have anti-microbial, anti-oxidant, 
and anti-obesogenic activities (Chilton et al., 2015; Tamang et al., 2016; Wilburn 
and Ryan, 2017). One randomised controlled trial (RCT) observed that consumption 
of a seaweed Kimchi made from L. japonica for four weeks promoted the growth 
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and survival of gut microbial lactic acid bacteria in humans (Seok-Jae et al., 2014), 
whilst another RCT concluded that consumption of 1.5 g/day fermented L. japonica 
containing 5.56% γ-aminobutyric acid (GABA) (Lactobacillus brevis BJ2 culture) was 
associated with a reduction in oxidative stress in healthy adults over four weeks, 
indicated by decreased serum γ-glutamyltransferse (GGT) and malondialdehyde, 
and increased antioxidant activity of superoxide dismutase and catalase compared 
to the placebo (Kang et al., 2012). The latter study indicates that foods containing 
fermented brown seaweeds, such as L. japonica, may offer a novel source of GABA 
enriched ingredients, which are associated with hypotensive and anti-inflammatory 
effects (Wilburn and Ryan, 2017). Anti-oxidant, anti-diabetic, and anti-hypertensive 
efficacies are also reported for Korean rice wine fermented with L. japonica (Choi 
et al., 2014), while Sargassum fermented with a starter culture of Enterococcus 
faecium was reported to contain higher soluble polyphenol and mannuronic acid-
rich alginate contents (Shobharani et al., 2014), which may increase the provision 
of microbiota accessible components for colonic fermentation.  
Reports of the functional properties of fermented foods containing red seaweeds 
are scarce; however, examples of red seaweed fermented foods include a 
fermented Porphyra yezoensis seaweed sauce, which used the marine halophilic 
lactic acid bacteria, Tetragenococcus halophilus, as a starter culture (Uchida et al., 
2014); a Gracilaria domingensis aqueous extract applied as a texture modifier in 
fermented milks as a non-animal alternative to gelatin (Tavares Estevam et al., 
2016); and carrageenan as a salt replacer in the production of fat-free cheese 
(Blaszak et al., 2018).  
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Given the availability of red, brown, and green seaweeds both commercially and 
locally (Bixler and Porse, 2011), the production of seaweed-containing fermented 
foods could be a cost-effective alternative to bioactive component extraction. 
Nevertheless, an understanding of how live bacteria and bacterial metabolites 
present in fermented foods contribute towards health is required (Marco et al., 
2017). 
 Seaweeds and animal health 
Seaweeds also have a historical use as animal feed ingredients (Makkar et al., 
2016). The capacity for seaweeds to modulate the gut microbiota of monogastrics, 
such as pigs and hens, is presented in Table 3-8 Error! Reference source not 
found.and Table 3-9, respectively, which complements the recent evidence for the 
application of seaweed bioactives in monogastric animal feed (Øverland et al., 
2019). Table 3-8 shows limited evidence that the β-glucan, laminarin, may increase 
Lactobacillus populations but not Bifidobacterium populations. While there is 
scarce evidence for the selective stimulation of health-associated bacteria in pigs 
by the sulphated fucose, fucoidan. Only one recent study has evaluated the effect 
of dietary alginate on the porcine microbiota, where the genera Ruminococcus, 
Roseburia and Lachnospira, and an unclassified bacterium of the F16 family were 
increased, alongside a significant decrease in the genus Blautia, the family 
Clostridiaceae, and an unclassified bacterium of RF39 family (Umu et al., 2015). In 
Table 3-9, recent evidence indicates that hens fed Chondrus crispus and 
Sarcodiotheca gaudichaudii red seaweeds may increase ceacal SCFA concentrations 
and modulate populations of Bifidobacterium longum, Lactobacillus acidophilus, 
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Streptococcus salivarius, and Clostridium perfringens (Kulshreshtha et al., 2017, 
2014); however, a bidirectional change in microbial composition was dose 
dependent and has only been assessed in two studies to date. Given the use of pigs 
as an animal model of humans (Litten-Brown et al., 2010), data from in vivo 
monogastric studies which are designed to evaluate the prebiotic potential of 
dietary seaweeds and seaweed-derived components could provide insight into the 
potential for human applications. 
Table 3-10 and Table 3-11 summarise recent studies which have examined the 
impact of seaweed diets on the ruminant microbiota of cows and sheep, 
respectively, with the potential application of reducing methane production. 
Despite demonstrating decreased methane production, the cow rumen in vitro 
fermentation studies presented in Table 3-10 did not assess microbiota 
compositional changes, thus a knowledge gap is presented to understand which 
bacteria (if any), are increased or decreased, and are associated with a reduction in 
methane production. Table 3-11 shows that methanogenic bacteria and methane 
production were significantly decreased compared to the basal grass substrate 
control following the in vitro fermentation of sheep rumen with the red seaweed 
Asparagopsis taxiformis (Machado et al., 2018). While sheep given an ad libitum 
diet of Ascophyllum nodosum brown seaweed (1%, 3%, or 5% w/w) for 21 days 
demonstrated a dose-dependent decrease in propionate and butyrate SCFAs and a 
dose-dependent increase in acetate (Zhou et al., 2018), while several bacteria were 
significantly decreased, including Prevotella copri, Roseburia, and Coprococcus, 
while Blautia producta and the family Veillonellaceae were significantly increased 
compared to the basal diet. Moreover, the specific case of seaweed-fed North 
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Ronaldsay sheep highlights how isolated organisms of the ruminant microbiome, 
such as Prevotella, Clostridium butyricum, Butyrivibrio fibrisolvens, and 
Spirochaetes have adapted to hydrolyse alginate laminarin, and fucoidan (Orpin et 
al., 1985; Williams et al., 2013). However, there is a paucity of evidence to 
implicate any health benefits attributed to a seaweed diet in these animals. 
 Conclusions 
Current evidence regarding the prebiotic effects of seaweeds is dominated by 
complex polysaccharide components. This is because prebiotic research was 
previously focused on saccharolytic fermentation by the gut microbiota. 
Accumulating evidence from in vitro and in vivo animal studies provides 
encouraging data regarding the utilisation of red seaweed galactans and brown 
seaweed glycans, such as alginates and laminarins, with minor evidence for 
fucoidan and the green seaweed polysaccharide, ulvan.  
Given that the most recent definition of prebiotic places non-complex 
polysaccharide components in vogue, an opportunity is presented to explore how 
other seaweed phytochemicals, including polyphenols, carotenoids, and PUFAs, are 
metabolised by host microbial populations to benefit host health. Future 
investigations should consider the use of in vitro screening studies and in vivo 
animal studies to identify putative prebiotic compounds from seaweeds via the 
identification of host organisms which utilise seaweed components and the 
bioactive metabolites produced (via untargeted metabolomics). Furthermore, 
controlled human intervention studies with health-related end points to elucidate 
prebiotic efficacy are required. 
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 Tables 
Table 3-1. Potential degradation of brown seaweed glycans by the human gut 
microbiota. 
Carbohydrate 
Carbohydrate-
Active Enzyme 
(CAZyme) 
Evidenced 
Glycolytic 
Bacteria 
Reference 
Alginate 
1,4-β-d-
mannuronic 
acid 
α-l-
guluronic 
acid 
PL6 Alginate 
lyase 
PL6 MG-specific 
alginate lyase 
Bacteroides 
clarus 
Bacteroides 
eggerthii 
 
PL15 Alginate 
lyase 
PL15 
Oligoalginate 
lyase 
Bacteroides 
ovatus 
Bacteroides 
thetaiotaomicron 
Bacteroides 
xylanisolvens 
(Bai et al., 2017; 
Brownlee et al., 
2005; Li et al., 
2017; Mathieu et 
al., 2018; 
Thomas et al., 
2012) 
PL17 Alginate 
lyase 
PL17 
Oligoalginate 
lyase 
Bacteroides 
clarus 
Bacteroides 
eggerthii 
 
Fucoidan 
Sulphated 
1,2-1,3-1,4-
α-l-fucose 
GH29 α-l-
fucosidase 
GH29 α-1,3/1,4-
l-fucosidase 
Not determined 
(Zhang et al., 
2009) 
GH95 α-l-
fucosidase 
GH95 α-1,2-l-
fucosidase 
Laminarin 
1,3-1,6-β-
glucose 
GH16 β-
glucanase 
GH16 β-1,3-1,4-
glucanase 
GH16 endo-1,3-
β-glucanase 
Bacteroides 
distasonis 
Bacteroides 
fragilis 
Bacteroides 
thetaiotaomicron 
(Devillé et al., 
2004; Salyers et 
al., 1977) 
PL, Polysaccharide Lyase family; GH, Glycoside Hydrolase family. Potential glycolytic bacteria were 
identified using the Carbohydrate-Active enZYmes Database (Cantarel et al., 2008). 
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Table 3-2. Potential degradation of red seaweed glycans by the human gut microbiota. 
Carbohydrate 
Carbohydrate-Active Enzyme 
(CAZyme) 
Evidenced 
Glycolytic 
Bacteria 
Reference 
Agar 
(Galactan) 
1,3-β-d-
galactose 
1,4-3,6-
anhydro-α-l-
galactose 
GH2 β-galactosidase 
Bacteroidetes 
plebeius 
(Dousip et al., 
2014; 
Hehemann et 
al., 2010; 
Lahaye and 
Rochas, 1991; 
Rebuffet et al., 
2011) 
GH16 β-agarase 
GH86 β-agarase 
GH117 1,3-α-3,6-anhydro-l-
galactosidase 
Carrageenan 
(Galactan) 
1,4-β-d-
galactose 
1,3-α-d-
galactose 
3,6-anhydro-
d-galactose 
 
GH2 β-galactosidase 
Bacteroides 
plebeius 
(Hehemann et 
al., 2010; 
Weiner, 2014) 
GH117 1,3-α-3,6-anhydro-l-
galactosidase 
Porphyran 
(Galactan) 
Sulphated 
1,3-β-d-
galactose 
1,4-α-l-
galactose-6-
sulfate 
3,6-anhydro-
α-l-galactose 
GH16 β-porphyranase 
GH86 β-porphyranase 
Bacteroides 
plebeius 
(Hehemann et 
al., 2012, 2010; 
Zhang et al., 
2005) 
Xylan 
1,3-1,4-β-d-
xylose 
GH3 xylan 1,4-β-xylosidase 
Not determined 
(Despres et al., 
2016; Hong et 
al., 2014; 
Mirande et al., 
2010; Usov, 
2011) 
GH5 endo-1,4-β-xylanase 
GH10 endo-1,4-β-xylanase 
GH10 endo-1,3-β-xylanase 
GH11 endo-β-1,4-xylanase 
GH11 endo-β-1,3-xylanase 
GH43 β-xylosidase 
GH43 xylanase 
GH43 β-1,3-xylosidase 
GH67 xylan α-1,2-
glucuronidase 
GH115 xylan α-1,2-
glucuronidase 
CE1−CE7 and CE12 acetyl 
xylanesterases 
PL, Polysaccharide Lyase family; GH, Glycoside Hydrolase family. Potential glycolytic bacteria were identified using the 
Carbohydrate-Active enZYmes Database (Cantarel et al., 2008). 
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Table 3-3. Potential degradation of green seaweed glycans by the human gut 
microbiota. 
Carbohydrate 
Carbohydrate-Active 
Enzyme (CAZyme) 
Evidenced 
Glycolytic 
Bacteria 
Reference 
Ulvan 
Sulphated 1,4-
β-d-Glucuronic 
acid 
α-l-Rhamnose 
1,4-β-d-
xyloglucan 
GH78 α-l-rhamnosidase 
Not determined 
(Lahaye and 
Robic, 
2007; 
Munoz-
Munoz et 
al., 2017) 
GH145 α-l-rhamnosidase 
Xylan 1,3-β-d-xylose 
GH10 endo-1,3-β-
xylanase, 
Not determined 
(Liang et al., 
2015) GH11 endo-β-1,3-xylanase 
GH43 β-1,3-xylosidase 
PL, Polysaccharide Lyase family; GH, Glycoside Hydrolase family. Potential glycolytic bacteria were 
identified using the Carbohydrate-Active enZYmes Database (Cantarel et al., 2008). 
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Table 3-4. In vitro fermentation of brown seaweeds with human faecal inoculum. 
Seaweed Substrate Dose 
Use of a 
Simulated in 
vitro Digestion 
Before 
Fermentation? 
Experimental 
Parameters 
Microbial 
Enumeration 
Microbial Changes 
Metabolomics 
Analysis 
Technique 
Metabolite Changes Reference 
Ecklonia 
radiata 
Crude fraction (CF) 
Phlorotannin-enriched 
fraction (PF) 
Low-molecular weight 
polysaccharide fraction (LPF) 
High-molecular weight 
polysaccharide fraction (HPF) 
1.5% 
(w/v) 
Yes 
CF = 71.5% 
digestible 
PF = 87.3% 
digestible 
LPF = 86.1% 
digestible 
HPF = non-
digestible 
10% (w/v) 
pooled 
inoculum 
(n = 3) 
24 h 
qPCR 
↑ Bifidobacterium  
↑ Lactobacillus 
 (LPF) 
 
↑ F. prausnitzii  
↑ C. coccoides  
↑ Firmicutes 
(CF, LPF) 
 
↑ Bacteroidetes 
↑E. coli 
(CF, PF, LPF, HPF) 
 
↓ Enterococcus  
(CF, PF) 
GC-FID 
↑Acetate 
(CF) 
 
↑Propionate 
(CF, LPF, HPF) 
 
↑ Butyrate 
(CF, LPF, HPF) 
 
↑ Total SCFA 
(CF, LPF, HPF) 
(Charoensiddhi 
et al., 2017c) 
Ecklonia 
radiata 
Water extract (WE) 
Acid extract (AE) 
Celluclast enzyme extract 
(CEE) 
Alcalase enzyme extract (AEE) 
Free sugar fraction (FF) 
Polysaccharide fraction (PF) 
Seaweed residue (SR) 
Seaweed powder (SP) 
1.5% 
(w/v) 
No – digestibility 
unknown 
10% (w/v) 
pooled 
inoculum  
(n = 3) 
24 h 
qPCR 
= F. prausnitzii  
= C. leptum 
= R. bromii  
↑ Total bacteria  
(CEE, AEE, WE, FF) 
 
↑ Bifidobacterium  
↑ Bacteroidetes 
↑ Lactobacillus  
↑ C. coccoides 
(CEE) 
 
↑ E. coli ↑ Enterocccus 
(WE, AE, CEE, AEE, FF, PF, 
SP) 
GC-FID 
↑ Acetate 
↑ Propionate 
↑ Butyrate 
(WE, AE, CEE, AEE, FF, 
PF, SP) 
↑ Total SCFA 
(Charoensiddhi 
et al., 2016) 
qPCR, Quantitative PCR; GC-FID, Gas Chromatography with Flame Ionisation Detector; SCFA, Short Chain Fatty Acid; =, no statistical difference compared to the control; ↑, significant increase compared to the control; 
↓ significant decrease compared to the control. Microbial and metabolite changes with abbreviations in parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, 
then all of the seaweed substrates tested exerted the effect. 
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Table 3-4 continued. In vitro fermentation of brown seaweeds with human faecal inoculum. 
Seaweed  Substrate Dose 
Use of a 
Simulated in 
vitro Digestion 
Before 
Fermentation? 
Experimental 
Parameters 
Microbial 
Enumeration 
Microbial Changes 
Metabolomics 
Analysis 
Technique 
Metabolite 
Changes 
Reference 
Sargassum 
muticum  
Sargassum 
muticum 
Alcalase 
enzyme 
extract (SAE) 
1% 
(w/v) 
Yes – non-
digestible (% 
digestible 
undisclosed) 
10% (w/v) 
single 
inoculum 
24 h 
FISH 
= Bifidobacterium  
= Lactobacillus 
= Clostridium histolticum 
↑ Bacteroides/Prevotella  
↓ C.coccoides/E.rectale 
HPLC 
↑ Total 
SCFA 
(Rodrigues 
et al., 
2016) 
Sargassum 
thunbergii 
Polysaccharide 
extract 
0.3% 
(w/v) 
No – 
digestibility 
unknown 
20% (w/v) 
pooled 
inoculum  
(n=3)  
24 h 
16S rRNA  
NGS 
↑ Bacteroidetes  
↑Bacteroidetes:Firmicutes 
ratio  
↑ Bifidobacterium  
↑ Roseburia  
↑ Parasutterella  
↑ Fusicatenibacter  
↑ Coprococcus  
↑ Fecalibacterium  
GC-MS 
↑ Acetate  
↑ 
Propionate  
↑ 
Butyrate  
↑ Valerate  
↑ Total 
SCFA 
(Fu et al., 
2018) 
FISH, Flourescence in situ Hybridisation; 16S rRNA NGS, 16S rRNA Next Generation Sequencing; HPLC, High Performance Liquid Chromaography; GC-MS, Gas Chromatography-Mass Spectrometry; SCFA, Short Chain Fatty 
Acid; =, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes with abbreviations in 
parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-4 continued. In vitro fermentation of brown seaweeds with human faecal inoculum. 
Seaweed 
 
Substrate Dose 
Use of a 
Simulated in 
vitro Digestion 
Before 
Fermentation? 
Experimental 
Parameters 
Microbial 
Enumeration 
Microbial 
Changes 
Metabolomics 
Analysis 
Technique 
Metabolite 
Changes 
Reference 
- 
 
Alginate 5% (w/v) 
No – 
digestibility 
unknown 
10% (w/v) 
single 
inoculum 
72 h 
16S rRNA 
DGGE 
16S rRNA 
NGS 
↑ Bacteroides  GC-FID 
↑ Propionate 
 
↑ Butyrate 
 
↑ Total SCFA 
(Bai et al., 
2017) 
- 
 Alginate (A) 
 
Mannuronic 
acid 
oligosaccharid
es (MO) 
 
Guluronic acid 
oligosaccharid
es (GO)  
 
Propylene 
glycol alginate 
sodium 
sulphate (PSS) 
5g/L (A) 
8g/L (MO, 
GO, PSS) 
No – 
digestibility 
unknown 
10% (w/v) 
single 
inoculum 
48 h 
16S rRNA 
DGGE 
Detection of 
Bacteroides 
xylanisolvens, 
Clostridium 
clostridioforme/ 
Clostridium 
symbiosum, 
Bacteroides 
finegoldii, 
Shigella 
flexneri/E.coli, 
E.fergusonii, 
and Bacteroides 
ovatus 
HPLC 
A, MO, GO: 
↑ Acetate 
↑ Propionate 
↑ Butyrate 
↑ Total SCFA 
(Li et al., 
2016) 
Ascophyllum 
nodosum 
 
Sulphated 
polysaccharide 
extract 
9 mg/mL 
Yes – non-
digestible (% 
digestible 
undisclosed) 
10% (w/v) 
pooled 
inoculum  
(n = 4) 
24 h 
16S rRNA NGS 
↑ Bacteroides  
↑ 
Phascolarctobac
terium  
↑ Oscillospira  
↑ 
Fecalibacterium  
GC-FID 
↑ Acetate 
↑ Propionate 
↑ Butyrate 
↑ Total SCFA 
(Chen et al., 
2018) 
16S rRNA DGGE, 16S rRNA Denaturing Gradient Gel Electrophoresis; 16S rRNA NGS, 16S rRNA Next Generation Sequencing; GC-FID, Gas Chromatography with Flame Ionisation Detector; HPLC, High Performance Liquid 
Chromaography; SCFA, Short Chain Fatty Acid; =, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and 
metabolite changes with abbreviations in parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-4 continued. In vitro fermentation of brown seaweeds with human faecal inoculum. 
Seaweed  Substrate Dose 
Use of a 
Simulated in 
vitro Digestion 
Before 
Fermentation
? 
Experime
ntal 
Paramete
rs 
Microbial 
Enumeration 
Microbial 
Changes 
Metabolomics 
Analysis 
Technique 
Metabolite 
Changes 
Refer
ence 
Laminaria 
digitata 
Crude 
polysaccharide 
extract (CE) 
Depolymerised 
crude 
polysaccharide 
extract (DE) 
1% (w/v) 
Yes – non-
digestible (% 
digestible 
undisclosed) 
20% (w/v) 
pooled 
inoculum  
(n = 3) 
48 h 
16S rRNA 
NGS 
↑ 
Parabacteroides 
(CE, DE) 
↑ Fibrobacter 
(CE) 
↓ 
Streptococcus  
↓ 
Ruminococcus  
↑ 
Lachnospiracea
e UC (DE) 
↓ 
Peptostreptococ
caceae IS (DE) 
↑ Dialister (CE, 
DE) 
↑ γ B38UC (CE) 
GC-FID 
↑ Acetate (CE, 
DE) 
↑ Propionate 
(CE, DE) 
↑ Butyrate (CE, 
DE) 
↑ Total SCFA 
(CE, DE) 
(Strai
n et 
al., 
2019) 
- Laminarin 1% (w/v) 
No – 
digestibility 
unknown 
10% (w/v) 
pooled 
inoculum  
(n = 5) 
24 h 
qPCR 
↑ 
Bifidobacterium  
↑ Bacteroides  
HPLC 
↑ Acetate 
↑ Propionate 
↑ Total SCFA 
(Seon
g et 
al., 
2019) 
16S rRNA NGS, 16S rRNA Next Generation Sequencing; qPCR, Quantitative PCR; GC-FID, Gas Chromatography with Flame Ionisation Detector; HPLC, High Performance Liquid Chromatography; SCFA, Short Chain Fatty 
Acid; =, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes with abbreviations in 
parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect.
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Table 3-5. In vitro fermentation of red seaweeds with human faecal inoculum. 
Seaweed  Substrate Dose 
Use of a 
Simulated in 
vitro Digestion 
Before 
Fermentation? 
Experimental 
Parameters 
Microbial 
Enumeration 
Microbial 
Changes 
Metabolomics 
Analysis 
Technique 
Metabolite 
Changes 
Reference 
Kappaphycus 
alvarezii 
Whole 
Seaweed (WS) 
1% (w/v) 
Yes – non-
digestible  
(% digestible 
undisclosed) 
10% (w/v) 
single inoculum 
24 h 
FISH 
↑ Bifidobacterium   
↓ Clostridium 
coccoides/ 
Eubacterium rectale 
HPLC ↑ Total SCFA 
(Bajury et al., 
2017) 
Osmundea 
pinnatifida 
Osmundea 
pinnatifida  
Viscozyme 
extract (OVE) 
1% (w/v) 
Yes – non-
digestible  
(% digestible 
undisclosed) 
10% (w/v) 
single inoculum 
24 h 
FISH 
= 
Bifidobacteriu
m   
= Lactobacillus   
= Clostridium 
histolticum 
HPLC ↑Total SCFA 
(Rodrigues et 
al., 2016) 
Gracilaria rubra 
Polysaccharide 
extract (PE) 
1% 
(w/v) 
Yes – non-
digestible 
(% digestible 
undisclosed) 
10% (w/v) 
pooled  
inoculum (n = 
4) 
24 h 
16S rRNA  
NGS 
↑ Bacteroides  
↑Prevotella  
↑Phascolarcto
bacterium  
↓Firmicutes:B
acteroidetes 
GC-FID 
↑ Acetate 
↑ Propionate 
↑ Isobutyrate 
↑ Total SCFA 
(Di et al., 2018) 
- Porphyran 1% (w/v) 
No – 
digestibility 
unknown 
10% (w/v) 
pooled 
inoculum (n = 
5) 
24 h 
qPCR 
↑ 
Bifidobacteriu
m  
↑ Bacteroides  
HPLC 
= Acetate 
= Propionate 
= Butyrate 
= Total SCFA 
(Seong et al., 
2019) 
FISH, Flourescence in situ Hybridisation; 16S rRNA NGS, 16S rRNA Next Generation Sequencing; qPCR, Quantitative PCR; GC-FID, Gas Chromatography with Flame Ionisation Detector; HPLC, High Performance Liquid 
Chromatography; SCFA, Short Chain Fatty Acid; =, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and 
metabolite changes with abbreviations in parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-6. In vitro fermentation of green seaweeds with human faecal inoculum. 
Seaweed  Substrate Dose 
Use of a 
Simulated in 
vitro Digestion 
Before 
Fermentation? 
Experimental 
Parameters 
Microbial 
Enumeration  
Microbial 
Changes 
Metabolomics 
Analysis 
Technique 
Metabolite 
Changes 
Reference 
Enteromorpha 
prolifera 
Polysaccharide 
extract (PE) 
0.2 g in 
9.5 mL 
0.8 g in 
9.5mL 
Yes-non-
digestible 
(% digestible 
undisclosed) 
10.5% (w/v) 
pooled 
inoculum (n = 
3) 
12, 24, and 48 
h 
Microbial 
culture 
↑ Enterobacter 
(0.2 PE and 0.8 
PE at 24 h and 
48 h) 
= Enterococcus  
= Lactobacillus  
= 
Bifidobacterium  
GC-FID 
= Acetate 
= Butyrate 
= Lactate 
(Kong et 
al., 2016) 
- Ulvan 1% (w/v) 
No-digestibility 
unknown 
10% (w/v) 
pooled 
inoculum (n = 
5) 
24 h 
qPCR 
↑ 
Bifidobacterium  
↑ Lactobacillus  
HPLC 
↑ Acetate 
↑ Lactate 
(Seong et 
al., 2019) 
qPCR, Quantitative PCR; GC-FID, Gas Chromatography with Flame Ionisation Detector; HPLC, High Performance Liquid Chromatography; =, no statistical difference compared to the control; ↑, significant increase 
compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes with abbreviations in parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in 
parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-7. Impact of seaweeds on the rodent gut microbiota. 
Animal Substrate Dose 
Durati
on 
Biological 
Sample 
Microbial Changes Metabolite Changes 
Refere
nce 
30 Male 
Sprague-
Dawley Rats 
Chondrus crispus  
Whole Seaweed 
(WS) 
0.5% 
(w/w)  
2.5% 
(w/w)  
21 
days 
Faeces 
↑Bifidobacterium ↑ Legionella ↑ Sutterella  
↑ Blautia ↑ Holdemania  
↑ Shewanella ↑ Agarivorans  
↓ Streptococcus  
↑ Bifidobacterium breve (2.5% WS) 
↑ Acetate  
↑ Propionate (2.5% WS) 
↑ Butyrate  
↑ Total SCFA 
(Liu et 
al., 
2015) 
24 Male 
Sprague-
Dawley Rats 
Ecklonia radiata 
Whole Seaweed 
(WS) 
Ecklonia radiata 
Polysaccharide 
Fraction (PF) 
5% (w/w) 
WS 
5% (w/w) 
PF 
7 days Caecum 
↑ F. prausnitzii ↑ E. coli (PF) 
↓ Enterococcus (WS) 
↓ Lactobacillus ↓ Bifidobacterium  
↓ Firmicutes:Bacteroidetes  
↑ Acetate  
↑ Propionate  
↑ Butyrate (PF) 
↓ Valerate 
↓ Hexanoate 
↑ Total SCFA  
↓ i-Butyrate  
↓ i-Valerate  
↓ phenol  
↓ p-cresol 
(Charo
ensidd
hi et 
al., 
2017b
) 
18 Male Wistar 
Rats 
Alginate (A) 
Laminarin (L) 
Fucoidan (F) 
2% (w/w) 
14 
days 
Caecum 
↑ Bacteroides (Bacteroides capillosus) 
Presence of Enterorhabdus (A) 
↑ Proteobacteria. Presence of Lachnospiracea, 
Parabacteroides (Parabacteroides distasonis) and 
Parasutterella (L) 
Not fermented (F) 
↑ Propionate (L) 
↑ Total SCFA (A, L) 
(C. An 
et al., 
2013) 
SCFA, Short Chain Fatty Acid; =, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes with 
abbreviations in parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-8. Impact of seaweeds on the porcine gut microbiota. 
Animal 
Seaweed 
Component 
Dose Duration 
Biological 
Sample 
Microbial Changes 
Metabolite 
Changes 
Reference 
20 pregnant gilts 
and 48 piglets 
Laminarin/Fucoida
n Extract 
10 g/day  
Gestation (day 83) 
to weaning (day 
28) 
Faeces 
(Sow) 
Colonic 
digesta 
(Piglet) 
Sows (parturition):  
↓ Enterobacteriaceae 
 = lactobacilli 
Piglets (birth, 48h after 
birth, weaning): 
= Enterobacteriaceae = 
lactobacilli 
- (Heim et al., 2015) 
200 pigs 
Ecklonia cava 
Whole Seaweed 
0.05% (w/w) 
0.1% (w/w) 
0.15% (w/w)  
28 days Caecum 
↑ Lactobacillus  
↓ E. coli 
= Total Anaerobes 
- (Choi et al., 2017) 
24 pigs 
Laminarin/Fucoida
n 
Extract (SD) 
Laminarin/Fucoida
n Wet Seaweed 
(WS) 
5.37 Kg/tonne SD 
26.3 Kg/tonne WS 
21 days 
Ileum  
Caecum  
Colon 
= Bifidobacterium  
= Lactobacillus 
= Enterobacterium (SD, 
WS) 
↑ Lactobacillus agilis 
(colon) 
- 
(Murphy et al., 
2013) 
48 pigs Laminarin Extract 300 ppm  32 days Faeces 
↑ Lactobacillus  
= Bifidobacteria 
= Acetate 
↓ Propionate  
= Butyrate 
= Valerate  
= i-Butyrate 
= i-Valerate 
(Heim et al., 2014) 
48 pigs β-glucan 
250 g/tonne 
150 g/tonne 
29 days 
Ileum 
Caecum 
Proximal 
Colon Distal 
Colon 
= lactobacilli  
= bifidobacteria 
↑ Lactobacillus diversity 
- 
(Murphy et al., 
2013) 
=, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes with abbreviations in parenthesis 
indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-8 continued. Impact of seaweeds on the porcine gut microbiota. 
Animal 
Seaweed 
Component 
Dose Duration Biological Sample Microbial Changes 
Metabolite 
Changes 
Reference 
168 pigs 
Laminarin (L)  
Fucoidan (F) 
240 mg/kg F 
150 mg/kg L 
300 mg/kg L 
150 mg/kg L and 
240 mg/kg F 
300 mg/kg L and 
240 mg/kg F 
35 days Faeces 
= E. coli  
= Bifidobacterium 
↑ lactobacilli 
= Acetate 
= Propionate 
= Butyrate 
= Valerate 
= i-Butyrate 
= i-Valerate 
= Total SCFA 
(Walsh et al., 
2013) 
9 pigs Alginate 5.14% (w/w)  84 days Faeces 
= Diversity 
↑ Unclassified F16 
family  
↓ Clostridiaceae  
↓ Unclassified 
RF39 (Mollicutes) 
↑ Ruminococcus  
↑ Roseburia  
↑ unclassified F16 
genus (TM7)  
↑ Lachnospira  
↓ Blautia  
- (Umu et al., 2015) 
=, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes with abbreviations in parenthesis 
indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-9. Impact of seaweeds on the hen gut microbiota. 
Animal 
Seaweed 
Component 
Dose Duration Biological Sample Microbial Changes 
Metabolite 
Changes 
Reference 
160 laying hens 
Chondrus crispus  
Whole Seaweed 
(CC) 
Sarcodiotheca 
gaudichaudii  
Whole Seaweed 
(SG) 
0.5% (w/w)  
1% (w/w)  
2% (w/w)  
30 days 
Ileum 
Caecal digesta 
↑ Bifidobacterium 
longum (CC2, SG1, 
SG2) 
↑ Streptococcus 
salivarius (CC1, 
CC2, SG2) 
↓ Clostridium 
perfringens (CC1, 
CC2, SG1, SG2) 
↓ Lactobacillus 
acidophilus (CC1, 
CC2) 
↑ Acetate (CC1, 
SG1) 
↑ Propionate 
(CC2) 
↑ Butyrate (SC2) 
(Kulshreshtha et 
al., 2014) 
96 laying hens 
Chondrus crispus  
Whole Seaweed 
(CC) 
Sarcodiotheca 
gaudichaudii  
Whole Seaweed 
(SG) 
Control diet + 2% 
(w/w) seaweed 
Control diet + 4% 
(w/w) seaweed 
28 days Caecum 
↑ Lactobacillus 
acidophilus (CC4) 
↓ Bifidobacterium 
longum (SG2, SG4, 
CC4) 
↓ Streptococcus 
salivarius (SG2, 
SG4, CC2, CC4) 
↑ Bacteroidetes 
(SG4, CC2, CC4) 
↑ Propionate 
(CC4) 
(Kulshreshtha et 
al., 2017) 
=, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes with abbreviations in parenthesis 
indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-10. In vitro fermentation of seaweeds with cow rumen inoculum. 
Seaweed Substrate 
Experimental 
Parameters 
Dose 
(w/v) 
Microbial 
Enumeration 
Microbial Changes 
Metabolomics 
Analysis 
Technique 
Metabolite Changes Reference 
Ascophyllum 
nodosum (AN)  
Laminaria 
digitata (LD)  
Whole 
Seaweed 
50% pooled 
inoculum  
(n = 4)  
24 h 
0.5g/L 
1g/L  
2g/L 
-  - GC-FID 
↑Propionate  
↑Butyrate (LD) 
↓ BCFA 
↓Methane 
(Belanche et 
al., 2016) 
Asparagopsis 
taxiformis 
Whole 
Seaweed 
20% pooled 
inoculum  
(n = 4) 
72 h 
0.5% 
1% 
2% 
5% 
10% 
-  - GC-FID 
↓ Total gas production 
↓ Methane  
↓ Acetate  
↑ Propionate 
↑ Butyrate (2%, 10%) 
↓ Total SCFA (5%, 10%) 
(Kinley et al., 
2016) 
Ulva sp. 
Laminaria 
ochroleuca 
Saccharina 
latissima 
Gigartina sp. 
Gracilaria 
vermiculophylla 
Whole 
Seaweed 
20% pooled 
inoculum  
(n = 2) 
24 h 
25% - - GC-FID ↓ Methane 
(Maia et al., 
2016) 
Brown 
seaweed by-
products (BSB) 
- 
50% (v/v) 
single 
inoculum 
0, 3, 6, 9, 12, 
and 24 h 
2% 
4% 
- - GC-FID 
↓ Ammonia (3, 9, 12 and 
24h) 
↓ Total SCFA (24h) 
(Hong et al., 
2015) 
GC-FID, Gas Chromatography; =, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ significant decrease compared to the control. Microbial and metabolite changes 
with abbreviations in parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, then all of the seaweed substrates tested exerted the effect. 
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Table 3-11. Impact of seaweeds on the sheep rumen microbiota. 
Seaweed Dose 
Experimental 
Parameters 
Microbial 
Enumeration 
Microbial Changes 
Metabolomics 
Analysis Technique 
Metabolite Changes Reference 
Asparagopsis 
taxiformis 
Whole 
Seaweed 
2% 
in vitro batch culture 
fermentation 
20% (v/v) pooled sheep 
rumen fluid inoculum 
(n = 4) 
48 and 72 h 
16S rRNA NGS 
qPCR 
↓Methanogens 
↓Bacteroidetes/Firmicutes 
ratio 
↓ mcrA gene expression 
GC-MS 
↓ Total Gas 
↓ Methane 
↑ Hydrogen 
(Machado et 
al., 2018) 
Ascophyllum 
nodosum 
Whole 
Seaweed 
1% 
3% 
5% 
Rams (n = 8) 
21 days ad libitum 
16S rRNA NGS 
↓ undefined TM7-1 
↓undefined Coriobacteriaceae 
↓Roseburia 
↓Coprococcus  
↓Prevotella copri 
↑Blautia producta 
↑ Entodinium species 1 
↑Veillonellaceae 
GC-FID 
Dose dependent: 
↑ Acetate 
↓ Propionate 
↓ Butyrate 
PICRUSt: 
↑Butanoate metabolism 
↑ Fatty acid metabolism 
↓Glycerophospholipid 
metabolism 
(Zhou et al., 
2018) 
16S rRNA NGS, 16S rRNA Next Generation Sequencing; qPCR, Quantitative PCR; GC-FID, Gas Chromatography; =, no statistical difference compared to the control; ↑, significant increase compared to the control; ↓ 
significant decrease compared to the control. Microbial and metabolite changes with abbreviations in parenthesis indicate the substrate(s) which exerted the effect. If no abbreviations in parenthesis are presented, 
then all of the seaweed substrates tested exerted the effect. 
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4 Effects of the edible Irish brown seaweeds, Fucus vesiculosus 
and Laminaria digitata, on the composition and metabolic 
activity of the human gut microbiota using an in vitro model of 
the distal colon. 
 Abstract 
There is increasing interest in the health benefits of brown seaweeds, with many 
postulating that the fibre component may confer health benefits due to its 
prebiotic properties. This study investigated the prebiotic potential of Fucus 
vesciulosus and Laminaria digitata whole seaweed powders (FVWS and LDWS, 
respectively), as well as their isolated polysaccharide rich extracts (FVE and LDE, 
respectively), using in vitro faecal batch culture fermentation experiments. The 
effect of the seaweed treatments on microbiota composition (qPCR & 16S rRNA 
amplicon sequencing) and metabolism (short chain fatty acids via GC-MS) was 
compared with cellulose (negative control) and Synergy 1 (positive control).  
None of the seaweed substrates stimulated the growth of Bifidobacterium spp. 
when compared to cellulose (qPCR), whilst significant reductions of Lactobacillus 
spp. were evident in LDWS (5 & 10 hrs) and LDE (5 hrs). 16S rRNA amplicon 
sequencing showed no effect of seaweed treatments on alpha and beta measures 
of bacterial diversity when compared to cellulose. Inclusion of FVE in the 
fermentation showed a stimulation of the genera Phascolarctobacterium, 
Oscillospira, and Faecalibacterium, and several genera within the Lachnospiraceae, 
Prevotellaceae, and Ruminococcaceae families when compared to cellulose. LDWS 
treatment showed significant changes in the genera Bacteroides, Coprococcus, and 
Parasutterella, in addition to genera from the families Ruminococcaceae and 
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Lachnospiraceae when compared to cellulose. LDE treatment showed significant 
changes in the genera Butyricimonas, Coprococcus, Phascolarctobacterium, 
Pseudobutyrivibrio and Roseburia when compared to cellulose. FVWS and FVE 
treatment resulted in significantly higher concentrations of acetic acid (24, 36 & 48 
h, p < 0.05) when compared to cellulose. FVWS treatment also resulted in 
significantly higher propionic acid concentrations when compared to cellulose after 
48 h. LDWS treatment resulted in significantly higher concentrations of acetic acid 
(10 h, p < 0.05) and butyric acid (24 & 36 h, p < 0.05) and total SCFA (24 & 36 h, p < 
0.05) when compared to cellulose. This study showed that neither seaweed 
mediated bifidogenic effects nor altered bacterial diversity, however, the noted 
increases in short chain fatty acid concentrations, particularly following the whole 
seaweed treatments, warrant further research in an in vivo setting. 
 Introduction 
Beneficial effects of adequate dietary fibre intake are associated with a reduced 
risk and mortality of a range of non-communicable diseases (NCDs) such as obesity, 
type 2 diabetes, and cardiovascular disease (Reynolds et al., 2019). The 
recommended fibre intake can vary greatly between 25-38 g/day, depending on 
the country; however, many populations struggle to achieve adequate intakes, and 
this is suggested to negatively impact health (EFSA, 2010; US Institute of Medicine, 
2001). The health benefits of fibre, beyond the established faecal bulking 
properties, have been attributed to its viscosity and gel-forming properties, which 
can influence gastrointestinal transit time to impact appetite, nutrient absorption 
and metabolism (Mattea Müller et al., 2018). Additionally, high fibre diets have 
been shown to promote increased gut bacterial diversity, and increase the 
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abundance and metabolic activity of beneficial microorganisms (O’Grady et al., 
2019). 
The fermentation of dietary fibre components in the lower GI tract, dictated by the 
expression of enzymes present in the human gut microbiome, has been shown to 
modulate changes in gut microbiota composition, diversity, and metabolic output 
(O’Grady et al., 2019). Such modulation may exert positive effects on the intestinal 
epithelium, immune cells, and systemically, beyond the gut where substrates 
(including dietary fibre), that are selectively utilized by host microorganisms to 
confer a health benefit, are considered prebiotics (Gibson et al., 2017). 
The most researched commercially available prebiotics, inulin, fructo-
oligosaccharides and galacto-oligosaccharides have historically focused on the 
selective enhancement of Bifidobacterium and Lactobacillus and the production of 
short chain fatty acids (SCFA), as candidate mediators of health. SCFA are a group 
of fermentation metabolites which are proposed to exert beneficial effects on 
health by affecting host physiology via the regulation of gut barrier function, 
control of appetite, glucose and lipid homeostasis as well as immunomodulation 
(O’Grady et al., 2019; Chambers et al., 2018). The microbial compositional and 
metabolic changes that can be deemed as indicators of prebiotic activity continue 
to evolve with the development of next-generation sequencing and metabolomics 
analysis techniques. More recently, the accumulating evidence to implicate 
increased gut microbial diversity with positive health outcomes, has increased 
attention on microbial function and diversity as indicators of prebiotic potential.   
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There is increasing interest in the identification of alternative sources of prebiotic 
fibres, where seaweeds represent a potentially novel source of prebiotic 
compounds owing to the presence of non-digestible polysaccharides that are not 
generally found in other dietary sources. For brown seaweeds, this includes 
alginate, laminarin, and fucoidan polysaccharides. Previous batch culture 
experiments have provided indications of prebiotic activity of isolated fibre 
components from brown seaweeds, however, a variability in experimental 
parameters and analysis limits their interpretation.  
This study aims to examine the prebiotic potential of Irish-sourced Fucus 
vesiculosus (F.  vesiculosus) and Laminaria digitata (L. digitata) brown seaweeds, 
by investigating the fermentability of F. vesiculosus powder (FVWS) and L. digitata 
powder (LDWS), and polysaccharide-rich complex carbohydrate extracts of F. 
vesiculosus (FVE) and L. digitata (LDE), using an in vitro model of human colonic 
fermentation in comparison to cellulose and Synergy 1 negative and positive 
controls, respectively.  
 Materials and Methods  
 Chemicals and reagents 
Chemicals were purchased from Sigma Aldrich (St. Louis, USA) unless otherwise 
stated. Reagents used during HPSEC and GC-MS were HPLC grade. Reagents used 
for DNA extraction, qPCR, and 16S rRNA amplicon sequencing were molecular 
biology grade. 
 Seaweed harvest 
F. vesiculosus and L. digitata were harvested from Spiddal, Co. Galway, Ireland (53° 
14' 48" North, 9° 18' 10" West) in September 2014. Only the leaf was used, and the 
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stipe was removed from the holdfast during harvesting. The seaweed was 
immediately washed in seawater to remove contaminants (e.g. epiphytes, molluscs 
and other seaweeds). Washed seaweed was freeze-dried, ground into a fine 
powder using an electronic blender, and stored at -20 °C until required. 
 Polysaccharide-rich extract production 
F. vesiculosus and L. digitata powders were shaken in dH2O (1:20, w/v) for two 
mins to reduce the initial salt content of the seaweed and then filtered through 
muslin cloth to remove the water. A total of 30g of washed seaweed was 
immediately freeze-dried and stored for in vitro digestion and the batch culture 
fermentation experiments (FVWS and LDWS). Seaweed powders then underwent 
hot acid extraction, neutralisation, desalination, ethanol precipitation, and 
lyophilisation to generate crude F. vesiculosus and L. digitata polysaccharide-rich 
extract powders (FVE and LDE, respectively). 
 FVE and LDE characterisation 
The average molecular weight of FVE and LDE was determined using a modified 
high performance size exclusion chromatography method (Gomez-Ordonez et al., 
2012). In brief, separation was performed on a PL aquagel-oh mixed-H 8μm SEC 
analytical column (7.5 x 300 mm i.d) with isocratic elution at 50°C and a flow rate 
of 0.6 mL/min and a run time of 31 mins, using a 50mM ammonium formate 
mobile phase and a ten-point pullulan standard curve (0.34 to 708 kDa). 
Total carbohydrate content of FVE and LDE was quantified using a modified 
phenol-sulfuric acid colorimetric assay (DuBois et al., 1956). Sulphate content of 
FVE and LDE was quantified using a modified Azure A colorimetric assay, expressed 
as percentage equivalents of purified fucoidan (Fucoidan from Fucus vesiculosus 
230 
 
 
F5631, Sigma Aldrich, USA) (Torode et al., 2015). Structural information of FVE and 
LDE was determined using Fourier Transform Infrared Spectroscopy (FTIR) using 
the Bruker Tensor 27 FT-IR spectrophotometer (Bruker Corporation, UK) with OPUS 
5.5 software.  
 Mineral and trace element content of FVWS, LDWS, FVE and LDE 
Mineral and trace element analysis of FVWS, LDWS, FVE and LDE (1 x 10 g of each) 
was outsourced to Advanced Laboratories (Salt Lake City, Utah, USA). 
Concentrations of aluminium, copper, sodium and zinc were determined by 
inductively coupled plasma optical emission spectrometry (ICP-OES). 
Concentrations of mercury, lead, arsenic, and cadmium were determined by 
inductively coupled plasma mass spectrometry (ICP-MS). Iodine concentration was 
determined using AOAC 932.21. 
 In vitro digestion 
An in vitro simulated digestion was completed on FVWS, LDWS, FVE and LDE using 
a standardised method (Minekus et al., 2014) with oral, gastric, and intestinal 
phases of digestion. All simulated fluids were incubated at 37°C before use and at 
all digestion stages the fluids were incubated at 37°C in an orbital shaker (160 
rpm). The oral suspension was incubated for 2 mins, while both the gastric and 
intestinal suspensions were incubated for 2 hrs. The intestinal phase digesta was 
then dialysed for 24 hrs using 1kDa dialysis tubing (Spectrum Labs, USA) and the 
retentate was freeze dried (Labconco, USA) to obtain powders prior to batch 
culture fermentation. 
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 In vitro batch culture fermentation 
A 20% faecal slurry was prepared as described by O’Donnell et al. (O’Donnell et al., 
2016). The resulting faecal bacteria suspension was amended with sterile glycerol 
to a final concentration of 25% (v/v) and stored frozen at -80°C until use. Nutrient 
basal medium stock solution was prepared using methodology of Fooks and Gibson 
(Fooks and Gibson, 2003). In vitro batch culture fermentation was performed using 
the Multifors parallel bioreactor with Iris 6.0 software (Infors HT, Basel, 
Switzerland). A total of 2g of either FVWS, LDWS, FVE, LDE, cellulose (negative 
control), or Synergy 1 (positive control) was added to 190ml nutrient basal medium 
stock solution (final carbohydrate concentration = 1% w/v). Vessels were sparged 
with N2 gas for 2 hrs (2 psi) before inoculation with 10ml of 20% faecal slurry 
(previously thawed at 37°C). Vessels were stirred at 200 revolutions min-1, 
maintained at pH 6.8 and 37°C. A 7mL sample was taken at t = 0, 5, 10, 24, 36 and 
48 hrs for culture-dependent, culture-independent (qPCR and 16S rRNA amplicon 
sequencing), and SCFA analysis. Substrate fermentation was performed in 
triplicate. 
 DNA extraction 
Genomic DNA was extracted from samples after 0, 5, 10, 24, 36, and 48 hrs 
fermentation using the PowerFecal DNA extraction kit (Mo Bio Laboratories, 
Carlsbad, USA) according to manufactures’ instructions. The bead beating step was 
completed using the Mo Bio vortex adapter. 
 qPCR  
Total bacteria, Lactobacillus, and Bifidobacterium were quantified using qPCR. The 
primer sequences used for qPCR were: (Target: Forward primer 5'-3'; Reverse 
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primer 5'-3'; Size bp; Tm °C); Total Bacteria (Eubacterial): 
ACTCCTACGGGAGGCAGCAG; ATTACCGCGGCTGCTGG; 200 bp; 60°C; Lactobacillus 
genus: GCAGCAGTAGGGAATCTTCCA; GCATTYCACCGCTACACATG; 349 bp; 60°C; and 
Bifidobacterium genus: CTCCTGGAAACGGGTGGT; GCTGCCTCCCGTAGGAGT; 203 
bp; 60°C. A standard curve of 109-103 CFU/ml was prepared in duplicate for each 
plate. A PCR master mix was prepared with the forward and reverse primers, 
SYBR® FAST pPCR Master Mix (KAPA Biosystems, USA), and PCR water. 1 µl of 
sample DNA or PCR water (negative control) was added to 9 µl master mix per well 
(reaction volume = 10 µl) and ran in duplicate on two plates (n = 4). The 
Lightcycler® 480 Instrument II (Roche, Switzerland) was used with the following 
PCR conditions: denaturation = 1 cycle; amplification = 40 cycles; melting = 1 cycle; 
cooling = 1 cycle. Target temperature was 95°C with a hold time of 3 min and a 
ramp rate of 4.4°C/sec.  
 16S rRNA amplicon sequencing 
Illumina MiSeq sequencing library preparation was completed following the 16S 
metagenomic sequencing library protocol (Illumina, USA) and as described by 
Fouhy et al. (Fouhy et al., 2015). Amplicon PCR: Genomic DNA was amplified using 
primers specific to the V3-V4 hypervariable region of the 16S ribosomal RNA gene 
to create a 460bp amplicon. These primers also incorporated the Illumina overhang 
adaptor (Forward primer  5’   
 TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG; 
reverse primer 5’  
 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC). 
Each PCR reaction contained 2.5 μL template DNA, 5 µL forward primer (1 µM), 5 
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µL reverse primer (1 µM), 12.5 µL 2X Kapa HiFi Hotstart ready mix (KAPA 
Biosystems, USA) giving a total of 25µL in the final reaction volume. PCR 
amplification was carried out using the Applied Biosystems 2720 thermal cycler 
(Life Technologies, USA) with the following parameters: heated lid 110°, 95°C for 3 
mins; then 25 cycles of: 95°C for 30 secs, 55°C for 30 secs, 72°C for 30 secs; hold at 
72°C for 5 mins; hold at 4°C. Successful PCR products were cleaned using 
Agentcourt AMPure XP kit (Beckman Coulter Genomics, UK). A second PCR reaction 
was completed to attach the Illumina sequencing adapters onto the amplicons 
using the Nextera XT Index kit (Illumina, USA). The DNA concentration of each 
sample was determined using the Qubit High Sensitivity DNA kit and the Qubit 3 
Fluorometer (Invitrogen, USA). DNA samples were then pooled as an equimolar 
mix and sequenced on the MiSeq sequencing platform at Teagasc, Moorepark, 
Ireland following standard Illumina sequencing protocols for the 2 × 250 cycle V3 
Kit. 
 Bioinformatics  
Two hundred and fifty base pair paired-end reads were assembled using FLASH 
(FLASH: fast length adjustment of short reads to improve genome assemblies). 
Further processing of paired-end reads including quality filtering based on a quality 
score of > 25 and removal of mismatched barcodes and sequences below length 
thresholds was completed using QIIME (Caporaso et al., 2010). Denoising, chimera 
detection and clustering into operational taxonomic units (OTUs) (97% identity) 
were performed using USEARCH v7 (64-bit) (Edgar, 2010). OTUs were aligned using 
PyNAST (PyNAST: python nearest alignment space termination; a flexible tool for 
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aligning sequences to a template alignment) and taxonomy was assigned using 
BLAST against the SILVA SSURef database release v123. 
 Short chain fatty acid and branched chain fatty acid analysis  
GC-MS analysis was carried out using a modified protocol described by Garcia-
Villalba et al. (Garcia-Villalba et al., 2012). In brief, phosphoric acid was added to 
samples to a final concentration of 0.5 % (v/v) prior to ethyl acetate extraction (1:1 
v/v). 180 µl organic phase was added to a GC vial alongside 20 µl of 4-methyl 
valerate internal standard. A standard curve of 10, 20, 50, 100, 500, 1000, 5000, 
10000, 50000, and 100,000 µM SCFA mix containing acetic acid, propionic acid, n-
butyric acid, i-butyric acid, valeric acid, i-valeric acid, and hexanoic acid was run 
within every sample batch. Quality control consisted of two 50 µM and two 100 
µM standard mixes every sixteen vials and ethyl acetate blanks every six vials, and 
between each standard vial/QC to prevent carryover. The GC-MS system consisted 
of an Agilent 6890N (Agilent Technologies, USA), equipped with an Agilent 7683 
AutoSampler and 7683B injector, coupled to an Agilent 5973 inert mass selective 
detector. Agilent MassHunter GC/MS Acquisition software was used. The GC was 
fitted with a DB-WAXetr capillary column (30m length, 0.25mm i.d, 0.25µm film 
thickness), with helium used as the carrier gas (1.2mL/min). Injections were made 
in splitless mode with an injection volume of 1µL (10 µL syringe) and an injection 
temperature of 250°C. The syringe undertook four pre-washes and four post-
washes in hexane. The initial column temperature was 90°C and ramped to 150°C 
at 15°C/min, then to 170°C at 5°C/min, then to 230°C at 20°C/min, where it was 
maintained for 2 mins. Total run time was 14 mins. Solvent delay was 2.5 mins. The 
detector was operated in electron impact ionisation mode.  
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 Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics (version 24) and 
GraphPad Prism 8 software. Graphs were made in GraphPad Prism 8 software. All 
statistical tests compared each individual fermentation substrate to the cellulose 
negative control. For qPCR data, statistical significance was determined using a 
non-parametric Kruskal-Wallis test (p value) with a Benjamini and Hochberg false 
discovery rate (FDR) correction for multiple comparisons (q value) with a 
significance level of ≤ 0.05. For SCFA data, statistical significance was determined 
using a one-way ANOVA with a Tukey’s post-hoc test for multiple comparisons with 
a significance level of p ≤ 0.05. 
Statistical analysis of 16S rRNA amplicon sequencing data was carried out using 
Calypso online software (version 8.68) (Zakrzewski et al., 2017). Data were 
normalized using cumulative sum scaling and log2 transformed to account for the 
non-normal distribution of sequencing data (Paulson et al., 2013). Up to 20,000 
taxa with > 0.01% abundance were used in the analysis. Chloroplasts and 
cyanobacteria were removed from the analysis.  
Alpha diversity was determined using rarefied Chao1, Evenness, Shannon and 
Simpson indices. Statistical significance was determined using a non-parametric 
Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false discovery rate 
(FDR) correction for multiple comparisons (q value). Beta diversity was determined 
Bray-Curtis dissimilarity distance matrices for each fermentation substrate and 
cellulose at a given time point. A Permutational multivariate analysis of variance 
(PerMANOVA) was used to determine the statistical difference between Bray–
Curtis dissimilarity indices of beta diversity. 
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Statistical significance of mean bacterial relative abundances, compared to 
cellulose, at the phylum, family, and genus level after 0, 10, and 24 hrs 
fermentation was determined using a one-way ANOVA with a Tukey’s post-hoc test 
for multiple comparisons and a significance level of p ≤ 0.05. Discriminate taxa 
between fermentation substrates and cellulose at a given time point were 
identified using linear discriminant analysis (LDA) effect size (LEfSe) (Segata et al., 
2011). 
 Results 
 FVE and LDE characterisation  
The average molecular weight of FVE and LDE were 6.2 kDa and 6.1 kDa, 
respectively. The total carbohydrate content of FVE and LDE were 86.50 ± 5.27 % 
and 99.72 ± 0.79 %, respectively. While the total sulphate content of FVE and LDE 
were 21.41 ± 0.11 % and 9.06 ± 0.99 % fucoidan equivalents, respectively. Figure 
4-1 shows the FT-IR spectra of FVE and LDE pre- and post- in vitro digestion.  
The spectrum of FVE showed absorption maxima indicative of the presence of 
alginate and/or laminarin from 1095 – 970cm-1 (Gomez-Ordonez et al., 2012; Yuan 
and Macquarrie, 2015). The band at 1625cm-1 indicated an uronic acid (Rioux et al., 
2010), while the 1265 – 1214cm-1 band indicated S=O vibration of a sulphated ester 
which may be attributed to fucoidan (Yuan and Macquarrie, 2015). Bands at 970 – 
939cm-1 indicate a CH3 or C-OH bend and absorbance at 883cm-1 showed a 
sulphated glucose (C6) (Ji et al., 2011; Teodosio Melo et al., 2013). Post-digestion 
spectra demonstrated structural similarity with the main carbohydrate band 
overlapping from 1084 – 1033 cm-1 with an asymmetric S=O  also present at 1267 – 
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1221 cm-1, where bands between 1537 – 1221 cm-1 indicated C-S and O=S=O 
sulphate esters (Jiao et al., 2012).  
The spectrum of LDE showed a large (and overlapping) band between 1083 and 
931 cm-1 with strongest absorbance at 1022 cm-1 and 1083 cm-1. This corresponds 
with a C-O and C-C pyranose ring of constituent polysaccharides such as alginate, 
laminarin or fucoidan (Gomez-Ordonez et al., 2012; Yuan and Macquarrie, 2015). 
Overlapping bands between 1265 and 1216 cm-1 are indicative of S=O vibration 
from a sulphated ester (Ji et al., 2011; Teodosio Melo et al., 2013; Yuan and 
Macquarrie, 2015). Two notable bands at 970 – 931 cm-1 and 890 – 877 cm-1 
represent C-O-S of sulphated glucose (C6) and a CH3 or COH bend (Ji et al., 2011; 
Teodosio Melo et al., 2013). Weak absorption at 1454cm-1 could indicate a C-O or 
C-H stretch; at 1344cm-1 a C-H stretch; and at 1133cm-1, a C-O-S=O stretch. The 
maxima of the post-digestion extract (1030 cm-1) may correspond with alginate. 
Prominent bands in the post-digestion extract included bands at 1641, 1419 - 1390 
and 1263 – 1218 cm-1, where the latter indicated an asymmetric S=O sulphated 
ester.  
 Mineral and trace element analysis 
Table 4-1 and Table 4-2 present data from the mineral and trace element analysis 
for Fucus vesiculosus and Laminaria digitata substrates, respectively. Of note, the 
iodine content of FVWS and FVE were 0.22 mg/g and 0.09 mg/g, respectively 
(Table 4-1). While the iodine content of LDWS and LDE were 0.163 mg/g and 0.13 
mg/g, respectively (Table 4-2).  
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 Batch culture fermentation 
4.4.4.1 Effects on microbial composition as assessed by qPCR  
There were no significant differences in the number of total bacteria (Figure 4-2) or 
Bifidobacterium spp. ( 
Figure 4-4) present in vessels treated with any test substrate when compared to 
cellulose at any time point (q > 0.5). Populations of Lactobacillus spp. were significantly 
lower than the cellulose control in vessels treated with LDWS after 5 hrs (q = 0.0038) 
and 10 hrs (q = 0.0071), and LDE after 10 hrs (q = 0.0066) ( 
Figure 4-3). 
4.4.4.2 Effects on microbial composition as assessed by 16S rRNA amplicon 
sequencing  
There were no significant differences between any test substrates when compared 
to cellulose for the alpha diversity indices of Chao1, Evenness, Simpson Index and 
Shannon Index after 10 hrs (q > 0.5) (Figure 4-5) or 24 hrs (q > 0.1) (Figure 4-6); nor 
for the Bray-Curtis dissimilarity index of beta diversity after 10 hrs or 24 hrs (p > 
0.5). 
There were no significant differences in the Firmicutes to Bacteroides ratio in 
vessels treated with any test compound when compared to cellulose at any time 
point. After 10 hrs fermentation, however, the Firmicutes to Bacteroidetes ratio 
(mean ± SD) was significantly higher in vessels treated with Synergy 1 (5.90 ± 0.37) 
when compared to FVWS (2.36 ± 0.33, p = 0.0128), FVE (2.20 ± 1.43, p = 0.009), and 
LDWS (2.13 ± 0.33, p = 0.008) (Figure 4-7).  
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The relative abundance of the bacteria present in vessels treated with cellulose, 
FVWS, FVE, LDWS, LDE, and Synergy 1, are shown at the phylum level (Figure 4-8), 
family level (Figure 4-9), and genus level (Figure 4-10, Figure 4-11, and Figure 
4-12), after 0, 10, and 24 hrs fermentation.  
Significant differences in bacterial taxonomy at the phylum, family, and genus 
level, after 10 and 24 hrs fermentation with FVWS, FVE, LDWS, LDE, and Synergy 1 
substrates when compared to cellulose are shown in Table 4-3, Table 4-4, Table 
4-5, Table 4-6, and Table 4-7, respectively. The relative abundance of the genera 
Bifidobacterium and Lactobacillus were not significantly different in vessels treated 
with any of the seaweed substrates (FVWS, FVE, LDWS or LDE) at any time point 
when compared to cellulose.  
Fucus vesiculosus whole seaweed (FVWS)  
Table 4-3 shows that after 10 hrs fermentation in the presence of FVWS, the 
relative abundance of several genera was significantly higher when compared to 
cellulose. This included Blastopirellula (1.110 ± 0.165 % vs < 0.001 %, p < 0.0001), 
Granulosicoccus (0.770 ± 0.288 % vs < 0.001 %, p < 0.0001), and Klebsiella (3.837 ± 
0.600 % vs 1.448 ± 0.362, p = 0.05). While fermentation in the presence of FVWS 
resulted in a significantly lower relative abundance of the genera Haemophilus 
(0.193 ± 0.168 % vs 0.885 ± 0.067 %, p = 0.034), Lachnospiraceae FCS020 group 
(0.081 ± 0.070 % vs 0.313 ± 0.107 %, p = 0.033), Peptoclostridium (0.773 ± 0.098 % 
vs 8.856 ± 0.976 %, p < 0.0001), Ruminiclostridium (0.375 ± 0.070 % vs 0.707 ± 
0.100 %, p = 0.040), Ruminococcus 1 (0.291 ± 0.045 % vs 0.586 ± 0.032 %, p = 
0.012), and Terrisporobacter (0.311 ± 0.052 % vs 1.505 ± 0.134 %, p < 0.0001) when 
compared to cellulose.  
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LEfSe analysis showed that fermentation in the presence of FVWS was associated 
with the genera Blastopirellula, Citrobacter, Dorea, Enterobacter, Granulosicoccus, 
Klebsiella, and an unclassified bacterium after 10 hrs when compared to cellulose 
(Figure 4-13). 
After 24 hrs fermentation in the presence of FVWS, the relative abundance of the 
genus Blastopirellula was significantly higher in FVWS treated vessels when 
compared to cellulose (0.838 ± 0.419 % vs < 0.001 %, p = 0.001). While 
fermentation in the presence of FVWS resulted in a significantly lower relative 
abundance of several genera when compared to cellulose, including the 
Eubacterium hallii group (0.640 ±  0.215 % vs 0.300 ± 0.174 %, p = 0.04), 
Flavonifractor (0.691 ± 0.191 % vs 0.125 ± 0.049 %, p = 0.045), Pseudoflavonifractor 
(< 0.001 % vs 0.517 ± 0.174 %, p = 0.044), and Ruminococcaceae UCG003 (0.139 ± 
0.133 % vs 0.884 ± 0.434 %, p = 0.034) (Table 4-3). 
LEfSe analysis showed that fermentation in the presence of FVWS was associated 
with the genera Blastopirellula, Butyricimonas, Granulosicoccus, and an 
unclassified bacterium after 24 hrs when compared to cellulose (Figure 4-13. LDA 
scores following LEfSe analysis to determine discriminative bacteria between 
fermentation vessels treated with 1% (w/v) F. vesiculosus whole seaweed (FVWS) 
when compared to 1% (w/v) cellulose at 0, 10, and 24 hrs fermentation (n = 3). 
Bacterial composition was determined using 16S rRNA amplicon sequencing on the 
MiSeq platform.Figure 4-13). 
  
241 
 
 
Fucus vesiculosus polysaccharide-rich extract (FVE) 
After 10 hrs fermentation in the presence of FVE, the relative abundance of several 
genera was significantly higher when compared to cellulose. This included the 
genera Alistipes (1.704 ± 0.148 % vs 1.134 ± 0.138 %, p = 0.0389), 
Christensenellaceae R7 group (0.866 ± 0.056% vs 0.436 ± 0.018 %, p = 0.027), 
Coprococcus 2 (0.746 ± 0.013 % vs 0.078 ± 0.135 %, p = 0.005), Eubacterium 
coprostanoligenes group (1.347 ± 0.558 % vs 0.119 ± 0.109 %, p = 0.002), 
Eubacterium ruminantium group (0.268 ± 0.094 % vs < 0.001 %, p = 0.001), 
Eubacterium ventriosum group (0.297 ± 0.054 % vs 0.089 ± 0.085 %, p = 0.035), 
Lachnospiraceae NC2004 group (0.389 ± 0.159 % vs 0.033 ± 0.056 %, p = 0.007), 
Lachnospiraceae NK4A136 group (0.602 ± 0.096% vs 0.218 ± 0.033 %, p = 0.014), 
Lachnospiraceae UCG001 (0.322 ± 0.082 % vs < 0.001 %, p = 0.00011), Oscillospira 
(0.241 ± 0.061 % vs < 0.001 %, p = 0.021), Prevotella 7 (1.544 ± 0.706 % vs 0.369 ± 
0.143 %, p = 0.01), Pseudobutyrivibrio (1.654 ± 0.231 % vs 0.675 ± 0.156 %, p = 
0.001), and Ruminococcaceae UCG005 (0.766 ± 0.114 % vs 0.371 ± 0.088, p = 
0.018) (Table 4-4). Furthermore, fermentation in the presence of FVE resulted in a 
significantly lower relative abundance of three genera when compared to cellulose:  
Megasphaera (2.549 ± 0.223 % vs 9.518 ± 1.665 %, p = 0.005), Peptoclostridium 
(0.570 ± 0.030 % vs 8.856 ± 0.976 %, p < 0.0001), and Terrisporobacter (0.443 ± 
0.081 % vs 1.505 ± 0.134%, p < 0.0001) (Table 4-4). 
LEfSe analysis showed that fermentation in the presence of FVE was associated 
with several genera belonging to the Eubacteriaceae, Lachnospiraceae, 
Prevotellaceae, and Ruminococcaceae families after 10 hrs when compared to 
cellulose (Figure 4-14), as well as Alistipes, Alloprevotella, Anaerostipes, 
242 
 
 
Anaerotruncus, Coprococcus 2, Christensenellaceae R7 group, Dorea, 
Faecalibacterium, the Family XIII AD3011 group Hungatella, Incertae Sedis group, 
Megamonas, Oscillospira, Pseudobutyrivibrio, and Yersinia.  
After 24 hrs fermentation in the presence of FVE, the relative abundance of the 
genera Eubacterium hallii group was significantly higher when compared to 
cellulose (0.297 ± 0.057 % vs 0.640 ± 0.215 %, p = 0.038). Whereas the relative 
abundance of two genera were significantly lower when compared to cellulose: 
Megasphaera (5.147 ± 2.515 % vs 10.625 ± 0.288 %, p = 0.007) and 
Ruminococcaceae UCG003 (0.060 ± 0.105 % vs 0.884 ± 0.434 %, p = 0.018) (Table 
4-4).  
LEfSe analysis showed that fermentation in the presence of FVE was associated 
with the Christensenellaceae R7 group, Enterococcus, Erysipelotrichaceae UCG003, 
Escherichia/Shigella, Phascolarctobacterium, Prevotella 7, and Veillonella, when 
compared to cellulose (Figure 4-14). 
Laminaria digitata whole seaweed (LDWS) 
Table 4-5 shows that after 10 hrs fermentation in the presence of LDWS, the 
relative abundance of three genera were significantly higher when compared to 
cellulose. This included Coprococcus 2 (0.584 ± 0.209 % vs 0.078 ± 0.135 %, p = 
0.032), Eubacterium ventriosum group (0.302 ± 0.077 % vs 0.089 ± 0.085%, p = 
0.03), and Lachnospiraceae NK4A136 group (0.565 ± 0.136 % vs 0.218 ± 0.033 %, p 
= 0.028). Fermentation in the presence of LDWS also resulted in a significantly 
lower relative abundance of three genera when compared to cellulose, namely 
Eubacterium hallii group (0.090 ± 0.156 % vs 0.568 ± 0.055 %, p = 0.006), 
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Peptoclostridium (0.562 ± 0.318 % vs 8.856 ± 0.976 %, p < 0.0001), and 
Terrisporobacter (0.142 ± 0.130 % vs 1.505 ± 0.134 %, p < 0.0001).  
LEfSe analysis showed that Coprococcus 2, Escherichia/Shigella, Eubacterium 
ventriosum, Family XIII AD3011 group, Lachnospiraceae NK4A135 group, 
Lachnospiraceae UCG008, and an uncultured bacterium were discriminative 
bacteria fermentation in the presence of LDWS when compared to cellulose after 
10 hrs (Figure 4-15). 
After 24 hrs fermentation in the presence of LDWS, the relative abundance of four 
genera were significantly higher when compared to cellulose, namely 
Butyricimonas (0.577 ± 0.005 % vs 0.234 ± 0.058%, p < 0.001), Coprococcus 2 (0.382 
± 0.205 % vs 0.052 ± 0.091 %, p = 0.018), Parasutterella (0.909 ± 0.081 % vs 0.606 ± 
0.069 %, p = 0.043), and Ruminococcaceae UCG004 (0.056 ± 0.050 % vs < 0.001 %, 
p = 0.049) (Table 4-5).  
Whereas fermentation in the presence of LDWS resulted in a significantly lower 
relative abundance of the Eubacterium hallii group (0.119 ± 0.018 % vs 0.640 ± 
0.215 %, p = 0.002) and the genera Ruminococcaceae UCG003 (0.180 ± 0.158 % vs 
0.884 ± 0.434 %, p = 0.048) after 24 hrs when compared to cellulose (Table 4-5). 
LEfSe analysis determined that Bacteroides, Butyricimonas, Coprococcus 2, 
Escherichia/Shigella, Parasutterella, Ruminococcaceae UCG003, Ruminococcus 2, 
and Veillonella, were discriminative bacteria of fermentation in the presence of 
LDWS when compared to cellulose (Figure 4-15). 
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Laminaria digitata polysaccharide-rich extract (LDE) 
10 hrs fermentation in the presence of LDE resulted in a significantly higher relative 
abundance of the genera Serratia (7.451 ± 3.981 % vs 0.030 ± 0.051 %, p = 0.001) 
and Yersinia (4.127 ± 0.720 % vs 0.099 ± 0.047 %, p < 0.0001) when compared to 
cellulose. Whereas the relative abundance of the genus Peptoclostridium (5.639 ± 
1.172 % vs 8.856 ± 0.976 %, p = 0.002) and Terrisporobacter (1.030 ± 0.188 % vs 
1.505 ± 0.134 %, p = 0.012) were significantly lower when compared to cellulose 
(Table 4-6).  
After 10 hrs, LEfSe analysis showed that fermentation in the presence of LDE was 
associated with the genera Asteroleplasma, Catenibacterium, Coprococcus 2, 
Enterococcus, Phascolarctobacterium, Pseudobutyrivibrio, Serratia, Streptococcus, 
Yersinia, and an unclassified bacterium, when compared to cellulose (Figure 4-16). 
After 24 hrs, fermentation in the presence of LDE resulted in a significantly higher 
relative abundance of the genera Solobacterium (2.150 ± 1.343 % vs 0.182 ± 0.072 
%, p = 0.016), Serratia (4.460 ± 3.525 % vs 0.081 ± 0.141 %, p = 0.027) and Yersinia 
(0.571 ± 0.348 % vs 0.089 ± 0.154 %, p = 0.032) when compared to cellulose. 
Whereas the relative abundance of the Eubacterium hallii group was significantly 
lower after 24 hrs fermentation in the presence of LDE when compared to cellulose 
(0.234 ± 0.049 % vs 0.640 ± 0.215 %, p = 0.013) (Table 4-6). 
After 24 hrs, LEfSe analysis showed that fermentation in the presence of LDE was 
associated with the genera Butyricimonas, Clostridium sensu stricto 1, 
Erysipelatoclostridium, Erysopelotrichaceae UCG003, Holdemanella, 
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Lachnospiraceae UCG008, Pseudobutyrivibrio, Roseburia, Serratia, Solobacterium, 
and Streptococcus (Figure 4-16).  
Synergy 1  
Fermentation in the presence of Synergy 1 resulted in a significantly higher relative 
abundance of Bifidobacterium after 10 hrs (p = 0.001) and 24 hrs (p < 0.0001). The 
significant differences in bacterial composition following Synergy 1 fermentation 
when compared to cellulose are presented in Table 4-7.  
After 24 hrs, LEfSe analysis showed that Anaerostipes, Bifidobacterium, Blautia, 
Catenibacterium, Collinsella, Enterococcus, Erysipelatoclostridium, Holdemanella, 
Lachnospiraceae UCG 004, Megamonas, Roseburia, Streptococcus, and Veillonella 
were discriminative genera of fermentation in the presence of Synergy 1 when 
compared to cellulose (Figure 4-17). 
4.4.4.3 Effects on short chain fatty acid and branched chain fatty acid 
production 
Fucus vesiculosus whole seaweed (FVWS)  
When compared to cellulose, fermentation in the presence of FVWS was 
associated with significantly higher concentrations of acetic acid after 24 hrs (p = 
0.048), 36 hrs (p < 0.0001), and 48 hrs (p < 0.0001) (Figure 4-18); of propionic acid 
after 24 hrs (p = 0.021) and 48 hrs (p = 0.049) (Figure 4-19); of isobutyric acid after 
24 hrs (p = 0.0001805) (Figure 4-24); of isovaleric acid after 24 hrs (p = 0.002), 36 
hrs (p = 0.038), and 48 hrs (p = 0.02) (Figure 4-25); and of total BCFA after 24 hrs (p 
= 0.000175), 36 hrs (p = 0.016), and 48 hrs (p = 0.002) (Figure 4-26). 
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Fucus vesiculosus polysaccharide-rich extract (FVE) 
When compared to cellulose, fermentation in the presence of FVE resulted in 
significantly higher concentrations of acetic acid after 24 hrs (p = 0.026), 36 hrs (p = 
0.015), and 48 hrs (p < 0.0001) (Figure 4-18); and of propionic acid after 24 hrs (p = 
0.048) (Figure 4-19).  
Laminaria digitata whole seaweed (LDWS) 
When compared to cellulose, fermentation in the presence of LDWS resulted in 
significantly higher concentrations of acetic acid after 10 hrs (p = 0.004) (Figure 
4-18); of butyric acid after 24 hrs (p = 0.002) and 36 hrs (p = 0.024) (Figure 4-20); of 
valeric acid after 24 hrs (p = 0.002) (Figure 4-21); of hexanoic acid after 24 hrs (p = 
0.037) (Figure 4-22); of total SCFA after 24 hrs (p = 0.000427) and 36 hrs (p = 0.011) 
(Figure 4-23); of isobutyric acid after 24 hrs (p < 0.0001), 36 hrs (p = 0.001), and 48 
hrs (p = 0.007) (Figure 4-24); of isovaleric acid after 24 hrs (p < 0.0001), 36 hrs (p = 
0.001), and 48 hrs (p = 0.002) (Figure 4-25); and of total BCFA after 24 hrs (p < 
0.0001), 36 hrs (p = 0.0001172), and 48 hrs (p = 0.00013788) (Figure 4-26). 
Laminaria digitata polysaccharide-rich extract (LDE) 
The concentration of acetic acid was significantly higher in vessels fermented in the 
presence of LDE when compared to cellulose after 5 hrs (p = 0.006), however, the 
acetic acid concentration was significantly greater in vessels fermented in the 
presence of LDE when compared to cellulose at 0 hrs (p = 0.00015) (Figure 4-18). 
Isobutyric acid was significantly higher in vessels fermented in the presence of LDE 
after 24 hrs when compared to cellulose (p = 0.032) (Figure 4-24). 
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Synergy 1  
There was no significant difference in the concentration of individual SCFA or total 
SCFA, nor individual BCFA or total BCFA, at any time point between vessels 
fermented in the presence of Synergy 1 when compared to cellulose. 
 Discussion 
The use of in vitro fermentation experiments as a proxy for colonic fermentation by 
the gut microbiota is a well-established approach to evaluate prebiotic candidates 
for their ability to modulate microbial composition and metabolic output (Pham 
and Mohajeri, 2018). This study aimed to determine the prebiotic potential of the 
brown seaweeds Fucus vesiculosus and Laminaria digitata, and polysaccharide-rich 
extracts of F. vesiculosus and L. digitata, and to characterise how these substrates 
modulated the microbial composition of the human faecal microbiota. The data 
obtained showed that neither F. vesiculosus, L digitata, or their polysaccharide 
extracts, impacted the targeted microbial markers of prebiotic activity (qPCR - 
Bifidobacterium spp. and Lactobacillus spp.), nor the purported marker of microbial 
diversity (16S rRNA amplicon sequencing). However, notable changes in short 
chain fatty acid concentrations occurred when compared to cellulose. This suggests 
that the brown seaweeds Fucus vesiculosus and Laminaria digitata contain 
components that are fermented by human gut microbiota populations to produce 
health associated SCFA.  
There is increasing interest in the application of brown seaweeds as functional food 
ingredients owing to the purported health benefits of their non-digestible 
carbohydrate components (Brown et al., 2014; Gueven et al., 2020; Wright et al., 
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2019). Such components include alginate (1,4-linked α-L-guluronic acid and β-D-
mannuronic acid (Vera et al., 2011), fucoidan (sulphated 1,2- or 1,3- or 1,4- α-L-
fucose (Jiao et al., 2011; Vera et al., 2011; Zaporozhets et al., 2014)), and laminarin 
(1,3- or 1,6- β-D-glucose (Kadam et al., 2015)) polysaccharides. Brown seaweed 
carbohydrates resist endogenous digestion and are hypothesised to be microbiota-
accessible carbohydrates for saccharolytic fermentation by the colonic microbiota 
(O’Sullivan et al., 2010). For example, Bacteroides spp. are reported to expresses 
the alginate lyase and laminarinase carbohydrate active enzymes (CAZymes), which 
break down alginate and laminarin polymers, respectively (Li et al., 2016; Mathieu 
et al., 2018; Salyers et al., 1977).  
In the present study, both FVWS and FVE treatment resulted in significantly higher 
concentrations of acetic and propionic acids when compared to cellulose. While 
acetic acid, butyric acid, and total SCFA were significantly higher following LDWS 
treatment when compared to cellulose. These data are in partial agreement with 
another in vitro fermentation of the brown seaweed kelp, Ecklonia radiata, where 
the whole seaweed and a crude fraction significantly increased acetate, 
propionate, butyrate and total SCFA concentrations after 24 hrs when compared to 
the cellulose control (Charoensiddhi et al., 2017).  
Acetic acid concentrations were significantly higher in LDE treated vessels 
compared to cellulose after 5 hrs, but not thereafter, which is in contrast to a 
previous in vitro fermentation of another L. digitata polysaccharide extract (Strain 
et al., 2019). This observation may be a false positive because acetic acid 
concentrations were significantly greater in vessels containing LDE when compared 
to cellulose at 0 hrs. Given that a previous in vitro fermentation study showed that 
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laminarin content reduced from 100 % to 6.65 % after 24 hrs (Devillé et al., 2007), 
the apparent low fermentability of LDE in the present study may be owing to low 
amounts of laminarin within the extract. 
The lag effect of SCFA production observed in vessels treated with FVWS, FVE, and 
LDWS, has been previously described for laminarin and alginate substrates (Kuda et 
al., 2005), and is in agreement with previous in vitro fermentation studies of brown 
seaweeds and their extracted polysaccharides (Chen et al., 2018; Devillé et al., 
2007; Fu et al., 2018; Li et al., 2016; Rodrigues et al., 2016; Seong et al., 2019; 
Strain et al., 2019). The lag phase of bacterial growth is understood to prioritise 
carbon source utilization enzyme expression over genes involved in biomass 
accumulation (Schultz and Kishony, 2013). Thus, the ex vivo microbiota in the 
present study may undergo a metabolic adaptation period upon exposure to a 
novel carbon source. This may have implications on the optimal dose and duration 
of dietary intervention studies in human participants (Leeming et al., 2019). 
Previous in vitro fermentation studies which have explored the prebiotic potential 
of brown seaweeds and their extracted complex polysaccharides and 
oligosaccharides have demonstrated the stimulation of bacterial genera such as 
Bifidobacterium, Bacteroides, Coprococcus, Fecalibacterium, Lactobacillus, 
Parabacteroides, Parasutterella, Roseburia and Ruminococcus (Bai et al., 2017; 
Charoensiddhi et al., 2017, 2016; Devillé et al., 2007; Fu et al., 2018; Li et al., 2016; 
Seong et al., 2019; Strain et al., 2019). In the present study, FVWS treatment 
elicited few changes to the bacterial community when compared to cellulose. 
Although LEfSe analysis indicated that FVWS fermentation was associated with the 
butyrate-producing genera Butyricimonas after 24 hrs (Sakamoto et al., 2014), 
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there were also associations with opportunistic pathogens such as Citrobacter, 
Enterobacter, and Klebsiella. Thus, it is necessary to investigate the impact of 
dietary consumption of Fucus vesiculosus seaweed in vivo, to understand whether 
this seaweed stimulates the growth of potential pathogens, or whether the 
observation in the current study is associated with the use of an in vitro 
fermentation model. Further, there is also a knowledge gap regarding the 
catabolism of complex carbohydrates by pathobionts, which may have wider 
implications concerning the use of microbiota accessible carbohydrates as 
supplements. 
Fucus vesiculosus polysaccharide-rich extract (FVE) treatment was associated with 
the stimulation of several genera which catabolise dietary complex carbohydrates, 
including those within the Lachnospiraceae, Prevotellaceae, and Ruminococcaceae 
families (Biddle et al., 2013; Kovatcheva-Datchary et al., 2015). Previous in vitro 
fermentation and in vivo animal studies have also reported increases in these 
bacterial families (An et al., 2013; Strain et al., 2019; Umu et al., 2015). The families 
Ruminococcaceae and Lachnospiraceae contain common gut commensals in 
individuals with fibre-rich and plant-based diets (Lagier et al., 2012; Schnorr et al., 
2014), owing to multiple CAZymes which harvest energy from complex 
polysaccharides to promote their survival (Biddle et al., 2013; Esquivel-Elizondo et 
al., 2017). Further, many of the major butyrate producers in the human gut are 
members of the Ruminococcaceae and Lachnospiraceae families (Vital et al., 2017). 
Thus, more in-depth microbial characterisation at the functional and strain level 
may be useful to understand how brown seaweed glycans are utilised by 
Lachnospiraceae and Ruminococcaceae. 
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FVE also stimulated the genera Phascolarctobacterium, Oscillospira, and 
Faecalibacterium, which corroborates previous findings following the in vitro 
fermentation of an Ascophyllum nodosum sulphated polysaccharide extract (Chen 
et al., 2018). Considering that Phascolarctobacterium produce acetate and 
propionate (Wu et al., 2017), and that Faecalibacterium prausnitzii is a candidate 
next generation probiotic and a major constituent of the adult human gut 
microbiota population (Martín et al., 2018), further experiments to characterise 
the effect of the sulphated polysaccharide, fucoidan, obtained from Fucus spp. may 
be warranted. 
Other SCFA-producing microbial genera associated with FVE fermentation were 
Anaerostipes (propionic acid) (Engels et al., 2016), Eubacterium hallii (propionic 
acid and butyric acid) (Flint et al., 2012), Anaerotruncus (butyric acid) (Le Chatelier 
et al., 2013) and Pseudobutyrivibrio (butyric acid) (Bailey et al., 2011). 
Pseudobutyrivibrio are suggested to reduce gut inflammation in mice (Bailey et al., 
2011; Neto and O’Toole, 2016), while a greater abundance of Anaerotruncus and 
has been reported in lean individuals when compared to obese individuals (Hou et 
al., 2017; Mancabelli et al., 2017).  
Similar to FVE, Laminaria digitata whole seaweed (LDWS) treatment was 
associated with genera from the families Ruminococcaceae and Lachnospiraceae, 
which corroborates previous evidence from in vitro fermentation and in vivo 
rodent studies (Choa An et al., 2013; Shang et al., 2016; Strain et al., 2019). LDWS 
also stimulated the genus Bacteroides, which utilises a range of dietary glycans and 
can adapt to the nutritional availability in the colonic environment owing to the 
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vast number of polysaccharide utilization loci present in their genomes (Benítez-
Páez et al., 2017; Patnode et al., 2019; Rios-Covian et al., 2017).  
The LDWS-associated changes in SCFA concentration may be attributed to some 
microbial genera that proliferated throughout the fermentation, including 
Veillonella (propionic acid) (Scheiman et al., 2019), Lachnospiraceae (butyric acid) 
(Tidjani Alou et al., 2016), Butyricimonas (butyric acid) (Sakamoto et al., 2014), and 
Coprococcus (butyric acid) (Valles-Colomer et al., 2019).  
The stimulation of the genera Coprococcus and Parasutterella by LDWS was also 
observed during an in vitro fermentation of a Sargassum thunbergii polysaccharide 
extract (Fu et al., 2018). Parasutterella are assaccharolytic bacteria and were 
recently suggested to be involved in bile acid and cholesterol metabolism (Ju et 
al., 2019), but further understanding of this genera is important to understand any 
potential benefit of stimulating their growth and metabolism by seaweed glycans. 
LDE treatment was associated with the genera Butyricimonas and Coprococcus, 
which were also stimulated by LDWS. Similarly, the stimulation of 
Phascolarctobacterium and Pseudobutyrivibrio by LDE was also observed in FVE-
treated vessels. This may suggest the presence of common carbohydrate 
constituents in these three fermentation substrates. The genus Roseburia was also 
associated with LDE fermentation, which corroborates previous reports of 
increased Roseburia spp. populations following the in vitro fermentation of a 
Sargassum thunbergii polysaccharide extract (Fu et al., 2018), and in pigs fed 
alginate (5.14 % (w/w) for 84 days) (Umu et al., 2015). Roseburia are a 
polysaccharide utilising genus of the Lachnospiraceae family that produce butyrate 
and have an anti-inflammatory role to maintain gut homeostasis (Duncan et al., 
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2006; La Rosa et al., 2019). Roseburia inulinivorans is reported to contain 
fucosidase enzymes for fucose utilisation (Scott et al., 2006), while R. intestinalis is 
predicted to specialize in the degradation of plant cell wall matrix polysaccharides 
(Sheridan et al., 2016).  
The average molecular weight of FVE and LDE in the currentstudy was similar (6.2 
kDa and 6.1 kDa, respectively), but the total sulphate content, as equivalents of 
purified fucoidan, varied (FVE = 21.41 ± 0.11 % and LDE = 9.06 ± 0.99 %). This 
would suggest differences in the amount of fucoidan in each extract. Although it is 
not possible to ascribe differences in molecular weight and sulphate content to the 
effects of the FVE and LDE substrates on SCFA and microbial composition in the 
present study, previous in vitro fermentation studies and in vivo rodent studies 
with alginate, fucoidan, and laminarin seaweed polysaccharides indicate that 
structural heterogeneity and variation of molecular weight impact fermentability 
(An et al., 2013; Kong et al., 2016; Ramnani et al., 2012; Shang et al., 2016; Terada 
et al., 1995; Vera et al., 2011; Wang et al., 2006) 
Serratia and Yersinia (Yersiniaceae family) were present in vessels treated with LDE 
and are genera which contain opportunistic pathogens. Although Yersinia are 
found in low abundance in the human ileum (Le Baut et al., 2018), Serratia and 
Yersinia are common food contaminants which can propagate during refrigeration 
and are reported as residential bacteria of food industry surfaces, including the 
dairy industry (Barton, 2016; Møretrø and Langsrud, 2017).  
The observed significant increase in BCFA concentrations in vessels fermented in 
the presence of FVWS, LDWS, and LDE suggests that proteolytic fermentation 
occurred. There is limited knowledge about the effects of BCFA on host health 
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(Oliphant and Allen-Vercoe, 2019), however, some protein fermentation 
metabolites such as hydrogen sulphide, ammonia, and p-cresol potentially 
genotoxic (Diether and Willing, 2019). Therefore, further investigation regarding 
the impact of dietary seaweed and seaweed-derived amino acids, on protein 
fermentation, is needed. 
The data obtained in the present study suggest that FVE and LDE had a lesser 
impact on SCFA production when compared to other in vitro fermentation studies. 
An obvious cause of variation between such studies is that the faecal microbiota 
originated from different donors. Another cause of this disparity could be a 
variation in polysaccharide composition between extracts, thus the heterogenous 
nature of polysaccharide extracts makes direct comparison difficult. Looking ahead, 
alternative extraction methodology, such as supercritical CO2 extraction, may 
provide a useful tool for homogenous extract production (Chen et al., 2014; Zou et 
al., 2018). 
The synergy of components found in the whole seaweed matrix (e.g. complex 
polysaccharides, polyphenols, polyunsaturated fatty acids, and carotenoids) may 
also provide a greater opportunity for bacterial metabolism and energy harvest 
when compared to extracted components alone. A similar observation was 
reported for oat bran when compared to beta glucan and polyphenol extracts 
(Kristek et al., 2019). This highlights the necessity to explore the structure-function 
relationship of well characterised and purified carbohydrates on bacterial 
composition and metabolic output during in vitro fermentation experiments. 
Further, a whole genome shogun sequencing approach could provide strain-level 
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characterisation and information on the functional capacity of the human gut 
microbiota when exposed to seaweeds and their unique polysaccharides. 
 Conclusion 
Brown seaweed-derived complex polysaccharides are resistant to human digestive 
enzymes, which provides scope to explore whether these glycans are accessible 
substrates for saccharolytic fermentation by the human gut microbiota, conducive 
to a prebiotic. The data obtained showed that neither F. vesiculosus, L digitata, or 
their polysaccharide extracts, impacted the targeted microbial markers of prebiotic 
activity (qPCR - Bifidobacterium spp. and Lactobacillus spp.), nor the purported 
marker of microbial diversity (16S rRNA amplicon sequencing). However, notable 
changes in short chain fatty acid concentrations occurred when compared to 
cellulose. This suggests that the brown seaweeds Fucus vesiculosus and Laminaria 
digitata contain components that are fermented by human gut microbiota 
populations to produce health associated SCFA. Based on this study, the brown 
seaweeds Laminaria digitata and Fucus vesiculosus show promise about containing 
putative prebiotic components, however, further investigation is needed to 
understand how the human gut microbiota degrades and utilises brown seaweeds 
and their unique polysaccharides. 
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 Figures 
 
 
Figure 4-1. Fourier transform infrared spectroscopy (FTIR) spectra was used to 
provide structural information of the F. vesiculosus (FVE) and L. digitata (LDE) 
crude polysaccharide extracts. Blue denotes the extract before in vitro digestion 
and red denotes the extract after in vitro digestion.  
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Figure 4-2. qPCR was used to quantify total bacteria from DNA extracted from 
fermentation vessels treated with either 1% (w/v) cellulose, F. vesiculosus whole 
seaweed (FVWS), F. vesiculosus polysaccharide extract (FVE), L. digitata whole 
seaweed (LDWS), L. digitata polysaccharide extract (LDE), or Synergy 1 substrates. 
Samples were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots 
represent the mean + standard deviation of the mean (n = 3). Statistical 
significance when compared to cellulose was determined using a non-parametric 
Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false discovery rate 
(FDR) correction for multiple comparisons (q value). * q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 
0.005, **** q ≤ 0.0001. 
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Figure 4-3. qPCR was used to quantify Lactobacillus spp., from DNA extracted from 
fermentation vessels treated with either 1% (w/v) cellulose, F. vesiculosus whole 
seaweed (FVWS), F. vesiculosus polysaccharide extract (FVE), L. digitata whole 
seaweed (LDWS), L. digitata polysaccharide extract (LDE), or Synergy 1 substrates. 
Samples were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots 
represent the mean + standard deviation of the mean (n = 3). Statistical 
significance when compared to cellulose was determined using a non-parametric 
Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false discovery rate 
(FDR) correction for multiple comparisons (q value). * q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 
0.005, **** q ≤ 0.0001. 
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Figure 4-4. qPCR was used to quantify Bifidobacterium spp. from DNA extracted 
from fermentation vessels treated with either 1% (w/v) cellulose, F. vesiculosus 
whole seaweed (FVWS), F. vesiculosus polysaccharide extract (FVE), L. digitata 
whole seaweed (LDWS), L. digitata polysaccharide extract (LDE), or Synergy 1 
substrates. Samples were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data 
plots represent the mean + standard deviation of the mean (n = 3). Statistical 
significance when compared to cellulose was determined using a non-parametric 
Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false discovery rate 
(FDR) correction for multiple comparisons (q value). * q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 
0.005, **** q ≤ 0.0001. 
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Figure 4-5. Mean alpha diversity indices of Evenness, Chao1, Shannon Index and 
Simpson Index of fermentation vessels treated with either 1% (w/v) cellulose, F. 
vesiculosus seaweed (FVWS), F. vesiculosus polysaccharide extract (FVE), L. digitata 
seaweed (LDWS), L. digitata polysaccharide extract (LDE), or Synergy 1 after 10 hrs. 
Plots represent individual values and the mean ± one standard deviation of the 
mean (n = 3). Statistical significance was accepted as p ≤ 0.05 following a one-way 
ANOVA with a Tukey’s post-hoc test for multiple comparisons.  
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Figure 4-6. Mean alpha diversity indices of Evenness, Chao1, Shannon Index and 
Simpson Index of fermentation vessels treated with either 1% (w/v) cellulose, F. 
vesiculosus seaweed (FVWS), F. vesiculosus polysaccharide extract (FVE), L. digitata 
seaweed (LDWS), L. digitata polysaccharide extract (LDE), or Synergy 1 after 24 hrs. 
Plots represent individual values and the mean ± one standard deviation of the 
mean (n = 3). Statistical significance was accepted as p ≤ 0.05 following a one-way 
ANOVA with a Tukey’s post-hoc test for multiple comparisons.  
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Figure 4-7. Firmicutes to Bacteroidetes (F/B) ratio in fermentation vessels treated 
with either 1% (w/v) cellulose, F. vesiculosus seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 after 24 hrs. Plots represent individual 
values and the mean ± one standard deviation of the mean (n = 3). Statistical 
significance was accepted as p ≤ 0.05 following a one-way ANOVA with a Tukey’s 
post-hoc test for multiple comparisons. * p ≤ 0.05, ** p ≤ 0.01. 
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Figure 4-8. Mean relative abundances of bacterial phyla in fermentation vessels 
treated with either 1% (w/v) cellulose, F. vesiculosus seaweed (FVWS), F. 
vesiculosus polysaccharide extract (FVE), L. digitata seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 after 0, 10, and 24 hrs fermentation (n = 
3). Bacterial composition was determined using 16S rRNA amplicon sequencing on 
the MiSeq platform.  
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Figure 4-9. Mean relative abundances of bacterial families in fermentation vessels 
treated with either 1% (w/v) cellulose, F. vesiculosus seaweed (FVWS), F. 
vesiculosus polysaccharide extract (FVE), L. digitata seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 after 0, 10, and 24 hrs fermentation (n = 
3). Bacterial composition was determined using 16S rRNA amplicon sequencing on 
the MiSeq platform.  
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Figure 4-10. Mean relative abundances of bacterial genera in fermentation vessels 
treated with either 1% (w/v) cellulose, F. vesiculosus seaweed (FVWS), F. 
vesiculosus polysaccharide extract (FVE), L. digitata seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 at 0 hrs fermentation (n = 3). Individual 
stacks represent taxa with a mean relative abundance > 1% across all substrates. 
All remaining genera were assigned a single stack labelled “other”. Bacterial 
composition was determined using 16S rRNA amplicon sequencing on the MiSeq 
platform.  
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Figure 4-11. Mean relative abundances of bacterial genera in fermentation vessels 
treated with either 1% (w/v) cellulose, F. vesiculosus seaweed (FVWS), F. 
vesiculosus polysaccharide extract (FVE), L. digitata seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 at 10 hrs fermentation (n = 3). Individual 
stacks represent taxa with a mean relative abundance > 1% in the cellulose control. 
All remaining genera were assigned a single stack labelled “other”. Bacterial 
composition was determined using 16S rRNA amplicon sequencing on the MiSeq 
platform. 
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Figure 4-12. Mean relative abundances of bacterial genera in fermentation vessels 
treated with either 1% (w/v) cellulose, F. vesiculosus seaweed (FVWS), F. 
vesiculosus polysaccharide extract (FVE), L. digitata seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 at 24 hrs fermentation (n = 3). Individual 
stacks represent taxa with a mean relative abundance > 1% in the cellulose control. 
All remaining genera were assigned a single stack labelled “other”. Bacterial 
composition was determined using 16S rRNA amplicon sequencing on the MiSeq 
platform.  
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Figure 4-13. LDA scores following LEfSe analysis to determine discriminative 
bacteria between fermentation vessels treated with 1% (w/v) F. vesiculosus whole 
seaweed (FVWS) when compared to 1% (w/v) cellulose at 0, 10, and 24 hrs 
fermentation (n = 3). Bacterial composition was determined using 16S rRNA 
amplicon sequencing on the MiSeq platform. 
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Figure 4-14. LDA scores following LEfSe analysis to determine discriminative 
bacteria between fermentation vessels treated with 1% (w/v) F. vesiculosus crude 
polysaccharide extract (FVE) when compared to 1% (w/v) cellulose at 0, 10, and 24 
hrs fermentation (n = 3). Bacterial composition was determined using 16S rRNA 
amplicon sequencing on the MiSeq platform. 
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Figure 4-15. LDA scores following LEfSe analysis to determine discriminative 
bacteria between fermentation vessels treated with 1% (w/v) L. digitata whole 
seaweed (LDWS) when compared to 1% (w/v) cellulose at 0, 10, and 24 hrs 
fermentation (n = 3). Bacterial composition was determined using 16S rRNA 
amplicon sequencing on the MiSeq platform. 
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Figure 4-16. LDA scores following LEfSe analysis to determine discriminative 
bacteria between fermentation vessels treated with 1% (w/v) L. digitata crude 
polysaccharide extract (LDE) when compared to 1% (w/v) cellulose at 0, 10, and 24 
hrs fermentation (n = 3). Bacterial composition was determined using 16S rRNA 
amplicon sequencing on the MiSeq platform. 
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Figure 4-17. LDA scores following LEfSe analysis to determine discriminative 
bacteria between fermentation vessels treated with 1% (w/v) Synergy 1 when 
compared to 1% (w/v) cellulose at 0, 10, and 24 hrs fermentation (n = 3). Bacterial 
composition was determined using 16S rRNA amplicon sequencing on the MiSeq 
platform. 
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Figure 4-18. Acetic acid concentrations (µM) of fermentation vessels treated with 
either 1% (w/v) cellulose, F. vesiculosus whole seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata whole seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 substrates. Samples were taken at 0, 5, 
10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard 
error of the mean (n = 3). Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at each time point. 
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Figure 4-19. Propionic acid concentrations (µM) of fermentation vessels treated 
with either 1% (w/v) cellulose, F. vesiculosus whole seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata whole seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 substrates. Samples were taken at 0, 5, 
10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard 
error of the mean (n = 3). Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at each time point. 
 
 
 
Propionic acid
0 5 10 24 36 48
0
500
1000
1500
2000
2500
3000
3500
4000
Time (hours)
C
o
n
c
e
n
tr
a
ti
o
n
 (

M
)
* * *
Cellulose FVWS FVE LDWS LDE Synergy 1
290 
 
 
 
Figure 4-20. Butyric acid concentrations (µM) of fermentation vessels treated with 
either 1% (w/v) cellulose, F. vesiculosus whole seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata whole seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or synergy 1 substrates. Samples were taken at 0, 5, 
10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard 
error of the mean (n = 3). Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at each time point. 
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Figure 4-21. Valeric acid concentrations (µM) of fermentation vessels treated with 
either 1% (w/v) cellulose, F. vesiculosus whole seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata whole seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 substrates. Samples were taken at 0, 5, 
10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard 
error of the mean (n = 3). Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at each time point. 
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Figure 4-22. Haxanoic acid concentrations (µM) of fermentation vessels treated 
with either 1% (w/v) cellulose, F. vesiculosus whole seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata whole seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 substrates. Samples were taken at 0, 5, 
10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard 
error of the mean (n = 3). Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at each time point. 
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Figure 4-23 Total short-chain fatty acid concentrations (µM) of fermentation 
vessels treated with either 1% (w/v) cellulose, F. vesiculosus whole seaweed 
(FVWS), F. vesiculosus polysaccharide extract (FVE), L. digitata whole seaweed 
(LDWS), L. digitata polysaccharide extract (LDE), or Synergy 1 substrates. Samples 
were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots represent the 
mean + standard error of the mean (n = 3). Statistical significance was determined 
using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple 
comparisons. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at 
each time point. 
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Figure 4-24. Isobutyric acid concentrations (µM) of fermentation vessels treated 
with either 1% (w/v) cellulose, F. vesiculosus whole seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata whole seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 substrates. Samples were taken at 0, 5, 
10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard 
error of the mean (n = 3). Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at each time point. 
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Figure 4-25. Isovaleric acid concentrations (µM) of fermentation vessels treated 
with either 1% (w/v) cellulose, F. vesiculosus whole seaweed (FVWS), F. vesiculosus 
polysaccharide extract (FVE), L. digitata whole seaweed (LDWS), L. digitata 
polysaccharide extract (LDE), or Synergy 1 substrates. Samples were taken at 0, 5, 
10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard 
error of the mean (n = 3). Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at each time point. 
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Figure 4-26. Total branched-chain fatty acid concentrations (µM) of fermentation 
vessels treated with either 1% (w/v) cellulose, F. vesiculosus whole seaweed 
(FVWS), F. vesiculosus polysaccharide extract (FVE), L. digitata whole seaweed 
(LDWS), L. digitata polysaccharide extract (LDE), or Synergy 1 substrates. Samples 
were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots represent the 
mean + standard error of the mean (n = 3). Statistical significance was determined 
using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple 
comparisons. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.005 when compared to cellulose at 
each time point. 
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 Tables 
Table 4-1. Mineral and trace element contents of the Fucus vesiculosus whole seaweed (FVWS) (n = 1) and Fucus vesiculosus polysaccharide rich 
extract (FVE) batch culture fermentation substrates. ppm – parts per million; RNI - Reference Nutrient Intake. 
Fucus vesiculosus Whole Seaweed Polysaccharide Rich Extract 
Mineral / Trace 
Element 
Concentration 
(ppm) 
Equivalent in 
mg/g 
Amount (mg) in 
5g 
Amount (mg) in 
10g 
% RNI (mg/day) 
Concentration 
(ppm) 
Equivalent in 
mg/g 
Amount (mg) in 
5g 
Amount (mg) in 
10g 
% RNI (mg/day) 
Aluminium 40.1 0.0401 0.201 0.401 Not applicable 29.2 0.0292 0.146 0.292 Not applicable 
Chloride 46842 46.842 234.21 468.42 18.74 1630 1.63 8.15 16.3 0.652 
Copper <0.5 <0.0005 <0.005 <0.005 <0.0002 5.12 0.00512 0.0256 0.0512 4.27 
Mercury 0.034 0.000034 0.00017 0.00034 Not applicable <0.001 Negligible Negligible Negligible Not applicable 
Lead 0.847 0.000847 0.00424 0.00847 Not applicable 0.237 0.000237 0.00119 0.00237 Not applicable 
Arsenic 43.83 0.04383 0.220 0.4383 Not applicable 63.47 0.0635 0.317 0.635 Not applicable 
Cadmium 0.988 0.000988 0.00494 0.00988 Not applicable 0.187 0.000187 0.000935 0.00187 Not applicable 
Iodine 219.8 0.220 1.099 2.20 1465.33 90 0.09 0.45 0.9 600 
Sodium 24380 24.38 121.9 243.8 15.24 7941 7.941 39.71 79.41 4.96 
Zinc 33.9 0.0339 0.170 0.339 3.57 19.5 0.0195 0.0975 0.195 2.05 
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Table 4-2. Mineral and trace element contents of the Laminaria digitata whole seaweed (LDWS) (n = 1) and Laminaria digitata polysaccharide rich 
extract (LDE) (n = 1) batch culture fermentation substrates. ppm – parts per million; RNI - Reference Nutrient Intake. 
Laminaria 
digitata 
Whole Seaweed Polysaccharide Rich Extract 
Mineral / Trace 
Element 
Concentration 
(ppm) 
Equivalent in 
mg/g 
Amount (mg) in 
5g 
Amount (mg) in 
10g 
% RNI (mg/day) 
Concentration 
(ppm) 
Equivalent in 
mg/g 
Amount (mg) in 
5g 
Amount (mg) in 
10g 
% RNI (mg/day) 
Aluminium 3.66 0.00366 0.0183 0.0366 Not applicable 16.5 0.0165 0.0825 0.165 Not applicable 
Chloride 93785 93.79 468.93 937.85 37.514 810 0.81 4.05 8.1 0.324 
Copper <0.5 <0.0005 <0.005 <0.005 <0.0002 3.66 0.00366 0.0183 0.0366 3.05 
Mercury 0.021 0.000021 0.000105 0.00021 Not applicable <0.001 Negligible Negligible Negligible Not applicable 
Lead 0.076 0.000076 0.00038 0.00076 Not applicable 0.129 0.000129 0.000645 0.00129 Not applicable 
Arsenic 71.875 0.0719 0.360 0.719 Not applicable 57.3 0.0573 0.287 0.573 Not applicable 
Cadmium 0.069 0.000069 0.000345 0.00069 Not applicable 0.058 0.000058 0.00029 0.00058 Not applicable 
Iodine 163.1 0.163 0.816 1.631 1087.33 130 0.13 0.65 1.3 866.67 
Sodium 35160 35.16 175.8 351.6 21.975 5339 5.339 26.71 53.39 3.34 
Zinc 29.9 0.0299 0.150 0.299 3.15 26.4 0.0264 0.132 0.264 2.78 
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Table 4-3. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) F. vesiculosus whole seaweed (FVWS) when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose FVWS Effect P-value 
Mean (%) SD Mean (%) SD  
Phylum 
10 h Proteobacteria 4.083 0.104 6.853 0.395 ↑ 0.004 
24 h Planctomycetes < 0.001 < 0.001 0.563 0.076 ↑ < 0.0001 
Firmicutes 8.740 0.121 6.377 0.674 ↓ 0.007  
Family 
10 h 
Sva10996 marine group < 0.001 < 0.001 1.274 0.252 ↑ 0.000426 
Planctomycetaceae 2.159 0.113 1.681 0.073 ↑ < 0.0001 
Peptostreptococcaceae < 0.001 < 0.001 2.310 0.697 ↓ < 0.0001 
Pasteurellaceae < 0.001 < 0.001 1.753 0.916 ↓ 0.0377 
Granulosicoccaceae 0.038 0.066 1.035 0.283 ↑ < 0.0001 
Flavobacteriaceae 2.426 0.180 1.647 0.054 ↑ < 0.0001 
24 h Veillonellaceae 0.067 0.060 4.638 1.748 ↓ 0.0413 
Planctomycetaceae < 0.001 < 0.001 1.676 0.203 ↑ 0.000833 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-3 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) F. vesiculosus whole seaweed (FVWS) when compared to 1% (w/v) cellulose, after 10- and 24-hrs 
fermentation. Statistical significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a 
significance level of p ≤ 0.05. 
 
Cellulose FVWS Effect P-value 
Mean (%) SD Mean (%) SD  
Genus 
10 h 
Terrisporobacter 1.505 0.134 0.311 0.052 ↓ < 0.0001 
Ruminococcus 1 0.586 0.032 0.291 0.045 ↓ 0.012 
Ruminiclostridium 0.707 0.100 0.375 0.070 ↓ 0.040 
Peptoclostridium 8.856 0.976 0.773 0.098 ↓ < 0.0001 
Lachnospiraceae FCS020 group 0.313 0.107 0.081 0.070 ↓ 0.033 
Klebsiella 1.448 0.362 3.837 0.600 ↑ 0.050 
Haemophilus 0.885 0.067 0.193 0.168 ↓ 0.034 
Granulosicoccus < 0.001 < 0.001 0.770 0.288 ↑ < 0.0001 
Blastopirellula < 0.001 < 0.001 1.110 0.165 ↑ < 0.0001 
24 h Ruminococcaceae UCG003 0.884 0.434 0.139 0.133 ↓ 0.034 
Pseudoflavonifractor 0.517 0.174 < 0.001 < 0.001 ↓ 0.044 
Flavonifractor 0.691 0.191 0.125 0.049 ↓ 0.045 
Eubacterium hallii group 0.640 0.215 0.300 0.174 ↓ 0.040 
Blastopirellula < 0.001 < 0.001 0.828 0.419 ↑ 0.001 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-4. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) F. vesiculosus polysaccharide extract (FVE) when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose FVE Effect P-value 
Mean (%) SD Mean (%) SD  
Phylum 
10 h Firmicutes 8.740 0.121 6.740 1.000 ↓ 0.022  
Family 
10 h 
Veillonellaceae 15.323 2.295 7.471 0.190 ↓ 0.0181 
Ruminococcaceae 3.969 0.150 7.015 1.940 ↑ 0.0396 
Rikenellaceae 1.706 0.205 2.863 0.370 ↑ 0.0153 
Peptostreptococcaceae 4.264 0.629 6.454 10.404 ↑ < 0.0001 
Christensenellaceae 0.703 0.070 1.453 0.112 ↑ 0.0197 
24 h Veillonellaceae 16.261 0.236 12.177 0.850 ↓ 0.0420 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose. 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-4 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) F. vesiculosus polysaccharide extract (FVE) when compared to 1% (w/v) cellulose, after 10- and 24-hrs 
fermentation. Statistical significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a 
significance level of p ≤ 0.05. 
 
Cellulose FVE Effect P-value 
Mean (%) SD Mean (%) SD  
Genus 
10 h 
Alistipes 1.134 0.138 1.704 0.148 ↑ 0.039 
Terrisporobacter 1.505 0.134 0.443 0.081 ↓ < 0.0001 
Ruminococcaceae UCG005 0.371 0.088 0.766 0.114 ↑ 0.018 
Pseudobutyrivibrio 0.675 0.156 1.654 0.231 ↑ 0.001 
Prevotella 7 0.369 0.143 1.544 0.706 ↑ 0.010 
Peptoclostridium 8.856 0.976 0.570 0.030 ↓ < 0.0001 
Oscillospira < 0.001 < 0.001 0.241 0.061 ↑ 0.021 
Megasphaera 9.518 1.665 2.549 0.223 ↓ 0.005 
Lachnospiraceae UCG001 < 0.001 < 0.001 0.322 0.082 ↑ 0.000106 
Lachnospiraceae NK4A136 group 0.218 0.033 0.602 0.096 ↑ 0.014 
Lachnospiraceae NC2004 group 0.033 0.056 0.389 0.159 ↑ 0.007 
Eubacterium ventriosum group 0.089 0.085 0.297 0.054 ↑ 0.035 
Eubacterium ruminantium group < 0.001 < 0.001 0.268 0.094 ↑ 0.001 
Eubacterium coprostanoligenes group 0.119 0.109 1.347 0.558 ↑ 0.002 
Coprococcus 2 0.078 0.135 0.746 0.013 ↑ 0.005 
Christensenellaceae R7 group 0.436 0.018 0.866 0.056 ↑ 0.027 
Alistipes 1.134 0.138 1.704 0.148 ↑ 0.0389 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose. 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-4 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) F. vesiculosus polysaccharide extract (FVE) when compared to 1% (w/v) cellulose, after 10- and 24-hrs 
fermentation. Statistical significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a 
significance level of p ≤ 0.05. 
 
Cellulose FVE Effect P-value 
Mean (%) SD Mean (%) SD  
Genus 
24 h 
Ruminococcaceae UCG003 0.884 0.434 0.060 0.105 ↓ 0.018 
Megasphaera 10.625 0.288 5.147 2.515 ↓ 0.007 
Eubacterium hallii group 0.640 0.215 0.297 0.057 ↑ 0.038 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose. 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-5. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) L. digitata whole seaweed (LDWS) when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose LDWS Effect P-value 
Mean (%) SD Mean (%) SD  
Phylum 
10 h Firmicutes 8.740 0.121 6.940 0.489 ↓ 0.0428  
Family 
10 h 
Unclassified Fucus 
vesiculosus 
0.067 0.060 5.321 0.169 ↑ < 0.0001 
Unclassified Ectocarpus 
siliculosus 
< 0.001 < 0.001 4.078 0.694 ↑ < 0.0001 
Peptostreptococcaceae 13.508 1.446 0.925 0.466 ↓ < 0.0001 
24 h Unclassified Fucus 
vesiculosus 
0.151 0.183 2.457 1.150 ↑ 0.0432 
Unclassified Ectocarpus 
siliculosus 
0.075 0.130 1.801 0.759 ↑ 0.000519 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-5 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) L. digitata whole seaweed (LDWS) when compared to 1% (w/v) cellulose, after 10- and 24-hrs 
fermentation. Statistical significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a 
significance level of p ≤ 0.05. 
 
Cellulose LDWS Effect P-value 
Mean (%) SD Mean (%) SD  
Genus 
10 h 
Coprococcus 2 0.078 0.135 0.584 0.209 ↑ 0.032 
Eubacterium hallii group 0.568 0.055 0.090 0.156 ↓ 0.006 
Eubacterium ventriosum 
group 
0.089 0.085 0.302 0.077 ↑ 0.030 
Lachnospiraceae NK4A136 
group 
0.218 0.033 0.565 0.136 ↑ 0.028 
Peptocl stridium 8.856 0.976 0.562 0.318 ↓ < 0.0001 
Unclassified Ectocarpus 
siliculosus 
< 0.001 < 0.001 2.597 0.413 ↑ < 0.0001 
Unclassified Fucus 
vesiculosus 
0.045 0.040 3.393 0.032 ↑ < 0.0001 
Terrispor bacter 1.505 0.134 0.142 0.130 ↓ < 0.0001 
24 h 
Uncla sified Fucus 
vesiculosus 
0.104 0.126 1.655 0.723 ↑ 0.042 
Unclassified Ectocarpus 
siliculosus 
0.052 0.090 1.214 0.474 ↑ 0.000306 
Ruminococcaceae UCG004 < 0.001 < 0.001 0.056 0.050 ↑ 0.049 
Ruminococ aceae UCG003 0.884 0.434 0.180 0.158 ↓ 0.048 
Parasutterella 0.606 0.069 0.909 0.081 ↑ 0.043 
Eubacterium hallii group 0.640 0.215 0.119 0.018 ↓ 0.002 
Coprococcus 2 0.052 0.091 0.382 0.205 ↑ 0.018 
Butyricimonas 0.234 0.058 0.577 0.005 ↑ 0.000294 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-6. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) L. digitata polysaccharide extract (LDE) when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose LDE Effect P-value 
Mean (%) SD Mean (%) SD  
Phylum 
No statistically significant differences observed  
Family 
10 h Peptostreptococcaceae 13.508 1.446 8.791 2.208 ↓ 0.00565  
Genus 
10 h 
Peptoclostridium 8.856 0.976 5.639 1.172 ↓ 0.002 
Serratia 0.030 0.051 7.451 3.981 ↑ 0.001 
Terrisporobacter 1.505 0.134 1.030 0.188 ↓ 0.012 
Yersinia 0.099 0.047 4.127 0.720 ↑ < 0.0001 
24 h 
Yersinia 0.089 0.154 0.571 0.348 ↑ 0.032 
Solobacterium 0.182 0.072 2.150 1.343 ↑ 0.016 
Serratia 0.081 0.141 4.460 3.525 ↑ 0.027 
Eubacterium hallii group 0.640 0.215 0.234 0.049 ↓ 0.013 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-7. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) Synergy 1 when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical significance was determined 
using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of p ≤ 0.05. 
 
Cellulose Synergy 1 Effect P-value 
Mean (%) SD Mean (%) SD  
Phylum 
10 h Actinobacteria 0.723 0.080 1.700 0.369 ↑ 0.012 
24 h Actinobacteria 0.377 0.080 2.123 0.137 ↑ < 0.0001  
Family 
10 h 
Streptococcaceae 1.116 0.089 5.697 0.892 ↑ < 0.0001 
Peptostreptococcaceae 13.508 1.446 6.086 1.414 ↓ 0.000104 
Enterococcaceae 3.896 0.510 14.013 2.035 ↑ 0.027297 
Clostridiaceae 1 3.356 1.180 9.621 4.907 ↑ 0.038454 
Bifidobacteriaceae 1.837 0.320 4.543 0.940 ↑ 0.003847 
24 h 
Streptococcaceae 0.448 0.108 5.200 0.522 ↑ < 0.0001 
Erysipelotrichaceae 1.599 0.469 4.879 1.185 ↑ 0.018202 
Coriobacteriaceae 0.566 0.184 1.645 0.108 ↑ 0.000126 
Bifidobacteriaceae 1.069 0.194 6.174 0.389 ↑ < 0.0001 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-7 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) Synergy 1 when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose Synergy 1 Effect P-value 
Mean (%) SD Mean (%) SD  
Genus 
10 h 
Terrisporobacter 1.505 0.134 0.778 0.186 ↓ < 0.0001 
Streptococcus 0.742 0.061 4.175 0.713 ↑ < 0.0001 
Peptoclostridium 8.856 0.976 4.385 1.000 ↓ < 0.0001 
Erysipelotrichaceae UCG003 0.474 0.026 0.229 0.045 ↓ 0.036 
Enterococcus 2.589 0.333 10.240 1.327 ↑ 0.007 
Clostridium sensu stricto 1 2.230 0.781 7.077 3.711 ↑ 0.032 
Catenibacterium 1.302 0.210 3.197 0.718 ↑ 0.019 
Bifidobacterium 1.221 0.216 3.318 0.644 ↑ 0.001 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 4-78 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) Synergy 1 when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose Synergy 1 Effect P-value 
Mean (%) SD Mean (%) SD  
Genus 
24 h 
Veillonella 2.596 0.280 8.125 0.817 ↑ 0.003 
Streptococcus 0.306 0.070 3.724 0.464 ↑ < 0.0001 
Holdemanella 0.205 0.031 0.550 0.154 ↑ 0.037 
Eubacterium hallii group 0.640 0.215 0.223 0.053 ↓ 0.011 
Collinsella 0.219 0.060 1.038 0.070 ↑ < 0.0001 
Citrobacter 2.009 0.282 0.939 0.100 ↓ 0.029 
Catenibacterium 0.974 0.280 3.366 0.783 ↑ 0.001 
Blautia 1.055 0.277 2.120 0.144 ↑ 0.020 
Bifidobacterium 0.730 0.125 4.417 0.340 ↑ < 0.0001 
Anaerotruncus 0.757 0.207 0.157 0.047 ↓ 0.040 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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5 Effects of the edible Irish red seaweed, Palmaria palmata, on 
the composition and metabolic activity of the human gut 
microbiota using an in vitro model of the distal colon 
 Abstract 
Palmaria palmata (P. palmata), a red seaweed grown and harvested in Ireland, has 
been proposed as a source of prebiotic fibre due to the presence of xylan, however 
there is a paucity of evidence on its impact on the human microbiota. This study 
used an in vitro batch culture model of the distal colon to investigate the effect of 
P. palmata whole seaweed (PPWS) as well as a crude polysaccharide-rich extract 
from P. palmata (PPE) on gut microbiota composition (culture-dependent 
enumeration, qPCR, and 16S rRNA amplicon sequencing) and metabolism (short 
chain fatty acid quantification via GC-MS).  Cellulose and Synergy 1 were used as 
negative and positive controls, respectively. 
PPWS & PPE treatments had no impact on either alpha or beta measures of 
microbial diversity, however, both PPWS & PPE were shown to significantly 
stimulate Bifidobacterium populations. Both treatments also induced significant 
changes in a range of genera including Bacteroides, Butyricimonas, Dorea, 
Parabacteroides, Phascolarctobacterium, and Pseudobutyrivibrio (PPWS); 
Butyricimonas, Coprococcus, Lachnospiraceae UCG008, and Prevotella (PPE). No 
significant changes in any measured SCFA were noted when PPE was included in 
the fermentation, while inclusion of PPWS in the fermentation resulted in 
significantly higher concentrations of total SCFA (24 and 36 h, p < 0.05) and the 
individual SCFA, propionic acid (10 h, p < 0.05), butyric acid (24, 36 and 48 h, p < 
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0.05), valeric acid (10, 24, 36 and 48 h, p < 0.05), and hexanoic acid (10, 24, 36 and 
48 h, p < 0.05) when compared to cellulose.  
The results of this study indicate that the both PPE & PPWS can favourably impact 
microbiota composition, however the notable increase SCFA production induced 
by PPWS make it a more promising prebiotic candidate and warrants further 
investigation.   
 Introduction 
Seaweed consumption is known to make a considerable contribution to the 
indigenous diet of Asian countries such as China and Japan, with a reported intake 
of 5.2g/day and 5.3g/day, respectively (Chen et al., 2018; Matsumura, 2001). 
Evidence, albeit limited, from observational studies indicates that seaweed 
consumption may be associated with a reduced risk of non-communicable diseases 
(NCDs), including cardiovascular disease, type two diabetes, and obesity (Brown et 
al., 2014). While seaweeds contain a range of health promoting nutrients 
associated with reduced NCD risk, there is an increasing interest in the potential 
health promoting impact of the high complex polysaccharide content in seaweeds 
(MacArtain et al., 2007). The health benefits of  dietary fibre has been attributed to 
the physicochemical viscous properties affecting digestion and absorption in the 
upper gastrointestinal tract, as well as their uptake, utilisation and metabolism by 
the gut microbiota (Anderson et al., 2009; O’Grady et al., 2019). Furthermore, 
fibre-mediated modulation of the gut microbiota has the potential to exert 
prebiotic effects by enabling selective metabolism by gut commensals to improve 
host health (Gibson et al., 2017). Historically, the prebiotic potential of fibre was 
associated with increased numbers of bifidobacteria and/or lactobacilli, and the 
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increased production of health promoting SCFA such as propionate or butyrate. 
More recent evidence indicates that dietary fibre may improve health though the 
maintenance or enhancement of gut bacterial diversity to inhibit pathogens, to 
stimulate putative next generation probiotics (e.g. strains of Bacteroides, 
Akkermansia and Faecalibacterium) (O’Toole et al., 2017),  and to protect against 
metabolic and inflammatory disease (Desai et al., 2016; Sonnenburg and 
Sonnenburg, 2014; Valdes et al., 2018). 
The potential health benefits of prebiotics such as inulin, fructo-oligosaccharides 
(FOS) and galacto-oligosaccharides (GOS) include increased mineral bioavailability, 
pathogen inhibition, immune system stimulation, reduced blood lipids, improved 
insulin sensitivity, and improved brain function through the influence of bacterial 
metabolites on the microbiota-gut-brain axis (Burokas et al., 2017; Carlson et al., 
2018; Gibson et al., 2017). Current interest in seaweeds as a potential source of 
prebiotic fibres has focused primarily on brown seaweed fibre components where 
polysaccharides such as alginate, laminarin and fucoidan have previously 
demonstrated increased production of acetate, propionate, butyrate, and total 
SCFA during in vitro fermentation experiments. Modulation of bacterial 
composition from these experiments has included an increase in populations such 
as Bifidobacterium, Bacteroides, Lactobacillus, Roseburia, Parabacteroides, 
Parasutterella, Fusicatenibacter, Coprococcus, Faecalibacterium (Charoensiddhi et 
al., 2017, 2016; Fu et al., 2018; Strain et al., 2019). There is emerging evidence for 
the prebiotic activity of sulphated galactans from red seaweeds (Bajury et al., 2017; 
Bhattacharya et al., 2015; Di et al., 2018; Hu et al., 2006; Ramnani et al., 2012; 
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Rodrigues et al., 2016), albeit limited evidence exists with regards to the effect of 
red seaweed xylan polysaccharides on gut microbial composition and metabolism. 
There is increasing interest in the potential health benefits of the red seaweed P. 
palmata owing to its high xylan content, and further, its widespread consumption 
in European and coastal communities. The prebiotic potential of xylan has been 
reported for cereal derived 1,4- linked β-D-xylopyranose xylan, however, this 
structure differs to the 1,3- and 1,4- linked β-D-xylopyranose xylan present in P. 
palmata (Grote, 2017; Lahaye and Rochas, 1991).Using an in vitro batch culture 
model of the human colonic microbiota, this study aimed to evaluate the 
fermentability of P. palmata whole seaweed (PPWS) and a P. palmata 
polysaccharide rich fibre extract (PPE) in comparison to cellulose. Furthermore, to 
obtain indications on the prebiotic potential of PPWS and PPE, we investigated any 
effects on microbiota composition and SCFA production.  
 Materials and Methods  
 Chemicals and reagents 
Chemicals were purchased from Sigma Aldrich (St. Louis, USA) unless otherwise 
stated. Reagents used during HPSEC and GC-MS were HPLC grade. Reagents used 
for DNA extraction, qPCR, and 16S rRNA amplicon sequencing were molecular 
biology grade. 
 Seaweed harvest 
P. palmata was harvested from Spiddal, Co. Galway, Ireland (53° 14' 48" North, 9° 
18' 10" West) in September 2014. Only the leaf was used, and the stipe was 
removed from the holdfast during harvesting. The seaweed was immediately 
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washed in seawater to remove contaminants (e.g. epiphytes, molluscs and other 
seaweeds). Washed seaweed was freeze-dried, ground into a fine powder using an 
electronic blender and stored at -20 °C until required. 
 Polysaccharide-rich extract (PPE) production 
P. palmata powder was shaken in dH2O (1:20, w/v) for two mins to reduce the 
initial salt content of the seaweed and then filtered through muslin cloth to 
remove water. A total of 30g of washed P. palmata whole seaweed (PPWS) was 
freeze-dried and stored for in vitro digestion and batch culture fermentation 
experiments. The seaweed powder underwent hot acid extraction, neutralisation, 
desalination, ethanol precipitation, and lyophilisation to generate a crude P. 
palmata polysaccharide-rich extract powder (PPE). 
 PPE characterisation 
The average molecular weight of PPE was determined using a modified high 
performance size exclusion chromatography method (Gomez-Ordonez et al., 
2012). In brief, separation was performed on a PL aquagel-oh mixed-H 8μm SEC 
analytical column (7.5 x 300 mm i.d) with isocratic elution at 50°C and a flow rate 
of 0.6 mL/min and a run time of 31 mins, using a 50mM ammonium formate 
mobile phase and a ten-point pullulan standard curve (0.34 to 708 kDa). 
Total carbohydrate content of FVE and LDE was quantified using a modified 
phenol-sulfuric acid colorimetric assay (DuBois et al., 1956). Sulphate content of 
FVE and LDE was quantified using a modified Azure A colorimetric assay, expressed 
as percentage equivalents of purified fucoidan (Fucoidan from Fucus vesiculosus 
F5631, Sigma Aldrich, USA) (Torode et al., 2015). Structural information of FVE and 
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LDE was determined using Fourier Transform Infrared Spectroscopy (FTIR) using 
the Bruker Tensor 27 FT-IR spectrophotometer (Bruker Corporation, UK) with OPUS 
5.5 software.  
 Mineral and trace element content of PPWS and PPE 
Mineral and trace element analysis of PPWS and PPE (1 x 10g of each) was 
outsourced to Advanced Laboratories (Salt Lake City, Utah, USA). Concentrations of 
aluminium, copper, sodium and zinc were determined by inductively coupled 
plasma optical emission spectrometry (ICP-OES). Concentrations of mercury, lead, 
arsenic, and cadmium were determined by inductively coupled plasma mass 
spectrometry (ICP-MS). Iodine concentration was determined using AOAC 932.21. 
 In vitro digestion 
An in vitro simulated digestion was completed on FVWS, LDWS, FVE and LDE using 
a standardised method (Minekus et al., 2014) with oral, gastric, and intestinal 
phases of digestion. All simulated fluids were incubated at 37°C before use and at 
all digestion stages the fluids were incubated at 37°C in an orbital shaker (160 
rpm). The oral suspension was incubated for 2 mins, while both the gastric and 
intestinal suspensions were incubated for 2 hrs. The intestinal phase digesta was 
then dialysed for 24 hrs using 1kDa dialysis tubing (Spectrum Labs, USA) and the 
retentate was freeze dried (Labconco, USA) to obtain powders prior to batch 
culture fermentation. 
 In vitro batch culture fermentation 
A 20% faecal slurry was prepared following the methods of O’Donnell et al. 
(O’Donnell et al., 2016). The resulting faecal bacteria suspension was amended 
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with sterile glycerol to a final concentration of 25% (v/v) and stored frozen at -80°C 
until use. Nutrient basal medium stock solution was prepared using the 
methodology of Fooks and Gibson (Fooks and Gibson, 2003). In vitro batch culture 
fermentation was performed using the Multifors parallel bioreactor with Iris 6.0 
software (Infors HT, Basel, Switzerland). A total of 2g of either PPE, PPWS, cellulose 
(negative control), or Synergy 1 (positive control) was added to 190ml nutrient 
basal medium stock solution (final carbohydrate concentration = 1% w/v). Vessels 
were sparged with N2 gas for 2 hrs (2 psi) before inoculation with 10ml of 20% 
faecal slurry (previously thawed at 37°C). Vessels were automatically stirred at 200 
revolutions min-1, maintained at pH 6.8 (dropwise addition of 1M HCl or 1M 
NaOH), and incubated at 37°C. A 7mL sample was taken at t = 0, 5, 10, 24, 36 and 
48 hrs for culture-dependent, culture-independent (qPCR and 16S rRNA amplicon 
sequencing), and SCFA analysis. Substrate fermentation was performed in 
triplicate. 
 Culture-dependent analysis 
100 μL of fermentation sample was serially diluted in a maximum recovery diluent 
(101 - 105) and dilutions were plated in triplicate on modified De Man, Rogosa and 
Sharpe agar (MRS) agar selective for Bifidobacterium (sterile filtered with 
5ml/100ml Mupirocin and 1ml/100ml Nystatin), and Lactobacillus selection agar 
(LBS) selective for Lactobacillus (sterile filtered with 1ml/100ml Nystatin). Cultures 
were incubated anaerobically at 37°C for 72 hrs before counting. Counts were 
corrected for each dilution factor and then calculated as log10 CFU/mL.  
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 DNA extraction 
Genomic DNA was extracted from samples after 0, 5, 10, 24, 36, and 48 hrs 
fermentation using the PowerFecal DNA extraction kit (Mo Bio Laboratories, USA) 
according to manufactures’ instructions. The bead beating step was completed 
using the Mo Bio vortex adapter. 
 qPCR  
Total bacteria, Lactobacillus, and Bifidobacterium were quantified using qPCR. 
Primer sequences used for qPCR (Target: Forward primer 5'-3'; Reverse primer 5'-
3'; Size bp; Tm °C): Total Bacteria (Eubacterial): ACTCCTACGGGAGGCAGCAG; 
ATTACCGCGGCTGCTGG; 200 bp; 60°C. Lactobacillus genus: 
GCAGCAGTAGGGAATCTTCCA; GCATTYCACCGCTACACATG; 349 bp; 60°C. 
Bifidobacterium genus: CTCCTGGAAACGGGTGGT; GCTGCCTCCCGTAGGAGT; 203 
bp; 60°C. A standard curve of 109-103 CFU/ml was prepared in duplicate for each 
plate. A PCR master mix was prepared with the forward and reverse primers, 
SYBR® FAST pPCR Master Mix (KAPA Biosystems, USA), and PCR water. 1 µl of 
sample DNA or PCR water (negative control) was added to 9 µl master mix per well 
(reaction volume = 10 µl) and ran in duplicate on two plates (n = 4). The 
Lightcycler® 480 Instrument II (Roche, Switzerland) was used with the following 
PCR conditions: denaturation = 1 cycle; amplification = 40 cycles; melting = 1 cycle; 
cooling = 1 cycle. Target temperature was 95°C with a hold time of 3 min and a 
ramp rate of 4.4°C/sec.  
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 16S rRNA amplicon sequencing 
Illumina MiSeq sequencing library preparation was completed following the 16S 
metagenomic sequencing library protocol (Illumina, USA) and the methods of 
Fouhy et al. (Fouhy et al., 2015). Amplicon PCR: Genomic DNA was amplified using 
primers specific to the V3-V4 hypervariable region of the 16S ribosomal RNA gene 
to create a 460bp amplicon. These primers also incorporated the Illumina overhang 
adaptor (Forward primer 5’  
 TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG; 
reverse primer 5’  
 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC). 
Each PCR reaction contained 2.5 μL template DNA, 5 µL forward primer (1 µM), 5 
µL reverse primer (1 µM), 12.5 µL 2X Kapa HiFi Hotstart ready mix (KAPA 
Biosystems, USA) - 25µL final reaction volume. PCR amplification was carried out 
using the Applied Biosystems 2720 thermal cycler (Life Technologies, USA) with the 
following parameters: heated lid 110°, 95°C for 3 mins; then 25 cycles of: 95°C for 
30 secs, 55°C for 30 secs, 72°C for 30 secs; hold at 72°C for 5 mins; hold at 4°C. 
Successful PCR products were cleaned using Agentcourt AMPure XP kit (Beckman 
Coulter Genomics, UK) a second PCR reaction was completed to attach Illumina 
sequencing adapters onto the amplicons, using the Nextera XT Index kit (Illumina, 
USA). The DNA concentration of each sample was determined using the Qubit High 
Sensitivity DNA kit and the Qubit 3 Fluorometer (Invitrogen, USA). DNA samples 
were then pooled as an equimolar mix and sequenced on the MiSeq sequencing 
platform at Teagasc, Moorepark, Ireland following standard Illumina sequencing 
protocols for the 2 × 250 cycle V3 Kit. 
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 Bioinformatics  
Two hundred and fifty base pair paired-end reads were assembled using FLASH 
(FLASH: fast length adjustment of short reads to improve genome assemblies). 
Further processing of paired-end reads including quality filtering based on a quality 
score of > 25 and removal of mismatched barcodes and sequences below length 
thresholds was completed using QIIME (Caporaso et al., 2010). Denoising, chimera 
detection and clustering into operational taxonomic units (OTUs) (97% identity) 
were performed using USEARCH v7 (64-bit) (Edgar, 2010). OTUs were aligned using 
PyNAST (PyNAST: python nearest alignment space termination; a flexible tool for 
aligning sequences to a template alignment) and taxonomy was assigned using 
BLAST against the SILVA SSURef database release v123. 
 Short chain fatty acid and branched chain fatty acid analysis  
GC-MS analysis was carried out using a modified protocol described by Garcia-
Villalba et al. (Garcia-Villalba et al., 2012). In brief, phosphoric acid was added to 
samples to a final concentration of 0.5% (v/v) prior to ethyl acetate extraction (1:1 
v/v). 180µl organic phase was added to a GC vial alongside 20µl of 4-methyl 
valerate internal standard. A standard curve of 10, 20, 50, 100, 500, 1000, 5000, 
10000, 50000, and 100,000 µM SCFA mix containing acetic acid, propionic acid, n-
butyric acid, i-butyric acid, valeric acid, i-valeric acid, and hexanoic acid was ran 
within every sample batch. Quality control consisted of two 50 µM and two 100 
µM standard mixes every sixteen vials and ethyl acetate blanks every six vials, and 
between each standard vial/QC to prevent carryover. The GC-MS system consisted 
of an Agilent 6890N (Agilent Technologies, USA), equipped with an Agilent 7683 
AutoSampler and 7683B injector, coupled to an Agilent 5973 inert mass selective 
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detector. Agilent MassHunter GC/MS Acquisition software was used. The GC was 
fitted with a DB-WAXetr capillary column (30m length, 0.25mm i.d, 0.25µm film 
thickness), with helium used as the carrier gas (1.2mL/min). Injections were made 
in splitless mode with an injection volume of 1µL (10 µL syringe) and an injection 
temperature of 250°C. The syringe undertook four pre-washes and four post-
washes in hexane. The initial column temperature was 90°C and ramped to 150°C 
at 15°C/min, then to 170°C at 5°C/min, then to 230°C at 20°C/min, where it was 
maintained for 2 mins. Total run time was 14 mins. Solvent delay was 2.5 mins. The 
detector was operated in electron impact ionisation mode. 
 Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics (version 24) and 
GraphPad Prism 8 software. Graphs were made in GraphPad Prism 8 software. To 
determine the significant effects of each treatment on bacterial enumeration 
(culture and qPCR), a non-parametric Kruskal-Wallis test with a Bonferroni 
correction for multiple comparisons and a significance level of 0.05 was used to 
compare each treatment to cellulose. To determine the significant effects of each 
treatment on SCFA concentrations, statistical significance was determined 
between each treatment and cellulose using a one-way ANOVA with a Tukey’s 
post-hoc test for multiple comparisons with a significance level of p ≤ 0.05. 
Statistical analysis of 16S rRNA amplicon sequencing data was carried out using 
Calypso online software (version 8.68) (Zakrzewski et al., 2017). Data were 
normalized using cumulative sum scaling and log2 transformed to account for the 
non-normal distribution of sequencing data (Paulson et al., 2013). Up to 20,000 
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taxa with > 0.01% abundance were used in the analysis. Chloroplasts and 
cyanobacteria were removed from the analysis.  
Alpha diversity was determined using rarefied Chao1, Evenness, Shannon and 
Simpson indices. Statistical significance was determined using a non-parametric 
Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false discovery rate 
(FDR) correction for multiple comparisons (q value). Beta diversity was determined 
Bray-Curtis dissimilarity distance matrices for each fermentation substrate and 
cellulose at a given time point. A Permutational multivariate analysis of variance 
(PerMANOVA) was used to determine the statistical difference between Bray–
Curtis dissimilarity indices of beta diversity. 
Statistical significance of mean bacterial relative abundances, when compared to 
cellulose, at the phylum, family, and genus level after 0, 10, and 24 hrs 
fermentation was determined using a one-way ANOVA with a Tukey’s post-hoc test 
for multiple comparisons and a significance level of p ≤ 0.05. Discriminate taxa 
between fermentation substrates and cellulose at a given time point were 
identified using linear discriminant analysis (LDA) effect size (LEfSe) (Segata et al., 
2011). 
 Results 
 PPE characterisation  
The average molecular weight of PPE was 4.5 kDa and the molecular weight 
distribution ranged from 1 kDa to 10 kDa. The total carbohydrate content of PPE 
was 93.9 ± 4.64 % while the total sulphate content, expressed as fucoidan 
equivalents, was negligible (below the limit of detection of the 
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spectrophotometer). Qualitative determination of monosaccharide content (Figure 
5-1) indicated that hydrolysed PPE consisted of xylose. Figure 5-2 shows the FTIR 
spectra of PPE pre- and post- in vitro digestion. The main band at 1038cm-1 could 
be attributed to the C-C ring and C-O (C-OH side chain) stretching vibrations of 1, 4-
linked xylan (Buslov et al., 2009; Kačuráková et al., 1999). Several major 
overlapping bands from 1168 cm-1 (C-C, C-O, or C-O-C stretch) to 1076 cm-1 (C-C or 
C-O stretch) and 991 cm-1 (C-H3 or C-OH bend) could indicate a large proportion of 
sugar rings present in the PPE sample. Absorption at 899cm-1 indicates a C-1-H 
bend within the pentose sugar (Kačuráková et al., 1999). Similar absorption bands 
were produced between pre- and post-digested samples, with differences in water 
absorption at 1628cm-1. 
 Mineral and trace element analysis 
Table 5-1 shows data from the mineral and trace element analysis of PPE and 
PPWS fermentation substrates. The iodine content of PPE and PPWS was 0.15 
mg/g and 0.52 mg/g, respectively.  
 Batch culture fermentation 
5.4.3.1 Bacterial enumeration: culture-dependent analysis 
There was no statistical difference in the number of cultured Lactobacillus spp. and 
Bifidobacterium spp. colonies when either PPWS, PPE, or Synergy 1 were included 
in the fermentation when compared to cellulose at any time point after false 
discovery rate correction for multiple comparisons (Figure 5-3). 
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5.4.3.3 Bacterial enumeration: qPCR 
The total bacteria present in vessels fermented with either PPWS, PPE, or Synergy 
1 was not significantly different to vessels fermented with cellulose at any time 
point (Figure 5-4). Inclusion of PPWS in the fermentation resulted in a significant 
reduction of Lactobacillus spp. after 5 hrs (p = 0.0046, q = 0.007) and 10 hrs (p = 
0.0034, q = 0.0103) when compared to cellulose, but not thereafter (Figure 5-5). 
Vessels treated with PPWS had significantly lower concentrations of 
Bifidobacterium spp. when compared to cellulose at 0 hrs (p = 0.001, q = 0.0029) 
and 5 hrs (p = 0.0083, q = 0.0124) fermentation, however, counts of 
Bifidobacterium spp. were significantly higher in vessels fermented with PPWS 
when compared to cellulose after 24 hrs (p = 0.0224, q = 0.0224) (Figure 5-6). PPE 
fermentation resulted in a significant reduction in Bifidobacterium spp. when 
compared to cellulose after 5 hrs (p = 0.017, q = 0.005), however, Bifidobacterium 
spp. were significantly higher in vessels fermented with PPE compared to cellulose 
after 10 hrs (p = 0.0283, q = 0.0424), 24 hrs (p = 0.0065, q = 0.0098), 36 hrs (p = 
0.0029, q = 0.0043) and 48 hrs (p = 0.0018, q = 0.0028) (Figure 5-6). Lactobacillus 
spp. were significantly lower after 5 hrs PPE fermentation when compared to 
cellulose (p = 0.0025, q = 0.007) but were not significantly different thereafter 
(Figure 5-5). Synergy 1 fermentation resulted in significantly higher Bifidobacterium 
spp. when compared to cellulose after 10 hrs (p = 0.0156, q = 0.0424), 24 hrs, 36 
hrs, and 48 hrs fermentation (p < 0.0001, q < 0.0001) (Figure 5-6). 
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5.4.3.5 16S rRNA amplicon sequencing: effect of PPWS and PPE 
fermentation on microbial diversity 
There were no significant differences between any fermentation substrates when 
compared to cellulose for the alpha diversity indices of Chao1, Evenness, Simpson 
Index and Shannon Index (Figure 5-7), nor the Bray-Curtis dissimilarity index of 
beta diversity at 0, 10, or 24 hrs fermentation (p > 0.5). 
5.4.3.6 16S rRNA amplicon sequencing: effect of PPE and PPWS 
fermentation on microbial abundance 
Relative abundances of the bacteria present in vessels fermented with cellulose, 
PPWS, PPE, and synergy 1 are shown at the phylum level (Figure 5-8), family level 
(Figure 5-9), and genus level (Figure 5-10, Figure 5-11, and Figure 5-12). 
The mean relative abundance of the genus Alloprevotella was significantly higher in 
vessels treated with PPWS treatment when compared to cellulose after 10 hrs 
(0.458 ± 0.066 % vs < 0.001 %, p = 0.005). PPWS treatment significantly reduced 
the relative abundance of several genera when compared to cellulose after 10 hrs, 
including Tyzzerella 3 (< 0.001 % vs 0.435 ± 0.186 %, p = 0.006), Lachnospiraceae 
FCS020 group (0.608 ± 0.108 % vs 0.862 ± 0.091 %, p = 0.030), Faecalibacterium 
(1.211 ± 0.127 % vs 1.519 ± 0.060 %, p = 0.021), Erysipelotrichaceae UCG003 (0.655 
± 0.099 % vs 0.996 ± 0.059 %, p = 0.003), and Christensenellaceae R7 group (0.810 ± 
0.081 % vs 1.030 ± 0.082 %, p = 0.028) (Table 5-2).  
After 24 hrs fermentation in the presence of PPWS, the relative abundance of four 
genera were significantly higher when compared to cellulose: Pseudobutyrivibrio 
(1.688 ± 0.235 % vs 1.046 ± 0.140 %, p = 0.021), Butyricimonas (1.448 ± 0.212 % vs 
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0.881 ± 0.0125 %, p = 0.021), Bifidobacterium (1.955 ± 0.184 % vs 1.221 ± 0.082 %, 
p = 0.002), and Bacteroides (3.365 ± 0.286 % 2.629 ± 0.061 %, p = 0.007). After 24 
hrs PPWS fermentation, the relative abundance of three bacterial genera were 
significantly lower when compared to cellulose: Ruminococcaceae UCG002 (< 0.001 
% vs 1.146 ± 0.131 %, p = 0.006), Clostridium sensu stricto 1 (0.687 ± 0.610 % vs 
1.823 ± 0.308 %, p = 0.048) and Christensenellaceae R7 group (< 0.001 % vs 0.846 ± 
0.0648 %, p = 0.012).  
The family Bifidobacteriaceae were significantly higher after including PPWS in the 
fermentation for 24 hrs when compared to cellulose (4.031 ± 0.270 % vs 2.708 ± 
0.154 %, p = 0.001), whereas the families Clostridiaceae 1 and Christensenellaceae 
were significantly lower (1.400 ± 1.215 % vs 4.150 ± 0.738 %, p = 0.032; and < 0.001 
% vs 1.812 ± 0.144 %, p = 0.017, respectively). The phylum Verrucomicrobia was 
significantly lower after fermentation with PPWS when compared to cellulose after 
24 hrs (9.112 ± 0.441 % vs 11.735 ± 0.470 %, p = 0.002). LEfSe analysis determined 
that Blastopirellula, Butyricimonas, Desulfovibrio, Kluyvera, Parabacteroides, and 
an uncultured bacterium were discriminative bacterial genera of PPWS 
fermentation when compared to cellulose after 10 hrs (Figure 5-13). While 
Ruminococcus 1, Bacteroides, Pseudobutyrivibrio, Bifidobacterium, 
Acidaminococcus, Mitsuokella, Phascolarctobacterium, Butyricimonas, Dorea, 
Enterobacter, Kluyvera, Bilophila, Citrobacter, Sutterella, Lachnospiraceae UCG004, 
and Parabacteroides were discriminative bacterial genera of PPWS fermentation 
when compared to cellulose after 24 hrs (Figure 5-13). 
By including PPE in the fermentation, there was a significantly higher relative 
abundance of the genus Coprococcus 2 after 10 hrs when compared to cellulose 
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(1.182 ± 0.161 % vs 0.387 ± 0.186 %, p = 0.005) (Table 5-3). After 24 hrs PPE 
fermentation, the relative abundance of the genera Ruminococcaceae UCG002 and 
Barnesiella was significantly lower when compared to cellulose (0.310 ± 0.536 % vs 
1.146 ± 0.131 %, p = 0.032; and < 0.001 vs 0.950 ± 0.070 %, p = 0.021, respectively), 
whereas the relative abundance of the genera Prevotella 2 and Bifidobacterium 
was significantly higher when compared to cellulose (0.794 ± 0.198 % vs < 0.001 %, 
p = 0.035 and p = 0.001, respectively). Significantly higher relative abundances of 
the family Bifidobacteriaceae and the phylum Actinobacteria were also observed 
after 24 hrs (4.467 ± 0.252 % vs 2.708 ± 0.154 %, p = 0.001; and 13.79 ± 0.30 % vs 
10.28 ± 0.17 %, p = < 0.001, respectively). The family Enterococcaceae were also 
significantly higher in vessels fermented with PPE when compared to cellulose 
after 24 hrs (5.29 ± 0.54 % vs 4.22 ± 0.17 %, p = 0.017). LEfSe analysis determined 
that Coprococcus 2, Asteroleplasma, Enterococcus, Desulfovibrio, 
Pseudobutyrivibrio, and two uncultured bacteria were discriminative bacterial 
genera of PPE fermentation when compared to cellulose after 10 hrs (). While 
Bifidobacterium, Lachnospiraceae UCG008, Veillonella, Enterococcus, and 
Butyricimonas were discriminative bacterial genera of PPE fermentation when 
compared to cellulose after 24 hrs (Figure 5-14). 
The significant differences in bacterial composition following Synergy 1 
fermentation when compared to cellulose are presented in Table 5-4. This included 
a significantly higher relative abundance of the Bifidobacterium genus after 24 hrs 
(2.362 ± 0.055 % vs 1.221 ± 0.082 %, p = < 0.001).  
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5.4.3.8 Short chain fatty acid and branched chain fatty acid analysis 
Inclusion of PPWS in the fermentation resulted in significantly higher 
concentrations of propionic acid after 10 hrs when compared to cellulose (p = 
0.014) (Figure 5-15). Inclusion of PPWS in the fermentation also resulted in 
significantly higher butyric acid concentrations after 24 hrs (p = 0.014), 36 hrs (p = 
0.002), and 48 hrs (p = 0.001), and significantly higher valeric acid concentrations 
after 10, 24, 36, and 48 hrs when compared to cellulose (p = 0.018, p = 0.005, p = 
0.002, and p = 0.049, respectively). Hexanoic acid was also significantly higher in 
PPWS treated vessels when compared to cellulose after 10, 24, and 36 hrs 
fermentation (p = 0.039, p = 0.012, and p = 0.012, respectively). Total SCFA were 
significantly higher in vessels when PPWS was included in the fermentation at 24 
hrs and 36 hrs (p = 0.047 and p = 0.006, respectively).  
Inclusion of PPWS in the fermentation resulted in significantly higher isobutyric 
acid concentrations after 24 and 36 hrs when compared to cellulose (p = 0.008 and 
p = 0.004, respectively) (Figure 5-16). Isovaleric acid concentrations were 
significantly higher when compared to cellulose after 5, 10, 24, and 36 hrs 
fermentation (p = 0.002, p = 0.017, p = 0.004, and p = 0.001, respectively). Total 
BCFA were significantly higher when including PPWS in the fermentation when 
compared to cellulose after 5, 10, 24, and 36 hrs fermentation (p = 0.004, p = 
0.026, p = 0.005, and p = 0.002, respectively). Inclusion of neither Synergy 1 nor 
PPE in the fermentation resulted in a significant difference in the concentration of 
individual SCFA and total SCFA (Figure 5-15) or individual BCFAs and total BCFAs 
(Figure 5-16) at any time point during fermentation when compared to cellulose.  
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 Discussion 
In this study, we investigated the fermentability of the Irish red seaweed P. 
palmata (PPWS), and a polysaccharide-rich extract of P. palmata (PPE), and their 
impact on the microbial composition, diversity and metabolic activity of the human 
gut microbiota, using an in vitro human colonic fermentation model. In line with 
the properties of a prebiotic dietary fibre, the data obtained showed that individual 
and total SCFA concentrations were significantly higher in vessels that included 
PPWS in the fermentation when compared to the cellulose control. Evaluation of 
Bifidobacterium and Lactobacillus, traditionally associated with prebiotic activity, 
showed that both PPWS (culture and 16S rRNA amplicon sequencing) and PPE 
(qPCR and 16S rRNA amplicon sequencing) significantly stimulated Bifidobacterium 
populations but that neither PPWS nor PPE had any impact on the growth of 
Lactobacillus spp. (culture, qPCR, and 16S rRNA amplicon sequencing). 
Furthermore, 16S rRNA amplicon sequencing indicated that both seaweed 
substrates stimulated the growth of other bacterial genera when compared to 
cellulose, including Bacteroides, Butyricimonas, Dorea, Parabacteroides, 
Phascolarctobacterium, and Pseudobutyrivibrio (PPWS); and Butyricimonas, 
Coprococcus, Lachnospiraceae UCG008, and Prevotella (PPE), however neither 
substrate significantly altered the alpha or beta diversity 
The fermentability of fibre present in PPWS and PPE is likely to be attributable to 
the presence of the digestion resistant complex hemicellulose polysaccharide, 
xylan, composed of 1,3- and 1,4- linked β-D-xylopyranose (Kobayashi et al., 2020), 
which has to capacity to be hydrolysed by carbohydrate active enzymes (CAZymes) 
such as β-(1→3)-xylosidases and α-L-arabinofuranosidases within a range of 
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bacterial species present in the human gut (Kobayashi et al., 2020). The 
fermentability and prebiotic potential of terrestrial-derived xylans, arabinoxylans, 
and their respective oligosaccharides, has previously been reported (Broekaert et 
al., 2011; Finegold et al., 2014; Lecerf et al., 2012; Lin et al., 2016; Walton et al., 
2012; Yang et al., 2015), however the unique composition of P. palmata and the 
structural differences of its constituent xylan warranted this investigation. Further, 
the present study builds on the only previous in vitro fermentation study of P. 
palmata-derived xylan which was limited to the quantification of SCFA 
concentrations without any investigation of microbial compositional analysis 
(Lahaye et al., 1993). 
The consistent bifidogenic effect of PPWS alongside the significantly higher 
concentrations of total SCFA, most notably propionate (10 hrs) and butyrate (24-48 
hrs) in comparison to cellulose highlights its considerable potential as a prebiotic 
candidate.  This suggests that P. palmata seaweed contains microbiota accessible 
components that are fermentable, which could potentially impact host physiology 
and benefit health. 
A range of alterations to the microbiota were noted following PPWS treatment, 
many of which are likely to have contributed, in part, to the observed higher SCFA 
concentrations when compared to cellulose. This included acetic acid producers 
such as Dorea and Phascolarctobacterium (Duncan et al., 2007; Wu et al., 2017), 
propionic acid producers such as Acidaminococcus, Phascolarctobacterium and 
Parabacteroides (Jumas-Bilak et al., 2007; Wu et al., 2017, 2019), and butyric acid 
producers such as Butyricimonas and Pseudobutyrivibrio (Bailey et al., 2011; Neto 
and O’Toole, 2016). Theoretically, the latter could metabolise xylose into butyrate 
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via the pentose-phosphate pathway (Rivière et al., 2016). The Pseudobutyrivibrio 
and Parabacteroides genera have been associated with anti-inflammatory effects 
in murine models (Henson and Phalak, 2018; Kverka et al., 2011; Wu et al., 2019) 
whilst Butyricimonas has been shown to be more abundant in lean individuals 
(Garcia-Mantrana et al., 2018). Interestingly, enhanced Parabacteroides have been 
reported to be stimulated during an in vitro fermentation of brown seaweed 
substrates (Strain et al., 2019), but decreased in mice that consumed a sulphated 
polysaccharide from the red seaweed Gelidium pacificum (Cui et al., 2020). These 
substrate-specific differences on the genus Parabacteroides exemplifies the 
difficulty of comparing previous prebiotic screening studies using seaweeds.  
The significant changes in Bacteroides associated with PPWS treatment may be 
important for the initial degradation of the polysaccharides present, considering 
the extensive glycobiome that Bacteroides spp. possess which makes them capable 
of degrading multiple complex dietary glycans (Ndeh and Gilbert, 2018). The 
presence of enzymes capable of degrading seaweed derived polysaccharide has 
been attributed to horizontal gene transfer of CAZymes from marine bacteria 
present on the seaweed vector (Hehemann et al., 2010; Ndeh and Gilbert, 2018; 
Schwalm and Groisman, 2017). 
The significantly higher relative abundance of the marine bacterium Blastopirellula 
following PPWS treatment is likely to result from its presence on the seaweed and 
may contribute to the catabolism of the seaweed polysaccharides and contribute 
to cross-feeding of metabolites with the human gut commensals, including 
Bacteroides and Bifidobacterium (Lage and Bondoso, 2014; Turroni et al., 2015). 
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In contrast to the higher concentration of SCFA following PPWS fermentation, 
concentrations of isobutyric acid (24 and 36 h), isovaleric acid (5, 10, 24, and 36 h) 
and total BCFA (5, 10, 24, and 36 h) were significantly higher than cellulose. Given 
that P. palmata has a high protein content, previously shown to resist digestion in 
vitro (Galland-Irmouli et al., 1999), a potential explanation for the observed 
increase in BCFA during PPWS fermentation is that proteins were liberated from 
the seaweed food matrix and catabolised by the ex vivo bacterial community 
(alongside carbohydrates and other phytochemicals present in the seaweed food 
matrix). Given that P. palmata could provide a non-animal source of dietary 
protein, further investigation to understand the concentrations of protein 
fermentation metabolites such as hydrogen sulphide, ammonia, and p-Cresol are 
needed, owing to their potential genotoxic effects (Diether and Willing, 2019).  
Proteolytic fermentation may also explain why PPWS was associated with the 
genus Bilophila (LEfSe analysis). Bilophila spp. produce hydrogen sulphide via 
taurine deconjugation (Xing et al., 2019), and red seaweeds such as P. palmata are 
reported to contain a high amount of the amino acid taurine (Kawasaki et al., 
2017). Given the pathobiont nature of certain Bilophila species, the impact of P. 
palmata seaweed consumption on the production of hydrogen sulphide, a 
mediator of gut homeostasis in both physiology and pathophysiology (Wallace et 
al., 2017), warrants further exploration. Similarly, the impact of PPWS on the 
potentially pathogenic genera, Citrobacter and Kluyvera should be considered. 
The inclusion of PPE in the fermentation was shown to exert bifidogenic effects as 
noted by the qPCR and 16S rRNA amplicon sequencing data in the absence of 
higher SCFA concentrations when compared to cellulose. The lack of significantly 
333 
 
 
higher bifidobacteria by the culture dependent quantification following PPE 
treatment raises a question mark over the comparison of genomic approaches and 
viable counts (Gloor et al., 2017; Hawinkel et al., 2019). The bifidogenic effect has 
been proposed to be an important factor in the health benefits associated with 
prebiotics because bifidobacteria are suggested to exert health promoting effects 
via immunomodulatory enhancement of regulatory T-cell function (Ruohtula et al., 
2019; Verma et al., 2018), the synthesis of vitamins B & K (Rossi et al., 2011; Yoshii 
et al., 2019), and also produce bacteriocins (Rivière et al., 2016). A recent study by 
Kobayashi et al. (Kobayashi et al., 2020) has reported that Bifidobacterium 
adolescents expresses β-(1→3)-xylosidases and α-L-arabinofuranosidases that 
degrade P. palmata derived xylan. This may help to explain, in part, the bifidogenic 
effect observed in this study.  
PPE fermentation did not stimulate the growth of Lactobacillus populations when 
compared to cellulose. These data are in agreement with one previous human 
intervention study which demonstrated significantly increased faecal bifidobacteria 
but not lactobacilli following xylo-oligosaccharide (XOS) treatment (Finegold et al., 
2014), but conflicts partly with another study which reported significant increases 
in both lactobacilli and bifidobacteria (Lin et al., 2016).  
The genus Prevotella 2 was also significantly higher in PPE treated vessels when 
compared to cellulose. Prevotella, of the Bacteroidetes phylum, are associated with 
high dietary fibre diets (O’Grady et al., 2019). Prevotella possess xylan utilisation 
system (XUS) gene clusters and glycoside hydrolase enzymes, and therefore 
Prevotella spp. may have the potential to be xylanolytic via the xylose isomerase 
pathway to produce SCFA such as acetate and propionate, and also facilitates 
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cross-feeding for other bacteria (Dodd et al., 2011; Franke and Deppenmeier, 2018; 
Poeker et al., 2018). 
Although the PPE treatment had no significant impact on SCFA concentration, 
several bacterial genera were stimulated by PPE treatment when compared to 
cellulose. This included Lachnospiraceae UCG008, Veillonella, Enterococcus and 
Butyricimonas. Of note, Butyricimonas produce butyric acid (Garcia-Mantrana et 
al., 2018), while Veillonella produce propionic acid (Henson and Phalak, 2018). 
Lachnospiraceae are common gut commensals capable of degrading plant 
biopolymers (Biddle et al., 2013; Esquivel-Elizondo et al., 2017; Tidjani Alou et al., 
2016) and are increased following high-fibre diets (Bishehsari et al., 2018).  
The higher concentrations of SCFA following PPWS treatment in comparison with 
the lack of any effect in the PPE treatment makes the PPWS a more suitable 
prebiotic source as a range of health benefits associated with fermentable 
polysaccharides have been attributed to SCFA production. For instance, SCFA are 
involved in both local and systemic functions in vivo, including pathogen inhibition 
(owing to decreased luminal pH),  hepatic gluconeogenesis (propionic acid), and 
the hormonal control of satiety (promotion of CCK, PYY and GLP-1 release) (Canani 
et al., 2011; Frost et al., 2014; González Hernández et al., 2019; Halford and 
Harrold, 2012). Further, butyric acid is the primary energy source for colonocytes 
energy and is understood to exert anti-cancer effects through its histone 
deacetylase inhibitory activities (Leonel and Alvarez-Leite, 2012; Plöger et al., 2012; 
Velazquez et al., 1997), as well as anti-inflammatory effects via Foxp3+ Treg cell 
proliferation and NF-κB transcription factor inhibition (Leonel and Alvarez-Leite, 
2012; Plöger et al., 2012).  
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Cellulose was selected as the negative control in this study because it is poorly 
fermented by the human gut microbiota and is not a prebiotic (Gibson et al., 2017). 
Nevertheless, PPWS, PPE, and Synergy 1 treated vessels had a significantly lower 
relative abundance of the genus Ruminococcaceae UCG002 when compared to 
cellulose after 24 hrs. Ruminococcus spp. are cellulolytic (Chassard et al., 2010; 
Flint et al., 2012).  
The whole seaweed had a more profound effect on SCFA production than PPE, 
which suggests that the synergy of multiple components present in the seaweed 
matrix is required for faecal bacterial communities to thrive within a closed, batch-
culture fermentation system. This was also observed in a recent in vitro 
fermentation study whereby whole oats increased bifidobacteria, acetic acid, and 
propionic acid to a greater extent than extracted oat beta glucans and oat 
polyphenols (Kristek et al., 2019). Nevertheless, the higher iodine content of PPWS 
may limit the amount of seaweed which could be safely consumed in order to test 
prebiotic efficacy in vivo, where a 5g portion of PPWS would exceed the 600 
μg/day and 1100 μg/day upper limits set by the European Food Safety Authority 
and the World Health Organisation, respectively (EFSA, 2014; Joint FAO/WHO 
Expert Committee on Food Additives, 1989). Indeed, one previous study found that 
supplementation of 5g/day P. palmata for 28 days improved iodine status in adults 
but it significantly increased serum thyroid stimulating hormone albeit within 
normal clinical ranges (Allsopp et al., 2016). Therefore, optimised methods which 
extract and purify the fibre content of P. palmata warrants further investigation, 
given that the observed stimulation of Bifidobacterium and Prevotella by PPE when 
compared to cellulose.   
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 Conclusion 
The data obtained from this in vitro study provide evidence that the edible red 
seaweed P. palmata, contains microbiota accessible components for fermentation 
by human faecal bacterial populations. The results of this study indicate that the P. 
palmata whole seaweed can favourably impact microbiota composition and 
metabolic output, whilst the changes induced by the P. palmata polysaccharide 
extract were limited to bacterial composition, albeit a bifidogenic effect was 
observed. PPWS would appear to be a food that promotes a health-associated gut 
microbiota; however, its high iodine concentration needs to be considered when 
preparing this for human consumption. Further research is needed to clarify 
whether crude polysaccharide extracts, purified xylan or xylo-oligosaccharides, or 
other phytochemicals such as polyphenols or polyunsaturated fatty acids obtained 
from P. palmata, can positively modulate gut microbiota composition and function 
to confer health benefits conducive to a prebiotic in vivo.  
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 Figures 
 
Figure 5-1. Silica-gel thin-layer chromatography (TLC) of PPE alongside monosaccharide 
standards of fucose, mannose, xylose, glucose, galactose, rhamnose, and arabinose. 
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Figure 5-2 Structural information of the P. palmata polysaccharide extract was 
determined using Fourier transform infrared spectroscopy (FTIR). Blue denotes the 
extract before in vitro digestion and red denotes the extract after in vitro digestion.  
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Figure 5-3. Bacterial enumeration (Log10 CFU/mL) of Lactobacillus spp. (LBS agar) and Bifidobacterium spp. (MRS agar) present in fermentation 
vessels treated with either 1% (w/v) cellulose, P. palmata whole seaweed (PPWS), P. palmata polysaccharide extract (PPE), or synergy 1 
substrates. Samples were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots represent the mean + standard deviation (n = 3). 
Statistical significance was determined using a non-parametric Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false discovery rate 
(FDR) correction for multiple comparisons (q-value). * q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 0.005, **** q ≤ 0.0001. 
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Figure 5-4. qPCR was used to quantify total bacteria from DNA extracted from 
fermentation vessels treated with either 1% (w/v) cellulose, P. palmata whole 
seaweed (PPWS), P. palmata polysaccharide extract (PPE), or Synergy 1 substrates. 
Samples were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots 
represent the mean + standard error of the mean (n = 3). Statistical significance 
was determined using a non-parametric Kruskal-Wallis test (p-value) with a 
Benjamini and Hochberg false discovery rate (FDR) correction for multiple 
comparisons (q-value). * q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 0.005, **** q ≤ 0.0001. 
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Figure 5-5. qPCR was used to quantify Lactobacillus spp. from DNA extracted from 
fermentation vessels treated with either 1% (w/v) cellulose, P. palmata whole 
seaweed (PPWS), P. palmata polysaccharide extract (PPE), or Synergy 1 substrates. 
Samples were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots 
represent the mean + standard error of the mean (n = 3). Statistical significance 
was determined using a non-parametric Kruskal-Wallis test (p-value) with a 
Benjamini and Hochberg false discovery rate (FDR) correction for multiple 
comparisons (q-value). * q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 0.005, **** q ≤ 0.0001. 
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Figure 5-6. qPCR was used to quantify Bifidobacterium spp. from DNA extracted 
from fermentation vessels treated with either 1% (w/v) cellulose, P. palmata whole 
seaweed (PPWS), P. palmata polysaccharide extract (PPE), or Synergy 1 substrates. 
Samples were taken at 0, 5, 10, 24, 36, and 48 hrs fermentation. Data plots 
represent the mean + standard error of the mean (n = 3). Statistical significance 
was determined using a non-parametric Kruskal-Wallis test (p-value) with a 
Benjamini and Hochberg false discovery rate (FDR) correction for multiple 
comparisons (q-value). * q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 0.005, **** q ≤0.0001.
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Figure 5-7. Chao1, Evenness, Shannon and Simpson alpha diversity indices of 
fermentation vessels treated with either 1% (w/v) cellulose, P. palmata whole 
seaweed (PPWS), P. palmata polysaccharide extract (PPE), or Synergy 1, after 10 
hrs and 24 hrs. Plots represent individual values and the mean ± one standard 
deviation of the mean (n = 3). Statistical significance was accepted as p ≤ 0.05 
following a one-way ANOVA with a Tukey’s post-hoc test for multiple comparisons.  
358 
 
 
 
Figure 5-8. Mean relative abundances of bacterial phyla in fermentation vessels 
treated with either 1% (w/v) cellulose, P. palmata seaweed (PPWS), P. palmata 
polysaccharide extract (PPE), or Synergy 1 after 0, 10, and 24 hrs fermentation (n = 
3). Bacterial composition was determined using 16S rRNA amplicon sequencing on 
the MiSeq platform. 
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Figure 5-9. Mean relative abundances of bacterial families in fermentation vessels 
treated with either 1% (w/v) cellulose, P. palmata seaweed (PPWS), P. palmata 
polysaccharide extract (PPE), or Synergy 1 after 0, 10, and 24 hrs fermentation (n = 
3). Bacterial composition was determined using 16S rRNA amplicon sequencing on 
the MiSeq platform. 
C
el
lu
lo
se
 0
h
P
PW
S 
0h
P
P
E 
0h
S
yn
er
gy
 1
 0
h
C
el
lu
lo
se
 1
0h
P
P
W
S 
10
h
P
P
E 
10
h
S
yn
er
gy
 1
 1
0h
C
el
lu
lo
se
 2
4h
P
P
W
S 
24
h
P
P
E 
24
h
S
yn
er
gy
 1
 2
4h
0
20
40
60
80
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
 (
%
)
Bacteroidales_S247_group
Unclassified.Palmaria_palmata
Verrucomicrobiaceae
Veillonellaceae
Succinivibrionaceae
Ruminococcaceae
Prevotellaceae
Lachnospiraceae
Bacteroidaceae
uncultured_bacterium
Unclassified
Streptococcaceae
Rikenellaceae
Rhodospirillaceae
Rhodobacteraceae
Porphyromonadaceae
Planctomycetaceae
Peptostreptococcaceae
Pasteurellaceae
Lactobacillaceae
Family_XIII
Erysipelotrichaceae
Enterococcaceae
Enterobacteriaceae
Desulfovibrionaceae
Coriobacteriaceae
Clostridiaceae_1
Christensenellaceae
Bifidobacteriaceae
Alcaligenaceae
Acidaminococcaceae
360 
 
 
 
Figure 5-10. Mean relative abundances of bacterial genera in fermentation vessels 
treated with either 1% (w/v) cellulose, P. palmata seaweed (PPWS), P. palmata 
polysaccharide extract (PPE), or Synergy 1 after 0 hrs fermentation (n = 3). The top 
30 most abundant genera are represented as individual stacks with all remaining 
genera assigned a single stack labelled “other”. Bacterial composition was 
determined using 16S rRNA amplicon sequencing on the MiSeq platform. 
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Figure 5-11. Mean relative abundances of bacterial genera in fermentation vessels 
treated with either 1% (w/v) cellulose, P. palmata seaweed (PPWS), P. palmata 
polysaccharide extract (PPE), or Synergy 1 after 10 hrs fermentation (n = 3). The 
top 30 most abundant genera are represented as individual stacks with all 
remaining genera assigned a single stack labelled “other”. Bacterial composition 
was determined using 16S rRNA amplicon sequencing on the MiSeq platform. 
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Figure 5-12. Mean relative abundances of bacterial genera in fermentation vessels 
treated with either 1% (w/v) cellulose, P. palmata seaweed (PPWS), P. palmata 
polysaccharide extract (PPE), or Synergy 1 after 24 hrs fermentation (n = 3). The 
top 30 most abundant genera are represented as individual stacks with all 
remaining genera assigned a single stack labelled “other”. Bacterial composition 
was determined using 16S rRNA amplicon sequencing on the MiSeq platform. 
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Figure 5-13. LDA scores following LEfSe analysis to determine discriminative 
bacteria between fermentation vessels treated with 1% (w/v) P. palmata whole 
seaweed (PPWS) when compared to 1% (w/v) cellulose at 0, 10, and 24 hrs 
fermentation (n = 3). Bacterial composition was determined using 16S rRNA 
amplicon sequencing on the MiSeq platform. 
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Figure 5-14. LDA scores following LEfSe analysis to determine discriminative 
bacteria between fermentation vessels treated with 1% (w/v) P. palmata 
polysaccharide extract (PPE) when compared to 1% (w/v) cellulose at 0, 10, and 24 
hrs fermentation (n = 3). Bacterial composition was determined using 16S rRNA 
amplicon sequencing on the MiSeq platform.  
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Figure 5-15. SCFA concentrations (µM) of fermentation vessels treated with either 
1% (w/v) cellulose, P. palmata whole seaweed (PPWS), P. palmata polysaccharide 
extract (PPE), or Synergy 1. Samples were taken at 0, 5, 10, 24, 36, and 48 hrs 
fermentation. Data plots represent the mean + standard error of the mean (n = 3). 
Statistical significance was determined using a one-way ANOVA with a Tukey’s 
post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 
0.005 when compared to cellulose at each time point. 
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Figure 5-16. BCFA concentrations (µM) of fermentation vessels treated with either 
1% (w/v) cellulose, P. palmata whole seaweed (PPWS), P. palmata polysaccharide 
extract (PPE), or Synergy 1. Samples were taken at 0, 5, 10, 24, 36, and 48 hrs 
fermentation. Data plots represent the mean + standard error of the mean. 
Statistical significance was determined using a one-way ANOVA with a Tukey’s 
post-hoc test to adjust for multiple comparisons. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 
0.005 when compared to cellulose at each time point. 
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 Tables 
Table 5-1. Mineral and trace element contents of the Palmaria palmata whole seaweed (PPWS) (n = 1) and Palmaria palmata polysaccharide rich 
extract (PPE) (n = 1) batch culture fermentation substrates. ppm – parts per million; RNI - Reference Nutrient Intake. 
Palmaria palmata Whole Seaweed Polysaccharide Rich Extract 
Mineral / Trace 
Element 
Concentration 
(ppm) 
Equivalent in 
mg/g 
Amount (mg) in 
5g 
Amount (mg) in 
10g 
% RNI (mg/day) 
Concentration 
(ppm) 
Equivalent in 
mg/g 
Amount (mg) in 
5g 
Amount (mg) in 
10g 
% RNI (mg/day) 
Aluminium 151 0.151 0.755 1.51 Not applicable 35.4 0.0354 0.177 0.354 Not determined 
Chloride 73435 73.44 367.18 734.4 29.374 6830 6.83 34.15 68.3 2.73 
Copper 5.25 0.00525 0.0263 0.0525 4.375 10.1 0.0101 0.0505 0.101 8.42 
Mercury 0.029 0.000029 0.000145 0.00029 Not applicable 0.004 0.000004 0.00002 0.00004 Not applicable 
Lead 3.961 0.00396 0.0198 0.0396 Not applicable 1.147 0.00115 0.00574 0.0115 Not applicable 
Arsenic 10.36 0.0104 0.0518 0.104 Not applicable 3.472 0.00347 0.0174 0.0347 Not applicable 
Cadmium 0.344 0.000344 0.00172 0.00344 Not applicable 0.184 0.000184 0.00092 0.00184 Not applicable 
Iodine 519.2 0.519 2.60 5.19 3461.33 150 0.15 0.75 1.5 1000 
Sodium 13200 13.2 66 132 8.25 3132 3.132 15.66 31.32 1.96 
Zinc 48.2 0.0482 0.241 0.482 5.074 13.3 0.0133 0.0665 0.133 1.4 
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Table 5-2. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) P. palmata whole seaweed (PPWS) when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
  Cellulose PPWS Effect P-Value 
Mean (%) SD Mean (%) SD 
  Phylum 
24 h Verrucomicrobia 11.735 0.47 9.112 0.441 ↓ 0.002 
  Family 
10 h Erysipelotrichaceae 3.845 0.222 3.152 0.269 ↓ 0.038 
24 h Clostridiaceae 1 4.15 0.738 1.4 1.215 ↓ 0.032 
Christensenellaceae 1.812 0.144 < 0.001 < 0.001 ↓ 0.017 
Bifidobacteriaceae 2.708 0.154 4.031 0.27 ↑ 0.001 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 5-2 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) P. palmata whole seaweed (PPWS) when compared to 1% (w/v) cellulose, after 10- and 24-hrs 
fermentation. Statistical significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a 
significance level of p ≤ 0.05. 
  Cellulose PPWS Effect P-Value 
Mean (%) SD Mean (%) SD 
  Genus 
10 h Tyzzerella 3 0.435 0.186 < 0.001 < 0.001 ↓ 0.006 
Lachnospiraceae FCS020 group 0.862 0.091 0.608 0.108 ↓ 0.03 
Faecalibacterium 1.519 0.06 1.211 0.127 ↓ 0.021 
Erysipelotrichacea UCG003 0.996 0.059 0.655 0.099 ↓ 0.003 
Christensenellaceae R7 group 1.03 0.082 0.81 0.081 ↓ 0.028 
Alloprevotella < 0.001 < 0.001 0.458 0.066 ↑ 0.005 
24 h Ruminococcaceae UCG002 1.146 0.131 < 0.001 < 0.001 ↓ 0.006 
Pseudobutyrivibrio 1.046 0.14 1.688 0.235 ↑ 0.021 
Clostridium sensu stricto 1 1.823 0.308 0.687 0.61 ↓ 0.048 
Christensenellaceae R7 group 0.846 0.0648 < 0.001 < 0.001 ↓ 0.012 
Butyricimonas 0.881 0.0125 1.448 0.212 ↑ 0.021 
Bifidobacterium 1.221 0.0819 1.955 0.184 ↑ 0.002 
Bacteroides 2.629 0.061 3.365 0.286 ↑ 0.007 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 5-3. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) P. palmata polysaccharide extract (PPE) when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose PPE Effect P-Value 
Mean (%) SD Mean (%) SD  
Phylum 
24 h Actinobacteria 10.280 0.172 13.791 0.302 ↑ 0.001  
Family 
24 h Enterococcaceae 4.221 0.166 5.294 0.539 ↑ 0.017 
Bifidobacteriaceae 2.708 0.154 4.467 0.252 ↑ 0.000153  
Genus 
10 h Coprococcus 2 0.387 0.186 1.182 0.161 ↑ 0.005 
24 h 
Ruminococcaceae 
UCG002 
1.146 0.131 0.310 0.536 ↓ 0.032 
Prevotella 2 < 0.001 < 0.001 0.794 0.198 ↑ 0.035 
Barnesiella 0.950 0.070 < 0.001 < 0.001 ↓ 0.021 
Bifidobacterium 1.221 0.082 2.056 0.221 ↑ 0.001 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 5-4. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) Synergy 1 when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical significance was determined 
using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of p ≤ 0.05. 
 
 Cellulose Synergy 1 Effect P-Value 
 Mean (%) SD Mean (%) SD  
 Phylum 
10 h Firmicutes  22.409 0.942 25.557 1.563 ↑ 0.036 
24 h Verrucomicrobia  11.735 0.470 7.901 0.895 ↓ < 0.0001 
Unclassified  10.352 0.203 5.349 1.781 ↓ 0.003 
Firmicutes  23.346 1.110 25.823 0.820 ↑ 0.045 
Actinobacteria  10.280 0.172 18.256 1.066 ↑ < 0.0001  
 Family 
10 h Enterococcaceae  4.710 0.319 6.533 0.542 ↑ 0.002 
24 h Verrucomicrobiaceae  3.355 0.057 2.804 0.288 ↓ 0.035 
Succinivibrionaceae  3.986 0.223 2.936 0.177 ↓ 0.015 
Streptococcaceae  2.075 0.317 5.019 0.231 ↑ 0.007 
Erysipelotrichaceae  3.529 0.259 5.408 0.623 ↑ 0.009 
Enterococcaceae  4.221 0.166 5.544 0.280 ↑ 0.005 
Bifidobacteriaceae  2.708 0.154 5.510 0.330 ↑ < 0.0001 
 ↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 5-4 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) Synergy 1 when compared to 1% (w/v) cellulose, after 10- and 24-hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p ≤ 0.05. 
 
Cellulose Synergy 1 Effect P-Value 
Mean (%) SD Mean (%) SD  
Genus 
10 h Tyzzerella 3 0.435 0.186 0.000 0.000 ↓ 0.006 
Ruminiclostridium 5 0.800 0.109 0.135 0.233 ↓ 0.003 
Enterococcus 1.917 0.051 2.873 0.140 ↑ < 0.0001 
Christensenellaceae R7 group 1.030 0.082 0.820 0.018 ↓ 0.035 
24 h Streptococcus 0.957 0.112 2.186 0.107 ↑ 0.020 
Ruminococcus 2 1.007 0.153 0.578 0.254 ↓ 0.041 
Lachnoclostridium 2.364 0.113 1.800 0.112 ↓ 0.001 
Bifidobacterium 1.221 0.082 2.362 0.055 ↑ < 0.0001 
Anaerostipes 0.906 0.081 1.722 0.291 ↑ 0.032 
Acidaminococcus 2.784 0.117 2.031 0.148 ↓ 0.040 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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6 Effects of seaweed polysaccharides on the composition and 
metabolic activity of the human gut microbiota using an in vitro 
model of the distal colon 
 Abstract 
Seaweed has been proposed as a source of potential prebiotic fibres, however, 
limited studies have evaluated the prebiotic potential of individual seaweed 
derived polysaccharides. This study used an in vitro model of distal colonic 
fermentation to investigate the prebiotic potential of  commercially available 
alginate, fucoidan, laminarin, ulvan, and xylan complex polysaccharides, isolated 
from seaweeds, by measuring changes in the composition (16S rRNA amplicon 
sequencing and qPCR analysis) and metabolic activity (short chain fatty acids) of 
the human gut microbiota. Prebiotic potential was compared to cellulose as a 
negative control. qPCR analysis showed that treatment with laminarin and xylan 
substrates resulted in significantly higher numbers of total bacteria and 
Bifidobacterium spp., respectively. 16S rRNA amplicon sequencing data showed 
significantly higher relative abundance of the Bifidobacterium genus for xylan, 
Bacteroides for alginate, and Lachnospiraceae for laminarin, when compared to 
cellulose. No significant changes in bacterial genera were noted for fucoidan and 
ulvan substrates. Xylan fermentation resulted in significantly higher concentrations 
of acetic, propionic, valeric and total short chain fatty acids, whilst laminarin and 
ulvan fermentation resulted in significantly higher concentrations of propionic acid 
and acetic acid, respectively. One of the two alginate substrates resulted in 
significantly higher concentrations of butyric acid. Fucoidan showed limited 
fermentability and showed no significant changes in bacterial composition. In 
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summary, most seaweed polysaccharides are fermentable, with xylan and 
laminarin showing the most promise as prebiotic polysaccharides derived from 
seaweed.  
 Introduction 
Seaweed consumption has been associated with a reduce risk of chronic diseases 
including cancer, hyperlipidaemia, and coronary heart disease (Brown et al., 2014), 
which has led to increasing interest in seaweed as a source of functional food 
ingredients. Seaweeds are a source of bioactive compounds, including polyphenols 
such as phlorotannins, polyunsaturated fatty acids, vitamins and minerals 
(MacArtain et al., 2007). There is also considerable interest in the potential impact 
of the fibre components of red, brown and green seaweeds on health. Dietary fibre 
can make up to 75% of seaweed dry weight and contains a diverse range of 
complex polysaccharides which are generally not present in terrestrial plants. The 
fibres include alginate, fucoidan, and laminarin in brown seaweeds; ulvan in green 
seaweeds; and xylan in red seaweeds (O’Sullivan et al., 2010). 
Interest in the biological activity of seaweed-derived complex polysaccharides is 
predominantly focused on its potential prebiotic effects through the selective 
stimulation of microbes deemed to be beneficial to health such Bifidobacterium, 
Lactobacillus, and other species that contribute to the production of health-
associated short chain fatty acids (SCFA) (Brown et al., 2014). Accumulating 
evidence from in vitro fermentation studies indicates that whole seaweeds and 
polysaccharide extracts may favourably modulate gut microbial composition and 
increase the production of SCFA (Bajury et al., 2017; Chen et al., 2018; Di et al., 
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2018; Fu et al., 2018; Kong et al., 2016; Rodrigues et al., 2016). The evidence, 
however, from in vivo animal models is inconclusive of a prebiotic effect 
(Bhattacharya et al., 2015; Charoensiddhi et al., 2017; Huebbe et al., 2017; Ren et 
al., 2017) and the limited number of studies which have assessed the fermentation 
of purified seaweed complex carbohydrates such as alginate, laminarin, fucoidan, 
and agar, present mixed results (An et al., 2013; Bai et al., 2017; Belanche et al., 
2016; Devillé et al., 2007; Nakata et al., 2016; Ramnani et al., 2012; Seong et al., 
2019; Shang et al., 2016). Given the structural diversity of polysaccharides present 
in seaweed there is a need to characterise the impact of each of these substrates 
on the composition and metabolism of the microbiota to determine their suitability 
as prebiotic candidates (O’Sullivan et al., 2010). Therefore, the aim of this study 
was to investigate the effects of alginate, fucoidan, laminarin, xylan and ulvan 
seaweed polysaccharides on the composition and metabolic activity of the ex vivo 
human gut microbiota, using an in vitro fermentation model of the distal colon, 
following a simulated in vitro digestion. 
 Materials and methods  
 Chemicals and reagents 
Chemicals were purchased from Sigma Aldrich (St. Louis, USA) unless otherwise 
stated. Reagents used during High Performance Size Exclusion Chromatography 
(HPSEC) and Gas Chromatography Mass Spectrometry (GC-MS) were HPLC grade. 
Reagents used for DNA extraction, quantitative PCR (qPCR), and 16S rRNA next 
generation sequencing were molecular biology grade. 
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 Seaweed polysaccharides 
Fucoidan from Fucus vesiculosus (F5631) and Laminarin from Laminaria digitata 
(L9634) were purchased from Sigma Aldrich (USA). Alginate from Fucus vesiculosus 
(ALG101), Alginate from Laminaria japonica (ALG100), Fucoidan from Ascophyllum 
nodosum (FUC400), Ulvan from Ulva spp. (ULV100), and Xylan from Palmaria 
palmata (XYL100) were purchased from Elicityl (France). These substrates were 
stored sealed at room temperature until required for in vitro digestion and in vitro 
fermentation experiments.   
 Polysaccharide molecular weight  
The average molecular weight of PPE was determined using a modified high 
performance size exclusion chromatography method from Gómez-Ordónez et al. 
(Gomez-Ordonez et al., 2012). In brief, separation was performed on a PL aquagel-
oh mixed-H 8μm SEC analytical column (7.5 x 300 mm i.d) with isocratic elution at 
50°C and a flow rate of 0.6 mL/min and a run time of 31 mins, using a 50mM 
ammonium formate mobile phase and a ten-point pullulan standard curve (0.34 to 
708 kDa).  
 Polysaccharide in vitro digestion 
An in vitro simulated digestion was completed on each seaweed polysaccharide 
following the method of Minekus et al. (Minekus et al., 2014), with oral, gastric, 
and intestinal phases of digestion. All simulated fluids were incubated at 37°C 
before use and all digestion stages were incubated at 37°C in an orbital shaker (160 
rpm). The oral suspension was incubated for 2 mins, while both the gastric and 
intestinal suspensions were incubated for 2 hrs. The intestinal phase digesta was 
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dialysed for 24 hrs using 1kDa dialysis tubing to mimic intestinal absorption 
(Spectrum Labs, USA) and the retentate was freeze dried (Labconco, USA) to obtain 
powders before batch culture fermentation. 
 Batch culture fermentation - preparation of human faecal inoculum and 
basal media 
A 20% faecal slurry was prepared following the methods of O’Donnell et al. 
(O’Donnell et al., 2016). The resulting faecal bacteria suspension was amended 
with sterile glycerol to a final concentration of 25% (v/v) and stored frozen at -80°C 
until use. Nutrient basal medium stock solution was prepared using methodology 
of Fooks and Gibson (Fooks and Gibson, 2003).  
 Batch culture fermentation 
Digested, freeze-dried, seaweed polysaccharide powders underwent in vitro batch 
culture faecal fermentation for 24 hrs using the MicroMatrix bioreactor (Applikon 
Biotechnology, The Netherlands) (O’Donnell et al., 2018). Synergy 1 (Beneo, 
Germany) was used as a positive control (n=8) and cellulose was used as a negative 
control (n = 8). Seaweed polysaccharides were fermented in quadruplicate. Vessels 
were inoculated with 5 % (v/v) faecal slurry and the designated carbon source was 
added at 1 % (w/v). The MicroMatrix bioreactor was operated using MicroMatrix 
Human Machine Interface software (Applikon Biotechnology, Delft, The 
Netherlands), which controlled orbiter speed (250 rpm), pH 6.8 (liquid addition of 
4M NaOH), temperature (37°C), and dissolved oxygen (individually controlled gas 
addition of N2 and CO2). Samples were obtained at t = 0 and 24 hrs and 
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immediately centrifuged at 21,382 RCF to provide a pellet for DNA extraction and a 
supernatant for SCFA analysis. All samples were stored at -80°C until analysis. 
 DNA extraction 
Genomic DNA was extracted from samples after 0 hrs and 24 hrs fermentation 
using the PowerFecal DNA extraction kit (Mo Bio Laboratories, Carlsbad, USA) 
according to manufactures’ instructions. The bead beating step was completed 
using the Mo Bio vortex adapter. 
 qPCR  
Total bacteria, Lactobacillus spp., and Bifidobacterium spp. were quantified using 
qPCR. Primer sequences used for qPCR (Target: Forward primer 5'-3'; Reverse 
primer 5'-3'; Size bp; Tm °C): Total Bacteria (Eubacterial): 
ACTCCTACGGGAGGCAGCAG; ATTACCGCGGCTGCTGG; 200 bp; 60°C. Lactobacillus 
genus: GCAGCAGTAGGGAATCTTCCA; GCATTYCACCGCTACACATG; 349 bp; 60°C. 
Bifidobacterium genus: CTCCTGGAAACGGGTGGT; GCTGCCTCCCGTAGGAGT; 203 
bp; 60°C. A standard curve of 109-103 CFU/ml was prepared in duplicate for each 
plate. A PCR master mix was prepared with the forward and reverse primers, 
SYBR® FAST pPCR Master Mix (KAPA Biosystems, USA), and PCR water. 1 µl of 
sample DNA or PCR water (negative control) was added to 9 µl master mix per well 
(reaction volume = 10 µl) and ran in duplicate on two plates (n = 4). The 
Lightcycler® 480 Instrument II (Roche, Switzerland) was used with the following 
PCR conditions: denaturation = 1 cycle; amplification = 40 cycles; melting = 1 cycle; 
cooling = 1 cycle. Target temperature was 95°C with a hold time of 3 min and a 
ramp rate of 4.4°C/sec.   
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 16S rRNA amplification and MiSeq sequencing  
Illumina MiSeq sequencing library preparation was completed following the 16S 
metagenomic sequencing library protocol (Illumina, USA) and as described by 
Fouhy et al. (Fouhy et al., 2015). Amplicon PCR: Genomic DNA was amplified using 
primers specific to the V3-V4 hypervariable region of the 16S ribosomal RNA gene 
to create a 460bp amplicon. These primers also incorporated the Illumina overhang 
adaptor (Forward primer 5’  
 TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG; 
reverse primer 5’  
 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC). 
Each PCR reaction contained 2.5 μL template DNA, 5 µL forward primer (1 µM), 5 
µL reverse primer (1 µM), 12.5 µL 2X Kapa HiFi Hotstart ready mix (KAPA 
Biosystems, USA) giving a total of 25µL in the final reaction volume. PCR 
amplification was carried out using the Applied Biosystems 2720 thermal cycler 
(Life Technologies, USA) with the following parameters: heated lid 110°, 95°C for 3 
mins; then 25 cycles of: 95°C for 30 secs, 55°C for 30 secs, 72°C for 30 secs; hold at 
72°C for 5 mins; hold at 4°C. Successful PCR products were cleaned using 
Agentcourt AMPure XP kit (Beckman Coulter Genomics, UK). A second PCR reaction 
was completed to attach the Illumina sequencing adapters onto the amplicons 
using the Nextera XT Index kit (Illumina, USA). The DNA concentration of each 
sample was determined using the Qubit High Sensitivity DNA kit and the Qubit 3 
Fluorometer (Invitrogen, USA). DNA samples were then pooled as an equimolar 
mix and sequenced on the MiSeq sequencing platform at Teagasc, Moorepark, 
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Ireland following standard Illumina sequencing protocols for the 2 × 250 cycle V3 
Kit. 
 Bioinformatics  
Two hundred and fifty base pair paired-end reads were assembled using FLASH 
(FLASH: fast length adjustment of short reads to improve genome assemblies). 
Further processing of paired-end reads including quality filtering based on a quality 
score of > 25 and removal of mismatched barcodes and sequences below length 
thresholds was completed using QIIME (Caporaso et al., 2010). Denoising, chimera 
detection and clustering into operational taxonomic units (OTUs) (97% identity) 
were performed using USEARCH v7 (64-bit) (Edgar, 2010). OTUs were aligned using 
PyNAST (PyNAST: python nearest alignment space termination; a flexible tool for 
aligning sequences to a template alignment) and taxonomy was assigned using 
BLAST against the SILVA SSURef database release v123. 
 Short chain fatty acid and branched chain fatty acid analysis 
GC-MS analysis was carried out using a modified protocol described by Garcia-
Villalba et al. (Garcia-Villalba et al., 2012). In brief, phosphoric acid was added to 
samples to a final concentration of 0.5 % (v/v) prior to ethyl acetate extraction (1:1 
v/v). 180µl organic phase was added to a GC vial alongside 20 µl of 4-methyl 
valerate internal standard. A standard curve of 10, 20, 50, 100, 500, 1000, 5000, 
10000, 50000, and 100,000 µM SCFA mix containing acetic acid, propionic acid, n-
butyric acid, i-butyric acid, valeric acid, i-valeric acid, and hexanoic acid was ran 
within every sample batch. Quality control consisted of two 50 µM and two 100 
µM standard mixes every sixteen vials and ethyl acetate blanks every six vials, and 
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between each standard vial/QC to prevent carryover. The GC-MS system consisted 
of an Agilent 6890N (Agilent Technologies, USA), equipped with an Agilent 7683 
AutoSampler and 7683B injector, coupled to an Agilent 5973 inert mass selective 
detector. Agilent MassHunter GC/MS Acquisition software was used. The GC was 
fitted with a DB-WAXetr capillary column (30m length, 0.25mm i.d, 0.25µm film 
thickness), with helium used as the carrier gas (1.2mL/min). Injections were made 
in splitless mode with an injection volume of 1µL (10 µL syringe) and an injection 
temperature of 250°C. The syringe undertook four pre-washes and four post-
washes in hexane. The initial column temperature was 90°C, and ramped to 150°C 
at 15°C/min, then to 170°C at 5°C/min, then to 230°C at 20°C/min, where it was 
maintained for 2 mins. Total run time was 14 mins. Solvent delay was 2.5 mins. The 
detector was operated in electron impact ionisation mode.  
 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics (version 24) and 
GraphPad Prism 8 software. Graphs were made in GraphPad Prism 8 software. To 
determine significant effects of each treatment on bacterial enumeration (qPCR) 
and SCFA concentration (GC-MS), statistical significance was determined using a 
non-parametric Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false 
discovery rate (FDR) correction for multiple comparisons (q value) with a 
significance level of ≤ 0.05. 
Statistical analysis of 16S rRNA sequencing data was carried out using Calypso 
online software (version 8.68) (Zakrzewski et al., 2017). Data were normalized 
using cumulative sum scaling and log2 transformed to account for the non-normal 
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distribution of sequencing data (Paulson et al., 2013). Up to 20,000 taxa with > 
0.01% abundance were used in the analysis. Chloroplasts and cyanobacteria were 
removed from the analysis.  
Alpha diversity (non-normalised operational taxonomic unit data) was determined 
using rarefied Chao1, Evenness, Shannon and Simpson indices. Statistical 
significance was determined using a non-parametric Kruskal-Wallis test (p value) 
with a Benjamini and Hochberg false discovery rate (FDR) correction for multiple 
comparisons (q value) with a significance level of ≤ 0.05. A Permutational 
multivariate analysis of variance (PerMANOVA) was used to determine statistical 
differences in Bray-Curtis dissimilarity distance matrices of beta diversity. 
Statistical significance of mean bacterial relative abundances, compared to 
cellulose, at the phylum, family, and genus level after 0, 10, and 24 hrs 
fermentation was determined using a one-way ANOVA with a Tukey’s post-hoc test 
for multiple comparisons and a significance level of p ≤ 0.05. A feature selection 
analysis (linear discriminant analysis effect size - LEfSe)  was used to highlight 
discriminate taxa between fermentation substrates and cellulose at 0 and 24 hrs 
(Segata et al., 2011). 
 Results 
 Seaweed polysaccharide molecular weight 
The average molecular weight of the seaweed polysaccharides used in this study is 
presented in Table 6-1. Both sources of alginate had a similar molecular weight, 
however, the molecular weight of the two fucoidan substrates differed almost 10-
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fold. It was also observed that Alginate-Fv had a minor peak of 7.2 kDa; Ulvan had 
minor peaks at 195 kDa and 4.5 kDa; and Xylan-Pp had a molecular weight 
distribution of 21 - 650 kDa.  
 qPCR 
Total bacteria was significantly higher in vessels fermented in the presence of 
Fucoidan An (p = 0.0169, q = 0.0438), Laminarin Ld (p = 0.0008, q = 0.0031), Xylan 
Pp (p = 0.0219, q = 0.0438), and Synergy 1 (p = 0.0001, q = 0.0012) when compared 
to cellulose after 24 hrs (Figure 6-1). 
There was no statistical difference in the number of Lactobacillus spp. in vessels 
fermented with any seaweed polysaccharide substrate when compared to cellulose 
after 24 hrs fermentation, although fermentation in the presence of Synergy 1 
resulted in significantly higher Lactobacillus populations when compared to 
cellulose (p = 0.0045, q = 0.0359) (Figure 6-2). The number of Bifidobacterium spp. 
were significantly higher following fermentation in the presence of Xylan-Pp (p = 
0.0025, q = 0.0101) and Synergy 1 (p = 0.0006, q = 0.0046) when compared to 
cellulose after 24 hrs (Figure 6-3). There was no statistical difference in the number 
of Bifidobacterium spp. detected in vessels fermented with Xylan-Pp and Synergy 1 
(p > 0.5, q > 0.5). 
 16S rRNA amplicon sequencing: Effect of seaweed polysaccharides on 
the bacterial diversity of the faecal microbiota  
There was no statistical difference in the alpha diversity metrics of Evenness, Chao 
1 richness, Shannon diversity index, and Simpson’s diversity index in vessels 
fermented with any test substrate when compared to cellulose after 24 hrs 
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fermentation (q > 0.5). The Bray-Curtis dissimilarity index of beta diversity was 
significantly different between vessels fermented with Synergy 1 when compared 
to cellulose after 24 hrs (p = 0.012), but not in vessels fermented with seaweed 
polysaccharides (Alginate-Lj, p = 0.265; Alginate-Fv, p = 0.0766; Fucoidan-Fv, p = 
0.0846; Fucoidan-An, p = 0.297; Laminarin-Ld, p = 0.0813; Ulvan, p = 0.486; Xylan-
Pp, p = 0.244). 
 16S rRNA amplicon sequencing: Effect of seaweed polysaccharides on 
the microbial abundance of the faecal microbiota 
The mean relative abundance of bacterial taxa in vessels fermented in the 
presence of cellulose, Alginate-Lj, Alginate-Fv, Fucoidan-Fv, Fucoidan-An, 
Laminarin-Ld, Ulvan, Xylan-Pp, and Synergy 1 are shown at the phylum (Figure 6-4), 
family (Figure 6-5), and genus (Figure 6-6 and Figure 6-7) levels of taxonomy.  
After 24 hrs fermentation in the presence of Alginate-Lj, there was no statistical 
difference in the relative abundance of bacterial taxa at the phylum, family, and 
genus levels when compared to cellulose (p > 0.05); however, fermentation in the 
presence of Alginate-Fv resulted in a significant higher relative abundance of the 
family Bacteroidaceae (p = 0.007) and the genus Bacteroides (p = 0.023) when 
compared to cellulose (Table 6-2) after 24 hrs. There was no statistical difference 
in the relative abundance of Bacteroides in vessels fermented with Alginate-Fv 
when compared to Synergy 1 (p = 0.122). LEfSe analysis indicated that the genera 
Acidaminococcus, Akkermanisa, Alistipes, Bacteroides, Bilophila, 
Christensenellaceae R7 group, Clostridium sensu stricto 1, Clostridium sensu stricto 
13, Dielma, Enterococcus, Erysipelatoclostridium, Haemophilus, Parabacteroides, 
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Peptoclostridium, Phascolarctobacterium, Sutterella, Veillonella, and an uncultured 
bacterium were discriminative bacteria of fermentation in the presence of 
Alginate-Fv when compared to cellulose (Figure 6-8). While Holdemania was a 
discriminative genus of Alginate-Lj fermentation when compared to cellulose 
(Figure 6-9). 
Fermentation in the presence of Fucoidan-Fv and fermentation in the presence of 
Fucoidan-An resulted in no statistically significant differences in the relative 
abundance of bacterial taxa at the phylum, family, and genus levels after 24 hrs 
when compared to cellulose (p > 0.05). LEfSe analysis indicated that genera of the 
Eubacterium coprostanoligenes group, Eubacterium hallii group, Dorea, 
Parasutterella, Pseudobutyrivibrio, Roseburia, and Ruminococcaceae UCG013 were 
discriminative genera of fermentation in the presence of Fucoidan-Fv (Figure 6-10), 
while Anaerotruncus, Barnesiella, and Peptococcus were discriminative genera of 
fermentation in the presence of Fucoidan-An (Figure 6-11).  
Fermentation in the presence of Laminarin-Ld resulted in a significantly higher 
relative abundance of the family Lachnospiraceae (p = 0.001) and the genera 
Erysipelatoclostridium (p = 0.001) and Catenibacterium (p = 0.001) after 24 hrs 
when compared to cellulose (Table 6-3). Fermentation in the presence of 
Laminarin-Ld resulted in a significantly lower relative abundance of the families 
Thermoanaerobacteraceae (p = 0.038), Family XI (p = 0.015), and 
Erysipelotrichaceae (p = 0.041); and the genera Turicibacter (p = 0.028), Howardella 
(p = 0.020), and Gelria (p = 0.019) when compared to cellulose after 24 hrs. LEfSe 
analysis indicated that Alistipes, Catenibacterium, Erysipelotrichaceae UCG003, 
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Erysipelatoclostridium, and Lachnospiraceae UCG004 were discriminative genera of 
fermentation in the presence of Laminarin-Ld (Figure 6-12). 
Fermentation in the presence of Ulvan resulted in a significantly lower relative 
abundance of the families Pasteurellaceae (p = 0.036) and Fusobacteriaceae (p = 
0.036) when compared to cellulose after 24 hrs; however, no statistically 
significant differences were observed at the genus level (Table 6-4). LEfSe analysis 
indicated that Parasutterella and Peptococcus were discriminative genera of 
fermentation in the presence of Ulvan when compared to cellulose (Figure 6-13).  
Fermentation in the presence of Xylan-Pp resulted in a significantly lower relative 
abundance of the genera Gelria (p = 0.042) and Paraprevotella (p = 0.016) when 
compared to cellulose after 24 hrs. While a significant higher abundance of the 
genus Bifidobacterium (p = 0.0002), the family Bifidobacteriaceae (p = 0.00017), 
and the phylum Actinobacteria (p = 0.00173) were observed in vessels fermented 
in the presence of Xylan-Pp when compared to cellulose (Table 6-5). There was no 
statistical difference in the relative abundance of Bifidobacterium in vessels 
fermented in the presence of Xylan-Pp when compared to Synergy 1 after 24 hrs (p 
> 0.5). LEfSe analysis demonstrated that Lachnoclostridium 5, Bifidobacterium, and 
Blautia were discriminative genera of Xylan-Pp fermentation when compared to 
cellulose after 24 hrs (Figure 6-14). 
Fermentation in the presence of Synergy 1 resulted in several significant 
differences in the mean relative abundance of bacterial taxa when compared to 
cellulose after 24 hrs (Table 6-6). This included significantly higher relative 
abundances of the genera Erysipelatoclostridium (p < 0.0001), Ruminococcus 1 (p = 
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0.039), Streptococcus (p = 0.024), Leuconostoc (p = 0.009), Catenibacterium (p < 
0.0001), and Bifidobacterium (p < 0.0001), alongside a significantly lower relative 
abundances of Paraprevotella (p = 0.001), Howardella (p = 0.031), and 
Desulfovibrio (p = 0.025). LEfSe analysis showed that Bacteroides, Bifidobacterium, 
Blautia, Catenibacterium, Clostridium sensu stricto 1, Collinsella, 
Erysipelatoclostridium, Lachnospiraceae UCG004, Leuconostoc, Streptococcus, 
Roseburia, Ruminococcus 1, and an uncultured bacterium were discriminative 
genera of fermentation in the presence of Synergy 1 when compared to cellulose 
(Figure 6-15). 
 Effect of seaweed polysaccharides on short chain fatty acid production  
There was no statistical difference between the concentrations of acetic, propionic, 
butyric, valeric, hexanoic, and total SCFA for any fermentation substrate when 
compared to cellulose at 0 hrs (Figure 6-16). After 24 hrs fermentation, the 
concentration of acetic acid was significantly higher in vessels fermented with 
Ulvan (p = 0.001) and Xylan-Pp (p = < 0.0001) when compared to cellulose (Figure 
6-16). These data were not statistically different to Synergy 1 (p > 0.5), which 
demonstrated a trend towards higher concentrations of acetic acid when 
compared to cellulose (p = 0.054). Propionic acid concentration was significantly 
higher in vessels fermented in the presence of Xylan-Pp (p < 0.0001) and 
Laminarin-Ld (p = 0.017) when compared to cellulose after 24 hrs (Figure 6-16). 
There was no statistical difference between propionic acid concentrations in 
vessels fermented with Xylan-Pp and Laminarin-Ld when compared to Synergy 1 (p 
> 0.5) (Figure 6-16). Fermentation in the presence of Synergy 1 also resulted in 
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significantly higher concentrations of propionic acid when compared to cellulose 
after 24 hrs (p < 0.001) (Figure 6-16). The concentration of butyric acid was also 
significantly higher in vessels fermented in the presence of Alginate-Fv (p = 0.034) 
and Synergy 1 (p < 0.001) when compared to cellulose after 24 hrs (Figure 6-16). 
There was no statistical difference between the butyric acid concentrations in 
vessels fermented in the presence of Alginate-Fv when compared to Synergy 1 (p > 
0.5) after 24 hrs. The concentration of valeric acid was significantly higher in 
vessels fermented in the presence of Xylan-Pp when compared to cellulose after 24 
hrs (p = 0.003) (Figure 6-16). This was not statistically different to Synergy 1 (p > 
0.5). The concentration of hexanoic acid was significantly lower in vessels 
fermented in the presence of Fucoidan-Fv when compared to cellulose after 24 hrs 
(p < 0.001), but not statistically different to Synergy 1 (p > 0.5) (Figure 6-16). Total 
SCFA concentrations were significantly higher in vessels fermented in the presence 
of Xlyan-Pp (p < 0.001) and Synergy 1 (p < 0.001) when compared to cellulose 
(Figure 6-16). Total SCFA concentration was not statistically different between 
vessels fermented with Xylan-Pp compared to Synergy 1 (p > 0.5).   
 Effect of seaweed polysaccharides on branched chain fatty acid 
production  
There was no statistical difference between the concentration of isobutyric, 
isovaleric, and total branched chain fatty acids (BCFA) in vessels fermented in the 
presence of any test substrate when compared to cellulose at 0 hrs (Figure 6-17). 
After 24 hrs fermentation, isobutyric acid concentrations were significantly higher 
in vessels fermented in the presence of Alginate-Fv (p = 0.001), Alginate-Lj (p = 
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0.005), and Xylan-Pp (p = 0.043) when compared to cellulose, but not when 
compared to Synergy 1 (p > 0.5) (Figure 6-17). Isovaleric acid concentrations were 
significantly higher in vessels fermented in the presence of Alginate-Lj (p = 0.008) 
and Fucoidan-An (p = 0.009) when compared to cellulose (Figure 6-17); while these 
data were not statistically different to Synergy 1 (p > 0.1). Total BCFA were 
significantly higher in vessels fermented in the presence of Alginate-Fv (p = 0.001) 
and Alginate-Lj (p = 0.003) when compared to cellulose after 24 hrs, but not when 
compared to Synergy 1 (p = 0.063 and p = 0.145, respectively) (Figure 6-17).  
 Discussion 
The data obtained in this study indicate that xylan, laminarin, and alginate seaweed 
polysaccharides were fermented by gut microbial populations owing to 
substantively higher concentrations of SCFA when compared to cellulose. 16S rRNA 
amplicon sequencing data showed a statistically significant higher relative 
abundance of Bifidobacterium for xylan, Bacteroides for alginate, and 
Lachnospiraceae for laminarin, when compared to cellulose. No significant changes 
in bacterial genera were noted for fucoidan and ulvan substrates there was no 
statistical difference in alpha and beta indices of phylogenetic diversity when 
compared to cellulose.  
6.5.1.1 Brown seaweed polysaccharides – Fucoidan, Alginate & Laminarin 
Fucoidan treatment had no statistical impact on total bacteria or the traditional 
prebiotic markers of Lactobacillus spp. or Bifidobacterium spp. (qPCR), or in 
bacterial mean relative abundance (16S rRNA sequencing). This contrasts with 
previous in vitro studies which reported that Laminaria japonica derived fucoidan 
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increased Lactobacillus and Bifidobacterium (Kong et al., 2016), whilst Ascophyllum 
nodosum derived fucoidan resulted in elevated Bacteroides, 
Phascolarctobacterium, Oscillospira, and Faecalibacterium (Chen et al., 2018). 
Evidence from animal studies has shown an impact of fucoidan on the caecal 
microbiota as noted by increased caecal Lactobacillus in healthy mice (Shang et al., 
2016); and increased caecal populations of Akkermansia, Alloprevotella, Blautia, 
and Bacteroides in mice with metabolic syndrome (Shang et al., 2017). Whilst the 
current study did not see any significant changes associated with fucoidan 
treatment in relation to phylum, family or genus, the discriminatory analysis 
identified fucoidan treatment to be associated with genera that express α-
fucosidases including Barnesiella spp. (Fucoidan-An), Roseburia (Fucoidan-Fv), and 
Ruminococcaceae UCG013. The current study showed that fucoidan from two 
different seaweed species had no significant impact on SCFA production (aside of 
minor changes to hexanoic acid) indicating limited fermentability of fucoidan, 
which has also been previously reported in rats (An et al., 2013). The lack of any 
significant changes in microbiota composition alongside no differences in SCFA 
concentration when compared to cellulose would collectively indicate a lack of 
fucoidan utilization by the microbiota. Nevertheless, this could potentially be 
explained by the limitations of establishing a representative microbiota in an in 
vitro experimental setup and should be investigated further in in vivo experiments.  
Neither of the two alginate substrates (from Alginate-Fv - 124kDa; Alginate-Lj - 
177kDa) exerted a bifidogenic effect. This is in agreement with one previous in 
vitro fermentation study with an alginate of 212kDa (Ramnani et al., 2012). 
Alginate consumption, however, has been shown to exert bifidogenic effects in 
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mice (3.5 kDa) (Wang et al., 2006) and in humans (30kDa) (Terada et al., 1995). The 
noted disparities may be explained by the differences in structural composition of 
alginate sources in relation to the ratio of 1-4-linked α-L-guluronic (G) and β-D-
mannuronic acid (M), which is an important factor to consider in relation to 
alginate utilization and bioactivity (Houghton et al., 2015).  
Alginate-Fv fermentation resulted in a significantly higher relative abundance of 
the genus Bacteroides in comparison to cellulose. This corroborates evidence from 
a previous in vitro faecal fermentation with an alginate substrate (Bai et al., 2017), 
as well as a rodent study which demonstrated increased caecal Bacteroides spp. 
after alginate supplementation (An et al., 2013). Bacteroides are primary degraders 
and have been reported to degrade alginate owing to the expression of alginate 
lyase enzymes (Li et al., 2017; Maruyama et al., 2015; Mathieu et al., 2018, 2016; 
Thomas et al., 2012). It could be postulated that degradation of alginate by 
Bacteroides may have contributed to the stimulation of Phascolarctobacterium 
Parabacteroides and Alistipes genera which were associated with alginate 
treatment in the discriminatory analysis and should be explored further. Bacterial 
mean relative abundance and SCFA concentration in vessels treated with Alginate-
Lj was not statistically different to vessels treated with cellulose. In contrast, 
Alginate-Fv fermentation resulted in a significantly higher concentration of butyric 
acid after 24 hrs indicating that Alginate-Fv was fermented by bacterial 
populations. 
Given the disparities in molecular weight and structure of alginates used between 
the present study and previous studies, there is scope to investigate how the 
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structure and molecular weight of alginate impacts its fermentability. Further, the 
current study indicates that specific alginates may increase concentrations of 
colonic butyrate and increase the relative abundance of genera within the 
CAZyme-rich Bacteroidetes phylum. In terms of health benefits, this may be 
associated with gut microbiota-mediated regulation of glucose and lipid 
metabolism, considering that alginate supplementation is reported to improve 
weight loss and reduce cholesterol and glucose uptake (Chater et al., 2015; Georg 
Jensen et al., 2012b, 2012a; Lange et al., 2015; Paxman et al., 2008).  
Laminarin-Ld did not stimulate populations of Bifidobacterium, Lactobacillus, or 
Bacteroides in comparison to cellulose. The noted higher relative abundance of the 
family Lachnospiraceae following Laminarin-Ld treatment corroborates similar 
observations noted in a previous in vitro fermentation study using a Laminaria 
digitata polysaccharide-rich extract (Strain et al., 2019), as well as an in vivo study 
in rodents fed 2% (w/w) laminarin (An et al., 2013). High fibre diets have been 
associated with higher faecal Lachnospiraceae populations, which has been 
proposed to be attributable to the a myriad of polysaccharide utilisation loci (PUL) 
which express CAZymes that degrade complex plant carbohydrates to produce 
SCFA such as butyrate (Biddle et al., 2013; Bishehsari et al., 2018; Tidjani Alou et 
al., 2016). Future studies should undertake genomic or proteomic approaches to 
determine the presence, expression and activity of β-glucanases or β-glucosidases 
in Lachnospiraceae following laminarin treatment.   
Laminarin-Ld fermentation resulted in a significant reduction in Turicibacter and 
Gelria when compared to cellulose. The impact of such changes is difficult to 
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determine but it must be noted that Turicibacter are pathobionts associated with 
gut inflammation (Goodrich et al., 2016; Rausch et al., 2015), while Gelria are 
methanogens (Mancabelli et al., 2017). Therefore, the capacity of laminarin to 
modulate the gut microbiota to potentially reduce gut inflammation and methane 
production could be beneficial to gastrointestinal health if confirmed in vivo.   
Laminarin-Ld treatment resulted in a significantly higher concentration of propionic 
acid after 24 hrs when compared to cellulose. This is in agreement with previous 
studies and suggests that the beta glucan, Laminarin (1,3- 1,6-linked β-D-glucose), 
is fermentable (An et al., 2013; Devillé et al., 2007; Michel et al., 1996; Seong et al., 
2019). It is understood that propionate can modulate hepatic and peripheral 
metabolism and stimulate anorexigenic signaling via free fatty acid receptor 
activation to regulate appetite and energy homeostasis (Byrne et al., 2015; 
Rowland et al., 2018). Therefore, an in vivo investigation into the effects of dietary 
Laminarin intake may be warranted, considering the evidence that increased 
colonic propionate has been shown to limit weight gain in overweight humans 
(Chambers et al., 2015).  
6.5.1.2 Green seaweed polysaccharide - Ulvan 
Ulvan fermentation did not stimulate Lactobacillus or Bifidobacterium populations 
when compared to cellulose, which is in agreement with a previous in vitro faecal 
fermentation experiment with an Enteromorpha prolifera polysaccharide extract 
(Kong et al., 2016). Data from the present study contrast with another in vitro 
fermentation study which observed an enrichment of Lactobacillus, 
Bifidobacterium, and Bacteroides in ulvan-treated vessels (Seong et al., 2019). 
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While murine studies have demonstrated that a polysaccharides from 
Enteromorpha spp. significantly increased faecal Actinobacteria (Ren et al., 2017) 
and caecal Bifidobacterium, Lactobacillus, and Akkermansia muciniphila (Shang et 
al., 2018).  
Ulvan-treated vessels had a significantly higher concentration of acetic acid when 
compared to cellulose after 24 h. Although this is in agreement with another in 
vitro fermentation study (Seong et al., 2019), it is in contrast with early studies 
which indicated that ulvan was poorly fermented (Andrieux et al., 1998; Bobin-
Dubigeon et al., 1997). One explanation for the lack of corroborating evidence 
regarding the fermentability of ulvan may be owing to its highly heterogenous 
structure (repeating α-L-rhamnose-3-sulfate-1,4-β-D-glucuronic acid, α-L-
rhamnose-3-sulfate-1,4-α-D-iduronic acid, and α-L-Rhamnose-3-sulfate-1,4-β-D-
xylose) (Michel and Czjzek, 2013). Moreover, very few ulvan-specific hydrolytic 
enzymes, such as ulvan lyase, have been identified (Konasani et al., 2018; Kopel et 
al., 2016), while human gut bacteria may need to express a similar enzymatic 
cascade of polysaccharide lyases, sulfatases and glycoside hydrolases, as described 
in the marine bacterium Formosa agariphila (Reisky et al., 2019). It has also been 
suggested that the fermentability of ulvan is related to the degree of sulphation 
and molecular weight (Kong et al., 2016). Given that some 40% of the sulphate 
content of ulvan is dissimulated to sulphide by sulphate reducing bacteria such as 
Desulfovibrio (Durand et al., 1997; Figliuolo et al., 2017), determination of 
potentially deleterious metabolites produced following the consumption of ulvan 
may also be warranted. A greater understanding of how ulvan structure affects its 
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fermentability by gut bacterial populations is needed, given the disparity between 
data from the current study and other in vitro and in vivo studies.  
6.5.1.3 Red seaweed polysaccharide - Xylan 
Xylan-Pp treatment resulted in significantly higher abundance of Bifidobacterium 
spp. when compared to cellulose, based on qPCR and 16S rRNA amplicon 
sequencing data, and this bifidogenic effect was not statistically different to the 
Synergy 1 positive control. Furthermore, LEfSe analysis indicated that 
Bifidobacterium was a discriminative genus of Xylan-Pp fermentation. Given that a 
bifidogenic effect is a seminal characteristic of a potential prebiotic, there is 
scope to examine the impact of xylan from Palmaria palmata on health-related 
endpoints in vivo. This aligns with the bifidogenic effect of xylans and xylo-
oligosaccharides extracted from terrestrial plants which have also been shown to 
improve plasma lipid profile and immune function in healthy adults (Childs et al., 
2014; Finegold et al., 2014; Lecerf et al., 2012; Moniz et al., 2016; Yang et al., 
2015). 
The genera Blautia and Lachnoclostridium 5 were also discriminative genera of 
Xylan-Pp fermentation. Lachnoclostridium-derived butyrate has been implicated in 
the promotion of intestinal immune homeostasis (Martin-Gallausiaux et al., 2018). 
Furthermore, Blautia can ferment dietary complex polysaccharides to produce 
acetate, propionate and butyrate SCFA and are a widely abundant genus of the 
human gut microbiota deemed beneficial to health (Park et al., 2013; Rojo et al., 
2017; Tidjani Alou et al., 2016). A significant increase in Blautia has been previously 
reported in pre-type-two-diabetic individuals following an eight week intervention 
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with 2 g/day xylo-oligosaccharides derived from terrestrial plants (Yang et al., 
2015). Similar to Laminarin-Ld, Xylan-Pp fermentation resulted in a significantly 
lower abundance of  the potentially putrefactive Gelria (Mancabelli et al., 2017) 
however, in vivo evidence is needed to ascertain whether dietary intakes of xylan 
can inhibit the growth of potential gut pathogens. 
Xylan-Pp treatment resulted in a significantly higher concentrations of acetic acid, 
propionic acid, valeric acid, and total SCFA in comparison to cellulose after 24 hrs, 
which aligns with the noted changes in SCFA producing genera and provides a clear 
indication that this substrate was fermentable. These data are in agreement with 
the only previous in vitro fermentation study of xylan extracted from Palmaria 
palmata, which described a rapid fermentation of xylan with the production of 
SCFA after six hrs (Lahaye et al., 1993). This would suggest that a repertoire of 
xylanases and xylosidases with specificity for the 1,3-1,4-β-D-xylose of seaweed-
derived xylans exists within the human gut bacteriome, akin to terrestrial plant-
derived xylans (Caroline Mirande et al., 2010; C. Mirande et al., 2010). An example 
of the latter includes Bifidobacterium spp., which are reported to transcribe 
enzymes which hydrolyse xylose from complex glycans (Turroni et al., 2016). Given 
the enrichment of health-associated bacteria, including Bifidobacterium spp., 
alongside higher concentrations of SCFA by Xylan-Pp when compared to cellulose 
in the present study, xylans and xylo-oligosaccharides obtained from the red 
seaweed Palmaria palmata warrant further evaluation for prebiotic efficacy. 
Future investigations should include in vivo studies to understand what impact 
dietary intake of xylan from Palmaria palmata has on host health, and to compare 
their effect with that of terrestrial plant-derived xylans. 
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The use of a pooled faecal inoculum in this study was intended to provide a 
reproducible inoculant for each fermentation vessel treatment to reduce the 
effect of inter-individual variation in microbiota composition between donors 
(O’Donnell et al., 2016). One limitation of using a batch culture in vitro colonic 
fermentation model compared to the in vivo situation is that certain bacteria are 
enriched or depleted, owing to inexact replication of the in vivo colonic 
environment (Verhoeckx K, 2015). For example, the lack of mucus within the 
fermentation system could impact the growth of mucin degraders such as 
Akkermansia spp.. An alternative screening approach could include dynamic in 
vitro models (Van den Abbeele et al., 2010), but this does not replicate the in vivo 
gut, either.  
Fermentation in the presence of Alginate-Lj, Alginate-Fv, Fucoidan-An, and Xylan 
substrates also resulted in higher BCFA concentrations compared to cellulose. This 
suggests that proteolytic fermentation occurred. Therefore, understanding how 
these substrates impact concentrations of potentially genotoxic compounds in the 
gut, such as ammonia and p-Cresol, is needed when considering future in vivo 
studies (Diether and Willing, 2019). 
 Conclusion 
The data obtained from this study provide evidence that the seaweed-derived 
polysaccharides, namely alginate, laminarin, and xylan are microbiota-accessible 
carbohydrates for bacterial fermentation and can modulate the composition and 
metabolic activity of the human faecal microbiota in vitro. Further investigation is 
required to understand the fermentability of fucoidan and ulvan complex 
399 
 
  
polysaccharides. The most promising prebiotic candidate is xylan obtained from 
Palmaria palmata, owing to its bifidogenic effect and increased production of 
health associated SCFA. Future directions should explore oligosaccharides obtained 
from seaweed polysaccharides, and to explore how the structure of seaweed 
polysaccharides impact saccharolytic fermentation by the gut microbiota. In vivo 
studies are needed to understand the impact of seaweed polysaccharides on gut 
microbiota composition and metabolic activity, and to understand whether such 
modulation can confer a benefit to host health.  
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 Figures  
 
Figure 6-1. qPCR was used to quantify total bacteria from DNA extracted from 
fermentation vessels treated with either 1% (w/v) cellulose, or Synergy 1 
substrates. Samples were taken at 0 and 24 hrs fermentation. Data plots represent 
the mean + standard deviation of the mean. Statistical significance was determined 
using a non-parametric Kruskal-Wallis test (p-value) with a Benjamini and 
Hochberg false discovery rate (FDR) correction for multiple comparisons (q value). 
* q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 0.005, **** q ≤ 0.0001. 
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Figure 6-2. qPCR was used to quantify Lactobacillus spp. from DNA extracted from 
fermentation vessels treated with either 1% (w/v) cellulose, or Synergy 1 
substrates. Samples were taken at 0 and 24 hrs fermentation. Data plots represent 
the mean + standard deviation of the mean. Statistical significance was determined 
using a non-parametric Kruskal-Wallis test (p-value) with a Benjamini and 
Hochberg false discovery rate (FDR) correction for multiple comparisons (q value). 
* q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 0.005, **** q ≤ 0.0001. 
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Figure 6-3. qPCR was used to quantify Bifidobacterium spp. from DNA extracted 
from fermentation vessels treated with either 1% (w/v) cellulose, or Synergy 1 
substrates. Samples were taken at 0 and 24 hrs fermentation. Data plots represent 
the mean + standard deviation of the mean. Statistical significance was determined 
using a non-parametric Kruskal-Wallis test (p-value) with a Benjamini and 
Hochberg false discovery rate (FDR) correction for multiple comparisons (q value). 
* q ≤ 0.05, ** q ≤ 0.01, *** q ≤ 0.005, **** q ≤ 0.0001. 
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Figure 6-4. Mean relative abundances of bacterial phyla in fermentation vessels 
treated with either 1% (w/v) cellulose, Alginate-Fv, Alginate-Lj, Fucoidan-An, 
Fucoidan Fv, Laminarin-Ld, Ulvan, Xylan-Pp or Synergy 1 after 0 and 24 hrs 
fermentation. Bacterial composition was determined using 16S rRNA sequencing 
on the MiSeq platform. 
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Figure 6-5. Mean relative abundances of bacterial families in fermentation vessels 
treated with either 1% (w/v) cellulose, Alginate-Fv, Alginate-Lj, Fucoidan-An, 
Fucoidan Fv, Laminarin-Ld, Ulvan, Xylan-Pp or Synergy 1 after 0 and 24 hrs 
fermentation. Bacterial composition was determined using 16S rRNA sequencing 
on the MiSeq platform. 
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Figure 6-6. Mean relative abundances of the top 30 bacterial genera in 
fermentation vessels treated with either 1% (w/v) cellulose, Alginate-Fv, Alginate-
Lj, Fucoidan-An, Fucoidan Fv, Laminarin-Ld, Ulvan, Xylan-Pp or Synergy 1 after 0 hrs 
fermentation. The percentage relative abundance of genera outside the top 30 
were added together and included as “other”. Bacterial composition was 
determined using 16S rRNA sequencing on the MiSeq platform. 
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Figure 6-7. Mean relative abundances of the top 30 bacterial genera in 
fermentation vessels treated with either 1% (w/v) cellulose, Alginate-Fv, Alginate-
Lj, Fucoidan-An, Fucoidan Fv, Laminarin-Ld, Ulvan, Xylan-Pp or Synergy 1 after 24 
hrs fermentation. The percentage relative abundance of genera outside the top 30 
were added together and included as “other”. Bacterial composition was 
determined using 16S rRNA sequencing on the MiSeq platform. 
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Figure 6-8. Feature selection analysis (linear discriminate analysis effect size - LEfSe 
analysis) was used to determine discriminative bacteria between fermentation 
vessels treated with 1% (w/v) Alginate-Fv compared to 1% (w/v) cellulose at 0 and 
24 hrs fermentation. Bacterial composition was determined using 16S rRNA 
sequencing on the MiSeq platform. 
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Figure 6-9. Feature selection analysis (linear discriminate analysis effect size - LEfSe 
analysis) was used to determine discriminative bacteria between fermentation 
vessels treated with 1% (w/v) Alginate-Lj compared to 1% (w/v) cellulose at 0 and 
24 hrs fermentation. Bacterial composition was determined using 16S rRNA 
sequencing on the MiSeq platform. 
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Figure 6-10. Feature selection analysis (linear discriminate analysis effect size - 
LEfSe analysis) was used to determine discriminative bacteria between 
fermentation vessels treated with 1% (w/v) Fucoidan-An compared to 1% (w/v) 
cellulose at 0 and 24 hrs fermentation. Bacterial composition was determined 
using 16S rRNA sequencing on the MiSeq platform. 
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Figure 6-11. Feature selection analysis (linear discriminate analysis effect size - 
LEfSe analysis) was used to determine discriminative bacteria between 
fermentation vessels treated with 1% (w/v) Fucoidan-Fv compared to 1% (w/v) 
cellulose at 0 and 24 hrs fermentation. Bacterial composition was determined 
using 16S rRNA sequencing on the MiSeq platform. 
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Figure 6-12. Feature selection analysis (linear discriminate analysis effect size - 
LEfSe analysis) was used to determine discriminative bacteria between 
fermentation vessels treated with 1% (w/v) Laminarin-Ld compared to 1% (w/v) 
cellulose at 0 and 24 hrs fermentation. Bacterial composition was determined 
using 16S rRNA sequencing on the MiSeq platform. 
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Figure 6-13. Feature selection analysis (linear discriminate analysis effect size - 
LEfSe analysis) was used to determine discriminative bacteria between 
fermentation vessels treated with 1% (w/v) Ulvan compared to 1% (w/v) cellulose 
at 0 and 24 hrs fermentation. Bacterial composition was determined using 16S 
rRNA sequencing on the MiSeq platform. 
426 
 
  
 
Figure 6-14. Feature selection analysis (linear discriminate analysis effect size - 
LEfSe analysis) was used to determine discriminative bacteria between 
fermentation vessels treated with 1% (w/v) Xylan-Pp compared to 1% (w/v) 
cellulose at 0 and 24 hrs fermentation. Bacterial composition was determined 
using 16S rRNA sequencing on the MiSeq platform. 
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Figure 6-15. Feature selection analysis (linear discriminate analysis effect size - 
LEfSe analysis) was used to determine discriminative bacteria between 
fermentation vessels treated with 1% (w/v) Synergy 1 compared to 1% (w/v) 
cellulose at 0 and 24 hrs fermentation. Bacterial composition was determined 
using 16S rRNA sequencing on the MiSeq platform. 
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Figure 6-16. Short chain fatty acid concentrations (µM) of fermentation vessels 
treated with either 1% (w/v) either 1% (w/v) cellulose, Alginate-Fv, Alginate-Lj, 
Fucoidan-An, Fucoidan Fv, Laminarin-Ld, Ulvan, Xylan-Pp or Synergy 1 after 0 and 
24 hrs fermentation. Data plots represent the mean + standard deviation of the 
mean. Statistical significance was determined using a non-parametric Kruskal-
Wallis test with a Bonferroni correction for multiple comparisons and a significance 
level of 0.05. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 when compared to cellulose at 
each time point. 
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Figure 6-17. Branched chain fatty acid concentrations (µM) of fermentation vessels 
treated with either 1% (w/v) either 1% (w/v) cellulose, Alginate-Fv, Alginate-Lj, 
Fucoidan-An, Fucoidan Fv, Laminarin-Ld, Ulvan, Xylan-Pp or Synergy 1 after 0 and 
24 hrs fermentation. Data plots represent the mean + standard deviation of the 
mean. Statistical significance was determined using a non-parametric Kruskal-
Wallis test with a Bonferroni correction for multiple comparisons and a significance 
level of 0.05. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 when compared to cellulose at 
each time point. 
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 Tables 
Table 6-1. Average molecular weight of the seaweed polysaccharides used as in 
vitro fermentation substrates. Average molecular weight was determined using 
high performance size exclusion chromatography. 
 
Seaweed 
Polysaccharide 
Average Molecular 
Weight (kDa) 
Alginate-Fv 124 
Alginate-Lj 177 
Fucoidan-An 850 
Fucoidan-Fv 80 
Laminarin-Ld 4.5 
Ulvan 950 
Xylan-Pp 168 
431 
 
  
Table 6-2. Statistically significant differences in the mean relative abundances of bacterial Families and Genera between fermentation vessels 
treated with 1% (w/v) alginate from Fucus vesiculosus (Alginate-Fv) compared to 1% (w/v) cellulose after 24 hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p < 0.05. There were no statistical differences at the Phylum level of taxonomy. 
 
Cellulose Alginate-Fv 
Effect P -Value 
Mean (%) SD Mean (%) SD 
Family 
Bacteroidaceae 4.877 0.792 7.658 0.494 ↑ 0.007186 
Genus 
Bacteroides 2.335 0.53766 4.442 0.378 ↑ 0.023 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
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Table 6-3. Statistically significant differences in the mean relative abundances of bacterial Families and Genera between fermentation vessels 
treated with 1% (w/v) laminarin from Laminaria digitata compared to 1% (w/v) cellulose after 24 hrs fermentation. Statistical significance was 
determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of p < 0.05. There 
were no statistical differences at the Phylum level of taxonomy. 
 Cellulose Laminarin-Ld 
Effect P-Value 
Mean (%) SD Mean (%) SD 
Family 
Thermoanaerobacteraceae 1.298 0.643 < 0.001 < 0.001 ↓ 0.03824 
Lachnospiraceae 5.503 0.416 6.932 0.407 ↑ 0.001007 
Family XI 1.832 0.603 < 0.001 < 0.001 ↓ 0.014987 
Erysipelotrichaceae 1.832 0.603 < 0.001 < 0.001 ↓ 0.04118 
Genus 
Turicibacter 0.946 0.302 0.116 0.231 ↓ 0.028 
Howardella 0.678 0.135 < 0.001 <0.001 ↓ 0.020 
Gelria 0.669 0.266 < 0.001 <0.001 ↓ 0.019 
Erysipelatoclostridium 0.530 0.345 1.571 0.407 ↑ 0.001 
Catenibacterium 1.1159 0.389 2.257 0.288 ↑ 0.001 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 6-4. Statistically significant differences in the mean relative abundances of bacterial Families between fermentation vessels treated with 1% 
(w/v) ulvan compared to 1% (w/v) cellulose after 24 hrs fermentation. Statistical significance was determined using a one-way ANOVA with a 
Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of p < 0.05. There were no statistical differences at the Phylum or 
Genus levels of taxonomy.  
 
Cellulose Ulvan 
Effect P-Value 
Mean (%) SD Mean (%) SD 
Family 
Pasteurellaceae 4.151 0.199 3.483 0.217 ↓ 0.035609 
Fusobacteriaceae 3.639 1.045 2.125 0.740 ↓ 0.036499 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 6-5. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation 
vessels treated with 1% (w/v) xylan from Palmaria palmata (Palmaria Pp) compared to 1% (w/v) cellulose after 24 hrs fermentation. Statistical 
significance was determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of 
p < 0.05. 
 
Cellulose Xylan-Pp 
Effect P-Value 
Mean (%) SD Mean (%) SD 
Phylum 
Actinobacteria 10.300 1.530 16.180 3.230 ↑ 0.00173 
Family 
Bifidobacteriaceae 2.797 0.472 5.105 1.044 ↑ 0.00017 
Genus 
Bifidobacterium 1.362 0.11637 2.6858 0.671 ↑ 0.000199 
Gelria 0.669 0.266 < 0.001 < 0.001 ↓ 0.042 
Paraprevotella 0.583 0.222 < 0.001 < 0.001 ↓ 0.016 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 6-6. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between fermentation vessels 
treated with 1% (w/v) Synergy 1 compared to 1% (w/v) cellulose after 24 hrs fermentation. Statistical significance was determined using a one-way 
ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of p < 0.05. 
 
Cellulose Synergy 1 
Effect P-Value 
Mean (%) SD Mean (%) SD 
Phylum 
Actinobacteria 10.300 1.530 14.290 2.040 ↑ 0.008046 
Family 
Verrucomicrobiaceae 2.889 0.227 2.124 0.320 ↓ 0.001864 
Streptococcaceae 3.757 0.267 5.140 0.657 ↑ 0.000112 
Porphyromonadaceae 3.608 0.150 4.954 0.360 ↑ < 0.0001 
Leuconostocaceae 0.813 0.778 3.038 0.552 ↑ 0.000939 
Lachnospiraceae 5.503 0.416 6.385 0.310 ↑ 0.032209 
Family XI 1.832 0.603 0.344 0.445 ↓ 0.023453 
Desulfovibrionaceae 2.713 0.393 1.864 0.181 ↓ 0.004723 
Christensenellaceae 3.131 0.3410 2.052 0.653 ↓ 0.006843 
Bifidobacteriaceae 2.797 0.4720 4.388 0.665 ↑ 0.000883 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Table 6-6 continued. Statistically significant differences in the mean relative abundances of bacterial Phyla, Families and Genera between 
fermentation vessels treated with 1% (w/v) Synergy 1 compared to 1% (w/v) cellulose after 24 hrs fermentation. Statistical significance was 
determined using a one-way ANOVA with a Tukey’s post-hoc test to adjust for multiple comparisons and a significance level of p < 0.05. 
 
Cellulose Synergy 1 
Effect P-Value 
Mean (%) SD Mean (%) SD 
Genus 
Erysipelatoclostridium 0.530 0.345 1.591 0.318 ↑ < 0.0001 
Paraprevotella 0.583 0.222 < 0.001 < 0.001 ↓ 0.001 
Ruminococcus 1 1.314 0.097 2.251 0.528 ↑ 0.039 
Streptococcus 1.818 0.322 2.855 0.846 ↑ 0.024 
Leuconostoc 0.482 0.459 1.778 0.613 ↑ 0.009 
Howardella 0.678 0.135 0.130 0.226 ↓ 0.031 
Desulfovibrio 0.659 0.114 0.086 0.228 ↓ 0.025 
Catenibacterium 1.115 0.3888 2.284 0.300 ↑ < 0.0001 
Bifidobacterium 1.362 0.116 2.442 0.568 ↑ < 0.0001 
↑ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly higher in seaweed treated vessels when compared to cellulose 
↓ The mean relative abundance of a given Phylum, Family, or Genus was statistically significantly lower in seaweed treated vessels when compared to cellulose 
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Chapter 7 
General Discussion  
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7 General Discussion 
The aims of this thesis were to evaluate the fermentability of seaweeds and their 
extracted polysaccharides, using in vitro batch culture fermentation models, and to 
assess whether this fermentation could modulate gut microbiota composition and 
metabolic activity, conducive to a prebiotic effect. Batch culture fermentation 
substrates included whole seaweeds (a food matrix), polysaccharide-rich extracts 
(a mixture of dietary fibre components), and purified seaweed polysaccharides 
(individual dietary fibre components).  
Whole seaweed powders of the red seaweed Palmaria palmata and the brown 
seaweeds Fucus vesiculosus and Laminaria digitata were chosen because this is the 
form of the seaweed most typically consumed in food products. However, owing to 
potentially high levels of trace elements such as iodine and arsenic in whole 
seaweeds, crude polysaccharide-rich extracts were generated from the whole 
seaweed powders using a low-cost chemical extraction method. Commercially 
available and purified forms of alginate, fucoidan, and laminarin (brown seaweed 
polysaccharides), ulvan (green seaweed polysaccharide) and xylan (red seaweed 
polysaccharide) were chosen to understand the effect of individual seaweed 
polysaccharides on gut microbiota composition and metabolic activity, rather than 
a crude mixture. Moreover, it was envisaged that data obtained in Chapter 6 could 
provide scope for future investigations akin to terrestrial plant derived complex 
polysaccharides (e.g. inulin) and oligosaccharides (e.g. fructooligosaccharides, 
galctooligosaccharides, and xylooligosaccharides), given that methods to extract 
and purify individual polysaccharides from seaweeds are currently expensive 
(Jönsson et al., 2020). 
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Dietary intake of seaweeds has been associated with the reduced risk of non-
communicable diseases, owing to the bioactivity of biomolecules present in the 
food matrix, such as complex polysaccharides, proteins, polyphenols, and 
polyunsaturated fatty acids (Brown et al., 2014; Peñalver et al., 2020). This has 
generated significant interest in the use of seaweeds as functional food ingredients 
(Peñalver et al., 2020), where functional foods are defined as a food which “is 
satisfactorily demonstrated to affect beneficially one or more target functions in 
the body, beyond adequate nutritional effects in a way that is relevant to either an 
improved state of health and well-being and/or reduction of risk of disease” 
(Diplock et al., 1999).  
Chapter 2 of this thesis evaluated the nutritional composition of seaweeds and 
explored the current evidence from studies which have investigated how dietary 
intake of seaweeds and seaweed phytochemicals may impact host physiology to 
benefit health. It is well established that seaweeds can provide a meaningful 
contribution to nutritional intakes of micronutrients including vitamins and 
minerals, and certain macronutrients including dietary fibre and protein, albeit this 
is highly variable between seaweed sources (Bouga and Combet, 2015; Brown et 
al., 2014; MacArtain et al., 2007). This literature review summarised the evidence 
relating to the health benefits of seaweed beyond the provision of essential 
nutrients and demonstrated where these benefits are supported by pre-clinical 
studies, particularly in the context of individual seaweed components benefiting 
cardiometabolic health. For instance, there is evidence to suggest that fucoidan 
and alginate polysaccharides have anti-obesogenic properties; polyphenols may 
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positively impact glucose homeostasis and lipid digestion/metabolism; and 
polyunsaturated fatty acids may exert anti-inflammatory and anti-obesity effects.  
This literature review also concluded that the number of human intervention 
studies with appropriate health related endpoints is scarce and moreover, that the 
variable and potentially high concentrations of salt, iodine, and arsenic contents in 
seaweeds can limit the portion size an individual can consume. Thus, the extraction 
and isolation of bioactive components from seaweeds represents an opportunity 
to create value-added functional food ingredients, while mitigating excessive trace 
element intakes. Hence the reason for mineral and trace element analysis of the 
seaweed powders and polysaccharide-rich extracts generated for the experiments 
contained within this thesis.   
The evidence presented in Chapter 3 highlights the range of polysaccharides 
present in seaweeds, such as alginate, fucoidan, and laminarin in brown seaweeds; 
agar, carrageenan, porphyran, and xylan in red seaweeds; and ulvan in green 
seaweeds. The findings indicated that the human gut microbiome does express 
some carbohydrate active enzymes (CAZymes) which can break down seaweed 
polysaccharides to facilitate fermentation. This literature review also indicated that 
the most promising prebiotic candidates were alginate, laminarin, and red 
seaweed galactans, owing to more evidence showing that their polysaccharides 
and oligosaccharides elicited favourable changes to microbiota composition and 
metabolic output. Nevertheless, there were also knowledge gaps identified in this 
literature review, including the lack of human studies that have investigated 
dietary interventions with seaweed polysaccharides as putative functional food 
ingredients.  
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Another outcome of this literature review was that experiments are needed to 
understand the structure-function relationships of the fermentation of seaweed 
polysaccharides, owing to variability in seaweed polysaccharide structure and 
differential effects on gut bacterial composition and metabolic output (typically 
SCFA concentration). Therefore, the seaweed powders and polysaccharide extracts 
generated for this thesis were obtained from seaweeds at the same geographical 
location, time of year, and were extracted using the same method. Furthermore, 
attempts were made to characterise the molecular weight and polysaccharide 
contents of the crude polysaccharide-rich extracts, to explain which components 
were fermented, if any.   
The data obtained in Chapter 4 showed that the brown seaweeds Fucus vesiculosus 
and Laminaria digitata contained fermentable components, owing to significantly 
higher concentrations of short chain fatty acids when compared to the poorly 
fermented negative control cellulose. This suggests that there were bacterial 
communities present in the ex vivo faecal microbiota that expressed CAZYmes that 
could break down the constituent polysaccharides present e.g. alginate, fucoidan, 
and laminarin. This is supported, in part, by the data obtained in Chapter 6, which 
showed that the fermentation of laminarin and alginate polysaccharides yielded 
significantly higher concentrations of propionic acid and butyric acid, respectively.  
Although fucoidan showed limited fermentability (Chapter 6), there may be scope 
to investigate higher doses of substrate and the structure-function effects on the 
fermentability of fucoidan because there is a dearth of studies which have 
investigated the effects of fucoidan on the gut microbiota (Chapter 3). This is 
surprising given the FDA GRAS status and EU novel food status of fucoidan, 
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alongside the purported anti-obesity effects of dietary intakes of fucoidan (Chapter 
2) and the role of diet-microbe-host interactions on metabolic disease (European 
Commission, 2017; FDA, 2016; Hernandez-Corona et al., 2014; Kim et al., 2014; Lim 
et al., 2017; O’Grady et al., 2019). 
The stimulation of glycan degrading bacterial families such as Bacteroidaceae, 
Ruminococcaceae and Lachnospiraceae in vessels treated with whole brown 
seaweed powders and polysaccharide extracts when compared to cellulose 
supports previous pre-clinical evidence (Choa An et al., 2013; Shang et al., 2016; 
Strain et al., 2019). This is also supported by the data obtained in Chapter 6 which 
demonstrated that purified alginate and laminarin substrates stimulated 
populations of Bacteroides and Lachnospiraceae, respectively. This may be 
explained by the expression of alginate lyase and laminarinase CAZymes present in 
the genome of Bacteoides spp. (Li et al., 2017; Maruyama et al., 2015; Mathieu et 
al., 2018, 2016; Salyers et al., 1977; Thomas et al., 2012). 
Human gut Bacteroides function as primary fermenters to facilitate cross-feeding 
for syntrophic bacteria such as Phascolarctobacterium spp., which convert 
succinate to acetate and propionate (Fischbach and Sonnenburg, 2011; Wu et al., 
2017). Given that Phascolarctobacterium were stimulated by both the FVE and LDE 
substrates in Chapter 4  and were a discriminative genus of Alginate-Fv 
fermentation in Chapter 6, it can be postulated that human gut Bacteroides were 
able to degrade alginate components present in the seaweed and seaweed extract, 
to cross feed for other stimulated genera such as the butyric acid producers 
Pseudobutyrivibrio, Butyricimonas and Coprococcus, which were also increased by 
the Laminaria digitata polysaccharide extract. The concept of cross-feeding was 
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recently suggested for the traditional markers of a prebiotic, since bifidobacteria 
and lactobacilli do not produce butyrate directly, rather acetate and lactate (Scott 
et al., 2013). Thus, the recycling of metabolites facilitates cross-feeding by 
acetate/lactate-consuming butyrate-producing Firmicutes such as Roseburia spp., 
Butyricicoccus spp., Anaerostipes spp., and Faecalibacterium prausnitzii  (Allen-
Vercoe et al., 2012; Eeckhaut et al., 2013; Kant et al., 2015; Miquel et al., 2013).  
Another knowledge gap identified in Chapter 3 showed the paucity of studies 
regarding the fermentability of xylan obtained from the red seaweed Palmaria 
palmata. The data obtained in Chapter 5 indicated that the whole seaweed 
powder contained fermentable components owing to a significantly higher 
concentration of SCFA when compared to cellulose, whereas the polysaccharide 
extract did not. The noted differences can most likely to be explained by the 
combination of components in the whole seaweed matrix provided a range of 
substrates for bacteria when compared to polysaccharide extract alone, an 
observation which was also previously reported for oat bran compared to its 
isolated beta glucans and polyphenols (Kristek et al., 2019). Despite this, 
fermentation of the purified Xylan-Pp substrate investigated in Chapter 6 resulted 
in significantly higher concentrations of acetic, propionic, valeric and total short 
chain fatty acids when compared to cellulose. The difference in effect on SCFA 
observed between the purified xylan and the Palmaria palmata polysaccharide-rich 
extract may be owing to fact that the purified compound was 100% xylan, whereas 
the extract was a mixture of polysaccharide such as cellulose and xylan. This is a 
limitation of using a crude extract that lacked full chemical characterisation, 
although it is envisaged that the low molecular weight carbohydrate, floridoside, 
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was removed from the Palmaria palmata polysaccharide-rich extract during the 
extract production and in vitro simulated digestion.  
Chapter 5 also showed that both the seaweed powder and polysaccharide-rich 
extract of Palmaria palmata stimulated the butyrate-producing genus, 
Butyricimonas, which also occurred with the brown seaweed substrates in Chapter 
4. Furthermore, the Palmaria palmata seaweed powder and polysaccharide-rich 
extract elicited a bifidogenic effect, and in Chapter 6, the purified Xylan-Pp 
substrate also elicited a bifidogenic effect. It may therefore be postulated that 
human gut Bifidobacterium spp. expressed β-(1→3)-xylosidase and α-L-
arabinofuranosidase CAZymes to break down the xylan components in each test 
substrate (Kobayashi et al., 2020).  
The evidence of a bifidogenic effect of xylan from Palmaria palmata is perhaps the 
most novel and impactful finding from this thesis. Given that the stimulation of 
bifidobacteria is a widely accepted indicator of a potential prebiotic, the noted 
changes induced by Palmaria palmata extracts and commercially available xylan 
supports the need for future work to scale up the production of purified xylans and 
xylooligosaccharides from Palmaria palmata to investigate their effects on the gut 
microbiota and host health in vivo. 
Chapter 6 also showed that the green seaweed polysaccharide, ulvan resulted in 
significantly higher concentrations of acetic acid which indicates fermentability. 
This was also shown in another in vitro fermentation study (Seong et al., 2019). 
However, no significant changes in bacterial composition were noted in the 
present study, which is in contrast to the promotion of Bifidobacterium, 
Lactobacillus and Akkermansia muciniphila populations elsewhere (Seong et al., 
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2019; Shang et al., 2018). Given the paucity of studies which have investigated the 
fermentability of ulvan (Chapter 3), further investigation is needed to understand 
whether this green seaweed polysaccharide is fermented by human gut bacterial 
populations given the purported anti-inflammatory effects of dietary intakes of 
ulvan (Ren et al., 2017).  
The use of a single stage closed system batch culture fermentation system in this 
study was useful for screening purposes, owing to its speed and simplicity to use. 
However, the lack of mucus and physiological relevance to the proximal and 
transverse colon present limitations of this model because they do not represent 
the complex gut microbiota ecosystem in vivo (Pham and Mohajeri, 2018). 
Cellulose was selected as the negative control in the experimental chapters of this 
thesis because it is poorly fermented by the human gut microbiota and is not a 
prebiotic (Gibson et al., 2017). While several studies have also used cellulose as a 
negative control (Charoensiddhi et al., 2017, 2016; de Godoy et al., 2015; 
Kaewmanee et al., 2019), it is recognised that a low level of fermentation does 
occur. Therefore, the use of a no substrate control may be a more appropriate 
negative control (Guergoletto et al., 2016). For the data obtained in this thesis, 
statistical analysis compared to the 0 hrs time point for each given substrate would 
be an alternative approach. In future, the use of cellulose as a non-fermentable 
fibre control, alongside a no substrate control, could be optimal (Han et al., 2020; 
Tsitko et al., 2019). 
By 2026, the global commercial seaweed and global prebiotics markets are 
estimated to be worth $85 billion and $8.5 billion, respectively (Ahuja and 
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Mamtani, 2019; Pulidindi and Prakash, 2020). The seaweed industry will be pivotal 
for the development of sustainable global food resources (Kraan, 2013; Mac 
Monagail et al., 2017), while the rapidly developing area of prebiotics has 
implications on human nutrition and health. This has focused on functional food 
ingredients which improve gastrointestinal health, glycaemic control, bone health, 
and improve weight management (Gibson et al., 2017). Therefore, the data 
obtained, and the discussion points raised throughout this thesis, have wider 
implications within two growing commercial markets that require innovation and 
investment. 
 Conclusion 
Extractable seaweed polysaccharide components have been suggested as potential 
value-added ingredients for the blue bioeconomy and functional food industry, 
owing to purported bioactivities of non-digestible carbohydrates and the 
opportunity to mitigate excessive iodine intake associated with consuming 
seaweeds.  
The data obtained from this thesis provides evidence that brown seaweeds and red 
seaweeds contain microbiota accessible components that are fermented by human 
gut microbiota populations to elicit changes to bacterial composition and 
metabolic output. It is postulated that the changes observed were due to the 
presence of alginate and laminarin (brown seaweeds) and xylan (red seaweed, 
Palmaria palmata) polysaccharides. 
Future opportunities should develop commercially viable and low-cost production 
methods to obtain purified seaweed polysaccharides and oligosaccharides, akin to 
marketed terrestrial plant fibre ingredients. This will facilitate in vivo animal studies 
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and dietary human intervention studies to understand the impact of seaweed poly- 
and oligosaccharides on gut microbiota composition and metabolic activity, and to 
understand whether such modulation can confer a benefit to host health. 
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8 Appendix  1 – Experimental materials and methods 
 Chemicals and reagents 
Chemicals were purchased from Sigma Aldrich (USA) unless otherwise stated. 
Reagents used during High Performance Size-Exclusion Chromatography (HPSEC) 
and Gas Chromatography Mass Spectrometry (GC-MS) were HPLC grade. Reagents 
used for DNA extraction, quantitative PCR (qPCR), and 16S rRNA next generation 
sequencing were molecular biology grade. 
 Seaweed fermentation substrates 
 Seaweed harvest 
Fucus vesiculosus, Laminaria digitata, and Palmaria palmata were harvested from 
Spiddal, Co. Galway, Ireland (53° 14' 48" North, 9° 18' 10" West) in September 
2014. Only the leaf was used, and the stipe was removed from the holdfast during 
harvesting. The seaweed was immediately washed in seawater to remove 
contaminants (e.g. epiphytes, molluscs and other seaweeds). Washed seaweed 
was freeze-dried, ground into a fine powder using an electronic blender, and 
stored at -20 °C until required. 
 Polysaccharide-rich extract production 
Fucus vesiculosus, Laminaria digitata, and Palmaria palmata powders were shaken 
independently in dH2O (1:20, w/v) for two mins to reduce the initial salt content of 
the seaweed and then filtered through muslin cloth to remove the water. 30g of 
washed whole seaweeds were immediately freeze-dried and stored for in vitro 
digestion and batch culture fermentation experiments. Seaweed powders were 
then shaken independently in 0.1 M HCl solution (1:10, w/v) at 170 rpm, 60°C for 
three hrs in the Labnet 311DS shaking incubator (Labnet International, New Jersey, 
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USA). The mixture was filtered through muslin cloth and filtrates were centrifuged 
at 3696 RCF for 10 mins to separate additional residue. The extraction protocol was 
then repeated on the residue, giving a total extraction time of six hrs. Filtrate 
supernatant was immediately collected and neutralised using 2 M NaOH to reduce 
the opportunity for depolymerisation. The neutralised aqueous extract was then 
desalinated using the MemBrain P EDR-Z lab-scale electrodialysis unit (MemBrain, 
Czech Republic). Conductivity, as an indicator of salinity, was recorded using the HI-
8733N Conductivity Meter (Hannah Instruments, USA). The reduction of extract 
salinity was recorded as follows: Fucus vesiculosus from 12.22 mS/cm to 1.43 
mS/cm after seven hrs; Laminaria digitata from 18.32 mS/cm to 0.76 mS/cm after 
six hrs; and Palmaria palmata from 17.91 mS/cm to 0.37 mS/cm after 4.5 hrs. 
The neutralised, desalinated, aqueous solution was freeze-dried using the 
FreeZone 12 plus freeze-dry system with stoppering tray dryer (Labconco, USA). 
The resultant powder was precipitated in 96% ethanol (1:5, w/v) and centrifuged at 
3696 RCF for 10 mins. The supernatant was carefully decanted and ethanol 
insoluble precipitates (pellets) were dried in a fume hood overnight to remove 
residual ethanol. Dried pellets were then lyophilised to obtain a polysaccharide-
rich extract powder of Fucus vesiculosus (FVE), Laminaria digitata (LDE), and 
Palmaria palmata (PPE). 
 Individual seaweed polysaccharides 
Fucoidan from Fucus vesiculosus (F5631) and Laminarin from Laminaria digitata 
(L9634) were purchased from Sigma Aldrich. Alginate from Fucus vesiculosus 
(ALG101), Alginate from Laminaria japonica (ALG100), Fucoidan from Ascophyllum 
nodosum (FUC400), Ulvan from Ulva spp. (ULV100), and Xylan from Palmaria 
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palmata (XYL100) were purchased from Elicityl (France). These substrates were 
stored sealed at room temperature until required for in vitro digestion and in vitro 
fermentation experiments.   
 Seaweed extract characterisation 
Average molecular weight of each polysaccharide extract was determined using 
modified methodology from Gómez-Ordónez et al. (Gomez-Ordonez et al., 2012) 
using high performance size exclusion chromatography (HPSEC) at the Institute of 
Technology, Sligo. 50mM ammonium formate was made using Millipore Milli-Q 
Ultrapure water, vacuum-filtered through 0.45µm filter and used for the 
preparation of all solutions and the mobile phase. A pullulan standard set with 
molecular masses of 708, 344, 194, 107, 47.1, 21.7, 10.0, 6.2, 1.32 and 0.34 kDa 
was used to perform system calibration and molecular weight estimation. 
Standards were separately injected at 0.5 mg/mL in 50mM ammonium formate 
buffer in triplicate. A standard calibration curve for the logarithm of the molecular 
weight versus the HPSEC retention time was obtained for each series of standards 
(retention volumes are directly proportional to the logarithm of their relative 
molecular mass). Instrument and chromatographic conditions: The HPLC system 
was equipped with the Dionex Ultimate 3000 pump system and autosampler, 
Varian 385LC Evaporative Light Scattering Detector and Chromeleon control 
software. Separation was performed on a PL aquagel-oh mixed-H 8μm SEC 
analytical column (7.5 x 300 mm i.d) with isocratic elution at 50°C and a flow rate 
of 0.6 mL/min. 10μL of standard or sample (0.5 mg/mL) was injected into the HPLC 
with a run time of 31 mins. 
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Total carbohydrate content of each extract was quantified using a modified 
phenol-sulfuric acid colorimetric assay (DuBois et al., 1956). Extracts were 
dissolved 1:20 (v/v) in dH2O and 25μL liquefied phenol was added, followed by 
2.5mL concentrated sulphuric acid and incubated at room temperature for 20 
mins. Absorbance was measured at 490nm (hexoses) and 480nm (pentoses) and 
concentration was interpreted from a standard curve of glucose and xylose ranging 
from 0.01, 0.02, 0.04, 0.06, 0.08 and 0.1mg/mL. 
Total sulphate content of each seaweed extract was measured using the Azure A 
method described by Torode et al. (Torode et al., 2015) with modifications. 75µL of 
2.5M concentrated H2SO4 was added to 75µL of 2mg/mL seaweed extract followed 
by 1350µL of Azure A solution. Solutions were vortexed briefly and incubated at 
room temperature for 10 mins, where a blue to purple colour change occurred 
following ionic complex formation between anionic sulphated polysaccharides and 
the Azure A cationic dye. Absorbance was then measured at 540nm. Standards of 
0, 0.2, 0.4, 0.6, 0.8 and 1 mg/mL of fucoidan F5631 sulphated polysaccharide was 
used and data was recorded as percentage equivalents of fucoidan.  
Silica-gel thin-layer chromatography (TLC) was used as a qualitative determinant of 
the monosaccharide content of PPE following the methods of Popper and Fry 
(Popper and Fry, 2003). 10mg of PPE was dissolved in 1 ml of 2 M trifluoroacetic 
acid and heated at 120°C for 1 hour to achieve hydrolysis, then centrifuged at 
2000g for 5 mins. 5μL of PPE, and monosaccharide standards consisting of fucose, 
mannose, xylose, glucose, galactose, rhamnose, and arabinose, were added 0.8cm 
apart on the Silica Gel 60 plate stationary phase and allowed to dry. Plates were 
then inserted into a TLC development tank and ran in 500mL of mobile phase 
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consisting of dH2O: butanol: acetic acid (1:3:1, v/v) for 8 hrs. The TLC plate was 
removed and allowed to dry at room temperature. The TLC plate was then stained 
using thymol-sulfuric acid staining (0.5g thymol: 95ml ethanol: 5ml sulphuric acid) 
and left to dry at room temperature before incubation at 70°C for 1 hour. 
Structural information of each seaweed extract was determined using Fourier 
Transform Infrared Spectroscopy (FTIR) using the Bruker Tensor 27 FT-IR 
spectrophotometer (Bruker Corporation, UK). 1-2mg of seaweed extract powder, 
before and after in vitro digestion, was pressed into a disk and the IR spectrum was 
analysed with a scan range of 4000–850 cm−1. Two hundred scans were taken with 
4 cm−1 resolution with an aperture of 3mm. Background reads were taken before 
the sample. Atmospheric manipulation was incorporated, and vector normalisation 
was complete between 1700cm-1 and 900cm-1 using OPUS 5.5 software.  
 Mineral and trace metal content of whole seaweeds and seaweed 
extracts 
Mineral and trace metal analysis of 1 x 10g of each whole seaweed and seaweed 
extract was outsourced to Advanced Laboratories (USA). Concentrations of 
aluminium, copper, sodium and zinc were determined by inductively coupled 
plasma optical emission spectrometry (ICP-OES). Concentrations of mercury, lead, 
arsenic, and cadmium were determined by inductively coupled plasma mass 
spectrometry (ICP-MS). Iodine concentration was determined using AOAC 932.21. 
 In vitro digestion 
An in vitro simulated digestion was completed on the whole seaweed powders, 
polysaccharide-rich extracts, and purified seaweed polysaccharides, following the 
460 
 
  
method of Minekus et al.  (Minekus et al., 2014), with oral, gastric, and intestinal 
phases of digestion. All simulated fluids were incubated at 37°C before use. Oral 
phase: 30g of whole seaweed powder or polysaccharide-rich extract was 
suspended in 21ml of Simulated Salivary Fluid (SSF), pH 7.0 (15.1mM KCl; 3.7mM 
KH2PO4; 13.6mM NaHCO3; 0.15mM MgCl2(H2O)6; 0.06mM (NH4)2CO3). 150μL of 
0.15M calcium chloride stock and 5.85ml H2O were added and the warmed to 
37°C. 3ml of 750 U/ml human salivary α-amylase stock solution was warmed to 
37°C and added to the product suspension to achieve a final concentration of 75 
U/ml. The suspension was incubated for 2 mins at 37°C in an orbital shaker (160 
rpm). Gastric phase: 22.5ml of Simulated Gastric Fluid (SGF) (6.9mM KCl; 0.9mM 
KH2PO4; 25mM NaHCO3; 47.2mM NaCl; 0.1mM MgCl2(H2O)6; 0.5mM (NH4)2CO3 and 
adjusted to pH 3.0 with 2M HCl) was added to the oral suspension, followed by 
2.085ml of H2O, 0.6ml of 1M HCl (to achieve a pH of 3) and 15μL of 0.15M calcium 
chloride. 4.8ml of a 25000 U/ml porcine pepsin stock solution was warmed to 37°C 
and added to the suspension to achieve a final concentration of 2000 U/ml. The 
final gastric suspension was incubated in an orbital shaker (160 rpm) for 2 hrs at 
37°C. 450μL of 1M NaOH was added to the gastric chyme suspension to obtain pH 
7.0. 33ml of Simulated Intestinal Fluid (SIF) (6.8mM KCl ; 0.8mM KH2PO4; 85mM 
NaHCO3; 38.4mM NaCl; 0.33mM MgCl2(H2O)6 and adjusted to pH 7.0 with 2M HCl) 
was added, followed by 7.5ml of a 160mM porcine bile extract stock solution to 
achieve a final concentration of 10mM. 15ml of an 800 U/ml porcine pancreatin 
stock solution was added to achieve a final concentration of 100 U/ml. The final 
intestinal suspension was incubated in an orbital shaker (160 rpm) for 2 hrs at 
37°C. The intestinal phase digesta was dialysed for 24 hrs using 1kDa dialysis tubing 
to mimic intestinal absorption (Spectrum Labs, USA) and the retentate was freeze 
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dried (Labconco, USA) to obtain powders prior to batch culture fermentation. The 
in vitro digestion of purified seaweed polysaccharides method was scaled down for 
1g starting mass. 
 Batch culture fermentation experiments 
 Preparation of human faecal inoculums 
A 20% faecal slurry was prepared following the methods of O’Donnell et al. 
(O’Donnell et al., 2016), where 400g faeces were collected from six healthy human 
subjects with no autoimmune or allergic diseases and no antibiotics for the 
previous 6 months. Samples were processed within four hrs of collection and 
placed into large stomacher bags in a dedicated anaerobic biological cabinet under 
nitrogen gas. 400mL of 50mM sterile phosphate buffered saline was added to the 
stomacher bag and the slurry was homogenized. The slurry was then centrifuged at 
3696 RCF for 25 mins in a Sorvall SLA-3000 rotor and resuspended to 400ml in PBS. 
The resulting faecal bacteria suspension was amended with sterile glycerol to a 
final concentration of 25% (v/v) and stored frozen at -80°C.  
 Preparation of basal media  
Nutrient basal medium stock solution was prepared using methodology of Fooks 
and Gibson (Fooks and Gibson, 2003). Reagents (mg/L): Tryptone Water = 2,000; 
Yeast Extract = 2,000; Cysteine HCl = 1,000; Bile Salts = 500; Candidate 
carbohydrate = 10,000; Tween 80 = 2mL; Hemin = 50 (dissolved in 3 drops of 1M 
NaOH); Vitamin K1 = 10μL; Antifoam = 200μL; NaCl = 100; KH2PO4 = 40; K2HPO4 = 
40; CaCl2.6H2O = 40; MgSO4.7H2O = 10; and NaHCO3 = 2,000. The media was 
sterilised using an autoclave (121°C for 15 mins) after production.  
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 in vitro batch culture fermentation: individual seaweed polysaccharides 
Digested, freeze-dried, seaweed polysaccharide powders underwent in vitro batch 
culture faecal fermentation using the MicroMatrix bioreactor with a 24-square well 
cassette (Applikon Biotechnology, The Netherlands) (O’Donnell et al., 2018). 
Synergy 1 (Beneo, Germany) was used as a positive control (n=8) and cellulose was 
used as a negative control (n=8). Seaweed polysaccharides were fermented in 
quadruplicate. Cassette preparation and sampling took place in an anaerobic 
cabinet under N2 gas. Slurry was thawed at 37°C in an anaerobic cabinet prior to 
inoculation. Well preparation: 6.65ml media was added to each well of the 
cassette and faecal slurry was seeded at 5% (v/v). 2ml was removed from each well 
to provide a 0 hrs sample, before adding a carbon source at 1% (w/v) to the final 
5ml volume. The cassette was sealed within the anaerobic cabinet and transferred 
to the MicroMatrix bioreactor workstation. The MicroMatrix bioreactor was 
operated using MicroMatrix Human Machine Interface software (Applikon 
Biotechnology, The Netherlands), with the following parameters measured and 
controlled throughout: orbiter speed (250 rpm), pH 6.8 (liquid addition of 4M 
NaOH), temperature (37°C), dissolved oxygen control (individually controlled gas 
addition of N2 and CO2). The bioreactor was switched off after 24 hrs of 
fermentation and the cassette was transferred to an anaerobic cabinet to take the 
24 hrs samples. Samples were immediately centrifuged at 21,382 RCF to provide 
samples for DNA extraction (pellet) and SCFA analysis (supernatant). All samples 
were stored at -80°C until analysis. 
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 in vitro batch culture fermentation: whole seaweeds and seaweed 
extracts 
In vitro batch culture fermentation was performed using the Multifors parallel 
bioreactor with Iris 6.0 software (Infors HT, Switzerland). 2g of either FVWS, FVE, 
LDWS, LDE, PPWS, PPE, Cellulose (negative control), or Synergy 1 (positive control) 
was added to 190 ml nutrient basal medium stock solution (final carbohydrate 
concentration = 1% w/v). Vessels were sparged with N2 gas for 2 hrs (2 psi) before 
inoculation with 10ml of 20% faecal slurry (previously thawed at 37°C). Vessels 
were stirred at 200 revolutions min-1, maintained at pH 6.8 and 37°C. Samples were 
taken at 0, 5, 10, 24, 36 and 48 hrs. Samples were immediately centrifuged at 
21,382 RCF to provide samples for DNA extraction (pellet) and SCFA analysis 
(supernatant). All samples were stored at -80°C until analysis.stored at-80°C for 
future analysis. During the Palmaria palmata red seaweed experiment, 100 μL 
fermentation media was taken for bacterial culture before centrifugation. 
 Culture-dependent analysis 
Culture-dependent analysis was performed for the whole seaweed and seaweed 
extract fermentation of Palmaria palmata only. 100 μL of fermentation vessel 
sample was serially diluted in maximum recovery diluent (MRD) (101 - 105) and 
dilutions were plated in triplicate on MRS Agar selective for Bifidobacterium (sterile 
filtered with 5ml/100ml Mupirocin and 1ml/100ml Nystatin) and LBS Agar selective 
for Lactobacillus (sterile filtered with 1ml/100ml Nystatin). Cultures were 
incubated at 37°C for 72 hrs before counting. LBS plates were incubated in 
anaerobic jars with Anaerocult® A (Merck Millipore, USA) gas packs in a 37°C 
incubator. MRS plates were incubated for 72 hrs at 37°C in an anaerobic biological 
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cabinet under N2 gas. Counting was performed using the Stuart Digital Colony 
Counter (Cole-Parmer, UK). Counts were corrected for each dilution factor and 
then calculated as log10 CFU/mL. Statistical analysis was performed using IBM SPSS 
Statistics (version 24) and GraphPad Prism 8 software. Graphs were made in 
GraphPad Prism 8 software. Statistical significance was determined using a non-
parametric Kruskal-Wallis test (p value) with a Benjamini and Hochberg false 
discovery rate (FDR) correction for multiple comparisons (q value) and a 
significance level of 0.05.  
 DNA extraction 
Genomic DNA was extracted from fermentation vessel media using the PowerFecal 
DNA extraction kit (Mo Bio Laboratories, Carlsbad, USA) according to 
manufactures’ instructions. The bead beating step was completed using the Mo Bio 
vortex adapter. For the whole seaweed and seaweed extract fermentation 
experiments, DNA was extracted from samples obtained at 0, 5, 10, 24, 36, and 48 
hrs fermentation. For the purified seaweed polysaccharide fermentation 
experiment, DNA was extracted from samples at 0 and 24 hrs fermentation. 
 Quantitative PCR  
Total Bacteria, Lactobacillus, and Bifidobacterium were quantified using qPCR. 
Standards of 1010 CFU/ml of Total Bacteria, Lactobacillus, and Bifidobacterium were 
kindly provided by Dr. Michelle O’Donnell (Teagasc Food Research Centre 
Moorepark, Ireland). Standards were originally generated via DNA extraction from 
E. coli for total bacteria; from Lactobacillus ruminis for Lactobacillus spp.; and from 
Bifidobacterium lactis Bb12 for Bifidobacterium spp., followed by amplification of 
the 16S target region and cloning of each fragment into E.coli TOP 10 chemically 
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competent cells using the TOPO TA Cloning Kit according to the manufacturer’s 
instructions (Thermo Scientific, USA). Plasmid extraction was completed using the 
QIAprepSpin Miniprep Kit (Qiagen, USA) following the manufacturer’s protocol. 
The obtained plasmid DNA was then digested using the Xbal restriction enzymes 
and restriction digest products were purified using the QIAquick PCR Purification 
Kit (Qiagen, USA). Dilutions of the linearised plasmid (1:5, 1:10, and 1:20) were 
then quantified using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, 
USA) and used to calculate the molecular weights of PCR products. Copies of the 
linearised plasmids were calculated as copies/µl and working stocks of each 
standard were prepared with 1x1010 copies/µl.  
The below calculation was then applied to generate the gene copy numbers for 
standards. Colony forming units (CFU) were calculated from the copy number 
results from each qPCR reaction using the following formula: 
[(C/µl)(TV) x (T cfu/ml)]/TCN = [cfu/ml(S)]/1. 
C/µl = Copy number/µl 
TV = Template volume 
TC = Total copy number of the standard used 
T cfu/ml = Total cfu/ml of standard used  
cfu/ml(S) = cfu/ml of test sample 
 
Primer sequences used for qPCR (Target: Forward primer 5'-3'; Reverse primer 5'-
3'; Size bp; Tm °C): Total Bacteria (Eubacterial): ACTCCTACGGGAGGCAGCAG; 
ATTACCGCGGCTGCTGG; 200 bp; 60°C. Lactobacillus genus: 
GCAGCAGTAGGGAATCTTCCA; GCATTYCACCGCTACACATG; 349 bp; 60°C. 
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Bifidobacterium genus: CTCCTGGAAACGGGTGGT; GCTGCCTCCCGTAGGAGT; 203 
bp; 60°C. 
A standard curve of 109-103 CFU/ml was prepared in duplicate for each plate. The 
following PCR master mix was prepared: Forward primer = 0.1µl/sample; reverse 
primer = 0.1µl/sample; SYBR® FAST pPCR Master Mix (KAPA Biosystems, USA) = 
5µl/sample; PCR water = 3.8µl/sample. 1 µl of sample DNA was added to 9 µl 
mastermix per well (reaction volume = 10 µl). The negative control was prepared 
using 1 µl PCR water. Each sample was run in duplicate on two plates (n=4). Plates 
were sealed and centrifuged at 1000 RCF for 30 seconds and loaded on to 
Lightcycler® 480 Instrument II (Roche, Switzerland). The PCR conditions were 
denaturation = 1 cycle; amplification = 40 cycles; melting = 1 cycle; cooling = 1 
cycle. Target temperature was 95°C with a hold time of 3 min and a ramp rate of 
4.4°C/sec. Statistical analysis was performed using IBM SPSS Statistics (version 24) 
and GraphPad Prism 8 software. Graphs were made in GraphPad Prism 8 software. 
Statistical significance was determined using a non-parametric Kruskal-Wallis test 
(p value) with a Benjamini and Hochberg false discovery rate (FDR) correction for 
multiple comparisons (q value) and a significance level of q ≤ 0.05. 
 16S rRNA amplification and MiSeq sequencing 
Illumina MiSeq sequencing library preparation was completed following the 16S 
metagenomic sequencing library protocol (Illumina, USA) and Fouhy et al. (Fouhy 
et al., 2015). Amplicon PCR: Genomic DNA was amplified using primers specific to 
the V3-V4 hypervariable region of the 16S ribosomal RNA gene to create a 460bp 
amplicon. These primers also incorporated the Illumina overhang adaptor   
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(Forward primer 5’  
 TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG; 
reverse primer 5’  
 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC). 
Each PCR reaction contained 2.5 μL template DNA, 5 µL forward primer (1 µM), 5 
µL reverse primer (1 µM), 12.5 µL 2X Kapa HiFi Hotstart ready mix (KAPA 
Biosystems, USA) - 25µL final reaction volume. PCR amplification was carried out 
using the Applied Biosystems 2720 thermal cycler (Life Technologies, USA) with the 
following parameters: heated lid 110°, 95°C for 3 mins; then 25 cycles of: 95°C for 
30 secs, 55°C for 30 secs, 72°C for 30 secs; hold at 72°C for 5 mins; hold at 4°C. A 3 
µl sample of each PCR reaction was mixed with 5 µl of 6x DNA loading buffer 
(Bioline, UK), and loaded onto a 1.5% agarose gel (1X TAE buffer) with 2 µl of 
Midori green added. 5 µl of 100bp hyperladder (Bioline, UK) was used to check 
DNA bands. Gel electrophoresis was run for 30 mins at 100V and visualised with a 
UV filter. 
Successful PCR products were removed of free dNTPs, salts, Taq and primers PCR 
products using Agentcourt AMPure XP kit (Beckman Coulter Genomics, UK). Using 
a multichannel pipette, 20 µl of homogenised room temperature XP bead solution 
was added to each well and pipetted up and down 20 times to ensure complete 
mixing. The samples were then incubated at room temperature for 5 mins before 
being placed on a 96 well magnetic plate stand (Life technologies, Carlsbad, USA) 
for 2 mins to allow the supernatant to clear. Using a multichannel pipette, the 
supernatant was carefully aspirated out and discarded. A series of 2 washes was 
carried out by adding, incubating for 30 seconds, and then removing 200 µl of 80% 
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ethanol. The plate was air dried at room temperature for 10 mins. The PCR plate 
was then removed from the magnetic stand. Using a multichannel pipette, the 
beads were re-suspended in 52.5 µl of 10mM Tris (pH 8.5). The PCR plate was 
placed back onto the magnetic stand for 2 mins and 50 µl of the cleaned sample 
was transferred into a new PCR plate. 
A second PCR reaction was completed on 5 µL of the purified DNA to attach dual 
indices and Illumina sequencing adapters onto the amplicons, using the Nextera XT 
Index kit (Illumina, USA). Each PCR reaction contained 5 µl index 1 primer (N7xx), 5 
µl index 2 primer (S5xx), 25 µl 2x Kapa HiFi Hot Start Ready mix, and 10 µl PCR 
grade water. PCR conditions were as described above, with only 8 amplification 
cycles. PCR products were visualised and cleaned as described above. 
The DNA concentration of each sample was determined using the Qubit High 
Sensitivity DNA kit and the Qubit 3 Fluorometer (Invitrogen, USA). DNA samples 
were then pooled to an equimolar mix following Illumina guidelines. A final clean-
up was conducted on the equimolar mix using 600 µl (1:1) AMPure XP bead 
solution (Beckman Coulter Genomics, UK) and incubated at room temperature for 
5 mins and placed on a magnetic stand for 10 mins. The supernatant was aspirated 
off and discarded. The bound beads were washed twice by adding 200 µl of 80% 
ethanol. Ethanol was removed by aspiration after incubated for 30 seconds and the 
tubes were air dried at room temperature for 10 mins. The tube was removed from 
the magnetic stand and the beads were re-suspended in 25 µl of 10mM Tris pH 8.5. 
The tube was placed back on the magnetic stand and incubated for 5 mins. 25 µl of 
the supernatant was removed and transferred to a new 1.5ml microtube and 
stored at -20°C until pre-sequencing steps were carried out.  
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The Agilent Bioanalyser (Agilent Technologies, USA) was used for quality control 
before sequencing, then samples were sequenced on the MiSeq sequencing 
platform (Teagasc Food Research Centre Moorepark, Cork, Ireland), using a 2 x 250 
cycle kit, following standard Illumina sequencing protocols. 
 Bioinformatics and statistical analysis 
Two hundred and fifty base pair paired-end reads were assembled using FLASH 
(FLASH: fast length adjustment of short reads to improve genome assemblies). 
Further processing of paired-end reads including quality filtering based on a quality 
score of > 25 and removal of mismatched barcodes and sequences below length 
thresholds was completed using QIIME (Caporaso et al., 2010). Denoising, chimera 
detection and clustering into operational taxonomic units (OTUs) (97% identity) 
were performed using USEARCH v7 (64-bit) (Edgar, 2010). OTUs were aligned using 
PyNAST (PyNAST: python nearest alignment space termination; a flexible tool for 
aligning sequences to a template alignment) and taxonomy was assigned using 
BLAST against the SILVA SSURef database release v123. 
Statistical analysis of 16S rRNA amplicon sequencing data was carried out using 
Calypso online software (version 8.68) (Zakrzewski et al., 2017). Data were 
normalized using cumulative sum scaling and log2 transformed to account for the 
non-normal distribution of sequencing data (Paulson et al., 2013). Up to 20,000 
taxa with > 0.01% abundance were used in the analysis. Chloroplasts and 
cyanobacteria were removed from the analysis.  
Alpha diversity was determined using rarefied Chao1, Evenness, Shannon and 
Simpson indices. Statistical significance was determined using a non-parametric 
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Kruskal-Wallis test (p-value) with a Benjamini and Hochberg false discovery rate 
(FDR) correction for multiple comparisons (q value). Beta diversity was determined 
Bray-Curtis dissimilarity distance matrices for each fermentation substrate and 
cellulose at a given time point. A Permutational multivariate analysis of variance 
(PerMANOVA) was used to determine the statistical difference between Bray–
Curtis dissimilarity indices of beta diversity. 
Statistical significance of mean bacterial relative abundances, compared to 
cellulose, at the phylum, family, and genus level after 0, 10, and 24 hrs 
fermentation was determined using a one-way ANOVA with a Tukey’s post-hoc test 
for multiple comparisons and a significance level of p ≤ 0.05. Discriminate taxa 
between fermentation substrates and cellulose at a given time point were 
identified using linear discriminant analysis (LDA) effect size (LEfSe) (Segata et al., 
2011). 
 Short chain fatty acid and branched chain fatty acid analysis  
The concentration of short chain fatty acids and branched chain fatty acids in 
fermentation vessel media supernatants was analysed using gas chromatography-
mass spectrometry (GC-MS) using a modified protocol described by Garcia-Villalba 
et al. (Garcia-Villalba et al., 2012). Phosphoric acid was added to samples to a final 
concentration of 0.5% (v/v) and vortexed to homogenise for 30 seconds. Samples 
were then centrifuged at 21,382 RCF for 10 mins and the supernatant was filtered 
through 0.2µm filters. 1ml of ethyl acetate was added to 1ml filtered supernatant 
(1:1 ratio of extractant solvent to sample matrix), vortexed to homogenise, and a 
minimum period of 2 mins was used for extraction (until clear phase separation 
was observed). Samples were centrifuged at 21,382 RCF for 10 mins, and 600µl of 
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the organic phase (upper layer) was removed. 180µl of the organic phase was 
added to a GC vial, alongside 20µl internal standard (4-methyl valerate). A standard 
curve of 10, 20, 50, 100, 500, 1000, 5000, 10000, 50000, and 100,000 µM SCFA mix, 
containing acetic acid, propionic acid, n-butyric acid, i-butyric acid, valeric acid, i-
valeric acid, and hexanoic acid was ran within every sample batch. Ethyl acetate 
blanks were run after every six vials, and in between each standard vial/QC to 
prevent carryover.  
The GC-MS system consisted of an Agilent 6890N (Agilent Technologies, USA), 
equipped with an Agilent 7683 AutoSampler and 7683B injector, coupled to an 
Agilent 5973 inert mass selective detector. Agilent MassHunter GC/MS Acquisition 
software was used. The GC was fitted with a DB-WAXetr capillary column (30m 
length, 0.25mm i.d, 0.25µm film thickness), with helium used as the carrier gas 
(1.2mL/min). Injections were made in splitless mode with an injection volume of 
1µL (10 µL syringe) and an injection temperature of 250°C. The syringe undertook 
four pre-washes and four post-washes in hexane. Sample skim depth was 3mm and 
four sample pre-washes and five sample pumps were completed. A glass liner with 
a glass wool plug at the end of the liner was used to avoid contamination of the GC 
column with non-volatile materials from faecal fermentations. An ethyl acetate 
blank was run every 6 samples. An autotune and tune evaluation was completed to 
check the amount of H2O, N2, O2, CO2 in the system. The initial column 
temperature was 90°C, then increased to 150°C at 15°C/min, then to 170°C at 
5°C/min, then to 230°C at 20°C/min, which was maintained for 2 mins. Total run 
time was 14 mins. Solvent delay was 2.5 mins. The detector was operated in 
electron impact ionisation mode. Statistical analysis was performed using IBM SPSS 
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Statistics (version 24). A one-way ANOVA with a Tukey’s post-hoc test to adjust for 
multiple comparisons was used with a significance level of p ≤ 0.05 for whole 
seaweed and seaweed extract experiments. A non-parametric Kruskal-Wallis test 
(p value) with a Benjamini and Hochberg false discovery rate (FDR) correction for 
multiple comparisons (q value) was used for the individual polysaccharide 
experiment with a significance level of q ≤ 0.05. 
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9 Appendix  2 – CPD Activities  
 Conferences 
- Irish Plant Scientists’ Association 11th – 12th May 2015 (oral) 
- NutraMara Conference, 29th – 30th June 2015 (poster) 
- The Nutrition Society Spring Meeting, 21st – 22nd March 2016 (poster) 
- ISAPP Students and Fellows Association, 27th – 29th June 2017 (poster) 
- The Nutrition Society Student Conference, 7th – 8th September 2017 (oral) 
 Voluntary  
- Student Representative, The British Phycological Society, 2015 – 2017 
- Early Career Symposium Committee, The Physiological Society, 2016 
- Treasurer/Secretary, ISAPP Students and Fellows Association, 2016 – 2018 
